0001213900-24-043520.txt : 20240515 0001213900-24-043520.hdr.sgml : 20240515 20240515153623 ACCESSION NUMBER: 0001213900-24-043520 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Complete Solaria, Inc. CENTRAL INDEX KEY: 0001838987 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40117 FILM NUMBER: 24949823 BUSINESS ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: (212) 618-1798 MAIL ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 FORMER COMPANY: FORMER CONFORMED NAME: Freedom Acquisition I Corp. DATE OF NAME CHANGE: 20210105 10-Q 1 ea0205629-10q_complete.htm QUARTERLY REPORT

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period         from        to

 

Commission file number 001-40117

 

COMPLETE SOLARIA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   93-2279786
(State or Other Jurisdiction of
Incorporation or Organization)
   (I.R.S. Employer
Identification Number)

 

45700 Northport Loop East, Fremont, CA 94538

(Address of Principal Executive Offices) (Zip Code)

 

(510) 270-2507

‎(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange
on Which Registered
Common stock, par value $0.0001 per share   CSLR   Nasdaq
         
Redeemable warrants, each whole warrant exercisable for one common stock   CSLRW   Nasdaq 

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ‎Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), ‎and (2) has been subject to such filing requirements for the past 90 days‎ Yes No

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted ‎pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the ‎Registrant was required to submit such files).‎ Yes No

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller ‎reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller ‎reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.‎

  

Large accelerated filer Accelerated filer
Non-accelerated filer  Smaller reporting company  
    Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for ‎complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.‎

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of ‎the Act).‎‎ Yes No

 

As of May 13, 2024, 49,096,537 shares of common stock, par value $0.0001 per share, were issued and outstanding.

 

 

 

 

 

 

COMPLETE SOLARIA, INC. AND SUBSIDIARIES

 

TABLE OF CONTENTS

 

    PAGES
  Special Note Regarding Forward-Looking Statements ii
  Summary Risk Factors iii
PART I. FINANCIAL INFORMATION 1
Item 1. Financial Statements 1
  Unaudited Condensed Consolidated Balance Sheets 1
  Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) 2
  Unaudited Condensed Consolidated Statements Stockholders’ Deficit 3
  Unaudited Condensed Consolidated Statements of Cash Flows 4
  Notes to Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 33
Item 3. Quantitative and Qualitative Disclosures about Market Risk 45
Item 4. Controls and Procedures 45
     
PART II. OTHER INFORMATION 47
Item 1. Legal Proceedings 47
Item 1A. Risk Factors 47
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 72
Item 3. Defaults Upon Senior Securities 72
Item 4. Mine Safety Disclosures 72
Item 5. Other Information 72
Item 6. Exhibits 72
Signatures 73

 

i

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this Quarterly Report on Form 10-Q may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our and our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

 

our ability to recognize the anticipated benefits of the Business Combination (as defined below), which may be affected by, among other things, competition and our ability to grow and manage growth profitably following the closing of the Business Combination;

 

our financial and business performance following the Business Combination, including financial projections and business metrics;

 

changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;

 

our ability to meet the expectations of new and current customers, and our ability to achieve market acceptance for our products;

 

our expectations and forecasts with respect to market opportunity and market growth;

 

the ability of our products and services to meet customers’ compliance and regulatory needs;

 

our ability to attract and retain qualified employees and management;

 

our ability to develop and maintain its brand and reputation;

 

developments and projections relating to our competitors and industry;

 

changes in general economic and financial conditions, inflationary pressures and the resulting impact demand, and our ability to plan for and respond to the impact of those changes;

 

our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others;

 

our future capital requirements and sources and uses of cash;

 

our ability to obtain funding for its operations and future growth; and

 

our business, expansion plans and opportunities.

 

Actual events or results may differ from those expressed in forward-looking statements. You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

 

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

 

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

ii

 

  

SUMMARY RISK FACTORS

 

Our management has identified conditions that raise substantial doubt about our ability to continue as a going concern.

 

Our business depends in part on the availability of rebates, tax credits and other financial incentives. The expiration, elimination or reduction of these rebates, credits or incentives or the ability to monetize them could adversely impact the business.

 

Existing regulations and policies and changes to these regulations and policies may present technical, regulatory, and economic barriers to the purchase and use of solar power products, which may significantly reduce demand for our products and services.

 

Risks associated with a highly complex global supply chain, including from disruptions, delays, trade tensions, or shortages.

 

We rely on net metering and related policies to offer competitive pricing to customers in many of our current markets and changes to net metering policies may significantly reduce demand for electricity from residential solar energy systems.

 

We utilize a limited number of suppliers of solar panels and other system components to adequately meet anticipated demand for our solar service offerings. Any shortage, delay or component price change from these suppliers or delays and price increases associated with the product transport logistics could result in sales and installation delays, cancellations, and loss of market share.

 

We provide warranties for solar system installations, solar panels, and other system components that may negatively impact overall profitability.

 

We utilize third-party sales and installation partners whose performance could result in sales and installation delays, cancellations, and loss of market share.

 

Risks associated with solar system installation and connection delays, including the potential for recoupment or clawback of payments by financing partners.

 

Due to the general economic environment and any market pressure that would drive down the average selling prices of solar power products, among other factors, we may be unable to generate sufficient cash flows or obtain access to external financing necessary to fund operations and make adequate capital investments as planned.

 

Our business substantially focuses on solar service agreements and transactions with residential customers.

 

We have incurred losses and may be unable to achieve or sustain profitability in the future.

 

Our business is concentrated in certain markets, including California, putting us at risk of region-specific disruptions.

 

We depend on a limited number of customers and sales contracts for a significant portion of revenues, and the loss of any customer or cancellation of any contract may cause significant fluctuations or declines in revenues.

 

  We have identified material weaknesses in our internal controls over financial reporting. If we cannot maintain effective internal controls over financial reporting and disclosure controls and procedures, the accuracy and timeliness of our financial and operating reporting may be adversely affected, and confidence in our operations and disclosures may be lost.

 

iii

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

COMPLETE SOLARIA, INC.

Unaudited Condensed Consolidated Balance Sheets

(in thousands except share and per share amounts)

 

   As of 
   March 31,   December 31, 
   2024   2023 
ASSETS        
Current assets:        
Cash and cash equivalents  $1,786   $2,593 
Accounts receivable, net   20,939    26,281 
Inventories   2,773    3,058 
Prepaid expenses and other current assets   5,776    5,817 
Total current assets   31,274    37,749 
Restricted cash   3,829    3,823 
Property and equipment, net   4,495    4,317 
Operating lease right-of-use assets   1,054    1,235 
Other noncurrent assets   198    198 
Total assets  $40,850   $47,322 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $10,521   $13,122 
Accrued expenses and other current liabilities   24,893    27,870 
Notes payable, net   29,365    28,657 
Deferred revenue, current   2,010    2,423 
Short-term debt with CS Solis   35,840    33,280 
SAFE Agreements   5,000    
-
 
Forward purchase agreement liabilities   9,409    3,831 
Total current liabilities   117,038    109,183 
Warranty provision, noncurrent   3,416    3,416 
Warrant liability   3,877    9,817 
Deferred revenue, noncurrent   1,055    1,055 
Operating lease liabilities, net of current portion   543    664 
Total liabilities   125,929    124,135 
           
Commitments and contingencies (Note 16)   
 
    
 
 
           
Stockholders’ (deficit) equity:          
Common stock, $0.0001 par value; Authorized 1,000,000,000 and 1,000,000,000 shares as of March 31, 2024 and December 31, 2023, respectively; issued and outstanding 49,096,537 and 49,065,361 shares as of March 31, 2024 and December 31, 2023, respectively   7    7 
Additional paid-in capital   279,332    277, 965 
Accumulated other comprehensive loss   98    143 
Accumulated deficit   (364,516)   (354,928)
Total stockholders’ (deficit) equity   (85,079)   (76,813)
Total liabilities and stockholders’ equity  $40,850   $47,322 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

COMPLETE SOLARIA, INC.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(in thousands except share and per share amounts)

 

   Thirteen-Weeks Ended 
   March 31,   April 2, 
   2024   2023 
Revenues  $10,040   $16,677 
Cost of revenues   7,757    13,827 
Gross profit   2,283    2,850 
Operating expenses:          
Sales commissions   3,116    5,677 
Sales and marketing   1,618    683 
General and administrative   5,093    8,913 
Total operating expenses   9,827    15,273 
Loss from continuing operations   (7,544)   (12,423)
Interest expense   (3,568)   (3,611)
Interest income   6    8 
Other income, net   1,519    317 
Total Other expense   (2,043)   (3,286)
Loss from continuing operations before income taxes   (9,587)   (15,709)
Income tax benefit (provision)   (1)   
 
Net loss from continuing operations   (9,588)   (15,709)
Loss from discontinued operations, net of tax   
    (7,805)
Net loss from discontinued operations, net of taxes   
    (7,805)
Net loss   (9,588)   (23,514)
Other Comprehensive (loss) income:          
Foreign currency translation adjustment   (45)   1 
Comprehensive loss (net of tax)  $(9,633)  $(23,513)
Net loss from continuing operations per share attributable to common stockholders, basic and diluted
  $(0.20)  $(0.62)
Net loss from discontinued operations per share attributable to common stockholders, basic and diluted
  $
   $(0.31)
Net loss per share attributable to common stockholders, basic and diluted
  $(0.20)  $(0.93)
Weighted-average shares used to compute net loss per share attributable to common stockholders’, basic and diluted
   49,077,330    25,200,347 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

COMPLETE SOLARIA, INC.

Unaudited Condensed Consolidated Statements of Stockholders’ Deficit

(in thousands except number of shares)

 

   Thirteen-Weeks Ended March 31, 2024 
   Redeemable Convertible
Preferred Stock
   Common Stock   Additional
Paid-in
   Accumulated   Accumulated
Other
Comprehensive
   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Income   Equity 
Balance as of December 31, 2023   
      —
   $
      —
    49,065,361   $7   $277,965   $(354,928)  $143   $(76,813)
Exercise of common stock options       
    31,176    
    26    
    
    26)
Stock-based compensation       
        
    1,341    
    
    1,341 
Net loss       
        
    
    (9,588)   
    (9,588)
Foreign currency translation adjustment       
        
    
    
    (45)   (45)
Balance as of March 31, 2024      $
    49,096,537   $7   $279,332   $(364,516)  $98   $(85,079)

  

   Redeemable Convertible
Preferred Stock
   Common Stock   Additional Paid-in   Accumulated   Accumulated
Other
Comprehensive
   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Income   Equity 
Balance as of December 31, 2022   34,311,133   $155,630    6,959,618   $
   $34,997   $(85,373)  $27   $(50,349)
Retroactive application of recapitalization   (34,311,133)   (155,630)   12,972,811    3    155,627    
    
    155,630 
Balance as of December 31, 2022, as adjusted       
    19,932,429    3    190,624    (85,373)   27    (105,281)
Exercise of common stock options       
    137,452    
    55    
    
    55 
Stock-based compensation       
        
    1,022    
    
    1,022 
Foreign currency translation       
        
    
    
    1    1 
Net loss       
        
    
    (23,514)   
    (23,514)
Balance as of April 2, 2023, as adjusted   
   $
    20,069,881   $3   $191,701   $(108,887)  $28   $82,845 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

COMPLETE SOLARIA, INC.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands except number of shares)

 

   Thirteen- Weeks Ended
March 31,
2024
   Thirteen- Weeks Ended
April 2,
2023
 
Cash flows from operating activities from continuing operations        
Net loss  $(9,588)  $(23,514)
Loss from discontinued operations, net of income taxes   
    (7,805)
Net loss from continuing operations, net of tax   (9,588)   (15,709)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:          
Stock-based compensation expense   1,341    270 
Non-cash interest expense   1,008    1,248 
Non-cash lease expense   181    248 
Depreciation and amortization   357    189 
Provision for credit losses   62    2,117 
Change in reserve for excess and obsolete inventory   (344)   791 
Change in fair value of forward purchase agreement liabilities   5,578    
 
Change in fair value of warrant liabilities   (7,246)   (209)
Accretion of debt in CS Solis   2,560    752 
Changes in operating assets and liabilities:          
Accounts receivable, net   5,280    (3,197)
Inventories   629    (570)
Prepaid expenses and other current assets   41    (1,857)
Other noncurrent assets   
    (848)
Accounts payable   (2,599)   2,132 
Accrued expenses and other current liabilities   (1,613)   (581)
Operating lease liabilities   (180)   (86)
Warranty provision, noncurrent   
    100)
Deferred revenue   (413)   (906)
Net cash used in operating activities from continuing operations   (4,946)   (16,116)
Net cash used in operating activities from discontinued operations   
    (162)
Net cash used in operating activities   (4,946)   (16,278)
Cash flows from investing activities from continuing operations          
Purchase of property and equipment   
    (30)
Capitalization of internal-use software costs   (536)   (457)
Proceeds from sale of property and equipment   
    1 
Net cash used in investing activities from continuing operations   (536)   (486)
Cash flows from financing activities from continuing operations          
Proceeds from issuance of notes payable, net   
    14,102 
Principal repayment of notes payable   (300)   (9,603)
Proceeds from issuance of convertible notes, net of issuance cost   
    11,000 
Proceeds from exercise of common stock options   26    55 
Proceeds from issuance of SAFE agreements   5,000    
 
Net cash provided by financing activities from continuing operations   4,726    15,554 
Effect of exchange rate changes   (45)   1 
Net decrease in cash, cash equivalents and restricted cash   (801)   (1,209)
Cash, cash equivalents, and restricted cash at beginning of period   6,416    8,316 
Cash, cash equivalents, and restricted cash at end of period  $5,615   $7,107 
           
Supplemental disclosures of cash flow information:          
Cash paid during the period for interest  $
   $1,608 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

(1)Organization

 

(a) Description of Business

 

Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”).

 

Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. were transferred to Complete Solar Holdings at their carrying value, and there were no changes to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application.

 

In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.

 

The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”

 

As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT effected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).

 

In connection with the closing of the Mergers:

 

Each share of the Company’s capital stock, inclusive of shares converted from the 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.

 

5

 

 

In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.

 

All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.

 

On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.

 

Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.

 

In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.

 

Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.

 

In November 2022, Complete Solar Holdings acquired Solaria and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. Refer to Note 1(b) – Divestiture and Note 7 – Divestiture.

 

6

 

 

(b) Divestiture

 

In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. As of December 31, 2023, the Company sold all its Maxeon shares and recorded a loss of $4.2 million in its unaudited condensed consolidated statements of operations and comprehensive loss within loss from continuing operations.

 

This divestiture represented a strategic shift in Complete Solaria’s business and qualified as held for sale and as a discontinued operation. Based on the held for sale classification of the assets, the Company reduced the carrying value of the disposal group to its fair value, less its cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive loss for all periods presented. The cash flows related to discontinued operations were segregated from continuing operations within the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 7 – Divestiture for additional information.

 

(c) Liquidity and Going Concern

 

Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $9.6 million and $23.5 million, during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, and had an accumulated deficit of $364.5 million and current debt of $65.2 million as of March 31, 2024. The Company had cash and cash equivalents of $1.8 million as of March 31, 2024. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

 

Management plans to obtain additional funding and restructure its current debt. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.

 

Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.

 

(2)Summary of Significant Accounting Policies

 

(a)Basis of Presentation

 

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the Unites States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

7

 

 

(b)Use of Estimates

 

The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:

 

The allocation of the transaction price to identified performance obligations;

 

Fair value of warrant liabilities;

 

The reserve methodology for inventory obsolescence;

 

The reserve methodology for product warranty;

 

The reserve methodology for the allowance for credit losses;

 

The fair value of the forward purchase agreements; and

 

The measurement of stock-based compensation.

 

To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.

 

(c)Segment Information

 

The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated Company. All the Company’s long-lived assets are maintained in the United States of America.

 

(d)Concentration of Risks

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of March 31, 2024, two customers had an outstanding balance that represented 36% and 19% of the total accounts receivable balance. As of December 31, 2023, two customers had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.

 

8

 

 

Concentration of customers

 

For the thirteen-weeks ended March 31, 2024, one customer represented 76% of gross revenues. For the thirteen-weeks ended and April 2, 2023, three customers represented 29%, 23% and 12% of gross revenues.

 

Concentration of suppliers

 

For the thirteen-weeks ended March 31, 2024, and December 31, 2023, one supplier represented 34% and 40% of the Company’s inventory purchases, respectively.

 

(e)Cash and Cash Equivalents

 

The Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.

 

(f)Restricted Cash

 

The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. The restricted cash balance was $3.8 million at each of March 31, 2024 and December 31, 2023. Restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in its unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Cash and cash equivalents  $1,786   $2,593 
Restricted cash   3,829    3,823 
Total cash, cash equivalents and restricted cash  $5,615   $6,416 

 

(g)Revenue Recognition

 

Disaggregation of revenue

 

Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):

 

   Thirteen-weeks Ended 
   March 31,   April 2, 
   2024   2023 
Solar energy system installations  $9,922   $15,843 
Software enhanced services   118    834 
Total revenue  $10,040   $16,677 

 

All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was in the United States.

 

Remaining performance obligations

 

The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of March 31, 2024, the Company has deferred $1.1 million associated with a long-term service contract. As of December 31, 2023, the Company has deferred $1.2 million associated with a long-term service contract, which will be recognized evenly through 2028.

 

9

 

 

Incremental costs of obtaining customer contracts

 

Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. As of March 31, 2024 and December 31, 2023, deferred commissions were $5.1 million and $4.2 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.

 

Deferred revenue

 

The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within 12-months, the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirteen-week periods ended March 31, 2024 and April 2, 2023 that was included in deferred revenue at the beginning of each period was $1.3 million and $1.9 million, respectively.

 

(h)Fair Value Measurements

 

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.

 

When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

 

Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

 

Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

 

Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

 

Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities, SAFE Agreements and FPA liabilities.

 

The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).

 

10

 

 

The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.

 

(i)Direct Offering Costs

 

Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional paid-in capital and netted against the Mergers proceeds received upon close. As of March 31, 2024 and December 31, 2023, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.

 

(j)Warrant Liabilities

 

The Company accounts for its warrant liabilities in accordance with the guidance in ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 12 – Warrants.

 

(k)Forward Purchase Agreements

 

The Company accounts for its FPAs in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.

 

(l)Net Loss Per Share

 

The Company computes net loss per share following ASC 260, Earnings Per Share. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.

 

(m)Accounting Pronouncements Not Yet Adopted

 

In November 2023, the FASB issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. The Company is currently evaluating ASU 2023-07,but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements. 

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. The Company is currently evaluating ASU 2023-09 but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements.

 

11

 

 

(3)Fair Value Measurements

 

The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):

 

   As of March 31, 2024 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                
Carlyle warrants  $   $   $3,086   $3,086 
Public warrants   437            437 
Private placement warrants       318        318 
Working capital warrants       36        36 
Replacement warrants           5    5 
Forward purchase agreement liabilities           9,409    9,409 
SAFE Agreements           5,000    5,000 
Total  $437   $354   $17,500   $18,291 

 

   As of December 31, 2023 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                    
Carlyle warrants  $
   $
   $9,515   $9,515 
Public warrants   167    
    
    167 
Private placement warrants   
    122    
    122 
Working capital warrants   
    14    
    14 
Replacement warrants   
    
    1,310    1,310 
Forward purchase agreement liabilities   
    
    3,831    3,831 
Total  $167   $136   $14,656   $14,959 

 

12

 

 

 

Carlyle Warrants

 

As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC and its affiliates (“Carlyle”), the Company issued Carlyle a warrant to purchase shares of Complete Solaria Common Stock at a price per share of $0.01. Refer to Note 12 – Warrants for further details. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:

 

   March 31,
2024
   December 31,
2023
 
Expected term   7.0 years    7.0 years 
Expected volatility   77.0%   77.0%
Risk-free interest rate   3.92%   3.92%
Expected dividend yield   0.0%   0.0%

 

Public, Private Placement and Working Capital Warrants

 

The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly-traded instruments.

 

Forward Purchase Agreement Liabilities

 

The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:

 

   March 31,
2024
   December 31,
2023
 
Common stock trading price  $0.59   $1.66 
Simulation period   1.30 years    1.55 years 
Risk-free interest rate   4.90%   4.48%
Volatility   112.0%   95.0%

 

Replacement Warrants

 

   March 31,
2024
   December 31,
2023
 
Expected term  0.8 years   0.3 years 
Expected volatility   78.5%   78.5%
Risk-free interest rate   5.49%   5.4%
Volatility   0.0%   0.0%

 

The Series D-7 redeemable convertible preferred stock warrants were initially accounted for as liabilities and measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 12 – Warrants, the redeemable convertible preferred stock warrants were reclassified to additional paid-in capital upon the closing of the Mergers. In October 2023, in connection with the Assignment and Acceptance Agreement as further described in Note 12 – Warrants, these warrants were replaced (“Replacement Warrants”), and the Replacement Warrants are classified as liabilities. Refer to Note 13 – Borrowings and SAFE Agreements.

 

13

 

 

(4)Reverse Recapitalization

 

As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria was determined to be the accounting acquirer based on an evaluation of the following facts and circumstances:

 

Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post- merged company;

 

Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;

 

Legacy Complete Solaria’s management team is considered the management team of the post-merged company;

 

Legacy Complete Solaria’s prior operations are comprised of the ongoing operations of the post-merged company;

 

Complete Solaria is the larger entity based on historical revenues and business operations; and

 

the post-merged company has assumed Complete Solaria’s operating name.

 

Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The unaudited condensed consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.

 

Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million less non-cash net liabilities assumed from FACT of $10.1 million.

  

Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:

 

   Recapitalization 
FACT Class A Ordinary Shares, outstanding prior to Mergers   34,500,000 
FACT Class B Ordinary Shares, outstanding prior to Mergers   8,625,000 
Bonus shares issued to sponsor   193,976 
Bonus shares issued to PIPE investors   120,000 
Bonus shares issued to FPA investors   150,000 
Shares issued from PIPE financing   1,690,000 
Shares issued from FPA agreements, net of recycled shares   5,558,488 
Less: redemption of FACT Class A Ordinary Shares   (31,041,243)
Total shares from the Mergers and PIPE Financing   19,796,221 
Legacy Complete Solaria shares   20,034,257 
2022 Convertible Note Shares   5,460,075 
Shares of Complete Solaria Common stock immediately after Mergers   45,290,553 

 

14

 

 

In connection with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. The Company did not make any cash payments to settle transaction costs in the thirteen-weeks ended March 31, 2024. As of December 31, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.

 

(5)Forward Purchase Agreements

 

In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).

 

Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.

 

The key terms of the forward contracts are as follows:

 

The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the Seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.

 

The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.

 

The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to the Counterparty at the Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading day-period (the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price.

 

The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815, Derivatives and Hedging, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.

 

Additionally, in accordance with ASC 480, Distinguishing Liabilities from Equity, the Company has determined that the forward contracts are financial instruments other than shares that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the forward purchase liabilities at fair value and has subsequently remeasured them at fair value with changes in fair value recognized in earnings.

 

15

 

 

Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock in association with the FPAs.

 

As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss. Subsequently, the change of fair value of the forward purchase liabilities amounted to an expense of $5.6 million for the thirteen-weeks ended March 31, 2024. As of March 31, 2024, and December 31, 2023, the forward purchase liabilities amounted to $9.4 million and $3.8 million, respectively. Of the balances as of March 31, 2024 and December 31, 2023, $7.9 million and $3.2 million, respectively, are due to related parties Refer to Note 19 – Related Party Transactions for further details.

 

On December 18, 2023, the Company and the FPA Sellers entered into separate amendments to the FPAs (the “Amendments”). The Amendments lower the reset floor price of each FPA from $5.00 to $3.00 and allow the Company to raise up to $10.0 million of equity from existing stockholders without triggering certain anti-dilution provisions contained in the FPAs; provided, the insiders pay a price per share for their initial investment equal to the closing price per share as quoted on the Nasdaq on the day of purchase; provided, further, that any subsequent investments are made at a price per share equal to the greater of (a) the closing price per share as quoted by Nasdaq on the day of the purchase or (b) the amount paid in connection with the initial investment.

 

(6)Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

   As of 
   March 31,
2024
   December 31,
2023
 

Deferred commissions

  $5,098   $4,185 
Inventory deposits   -    616 
Other   678    1,016 
Total prepaid expenses and other current assets  $5,776   $5,817 

 

(7)Divestiture

 

Discontinued operations

 

As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement Disposal Agreement.

 

The components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive loss related to discontinued operations are presented in the table, as follows (in thousands):

 

   Thirteen-Weeks 
   Ended April 2,
2023
 
Revenues  $18,721 
Cost of revenues   19,479 
Gross loss   (758)
Operating expenses:     
Sales and marketing   2,866 
General and administrative   4,185 
Total operating expenses   7,051 
Loss from discontinued operations   (7,809)
Other income (expense), net   
 
Loss from discontinued operations before income taxes   (7,809)
Income tax benefit   4
Net loss from discontinued operations  $(7,805)

 

16

 

 

(8)Property and Equipment, Net

 

Property and equipment, net consists of the following (in thousands, except year data):

 

   Estimated   As of 
     Useful Lives
(Years)
   March 31,
2024
   December 31,
2023
 
Developed software  5   $7,529   $6,993 
Manufacturing equipment  3    131    131 
Furniture and equipment  3    90    96 
Leasehold improvements  5    708    708 
Total property and equipment       8,464    7,928 
Less: accumulated depreciation and amortization               (3,969)   (3,611)
Total property and equipment, net      $4,495   $4,317 

 

Depreciation and amortization expense from continuing operations totaled $0.4 million and $0.2 million for the thirteen-week periods ended March 31, 2024 and April 2, 2023.

 

(9)Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of the following (in thousands):

 

   As of 
   March 31,
2024
   December 31,
2023
 
Accrued compensation and benefits  $3,715   $3,969 
Customer deposits   296    544 
Uninvoiced contract costs   80    671 
           
Accrued term loan and revolving loan amendment and final payment fees   2,400    2,400 
Accrued legal settlements   7,700    7,700 
Accrued taxes   930    931 
Accrued rebates and credits   32    677 
Operating lease liabilities, current   548    607 
Accrued warranty, current   1,449    1,433 
Other accrued liabilities   7,743    8,938 
Total accrued expenses and other current liabilities  $24,893   $27,870 

 

17

 

 

(10)Other Expense, Net

 

Other expense, net consists of the following (in thousands):

 

  

Thirteen-Weeks
Ended

 
   March 31,
2024
   April 2,
2023
 
Change in fair value of redeemable convertible preferred stock warrant liability  $1,305   $209 
Change in fair value of Carlyle warrants   6,429    
 
Change in fair value of FACT public, private placement and working capital warrants   (489)   
 
Change in fair value of forward purchase agreement liabilities(1)   (5,578)   
 
Loss on discontinued Solaria business and other, net   (148)   108 
Total other income (expense), net  $1,519   $317 

 

(1)Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.

 

(11)Common Stock

 

The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of March 31, 2024. No preferred stock has been issued.

 

Common Stock Purchase Agreements

 

On December 18, 2023, the Company entered into separate common stock purchase agreements (the “Purchase Agreements”) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a “Purchaser”, and together, the “Purchasers”). Pursuant to the terms of the Purchase Agreements, each Purchaser purchased 1,838,235 shares of common stock of the Company, par value $0.0001, (the “Shares”), at a price per share of $1.36, representing an aggregate purchase price of $4,999,999.20. The Purchasers paid for the Shares in cash. Thurman J. Rodgers is a trustee of each Purchaser and is the Executive Chairman of the board of directors of the Company.

 

The Company has reserved shares of common stock for issuance related to the following:

 

   As of
March 31,
2024
 
Common stock warrants   27,637,266 
Employee stock purchase plan   2,628,996 
Stock options and RSUs, issued and outstanding   11,436,369 
Stock options and RSUs, authorized for future issuance   3,850,462 
Total shares reserved   45,553,093 

 

18

 

 

(12)Warrants

 

Liability-classified warrants

 

    As of  
    March 31,     December 31,  
    2024     2023  
Carlyle warrants   $ 3,086     $ 9,515  

Replacement warrants

    5       1,310  
Public warrants     437       167  
Private placements warrants     318       122  
Working capital warrants     36       13  
    $ 3,882     $ 11,127  

 

Carlyle Warrants

 

In February 2022, as part of a debt financing from Carlyle (Refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with long-term debt issued to Carlyle (“CS Solis Debt”). The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, expired on December 31, 2022 prior to becoming exercisable. In December 2023, Carlyle was issued an additional warrant to purchase an additional 2,190,604 shares of the Company’s common stock related to an anti-dilution provision within the CS Solis Debt that provides for such additional warrants under such circumstances as provided within the CS Solis Debt.

 

At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and no dividend yield. The fair value of the warrant was initially recorded within additional paid-in capital as it met the conditions for equity classification.

 

In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of December 31, 2023.

 

The modification of the warrant resulted in the reclassification of previously equity-classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718, Compensation – Stock Compensation. The Company recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the pre-modification fair value of the warrants as a reduction to additional paid-in capital of $10.9 million and an expense of $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be $20.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and no dividend yield. As of March 31, 2024, the fair value of the warrant was $3.1 million, and the Company recorded an income of $6.4 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.

 

Series D-7 Warrants (Converted to common stock warrants “Replacement Warrants”)

 

In November 2022, the Company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series D-7 warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers.

 

19

 

 

In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), (Refer to Note 13 – Borrowings and SAFE Agreements). In connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series D-7 warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series D-7 preferred stock converted into warrants to purchase 656,630 shares of common stock, the Replacement Warrants. As a result of the warrant amendment, the Company reclassified the Replacement Warrants from equity to liability. The Replacement Warrants were remeasured to their fair value on the amendment effective date, and the Company has recorded subsequent changes in fair value in other income (expense), net on its unaudited condensed consolidated statements of operations and comprehensive loss. The Replacement Warrants remain outstanding as of March 31, 2024.

 

Public, Private Placement, and Working Capital Warrants

 

In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, the Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the Company’s unaudited condensed consolidated balance sheets.

 

The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.7 million. The fair value of these warrants was $0.8 million as of March 31, 2024, and the Company recorded the change in fair value of $0.5 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.

 

Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of March 31, 2024, the Working Capital warrants had a fair value of $0.03 million, and the Company recorded the change in fair value of $0.02 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.

 

Equity Classified Warrants

 

Series B Warrants (Converted to Common Stock Warrants)

 

In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other non-current liabilities upon issuance. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. Prior to its reclassification from equity to a liability during 2023, the changes in fair value were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023.

 

Series C Warrants (Converted to Common Stock Warrants)

 

In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability and changes in the fair value of the warrant were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock.

 

20

 

 

Series C-1 Warrants (Converted to Common Stock Warrants)

 

In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series C-1 preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

SVB Common Stock Warrants

 

In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of March 31, 2024. At issuance, the relative fair value of the warrants was determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and no dividend yield. The fair value of the warrant was recorded within additional paid-in-capital on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.

 

Promissory Note Common Stock Warrants

 

In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

November 2022 Common Stock Warrants

 

In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying (i) the shares of common stock to be purchased to 31,680, (ii) the exercise price to $0.01, and (iii) the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock.

 

July 2023 Common Stock Warrants

 

In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of the Company’s common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

Warrant Consideration

 

In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional paid-in capital, net of the issuance costs of the Mergers. As of March 31, 2024, all warrants issued as warrant consideration remain outstanding.

 

21

 

 

(13)Borrowings and SAFE Agreements

 

The Company’s borrowings consisted of the following (in thousands):

 

   As of 
   March 31,   December 31, 
   2024   2023 
2018 Bridge Notes  $11,376   $11,031 
Revolver Loan   5,290    5,168 
Secured Credit Facility   12,699    12,158 
Polar Settlement Agreement   
    300 
Total Notes payable   29,365    28,657 
Debt in CS Solis   35,840    33,280 
Total notes payable and convertible notes, net   65,205    61,937 
Less current portion   (65,205)   (61,937)
Notes payable and convertible notes, net of current portion  $
   $
 

 

Notes Payable

 

2018 Bridge Notes

 

In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice the face value of the 2018 Notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria. The 2018 Notes are secured by substantially all of the assets of Complete Solaria.

 

In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023, and the 2018 Notes remain outstanding as of March 31, 2024. In connection with the amendment, the 2018 Notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.

 

The Company concluded that the amendment represented a troubled debt restructuring as the Company was experiencing financial difficulty, and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of March 31, 2024 and December 31, 2023, the carrying value of the 2018 Notes was $11.4 million and $11.0 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.3 million and $0.3 million, respectively. As of March 31, 2024, the carrying value of the 2018 Notes approximates their fair value.

 

Revolver Loan

 

In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).

 

The SCI Loan Agreement is comprised of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination.

 

22

 

 

The Revolving Loan has a term of thirty-six months, with the principal due at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement requires the Company to meet certain financial covenants relating to the maintenance of specified restricted cash balance, achieve specified revenue targets and maintain specified contribution margins (“Financial Covenants”) over the term of the Revolving Loan. The Revolving Loan is collateralized by substantially all assets and property of the Company.

 

In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements with SCI to forbear SCI from exercising any rights and remedies available to it as a result of the Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendments changes were made to the Financial Covenants, and Solaria recorded a total of $1.9 million in amendment fees which amount was recorded in Other Liabilities, and this liability was included in the assumed liabilities for purchase price accounting.

 

Solaria had historically issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria (“SCI Series E-1 warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series E-1 warrants were assumed by the parent company, Complete Solaria.

 

The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting. The Revolving Loan principal balance at March 31, 2024 and December 31, 2023 amounted to $5.3 million and $5.1 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.1 million and $0.1 million, respectively. The Company was in compliance with all the Financial Covenants as of March 31, 2024.

 

In October 2023, the Company entered into an Assignment Agreement whereby Structural Capital Investments III, LP assigned the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, (collectively “Kline Hill”) and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this arrangement as a related party transaction, as discussed in Note 18 – Related Party Transactions. The SCI Revolving Loan continued to remain outstanding as of March 31, 2024 and is currently being renegotiated. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 1 - Subsequent Events for further details.

 

Secured Credit Facility

 

In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC (“Secured Credit Facility”). The Secured Credit Facility agreement allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as collateral. The amounts drawn under the Secured Credit Facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the Secured Credit Facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the Secured Credit Facility agreement was due to mature in April 2023. The Company is in the process of amending the Secured Credit Facility agreement to extend its maturity date.

 

At March 31, 2024, the balance outstanding was $12.7 million, including accrued financing cost of $5.0 million, and as of December 31, 2023, the balance outstanding was $12.2 million, including accrued financing cost of $4.5 million. The Company recognized interest expense of $0.5 million and $1.7 million related to the Secured Credit Facility during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively. As of March 31, 2024, the total estimated fair value of the Secured Credit Facility approximated its carrying value. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 19 - Subsequent Events for further details.

 

Polar Settlement Agreement

 

In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. The settlement agreement required the Company to pay Polar $0.5 million in ten equal monthly installments and did not accrue interest. As of December 31, 2023, the balance owed to Polar was $0.3 million all of which was paid in the period ended March 31, 2024.

 

23

 

 

Debt in CS Solis

 

As part of the Reorganization described in Note 1(a) Organization - Description of Business and Note 12 - Warrants, the Company received cash and recorded debt for an investment by Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment by Carlyle, the Company issued Carlyle a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, the purchase of 4,132,513 shares of the Company’s common stock is immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 11 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units.

 

On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.

 

The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is now March 31, 2024 subsequent to the modification. The acceleration of the redemption date of the investment, resulted in the total redemption amount to be 1.3 times the principal at December 31, 2023. The redemption amount will increase to 1.4 times the original investment at March 31, 2024. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the Company’s unaudited condensed consolidated statements of operations and comprehensive loss.

 

The Company accounted for the modification of the debt due with CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million in the thirteen-week period ended October 1, 2023. As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt with CS Solis. As of March 31, 2024, the debt has a redemption obligation of $35.8 million under the Carlyle Debt Modification Agreement. The debt in CS Solis is currently under negotiation.

 

The Company has recorded a liability of $35.8 million and $33.3 million included in short-term debt with CS Solis on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recorded accretion of the liability as interest expense of $2.5 million and $0.8 million, respectively, and made no payments of interest expense. For the thirteen-week periods ended March 31, 2024 and April 2, 2023 the Company recorded amortization of issuance costs as interest expense of zero and $0.3 million, respectively. As of March 31, 2024, the total estimated fair value of the Company’s debt with CS Solis was $35.8 million, which was estimated based on Level 3 inputs.

 

24

 

 

SAFE Agreements

 

First SAFE

 

On January 31, 2024, the Company entered into a simple agreement for future equity (the “First SAFE”) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the “Purchaser”), a related party, in connection with the Purchaser investing $1.5 million in the Company. The First SAFE does not accrued interest. The First SAFE was initially convertible into shares of the Company’s common stock, par value $0.0001 per share, upon the initial closing of a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company would have issued and sold shares of its common stock at a fixed valuation (an “Equity Financing”), at a per share conversion price which was equal to the lower of (i)(a) $53.54 million divided by (b) the Company’s capitalization immediately prior to such Equity Financing (such conversion price, the “SAFE Price”), and (ii) 80% of the price per share of its common stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the First SAFE, the Purchaser would have been automatically entitled to receive a portion of the proceeds of such liquidity event equal to the greater of (i) $1.5 million and (ii) the amount payable on the number of shares of common stock equal to (a) $1.5 million divided by (b)(1) $53.54 million divided by (2) the Company’s capitalization immediately prior to such liquidity event (the “Liquidity Price”), subject to certain adjustments as set forth in the First SAFE. The First SAFE was convertible into a maximum of 1,431,297 shares of the Company’s common stock, assuming a per share conversion price of $1.05, which is the product of (i) $1.31, the closing price per share of the Company’s common stock on January 31, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the First SAFE which resulted in the First SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.

 

Second SAFE

 

On February 15, 2024, the Company entered into a simple agreement for future equity (the “Second SAFE” and together with the First SAFE, the “SAFEs”) with the Purchaser, a related party, in connection with the Purchaser investing $3.5 million in the Company. The First SAFE does not accrued interest. The Second SAFE was initially convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing at a per share conversion price which was equal to the lower of (i) the SAFE Price, and (ii) 80% of the price per share of Common Stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the Second SAFE, the Purchaser would have been automatically entitled to receive an amount equal to the greater of (i) $3.5 million and (ii) the amount payable on the number of shares of Common Stock equal to $3.5 million divided by the Liquidity Price, subject to certain adjustments as set forth in the Second SAFE. The Second SAFE was convertible into a maximum of 3,707,627 shares of the Company’s common stock, assuming a per share conversion price of $0.94, which is the product of (i) $1.18, the closing per share price of its common stock on February 15, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the Second SAFE which resulted in the conversion of the Second SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.

 

(14)Stock-Based Compensation

 

In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria common stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria common stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s common stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s board of directors prior to the date of the increase. The maximum number of shares of Complete Solaria common stock that may be issued on the exercise of incentive stock options (“ISOs”) under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares).

 

Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction.

 

25

 

 

Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”).

 

A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:

 

    Options Outstanding  
    Number of
Shares
    Weighted Average
Exercise Price per Share
    Weighted Average
Contractual Term (Years)
    Aggregate
Intrinsic Value
(in thousands)
 
Outstanding—December 31, 2023     11,716,646     $ 3.48       8.53     $ 2,756  
Options granted    
––
     
––
                 
Options exercised     (31,176 )     0.83                  
Options canceled     (307,198 )     2.86                  
Outstanding—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and expected to vest—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and exercisable—March 31, 2024     4,536,233     $ 4.38       4.78     $ 139  

 

A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:

 

   Number of RSUs   Weighted
Average
Grant Date
Fair Value
 
Unvested at December 31, 2023   58,097   $2.07 
Granted   
––
   $
––
 
Vested and released   
––
   $
––
 
Cancelled or forfeited   
––
   $
––
 
Unvested at March 31, 2024   58,097   $2.07 

 

26

 

 

Stock-based compensation expense

 

The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):

 

   Thirteen-
Weeks
Ended
   Thirteen-
Weeks
Ended
 
   March 31,
2024
   April 2,
2023
 
Cost of revenues  $27   $11 
Sales and marketing   216    94 
General and administrative   1,098    165 

Total stock-based compensation expense from continuing operations

  $1,341   $270 

 

As of March 31, 2024, there was a total of $18.8 million and zero unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.16 years for service-based options.

 

(15) Employee Stock Purchase Plan

 

The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase shares of the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of March 31, 2024, 2,628,996 shares were reserved for future issuance under the ESPP Plan.

 

(16)Commitments and Contingencies

 

Warranty Provision

 

The Company typically provides a 10-year warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a 30-year warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business.

 

The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.

 

Activity by period relating to the Company’s warranty provision was as follows (in thousands):

 

   Thirteen-
Weeks
Ended
March 31,
2024
   Year Ended
December 31,
2023
 
Warranty provision, beginning of period  $4,849   $3,981 
Accruals for new warranties issued   265    2,968 
Settlements   (250)   (2,100)
Warranty provision, end of period  $4,864   $4,849 
Warranty provision, current  $1,448   $1,433 
Warranty provision, noncurrent  $3,416   $3,416 

 

27

 

 

Indemnification Agreements

 

From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.

 

Legal Matters

 

The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that may have a material adverse effect on its business, financial position, results of operations, or cash flows. The Company has recorded zero and $7.9 million as a loss contingency in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively, primarily associated with the pending settlement of the following legal matters.

 

SolarPark Litigation

 

In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the U.S. District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages.

 

On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, the Company filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

Siemens Litigation

 

On July 22, 2021, Siemens filed a lawsuit in which Siemens alleged that the Company breached express and implied warranties under a purchase order that Siemens placed with the Company for a solar module system. Siemens claimed damages of approximately $6.9 million, inclusive of amounts of the Company’s indemnity obligations to Siemens, plus legal fees.

 

On February 22, 2024, the Court issued an order against the Company which awarded Siemens approximately $6.9 million, inclusive of the Company’s indemnity obligations to Siemens, plus legal fees, the amount of which will be determined at a later hearing. On March 15, 2024, Siemens filed a motion seeking to recover $2.67 million for attorneys’ fees, expenses, and pre-judgment interest. The Court will conduct a hearing on Siemens’ motion in late May 2024. Pending entry of a final judgment by the Court, the Company intends to appeal such judgment. The Company has recorded $6.9 million as a legal loss related to this litigation, excluding the $2.67 million for attorneys’ fees, expenses, and pre-judgment interest, in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023.

 

28

 

 

China Bridge Litigation

 

On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

Letters of Credit

 

The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of March 31, 2024. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.8 million as of March 31, 2024 and December 31, 2023, respectively.

 

(17)Basic and Diluted Net Loss Per Share

 

The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid for the thirteen-week periods ended March 31, 2024 and April 2, 2023. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. The Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.

 

The unaudited basic and diluted shares and net loss per share for the thirteen-week period ended April 2, 2023 has been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit.

 

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen-week periods ended March 31, 2024 and April 2, 2023 (in thousands, except share and per share amounts):

 

   Thirteen-
Weeks
Ended
March 31,
2024
   Thirteen- Weeks
Ended
April 2,
2023
 
Numerator:        
Net loss from continuing operations  $(9,588)  $(15,709)
Net loss from discontinued operations   
––
    (7,805)
Net loss  $(9,588)  $(23,514)
Denominator:          
Weighted average common shares outstanding, basic and diluted
   49,077,330    25,200,347 
Net loss per share:          
Continuing operations – basic and diluted
  $(0.20)  $(0.62)
Discontinued operations – basic and diluted
  $
––
   $(0.31)
Net loss per share – basic and diluted
  $(0.20)  $(0.93)

 

The computation of basic and diluted net loss per share attributable to common stockholders is the same for the thirteen-week periods ended March 31, 2024 and April 2, 2023 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.

 

29

 

 

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:

 

   As of 
   March 31,
2024
   April 2,
2023
 
Common stock warrants   23,024,556    89,313 
Preferred stock warrants   
    2,386,879 
Stock options and RSUs issued and outstanding   11,436,369    9,714,894 
Potential common shares excluded from diluted net loss per share   34,460,924    12,191,086 

 

(18)Related Party Transactions

 

From October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recognized zero and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Notes.

 

In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp. In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million. In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. Refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization for further discussion.

 

In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for the fiscal year ended December 31, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of March 31, 2024, the Company has recognized a liability associated with the FPAs of $7.9 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $4.7 million in its unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.

 

30

 

 

In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. The Company paid $0.2 million in 2023 and the remaining balance of $0.3 million was paid in the thirteen-week period ended March 31, 2024.

 

The SAFEs, as described in Note 13 – Borrowing Arrangements, entered into in January 2024 and February 2024 were with the Rodgers Massey Freedom and Free Markets Charitable Trust, a related party. The Company received proceeds from the SAFEs totaling $5.0 million in exchange for debt that was subsequently converted into shares of the Company’s common stock as discussed in Note 19 – Subsequent Events.

 

There were no other material related party transactions during the thirteen-week periods ended March 31, 2024 and April 2, 2023.

 

(19)Subsequent Events

 

Amendment to SAFEs Agreements

 

As described in Note 13 – Borrowing Arrangements, the Company’s SAFEs were convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing. On April 21, 2024, the Company entered into an amendment for each of its First SAFE and Second SAFE to convert the invested amounts into shares of the Company’s common stock.

 

The conversion share price was $0.36, calculated as the product of (i) $0.45, the closing price of the Common Stock on April 19, 2024, multiplied by (ii) 80%. The First SAFE and Second SAFE converted into 4,166,667 and 9,722,222 shares of the Company’s common stock, respectively.

 

Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Bid Price Requirement

 

On April 16, 2024, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.

 

The Notice does not impact the listing of the Company’s common stock on The Nasdaq Global Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days before October 14, 2024. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period by effecting a reverse stock split if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.

 

The Company intends to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the minimum bid price requirement.

 

Amendments to Forward Purchase Agreements

 

On May 7 and 8, 2024, respectively, the Company entered into separate amendments to the Forward Purchase Agreements (the collectively the “Second Amendments”) with Sandia (the “Sandia Second Amendment”) and Polar (the “Polar Second Amendment”). The Second Amendments lower the reset price of each Forward Purchase Agreement from $3.00 to $1.00 per share and amend the VWAP Trigger Event provision to read as “After December 31, 2024, an event that occurs if the VWAP Price, for any 20 trading days during a 30 consecutive trading day-period, is below $1.00 per Share.”. The Sandia Second Amendment is not effective until the Company executes similar amendments with both Polar and Meteora.

 

31

 

 

Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Market Value of Listed Securities

 

On April 16, 2024, the Company received a letter (the “Letter”) from the staff at Nasdaq notifying the Company that, for the 30 consecutive trading days prior to the date of the Letter, the Company’s common stock had traded at a value below the minimum $50,000,000 “Market Value of Listed Securities” (“MVLS”) requirement set forth in Nasdaq Listing Rule 5450(b)(2)(A), which is required for continued listing of the Company’s common stock on The Nasdaq Global Market. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq.

 

In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until October 14, 2024, to regain compliance. The Letter notes that to regain compliance, the Company’s common stock must trade at or above a level such that the Company’s MVLS closes at or above $50,000,000 for a minimum of ten consecutive business days during the compliance period, which ends October 14, 2024. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Capital Market (provided that the Company then satisfies the requirements for continued listing on that market).

 

If the Company does not regain compliance by October 14, 2024, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.

 

The Company intends to actively monitor the Company’s MVLS between now and October 14, 2024, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

 

Entry into a Definitive Agreement to Cancel Debt in Exchange for Equity and Other Consideration

 

On May 1, 2024, the Company entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) with Kline Hill providing for (a) the cancellation of all indebtedness owed to Kline Hill by the Company, termination of all debt instruments by and between the Company and Kline Hill, and the satisfaction of all obligations owed to Kline Hill by the Company under the terminated debt instruments, (b) the issuance of 9,800,000 shares of the Company’s common stock to Kline Hill, (c) the issuance of warrants (the “Kline Hill Warrants” and the shares issuable therefrom, the “Warrant Shares”) to Kline Hill to purchase up to 3,700,000 shares of the Company’s common stock, with an exercise price per share of $0.62 (the closing price per share of the Company’s common stock as reported on the Nasdaq Capital Market of the date of the Agreement), and (d) a one-time $3,750,000 cash payment to Kline Hill upon the earlier of (i) the Company achieving $100,000,000 of trailing twelve month revenue, or (ii) the Company achieving $10,000,000 of trailing twelve month EBITDA. The Kline Hill Warrants will be sold to Kline Hill at a price of $0.125 per Warrant Share. The closing of the foregoing transactions will occur when the following conditions are met: Carlyle executes an agreement to cancel all debt owed to Carlyle by the Company, and all debt owed to Carlyle and its affiliates by the Company is no longer outstanding.

  

32

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with the unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and with our unaudited condensed consolidated financial statements and related notes included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2024, and related management’s discussion and analysis in Item 7 of the Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to such differences include those identified below and those discussed in the section titled “Risk Factors” included elsewhere in this Quarterly Report on Form 10-Q. Please also see the section titled “Special Note Regarding Forward-Looking Statements.”

 

Overview

 

Complete Solaria was formed in November 2022 through the merger of Complete Solar Holding Corporation, a Delaware corporation (“Complete Solar”), and The Solaria Corporation, a Delaware corporation (such entity, “Solaria,” and such transaction, the “Business Combination”). Founded in 2010, Complete Solar created a technology platform to offer clean energy products to homeowners by enabling a national network of sales partners and build partners. Our sales partners generate solar installation contracts with homeowners on our behalf. To facilitate this process, we provide the software tools, sales support and brand identity to its sales partners, making them competitive with national providers. This turnkey solution makes it easy for anyone to sell solar.

 

We fulfill our customer contracts by engaging with local construction specialists. We manage the customer experience and complete all pre-construction activities prior to delivering build-ready projects including hardware, engineering plans, and building permits to its builder partners. We manage and coordinate this process through our proprietary HelioTrackTM software system.

 

Effective January 1, 2023, we changed our fiscal quarters to four, thirteen-week periods within a standard calendar year. Each annual reporting period begins on January 1 and ends on December 31.

 

There is substantial doubt about our ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming we will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to our ability to continue as a going concern.

 

Growth Strategy and Outlook

 

Complete Solaria’s growth strategy contains the following elements:

 

Increase revenue by expanding installation capacity and developing new geographic markets - We continue to expand our network of partners who will install systems resulting from sales generated by our sales partners. By leveraging this network of skilled builders, we aim to increase our installation capacity in our traditional markets and expand our offering into new geographies throughout the United States. This will enable greater sales growth in existing markets and create new revenue in expansion markets.

 

Increase revenue and margin by engaging national-scale sales partners - We aim to offer a turnkey solar solution to prospective sales partners with a national footprint. These sales partners include electric vehicle manufacturers, national home security providers, and real estate brokerages. We expect to create a consistent offering with a single execution process for such sales partners throughout their geographic territories. These national accounts have unique customer relationships that we believe will facilitate meaningful sales opportunities and low cost of acquisition to both increase revenue and improve margin.

 

33

 

 

The Mergers

 

We entered into an Amended and Restated Business Combination Agreement with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), and Solaria on October 3, 2022 (“Merger”). The Merger was consummated on July 18, 2023. Upon the terms and subject to the conditions of the Merger, (i) First Merger Sub merged with and into Complete Solaria with Complete Solaria surviving as a wholly-owned subsidiary of FACT (the “First Merger”), (ii) immediately thereafter and as part of the same overall transaction, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Second Merger”), and FACT changed its name to “Complete Solaria, Inc.” and Second Merger Sub changed its name to “CS, LLC” and (iii) immediately after the consummation of the Second Merger and as part of the same overall transaction, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to “The SolarCA LLC” (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).

 

The Mergers between Complete Solaria and FACT has been accounted for as a reverse recapitalization. Under this method of accounting, FACT is treated as the acquired company for financial statement reporting purposes. This determination was primarily based on us having a majority of the voting power of the post-combination company, our senior management comprising substantially all of the senior management of the post-combination company, and our operations comprising the ongoing operations of the post-combination company. Accordingly, for accounting purposes, the Mergers have been treated as the equivalent of a capital transaction in which Complete Solaria is issuing stock for the net assets of FACT. The net assets of FACT have been stated at historical cost, with no goodwill or other intangible assets recorded.

 

Disposal Transaction

 

In October 2023, we completed the sale of our solar panel business (“Disposal Transaction”) to Maxeon, Inc. (“Maxeon”), pursuant to the terms of an asset purchase agreement (“Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. As of December 31, 2023, we had sold all the shares of Maxeon and recorded a loss of $4.2 million.

 

As part of the Disposal Transaction, we determined that the criteria were met for the “held for sale” and discontinued operations classifications as of the end of our third fiscal quarter in 2023 as the divestiture represented a strategic shift in our business. We recorded an impairment charge of $147.5 million associated with the recording of the assets as held for sale during the year ended December 31, 2023.

 

Below we have discussed our historical results of continuing operations which excludes product revenues and related metrics of our solar panel business, as all results of operations associated with the solar panel business have been presented as discontinued operations, unless otherwise noted.

 

Key Financial Definitions/Components of Results of Operations

 

Revenues

 

We generate revenue by providing customer solar solutions through a standardized platform to our residential solar providers and companies to facilitate the sale and installation of solar energy systems. Our contracts consist of two performance obligations; solar installation services and post-installation services that are performed prior to inspection by the authority having jurisdiction. The majority of our service revenue is recognized at a point in time upon the completion of the installation, and the remainder is recognized upon inspection. Service revenue is recognized net of a reserve for the performance guarantee of solar output.

 

We enter into three types of customer contracts for solar energy installations. The majority of our service revenue is recognized through contracts where the homeowner enters into a power purchase agreement with our distribution partner. We perform the solar energy installation services on behalf of our distribution partner, who owns the solar energy system upon installation. Additionally, we enter into a Solar Purchase and Installation Agreement directly with homeowners, whereby the homeowner either pays cash or obtains financing through a third-party loan partner. In cash contracts with homeowners, we recognize service revenue based on the price we charge to the homeowner. We record service revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which we consider to be a customer incentive.

 

As part of our service revenue, we also enter into contracts to provide our software enhanced service offerings, including design and proposal services to customers that include solar installers and solar sales organizations. We perform these leveraging our HelioQuoteTM platform and other software tools to create computer aided drawings, structural letters, and electrical reviews for installers and proposals for installers. We charge a fixed fee per service offering, which we recognize in the period the service is performed.

 

34

 

 

Operating Expenses

 

Cost of Revenues

 

Cost of revenues consists primarily of the cost of solar energy systems, installation and other subcontracting costs. Cost of revenues also includes associated warranty costs, shipping and handling, allocated overhead costs, depreciation, and amortization of internally developed software.

 

Sales Commissions

 

Sales commissions are direct and incremental costs of obtaining customer contracts. These costs are paid to third-party vendors who source residential customer contracts for the sale of solar energy systems.

 

Sales and Marketing

 

Sales and marketing expenses primarily consist of personnel related costs, including salaries and employee benefits, stock-based compensation, and other promotional and advertising expenses. We expense certain sales and marketing, including promotional expenses, as incurred.

 

General and Administrative

 

General and administrative expenses consist primarily of personnel and related expenses for our employees, in our finance, research, engineering, and administrative teams including salaries, bonuses, payroll taxes, and stock-based compensation. It also consists of legal, consulting, and professional fees, rent expenses pertaining to our offices, business insurance costs and other costs. We expect an increase in audit, tax, accounting, legal and other costs related to compliance with applicable securities and other regulations, as well as additional insurance, investor relations, and other costs associated with being a public company.

 

Interest Expense

 

Interest expense primarily relates to interest expense on the issuance of debt and convertible notes and the amortization of debt issuance costs.

 

Other Income (Expense), Net

 

Other income (expense), net consists of changes in the fair value of our convertible notes, the impact of debt extinguishment, changes in the fair value of stock warrant liabilities and forward purchase agreements and other costs.

 

Income Tax Expense

 

Income tax expense primarily consists of income taxes in certain foreign and state jurisdictions in which we conduct business.

 

Supply Chain Constraints and Risk

 

We rely on a small number of suppliers of solar energy systems and other equipment. If any of our suppliers was unable or unwilling to provide us with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to us, we would have very limited alternatives for supply, and we may not be able find suitable replacements for our customers, or at all. Such an event could materially adversely affect our business, prospects, financial condition and results of operations.

 

In addition, the global supply chain and our industry have experienced significant disruptions in recent periods. We have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase, which materially impacted our results of operations. In an effort to mitigate unpredictable lead times, we experienced a substantial build up in inventory on hand commencing in early 2022 in response to global supply chain constraints. In certain cases, the global supply chain constraints have caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the residual effects of the COVID-19 pandemic and resulting government action, as well as broader macroeconomic conditions, and have been exacerbated by the conflicts in Ukraine and Israel. While we believe that a majority our suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of March 2025, if these shortages and delays persist, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) we can begin to generate revenue from those systems. If any of our suppliers of solar modules experienced disruptions in the supply of the modules’ component parts, for example semiconductor solar wafers or inverters, this may decrease production capabilities and restrict our inventory and sales. In addition, we have experienced and are experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions. While inflationary pressures have resulted in higher costs of products, in part due to an increase in the cost of the materials and wage rates, these additional costs have been offset by the related rise in electricity rates.

 

35

 

 

We cannot predict the full effects the supply chain constraints will have on our business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. Given the dynamic nature of these circumstances on our ongoing business, results of operations and overall financial performance, the full impact of macroeconomic factors, including the conflicts in Ukraine and Israel, cannot be reasonably estimated at this time. In the event we are unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect our business, prospects, financial condition and results of operations. For additional information on risk factors that could impact our results, please refer to “Risk Factors” located elsewhere in this Quarterly Report on Form 10-Q.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with GAAP. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. In many instances, we could have reasonably used different accounting estimates, and in other instances, changes in the accounting estimates are reasonably likely to occur from period-to-period. Actual results could differ significantly from our estimates. Our future financial statements will be affected to the extent that our actual results materially differ from these estimates. For further information on all of our significant accounting policies, see Note 2 - Summary of Significant Accounting Policies, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

 

We believe that policies associated with our revenue recognition, product warranties, inventory excess and obsolescence and stock-based compensation have the greatest impact on our unaudited condensed consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

 

Revenue Recognition

 

We recognize revenue when control of goods or services is transferred to customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.

 

Revenue - Solar Energy System Installations

 

The majority of our revenue is generated from the installation of solar energy systems. We identify two performance obligations, which include installation services and post-installation services, and we recognize revenue when control transfers to the customer, upon the completion of the installation and upon the solar energy system passing inspection by the authority having jurisdiction, respectively. We apply judgment in allocating the transaction price between the installation and post-installation performance obligations, based on the estimated costs to perform our services. Changes in such estimates could have a material impact on the timing of our revenue recognition.

 

Our contracts with customers generally contain a performance guarantee of system output, and we will issue payments to customers if output falls below contractually stated thresholds over the performance guarantee period, which is typically 10 years. We apply judgment in estimating the reduction in revenue associated with the performance guarantee, which historically has not been material. However, due to the long-term nature of the guarantee, changes in future estimates could have a material impact on the estimate of our revenue reserve.

 

Revenue - Software Enhanced Services

 

We recognize revenue from software enhanced services, which include proposals generated from our HelioQuoteTM platform and design services performed using internally developed and external software applications. We contract with solar installers to generate proposals, and we contract with solar sales entities to perform design services for their potential customers. Under each type of customer contract, we generate a fixed number of proposals or designs for the customer in the month the services are contracted. Contracts with customers are enforceable on a month-to-month basis and we recognize revenue each month based on the volume of services performed.

 

36

 

 

Product Warranties

 

We typically provide a 10-year warranty on our solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by our performance. For solar panel sales recognized prior to the Disposal Transaction, we provide a 30-year warranty that the products will be free from defects in material and workmanship. We record a liability for estimated future warranty claims based on historical trends and new installations. To the extent that warranty claim behavior differs from historical trends, we may experience a material change in our warranty liability.

 

Inventory Excess and Obsolescence

 

Our inventory consists of completed solar energy systems and related components, which we classify as finished costs. We record a reserve for inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions. We apply judgment in estimating the excess and obsolete inventory, and changes in demand for our inventory components could have a material impact on our inventory reserve balance.

 

Stock-Based Compensation

 

We recognize stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees, non-employees and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees and non-employees, such as consultants and non-employee directors, are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur.

 

For accounting purposes, prior to the Business Combination, the fair value of the shares of common stock underlying stock options had historically been determined by our board of directors. Because there had been no public market for our common stock, the board of directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our common stock, including important developments in our operations, sales of redeemable convertible preferred stock, actual operating results and financial performance, the conditions in the renewable solar energy industry and the economy in general, the stock price performance and volatility of comparable public companies, and the lack of liquidity of our common stock, among other factors. Following the Business Combination, the fair value of common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Global Select Market.

 

We estimate the grant-date fair value of stock options using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option, the expected volatility of the price of our common stock and expected dividend yield. We determine these inputs as follows:

 

Expected Term-Expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method.

 

Expected Volatility-Expected volatility is estimated by studying the volatility of comparable public companies for similar terms.

 

Expected Dividend-The Black-Scholes valuation model calls for a single expected dividend yield as an input. We have never paid dividends and have no plans to pay dividends.

 

Risk-Free Interest Rate - We derive the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued.

 

If any assumptions used in the Black-Scholes option pricing model change significantly, stock-based compensation for future awards may differ materially compared to the awards granted previously. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, stock-based compensation expense was $1.3 million and $1.0 million, respectively, of which zero and $0.7 million, respectively, related to discontinued operations. As of March 31, 2024, we had approximately $18.8 million of total unrecognized stock-based compensation expense related to stock options.

 

37

 

 

Recent Accounting Pronouncements

 

A discussion of recently issued accounting standards applicable to Complete Solaria is described in Note 2 - Summary of Significant Accounting Policies, in the accompanying notes to the unaudited condensed consolidated financial statements. 

 

Results of Operations

 

Thirteen-weeks ended March 31, 2024 compared to the thirteen-weeks ended April 2, 2023

 

The following table sets forth our unaudited statements of operations data for the thirteen-weeks ended March 31, 2024 and the thirteen-weeks ended April 1, 2023. We have derived this data from our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. This information should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. The results of historical periods are not necessarily indicative of the results of operations for any future period.

 

(in thousands)  Thirteen-
Weeks
Ended
March 31,
2024
   Thirteen-
Weeks
Ended
April 2,
2023
   $
Change
   %
Change
 
Revenues  $10,040   $16,677   $(6,637)   (40)%
Cost of revenues(1)   7,757    13,827    (6,070)   (44)%
Gross profit   2,283    2,850    (567)   (20)%
Gross margin %   23%   17%          
Operating expenses:                    
Sales commissions   3,116    5,677    (2,561)   (45)%
Sales and marketing(1)   1,618    683    935    137%
General and administrative(1)   5,093    8,913    (3,820)   (43)%
Total operating expenses   9,827    15,273    (5,446)   (36)%
Loss from continuing operations   (7,544)   (12,423)   4,879    (39)%
Interest expense(2)   (3,568)   (3,611)   43    (1)%
Interest income   6    8    (2)   (25)%
Other income, net(3)   1,519    317    1,202    379%
Loss from continuing operations before taxes   (9,587)   (15,709)   6,122    (39)%
Income tax provision   (1)       (1)   *%
Net loss from continuing operations  $(9,588)  $(15,709)  $6,121    (39)%

 

*Percentage change not meaningful

 

(1)Includes stock-based compensation expense as follows (in thousands):

 

   Thirteen-
Weeks
Ended
March 31,
2024
   Thirteen-
Weeks
Ended
April 2,
2023
 
Cost of revenues  $27   $11 
Sales and marketing   216    94 
General and administrative   1,098    165 
Total stock-based compensation expense from continuing operations  $1,341   $270 

 

(2) Includes interest expense to related party of zero and $0.2 million during the thirteen-weeks ended March 31, 2024 and April 1, 2023, respectively.

 

(3) Includes other income (expense), net from related parties of $4.7 million and zero during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively.

 

38

 

 

Revenues

 

We disaggregate our revenues based on the following types of services (in thousands):

 

   Thirteen-Weeks
Ended
   Thirteen-Weeks
Ended
         
   March 31,
2024
   April 2,
2023
   $
Change
   %
Change
 
Solar energy system installations  $9,922   $15,843   $(5,921)   (37%)
Software enhanced services   118    834    (716)   (86)%
Total revenue  $10,040   $16,677   $(6,637)   (40)%

  

Revenues from solar energy system installations for the thirteen-weeks ended March 31, 2024 was $9.9 million compared to $15.8 million for the thirteen-weeks ended April 2, 2023. The decrease in solar energy system installation revenues of $5.9 million was primarily due to a decrease in the volume of solar energy system installations.

 

Revenues from software enhanced services for the thirteen-weeks ended March 31, 2024 was $0.1 million compared to $0.8 million for the thirteen-weeks ended April 2, 2023. The decrease was the result of a shift in focus towards solar energy installations.

 

Cost of Revenues

 

Cost of revenues for the thirteen-weeks ended March 31, 2024 was $7.8 million compared to $13.8 million for the thirteen-weeks ended April 2, 2023. The decrease in cost of revenues of $6.0 million, or 44%, was primarily due to the decrease in revenue of 40% and emphasis on managing costs.

 

Gross Margin

 

Gross margin for the thirteen-weeks ended March 31, 2024 was 23% compared to 17% for the thirteen-weeks ended April 2, 2023. The improvement in gross margin was principally attributable to managing costs.

 

Sales Commissions

 

Sales commissions for the thirteen-weeks ended March 31, 2024 was $3.1 million compared to $5.7 million for the thirteen-weeks ended April 2, 2023. The decrease of $2.6 million, or 45%, was primarily due to the decrease in revenues.

 

Sales and Marketing

 

Sales and marketing expense for the thirteen-weeks ended March 31, 2024 was $1.6 million compared to $0.7 million for the thirteen-weeks ended April 2, 2023. The increase is attributable to an increase of $0.6 million in payroll, an increase of $0.2 million in travel related expenses. 

 

General and Administrative

 

General and administrative costs for the thirteen-weeks ended March 31, 2024 was $5.1 million compared to $8.9 million for the thirteen-weeks ended April 2, 2023. The decrease was primarily attributed to decrease in bad debt expense of $2.4 million, decrease of $2.1 million in Outside Services, and an increase in stock-based compensation costs of $0.6 million.

 

39

 

 

Interest Expense

 

Interest expense remained unchanged in the amount of $3.6 million for the thirteen-weeks ended March 31, 2024 and April 2, 2023.

 

Other Income, Net

 

Other income, net for the thirteen-weeks ended March 31, 2024 increased by $1.2 million compared to the thirteen-weeks ended April 2, 2023. Other income, net in the thirteen-weeks ended March 31, 2024 was income of $1.5 million and was comprised of $7.2 million of income arising partially offset by $5.6 million of expense relating to changes in the fair value of our forward purchase agreements and $0.1 million relating to the residual costs of the disposed Solaria business.

 

Other income, net for the thirteen-weeks ended April 2, 2023 was income of $0.3 million and was comprised of $0.2 million change in the fair value of liability-classified warrants and $.1 million related to the Solaria discontinued operations.

 

Net Loss from Continuing Operations

 

As a result of the factors discussed above, our net loss from continuing operations for the thirteen-weeks ended March 31, 2024 was $9.6 million, a decrease of $6.1 million, as compared to a net loss from continuing operations of $15.7 million for the thirteen-weeks ended April 2, 2023.

 

Liquidity and Capital Resources

 

Since our inception, we have incurred losses and negative cash flows from operations. We incurred a net loss of $9.6 million during the thirteen-weeks ended March 31, 2024, and had an accumulated deficit of $364.5 million and current debt of $65.2 million as of March 31, 2024. We had cash and cash equivalents of $1.8 million as of March 31, 2024, which were held for working capital expenditures. We believe our operating losses and negative operating cash flows will continue into the foreseeable future. We have financed our operations primarily through sales of equity securities, issuance of convertible notes and cash generated from operations. Our cash equivalents are on deposit with major financial institutions. Our cash position raises substantial doubt regarding our ability to continue as a going concern for 12 months following the issuance of the unaudited condensed consolidated financial statements.

 

We will receive the proceeds from any cash exercise of warrants for shares of our common stock. The aggregate amount of proceeds could be up to $254.1 million if all the warrants are exercised for cash. However, to the extent the warrants are exercised on a “cashless basis,” the amount of cash we would receive from the exercise of those warrants will decrease. The Private Warrants and Working Capital Warrants, as so identified in our unaudited condensed consolidated financial statements, may be exercised for cash or on a “cashless basis.” The Public Warrants and the Mergers Warrants may only be exercised for cash provided there is then an effective registration statement registering the shares of common stock issuable upon the exercise of such warrants. If there is not a then-effective registration statement, then such warrants may be exercised on a “cashless basis,” pursuant to an available exemption from registration under the Securities Act. We expect to use any such proceeds for general corporate and working capital purposes, which would increase our liquidity. As of May 13, 2024, the price of our common stock was $0.55 per share. The weighted average exercise price of the warrants was $8.70 as of March 31, 2024. We believe the likelihood that warrant holders will exercise their warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the market price of our common stock. If the market price for our common stock remains less than the exercise price, we believe warrant holders will be unlikely to exercise.

 

Debt Financings

 

2018 Bridge Notes

 

In December 2018, The Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The 2018 Notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice the face value of the 2018 Notes at maturity. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria. The 2018 Notes are secured by substantially all of the assets of Complete Solaria.

 

40

 

 

In December 2022, we entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023, and the 2018 Notes remain outstanding as of March 31, 2024. In connection with the amendment, the 2018 Notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.

 

We concluded that the amendment represented was a troubled debt restructuring as we were experiencing financial difficulty, and the amended terms resulted in a concession to us. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of March 31, 2024 and December 31, 2023, the carrying value of the 2018 Notes was $11.4 million and $11.0 million, respectively. Interest expense recognized for the thirteen-weeks ended March 31, 2024 was $0.3 million. The terms of the 2018 Notes are currently being renegotiated.

 

Revolver Loan

 

In October 2020, Solaria entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”). The Loan Agreement with SCI is comprised of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the business combination.

 

The Revolving Loan has a term of thirty-six months, with the principal due at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. Interest expense recognized for the thirteen-weeks ended March 31, 2024 was $0.1 million. In October 2023, the Company entered into an Assignment and Acceptance Agreement whereby Structural Capital Investments III, LP assigned the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The SCI Revolving Loan continued to remain outstanding as of March 31, 2024 and is currently being renegotiated.

 

Secured Credit Facility

 

In December 2022, we entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC (“Secured Credit Facility”). The Secured Credit Facility agreement allows us to borrow up to 70% of the net amount of our eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serve as collateral. The amounts drawn under the Secured Credit Facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the Secured Credit Facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. We may prepay any borrowed amount without premium or penalty. Under the original terms, the Secured Credit Facility agreement was due to mature in April 2023. We are in the process of amending the secured credit facility agreement to extend its maturity date.

 

At March 31, 2024, the outstanding net debt amounted to $12.7 million, including accrued financing cost of $5.0 million compared to December 31, 2023, the balance outstanding was $12.2 million, including accrued financing cost of $4.5 million. We recognized interest expense of $0.5 million related to the Secured Credit Facility during the thirteen-weeks ended March 31, 2024. 

 

Revolver Loan and Secured Credit Facility Cancellation Agreement

 

On May 1, 2024, we entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) with Kline Hill providing for (a) the cancellation of all indebtedness owed to Kline Hill by us, termination of all debt instruments by and between us and Kline Hill, and the satisfaction of all obligations owed to Kline Hill by us under the terminated debt instruments, (b) the issuance of 9,800,000 shares of our common stock to Kline Hill, (c) the issuance of warrants (the “Kline Hill Warrants” and the shares issuable therefrom, the “Warrant Shares”) to Kline Hill to purchase up to 3,700,000 shares of the our common stock, with an exercise price per share of $0.62 (the closing price per share of the our common stock as reported on the Nasdaq Capital Market of the date of the Agreement), and (d) a one-time $3,750,000 cash payment to Kline Hill upon the earlier of (i) us achieving $100,000,000 of trailing twelve month revenue, or (ii) us achieving $10,000,000 of trailing twelve month EBITDA. The Kline Hill Warrants will be sold to Kline Hill at a price of $0.125 per Warrant Share. The closing of the foregoing transactions will occur when the following conditions are met: Carlyle executes an agreement to cancel all debt owed to Carlyle by us, and all debt owed to Carlyle and its affiliates by the Company is no longer outstanding.

 

CS Solis Debt

 

In February 2022, we received cash and recorded a liability for an investment by Carlyle into the Company. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis. The Class B Membership Units are mandatorily redeemable by us on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement. The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% which is accrued as an unpaid dividend, compounded annually, and subject to increases in the event we declare any dividends. In July 2023, we amended the debt of with Carlyle as part of the closing of the Mergers. The modification did not change the interest rate. The modification accelerated the redemption date of the investment from February 15, 2025 to March 31, 2024.

 

41

 

 

As of March 31, 2024 and December 31, 2023, we have recorded a liability of $35.8 million and $33.3 million, respectively, included in short-term debt in CS Solis on our unaudited condensed consolidated balance sheets. For the thirteen-weeks ended March 31, 2024, we have recorded accretion of the liability as interest expense of $2.5 million.

 

Forward Purchase Agreements

 

In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).

 

Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.

 

The key terms of the forward contracts are as follows:

 

The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.

 

The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.

 

The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading day-period (the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP is less than the then applicable Reset Price.

 

We entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, we incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. We accounted for the contingent obligation to issue shares in accordance with ASC 815, Derivatives and Hedging, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.

 

Additionally, in accordance with ASC 480, Distinguishing Liabilities from Equity, we have has determined that the forward contracts are financial instruments other than shares that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “forward purchase liability” on its consolidated balance sheets. We initially measured the forward purchase liability at fair value and have subsequently remeasured it at fair value with changes in fair value recognized in earnings.

 

Through the date of issuance of the Complete Solaria Common Stock in satisfaction of our obligation to issue shares around the closing of the Mergers, we recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock.

 

42

 

 

As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss. Subsequently, the change of fair value of the forward purchase liability amounted to an expense of $3.9 million for the fiscal year ended December 31, 2023. As of December 31, 2023, the forward purchase liabilities amounted to $3.8 million.

 

On December 18, 2023, the Company and the FPA Sellers entered into separate amendments to the FPAs (the “Amendments”). The Amendments lower the reset floor price of each FPA from $5.00 to $3.00 and allow the Company to raise up to $10.0 million of equity from existing stockholders without triggering certain anti-dilution provisions contained in the FPAs; provided, the insiders pay a price per share for their initial investment equal to the closing price per share as quoted on the Nasdaq on the day of purchase; provided, further, that any subsequent investments are made at a price per share equal to the greater of (a) the closing price per share as quoted by Nasdaq on the day of the purchase or (b) the amount paid in connection with the initial investment.

 

SAFE Agreements

 

On January 31, 2024, we entered into a simple agreement for future equity (the “First SAFE”) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the “Purchaser”) in connection with the Purchaser investing $1.5 million in the Company. The First SAFE was initially convertible into shares of our common stock, par value $0.0001 per share, upon the initial closing of a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which we have issued and sold common stock at a fixed valuation (an “Equity Financing”), at a per share conversion price which was equal to the lower of (i)(a) $53.54 million divided by (b) our capitalization immediately prior to such Equity Financing (such conversion price, the “SAFE Price”), and (ii) 80% of the price per share of our common stock sold in the Equity Financing. If we consummated a change of control prior to the termination of the First SAFE, the Purchaser will would have been automatically entitled to receive a portion of the proceeds of such liquidity event equal to the greater of (i) $1.5 million and (ii) the amount payable on the number of shares of our common stock equal to (a) $1.5 million divided by (b)(1) $53.54 million divided by (2) our capitalization immediately prior to such liquidity event (the “Liquidity Price”), subject to certain adjustments as set forth in the First SAFE. The First SAFE was convertible into a maximum of 1,431,297 shares of our common stock, assuming a per share conversion price of $1.05, which is the product of (i) $1.31, the closing price of our common stock on January 31, 2024, multiplied by (ii) 80%.

 

On February 15, 2024, we entered into a simple agreement for future equity (the “Second SAFE” and together with the First SAFE, the “SAFEs”) with the Purchaser in connection with the Purchaser investing $3.5 million in the Company. The Second SAFE was initially convertible into shares of our common stock upon the initial closing of an Equity Financing at a per share conversion price which was equal to the lower of (i) the SAFE Price, and (ii) 80% of the price per share of our common stock sold in the Equity Financing. If we consummated a change of control prior to the termination of the Second SAFE, the Purchaser would have been automatically entitled to receive an amount equal to the greater of (i) $3.5 million and (ii) the amount payable on the number of shares of our common stock equal to $3.5 million divided by the Liquidity Price, subject to certain adjustments as set forth in the Second SAFE. The Second SAFE was convertible into a maximum of 3,707,627 shares of our common stock, assuming a per share conversion price of $0.94, which is the product of (i) $1.18, the closing price of the Common Stock on February 15, 2024, multiplied by (ii) 80%.

 

On April 21, 2024, we entered into an amendment for each of our First SAFE and Second SAFE to convert the invested amounts into shares of the our common stock. The conversion share price was $0.36, calculated as the product of (i) $0.45, the closing price of our common stock on April 19, 2024, multiplied by (ii) 80%. The First SAFE and Second SAFE converted into 4,166,667 and 9,722,222 shares of our common stock, respectively.

 

Cash Flows for the -Thirteen-Weeks Ended March 31, 2024 and April 2, 2023

 

The following table summarizes Complete Solaria’s cash flows from operating, investing, and financing activities for the thirteen-weeks ended March 31, 2024 and April 2, 2023 (in thousands):

 

   Thirteen-Weeks
Ended
March 31,
2024
   Thirteen-Weeks
Ended
April 2,
2023
 
Net cash used in operating activities from continuing operations  $(4,946)  $(16,116)
Net cash used in operating activities from discontinued operations       (162)
Net cash used in investing activities from continuing operations   (536)   (486)
Net cash provided by financing activities from continuing operations   4,726    15,554 
Net decrease in cash, cash equivalents and restricted cash   (801)   (1,209)

 

43

 

 

Cash Flows from Operating Activities

 

Net cash used in operating activities from continuing operations of $4.9 million for the thirteen-weeks ended March 31, 2024 was primarily due to the net loss from continuing operations, net of tax of $9.6 million partially offset by non-cash charges of $3.5 million and net cash inflows of $1.1 million from changes in our operating assets and liabilities. Non-cash charges in our operating results consisted of a $5.6 million adjustment to our forward purchase agreement liabilities, $1.3 million stock-based compensation expense, $2.5 in million accretion of interest attributable to the CS Solis Debt, $1.0 million of other non-cash interest, $0.4 million of depreciation and amortization and $0.2 million of non-cash lease costs, partially offset by $7.2 million of income from the change in the fair value of our warrant liabilities and a $0.3 million decrease in our reserve for excess and obsolete inventory. The main drivers of net cash inflows derived from the changes in operating assets and liabilities were related to a decrease in accounts receivable, net of $5.3 million and a decrease in inventories of $0.6 million, partially offset by a decrease in accounts payable of $2.6 million, a decrease in accrued expenses and other liabilities of $1.6 million, a decrease in operating lease liabilities of $0.2 million and a decrease in deferred revenue of $0.4 million.

 

Net cash used in operating activities from continuing operations of $16.1 million for the thirteen-weeks ended April 2, 2023 was primarily due to the net loss from continuing operations, net of tax of $15.7 million and net cash outflows of $5.8 million from changes in operating assets and liabilities, adjusted for non-cash charges of $5.4 million. The main drivers of net cash outflows derived from the changes in operating assets and liabilities were related to an increase in accounts receivable, net of $3.2 million, an increase in prepaid and other current assets of $1.9 million, a decrease in deferred revenue of $0.9 million, an increase in other noncurrent assets of $0.8 million, a decrease in accrued expenses and other current liabilities of $0.6 million and an increase in inventories of $0.6 million, partially offset by an increase in accounts payable of $2.1 million and other of $0.1 million. Non-cash charges primarily consisted of a provision for credit losses of $2.1 million, non-cash interest expense of $1.2 million, a change in reserve for obsolete inventory of $0.8 million, accretion of long-term debt in CS Solis of $0.8 million, stock-based compensation of $0.3 million, and other changes, net of $0.2 million.

 

The net decrease in cash, cash equivalents and restricted cash from discontinued operations of $0.2 million for the thirteen-weeks ended April 2, 2023 was entirely attributable to net cash provided by operating activities from discontinued operations. This decrease was primarily due to the net loss from discontinued operations, net of tax of $7.8 million, adjusted for non-cash charges of $2.2 million and net cash inflows of $5.4 million from changes in our operating assets and liabilities. Non-cash charges primarily consisted of depreciation and amortization expense of $0.8 million, stock-based compensation expense of $0.7 million and a $0.7 million change in allowance for credit losses. The main drivers of net cash inflows derived from the changes in operating assets and liabilities were related to a decrease in inventories of $5.9 million and an increase in accounts payable of $0.6 million, partially offset by a decrease in accrued expenses of $0.6 million, a decrease in deferred revenue of $0.2 million and changes in other operating assets and liabilities, net of $0.3 million.

 

Cash Flows from Investing Activities

 

Net cash used in investing activities was $0.5 million and $0.5 million for the thirteen-weeks ended March 31, 2024, and April 2, 2023, respectively, and attributable to additions to internal-use-software.

 

Cash Flows from Financing Activities

 

Net cash provided by financing activities of $5.0 million for the thirteen-weeks ended March 31, 2024 was primarily due to $5.0 million in net proceeds from the issuance of SAFE agreements to a related party and $0.3 million final payment on the settlement of the amount due to Polar Multi-Strategy Master Fund.

 

Net cash provided by financing activities of $15.6 million for the thirteen-weeks ended April 2, 2023 was due to proceeds of $11.0 million in from the issuance of convertible notes and draws of $14.1 million, net of $9.6 million in repayments on our Secured Credit Facility and $0.1 million of proceeds from the issuance of shares of our common stock from the exercise of common stock options.

 

Off Balance Sheet Arrangements

 

As of the date of this Quarterly Report on Form 10-Q, Complete Solaria does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement, or other contractual arrangement to which an entity unconsolidated with Complete Solaria is a party, under which it has any obligation arising under a guaranteed contract, derivative instrument, or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity, or market risk support for such assets.

 

Currently, Complete Solaria does not engage in off-balance sheet financing arrangements.

 

44

 

 

Emerging Growth Company Status

 

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable.

 

Complete Solaria is an “emerging growth company” as defined in Section 2(a) of the Securities Act, and has elected to take advantage of the benefits of the extended transition period for new or revised financial accounting standards. Following the closing of the Mergers, our Post-Combination Company will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of common stock that is held by non-affiliates exceeds $700 million as of the end of that year’s second fiscal quarter, (ii) the last day of the fiscal year in which we has total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation), (iii) the date on which we have issued more than $1.0 billion in non-convertible debt in the prior three-year period, or (iv) December 31, 2025. Complete Solaria expects to continue to take advantage of the benefits of the extended transition period, although it may decide to early adopt such new or revised accounting standards to the extent permitted by such standards. This may make it difficult or impossible to compare our financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are exposed to certain market risks in the ordinary course of our business. The Company monitors and manages these financial exposures as an integral part of its overall risk management program.

 

Interest Rate Risk

 

We do not have significant exposure to interest rate risk that could affect the balance sheet, statement of operations, and the statement of cash flows, as we do not have any outstanding variable rate debt as of March 31, 2024.

 

Concentrations of Credit Risk and Major Customers

 

Our customer base consists primarily of residential homeowners. We do not require collateral on our accounts receivable. Further, our accounts receivable amounts are with individual homeowners, and we are exposed to normal industry credit risks. We continually evaluate our reserves for potential credit losses and establish reserves for such losses.

 

As of March 31, 2024 and April 2, 2023, two customers accounted for 10% or more of the total accounts receivable, net balance.

 

For the thirteen-weeks ended March 31, 2024 and April 1, 2023, one and three customer accounted for 10% or more of the total revenues.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (Disclosure Controls) within the meaning of Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). Our Disclosure Controls are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Our Disclosure Controls are also designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our Disclosure Controls, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily applied its judgment in evaluating and implementing possible controls and procedures.

 

45

 

 

As of the end of the period covered by this Quarterly Report on Form 10-Q, we evaluated the effectiveness of the design and operation of our Disclosure Controls, which was done under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer. Based on the evaluation of our Disclosure Controls, our Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2024, our Disclosure Controls were not effective due to a material weakness in our internal control over financial reporting as disclosed below.

 

Material Weaknesses in Internal Control Over Financial Reporting

 

Prior to the Business Combination, we were a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses. As a result, previously existing internal controls are no longer applicable or comprehensive enough as of the assessment date as our operations prior to the Business Combination were insignificant compared to those of the consolidated entity post-Business Combination. In addition, the design of internal controls over financial reporting for the Company following the Business Combination has required and will continue to require significant time and resources from our management and other personnel.

 

In connection with the preparation and audit of our financial statements for the year ended December 31, 2023, our management identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weaknesses are as follows:

 

We do not have sufficient full-time accounting personnel, (i) to enable appropriate reviews over the financial close and reporting process, (ii) to allow for an appropriate segregation of duties, and (iii) with the requisite experience and technical accounting knowledge to identify, review and resolve complex accounting issues under generally accepted accounting principles in the United States (“GAAP”). Additionally, we did not adequately design and/or implement controls related to conducting a formal risk assessment process.

 

Inventory controls related to the completeness, existence, and cut-off of inventories held at third parties, and controls related to the calculation of adjustments to inventory for items considered excessive and obsolete.

 

The Company was not required to perform an evaluation of internal control over financial reporting as of December 31, 2023 in accordance with the provisions of the Sarbanes-Oxley Act. Had such an evaluation been performed, additional control deficiencies may have been identified by the Company’s management, and those control deficiencies could have also represented one or more material weaknesses.

 

Plan to Remediate Material Weaknesses in Internal Control Over Financial Reporting

 

We have taken certain steps, such as recruiting additional personnel, in addition to utilizing third-party consultants and specialists, to supplement our internal resources, to enhance our internal control environment and plans to take additional steps to remediate the material weaknesses. Although we plan to complete this remediation process as quickly as possible, we cannot at this time estimate how long it will take. We cannot assure you that the measures we have taken to date and may take in the future, will be sufficient to remediate the control deficiencies that led to our material weakness in internal control over financial reporting or that it will prevent or avoid potential future material weaknesses.

 

If we are not able to maintain effective internal control over financial reporting and Disclosure Controls, or if material weaknesses are discovered in future periods, a risk that is significantly increased in light of the complexity of our business, we may be unable to accurately and timely report our financial position, results of operations, cash flows or key operating metrics, which could result in late filings of the annual and quarterly reports under the Exchange Act, restatements of financial statements or other corrective disclosures, an inability to access commercial lending markets, defaults under its secured revolving credit facility and other agreements, or other material adverse effects on our business, reputation, results of operations, financial condition or liquidity.

 

Changes in Internal Control over Financial Reporting

 

Other than the material weakness and remediation efforts described above, there were no changes in our internal control over financial reporting that occurred during the thirteen-weeks ended March 31, 2024, to which this report relates, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

46

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The information with respect to legal proceedings is set forth under Note 16 - Commitments and Contingencies, in the accompanying unaudited condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

 

ITEM 1A. RISK FACTORS

 

Investing in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all of the other information contained in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and related notes appearing in Part I, Item 1 of this Quarterly Report on Form 10-Q and in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” before deciding to invest in our securities. If any of the events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our common stock could decline, and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.

 

Risks Related to our Businesses and Industry

 

Our business depends in part on the availability of rebates, tax credits and other financial incentives. The expiration, elimination or reduction of these rebates, credits or incentives or the ability to monetize them could adversely impact our business.

 

U.S. federal, state and local government bodies provide incentives to end users, distributors, system integrators and manufacturers of solar energy systems to promote solar electricity in the form of rebates, tax credits and other financial incentives such as system performance payments, payments for renewable energy credits associated with renewable energy generation and the exclusion of solar energy systems from property tax assessments. These incentives enable us to lower the price charged to customers for energy and for solar energy systems. However, these incentives may expire on a particular date, end when the allocated funding is exhausted or be reduced or terminated as solar energy adoption rates increase. These reductions or terminations often occur without warning.

 

The Inflation Reduction Act (“IRA”) extended and modified prior law applicable to tax credits that are available with respect to solar energy systems. Under the IRA, the following credits are available: (i) a production tax credit under Code Section 44 (for facilities that begin construction before January 1, 2025) and Code Section 45Y (for facilities that begin construction between January 1, 2025 and the year that is four calendar years after the year in which certain U.S. greenhouse gas emissions percentages are met) (the “PTC”) in connection with the installation of certain solar facilities and energy storage technology, (ii) an investment tax credit under Code Section 48 (for facilities that begin construction before January 1, 2025) and Code Section 48E (for facilities that begin construction between January 1, 2025 and the year that is four calendar years after the year in which certain U.S. greenhouse gas emissions percentages are met) (the “ITC”) in connection with the installation of certain solar facilities and energy storage technology, and (iii) a residential clean energy credit (the “Section 25D Credit”) in connection with the installation of property that uses solar energy to generate electricity for residential use.

 

Prior to the IRA, the PTC for solar facilities had phased out and was no longer available. The IRA reinstated the PTC for solar facilities. The PTC available to a taxpayer in a taxable year is equal to a certain rate multiplied by the kilowatt hours of electricity produced by the taxpayer from solar energy at a facility owned by it and sold to an unrelated party during that taxable year. The base rates for the PTC is 0.3 cents. This rate is increased to 1.5 cents for projects that (i) have a maximum net output of less than one MW AC, (ii) begin construction before January 29, 2023, or (iii) meet certain prevailing wage and apprenticeship requirements. It also may be increased for projects that include a certain percentage of components that were produced in the U.S., projects that are located in certain energy communities, and projects that are located in low-income communities.

  

47

 

 

The ITC available to a taxpayer in a taxable year is equal to the “energy percentage” of the basis of “energy property” placed in service by the taxpayer during that taxable year. “Energy property” includes equipment that uses solar energy to generate electricity (including structural components that are necessary to the functioning of a solar facility as a whole) and certain energy storage systems (including batteries included as part of or adjacent to a solar facility). The base “energy percentage” for the ITC is 6%. This energy percentage is increased to 30% for projects that (i) have a maximum net output of less than one MW AC, (ii) begin construction before January 29, 2023, or (iii) meet certain prevailing wage and apprenticeship requirements. It also may be increased for projects that include a certain percentage of components that were produced in the U.S., projects that are located in certain energy communities, and projects that are located in low-income communities. ITCs are subject to recapture if, during the five-year period after a facility is placed in service, the facility is sold, exchanged, involuntarily converted, or ceases its business usage. If the event that causes such recapture occurs within the first year after a project is placed in service, 100% of the ITCs will be recaptured. The recapture percentage is reduced 20% for each subsequent year. Historically, we have utilized the ITC when available for both residential and commercial leases and power purchase agreements, based on ownership of the solar energy system.

 

The Section 25D Credit available to a taxpayer is equal to the “applicable percentage” of expenditures for property that uses solar energy to generate electricity for use in a dwelling unit used as a residence by the taxpayer. The applicable percentage is 26% for such systems that are placed in service before January 1, 2022, 30% for such systems that are placed in service after December 31, 2021 and before January 1, 2033, 26% for such systems that are placed in service in 2033, and 22% for such systems that are placed in service in 2034. The Section 25D Credit is scheduled to expire effective January 1, 2035. Although it is unlikely that Complete Solaria would qualify for the Section 25D Credit, the availability of the Section 25D Credit may impact the prices of its solar energy systems.

 

Reductions in, eliminations of, or expirations of, governmental incentives could adversely impact results of operations and ability to compete in this industry by increasing the cost of capital, causing us to increase the prices of our energy and solar energy systems and reduce the size of our addressable market.

 

We are an “emerging growth company” and a “smaller reporting company” and we cannot be certain if the reduced reporting requirements applicable to these companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (JOBS Act). For as long as we continue to be an emerging growth company, we intend to take advantage of exemptions from various reporting requirements that apply to other public companies that are not emerging growth companies, including:

 

being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure in our periodic reports;

 

not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”);

 

48

 

 

 

not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board (the “PCAOB”) regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements;

 

reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and

 

exemptions from the requirements of holding nonbinding advisory stockholder votes on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. As a result, our financial statements may be different from companies that comply with the new or revised accounting pronouncements as of public company effective dates.

  

We will remain an emerging growth company until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235 billion in total annual gross revenues; (2) the date we qualify as a “large accelerated filer,” with at least $700.0 million of equity securities held by non-affiliates; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) the last day of the fiscal year ending after the fifth anniversary of our IPO.

 

Even after we no longer qualify as an emerging growth company, we may still qualify as a “smaller reporting company,” as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which would allow us to continue to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation our periodic reports and proxy statements.

 

We cannot predict if investors will find our securities less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our securities and the trading price of our securities may be more volatile.

 

Existing regulations and policies and changes to these regulations and policies may present technical, regulatory, and economic barriers to the purchase and use of solar power products, which may significantly reduce demand for our products and services.

 

The market for electric generation products is heavily influenced by federal, state and local government laws, regulations and policies concerning the electric utility industry in the U.S. and abroad, as well as policies promulgated by electric utilities. These regulations and policies often relate to electricity pricing and technical interconnection of customer-owned electricity generation, and changes that make solar power less competitive with other power sources could deter investment in the research and development of alternative energy sources as well as customer purchases of solar power technology, which could in turn result in a significant reduction in the demand for our solar power products. The market for electric generation equipment is also influenced by trade and local content laws, regulations and policies that can discourage growth and competition in the solar industry and create economic barriers to the purchase of solar power products, thus reducing demand for our solar products. In addition, on-grid applications depend on access to the grid, which is also regulated by government entities. We anticipate that our solar power products and our installation will continue to be subject to oversight and regulation in accordance with federal, state, local and foreign regulations relating to construction, safety, environmental protection, utility interconnection and metering, trade, and related matters. It is difficult to track the requirements of individual states or local jurisdictions and design equipment to comply with the varying standards. In addition, the U.S. and European Union, among others, have imposed tariffs or are in the process of evaluating the imposition of tariffs on solar panels, solar cells, polysilicon, and potentially other components. These and any other tariffs or similar taxes or duties may increase the price of our solar products and adversely affect our cost reduction roadmap, which could harm our results of operations and financial condition. Any new regulations or policies pertaining our solar power products may result in significant additional expenses for our customers, which could cause a significant reduction in demand for our solar power products.

 

49

 

 

We rely on net metering and related policies to offer competitive pricing to customers in many of our current markets and changes to net metering policies may significantly reduce demand for electricity from residential solar energy systems.

 

Net metering is one of several key policies that have enabled the growth of distributed generation solar energy systems in the U.S., providing significant value to customers for electricity generated by their residential solar energy systems but not directly consumed on-site. Net metering allows a homeowner to pay his or her local electric utility for power usage net of production from the solar energy system or other distributed generation source. Homeowners receive a credit for the energy an interconnected solar energy system generates in excess of that needed by the home to offset energy purchases from the centralized utility made at times when the solar energy system is not generating sufficient energy to meet the customer’s demand. In many markets, this credit is equal to the residential retail rate for electricity and in other markets, such as Hawaii and Nevada, the rate is less than the retail rate and may be set, for example, as a percentage of the retail rate or based upon a valuation of the excess electricity. In some states and utility territories, customers are also reimbursed by the centralized electric utility for net excess generation on a periodic basis.

  

Net metering programs have been subject to legislative and regulatory scrutiny in some states and territories including, but not limited to, California, New Jersey, Arizona, Nevada, Connecticut, Florida, Maine, Kentucky, Puerto Rico and Guam. These jurisdictions, by statute, regulation, administrative order or a combination thereof, have recently adopted or are considering new restrictions and additional changes to net metering programs either on a state-wide basis or within specific utility territories. Many of these measures were introduced and supported by centralized electric utilities. These measures vary by jurisdiction and may include a reduction in the rates or value of the credits customers are paid or receive for the power they deliver back to the electrical grid, caps or limits on the aggregate installed capacity of generation in a state or utility territory eligible for net metering, expiration dates for and phasing out of net metering programs, replacement of net metering programs with alternative programs that may provide less compensation and limits on the capacity size of individual distributed generation systems that can qualify for net metering. Net metering and related policies concerning distributed generation also received attention from federal legislators and regulators.

 

In California, the California Public Utilities Commission (“CPUC”) issued an order in 2016 retaining retail-based net metering credits for residential customers of California’s major utilities as part of Net Energy Metering 2.0 (“NEM 2.0”). Under NEM 2.0, new distributed generation customers receive the retail rate for electricity exported to the grid, less certain non-bypassable fees. Customers under NEM 2.0 also are subject to interconnection charges and time-of-use rates. Existing customers who receive service under the prior net metering program, as well as new customers under the NEM 2.0 program, currently are permitted to remain covered by them on a legacy basis for a period of 20 years. On September 3, 2020, the CPUC opened a new proceeding to review its current net metering policies and to develop Net Energy Metering 3.0 (“NEM 3.0”), also referred to by the CPUC as the NEM 2.0 successor tariff. NEM 3.0 was finalized on December 15, 2022 and will include several changes from previous net metering plans. There will be changes that impact the amount that homeowners with solar power will be able to recuperate when selling excess energy back to the utility grid. With NEM 3.0, the value of the credits for net exports will be tied to the state’s 2022 Distributed Energy Resources Avoided Cost Calculator Documentation (“ACC”). Another significant change with NEM 3.0 will be applied to the netting period: the time period over which the utilities measure the clean energy being imported or exported. In general, longer netting periods have typically been advantageous for solar power customers because production can offset any consumption. NEM 3.0 will instead measure energy using instantaneous netting, which means interval netting approximately every 15 minutes. This will lead to more NEM customers’ electricity registering as exports, now valued at the new, lower ACC value.

 

50

 

 

We utilize a limited number of suppliers of solar panels and other system components to adequately meet anticipated demand for our solar service offerings. Any shortage, delay or component price change from these suppliers or delays and price increases associated with the product transport logistics could result in sales and installation delays, cancellations and loss of market share.

 

We purchase solar panels, inverters and other system components from a limited number of suppliers, which makes us susceptible to quality issues, shortages and price changes. If we fail to develop, maintain and expand relationships with existing or new suppliers, we may be unable to adequately meet anticipated demand for our solar energy systems or may only be able to offer our systems at higher costs or after delays. If one or more of the suppliers that we rely upon to meet anticipated demand ceases or reduces production, we may be unable to satisfy this demand due to an inability to quickly identify alternate suppliers or to qualify alternative products on commercially reasonable terms.

 

In particular, there are a limited number of inverter suppliers. Once we design a system for use with a particular inverter, if that type of inverter is not readily available at an anticipated price, we may incur additional delay and expense to redesign the system.

 

In addition, production of solar panels involves the use of numerous raw materials and components. Several of these have experienced periods of limited availability, particularly polysilicon, as well as indium, cadmium telluride, aluminum and copper. The manufacturing infrastructure for some of these raw materials and components has a long lead time, requires significant capital investment and relies on the continued availability of key commodity materials, potentially resulting in an inability to meet demand for these components. The prices for these raw materials and components fluctuate depending on global market conditions and demand and we may experience rapid increases in costs or sustained periods of limited supplies.

 

Despite efforts to obtain components from multiple sources whenever possible, many suppliers may be single-source suppliers of certain components. If we cannot maintain long-term supply agreements or identify and qualify multiple sources for components, access to supplies at satisfactory prices, volumes and quality levels may be harmed. We may also experience delivery delays of components from suppliers in various global locations. In addition, while there are alternative suppliers and service providers that we could enter into agreements with to replace its suppliers on commercially reasonable terms, we may be unable to establish alternate supply relationships or obtain or engineer replacement components in the short term, or at all, at favorable prices or costs. Qualifying alternate suppliers or developing our own replacements for certain components may be time-consuming and costly and may force us to make modifications to our product designs.

 

Our need to purchase supplies globally and our continued international expansion further subjects us to risks relating to currency fluctuations. Any decline in the exchange rate of the U.S. dollar compared to the functional currency of component suppliers could increase component prices. In addition, the state of the financial markets could limit suppliers’ ability to raise capital if they are required to expand their production to meet our needs or satisfy our operating capital requirements. Changes in economic and business conditions, wars, governmental changes and other factors beyond our control or which we do not presently anticipate, could also affect suppliers’ solvency and ability to deliver components on a timely basis. Any of these shortages, delays or price changes could limit our growth, cause cancellations or adversely affect profitability and the ability to compete in the markets in which we operate effectively.

 

Our business substantially focuses on solar service agreements and transactions with residential customers.

 

Our business substantially focuses on solar service agreements and transactions with residential customers. Our energy system sales to homeowners utilize power purchase agreements (“PPAs”), leases, loans and other products and services. We currently offer PPAs and leases through, EverBright, LLC, and other financial institutions. If we were unable to arrange new or alternative financing methods for PPAs and leases on favorable terms, our business, financial condition, results of operations, and prospects could be materially and adversely affected.

 

51

 

 

Changes in international trade policies, tariffs, or trade disputes could significantly and adversely affect our business, revenues, margins, results of operations, and cash flows.

 

On February 7, 2018, safeguard tariffs on imported solar cells and modules went into effect pursuant to Proclamation 9693, which approved recommendations to provide relief to U.S. manufacturers and impose safeguard tariffs on imported solar cells and modules, based on the investigations, findings, and recommendations of the U.S. International Trade Commission (the “International Trade Commission”). Since 2021, modules are subject to a tariff rate of 15%. Cells are subjected to a tariff-rate quota, under which the first 2.5 GW of cell imports each year will be exempt from tariffs, and cells imported after the 2.5 GW quota has been reached will be subject to the same 30% tariff as modules in the first year, with the same 5% decline in each of the three subsequent years. The tariff-free cell quota applies globally, without any allocation by country or region.

 

The tariffs could materially and adversely affect our business and results of operations. While solar cells and modules based on interdigitated back contact technology were granted exclusion from these safeguard tariffs on September 19, 2018, our solar products based on other technologies continue to be subject to the safeguard tariffs. Although we are actively engaged in efforts to mitigate the effect of these tariffs, there is no guarantee that these efforts will be successful.

 

Uncertainty surrounding the implications of existing tariffs affecting the U.S. solar market and potential trade tensions between the U.S. and other countries is likely to cause market volatility, price fluctuations, supply shortages, and project delays, any of which could harm our business, and the pursuit of mitigating actions may divert substantial resources from other projects. Further, the Uyghur Forced Labor Prevention Act may inhibit importation of certain solar modules or components. In addition, the imposition of tariffs is likely to result in a wide range of impacts to the U.S. solar industry and the global manufacturing market, as well as our business in particular. Such tariffs could materially increase the price of our solar products and result in significant additional costs to the company, its resellers, and the resellers’ customers, which could cause a significant reduction in demand for the company’s solar power products and greatly reduce our competitive advantage.

  

If we fail to manage operations and growth effectively, we may be unable to execute our business plan, maintain high levels of customer service or adequately address competitive challenges.

 

We have experienced significant growth in recent periods as measured by our number of customers; we intend to continue efforts to expand our business within existing and new markets. This growth has placed, and any future growth may place, a strain on management, operational and financial infrastructure. Our growth requires our management to devote a significant amount of time and effort to maintain and expand relationships with customers, dealers and other third parties, attract new customers and dealers, arrange financing for growth and manage expansion into additional markets.

 

In addition, our current and planned operations, personnel, information technology and other systems and procedures might need to be revised to support future growth and may require us to make additional unanticipated investments in its infrastructure. Our success and ability to further scale our business will depend, in part, on our ability to manage these changes in a cost-effective and efficient manner.

 

If we cannot manage operations and growth, we may be unable to meet expectations regarding growth, opportunity and financial targets, take advantage of market opportunities, execute our business strategies or respond to competitive pressures. This could also result in declines in quality or customer satisfaction, increased costs, difficulties in introducing new offerings or other operational difficulties. Any failure to effectively manage our operations and growth could adversely impact our reputation, business, financial condition, cash flows and results of operations.

 

We have international activities and customers in the European Union, and plans to continue these efforts, which subjects us to additional business risks, including logistical and compliance related complexity.

 

A portion of our sales are made to customers outside of the U.S., and a substantial portion of our supply agreements are with supply and equipment vendors located outside of the U.S. We have solar cell and module production lines located at our outsourced manufacturing facilities in Thailand, Vietnam, and India. We are also considering other manufacturing locations.

 

52

 

 

Risks we face in conducting business internationally include:

 

multiple, conflicting and changing laws and regulations, export and import restrictions, employment laws, data protection laws, environmental protection, regulatory requirements, international trade agreements, and other government approvals, permits and licenses;

 

difficulties and costs in staffing and managing foreign operations as well as cultural differences;

 

potentially adverse tax consequences associated with current, future or deemed permanent establishment of operations in multiple countries;

 

relatively uncertain legal systems, including potentially limited protection for intellectual property rights, and laws, changes in the governmental incentives that we rely on, regulations and policies which impose additional restrictions on the ability of foreign companies to conduct business in certain countries or otherwise place them at a competitive disadvantage in relation to domestic companies;

 

inadequate local infrastructure and developing telecommunications infrastructures;

 

financial risks, such as longer sales and payment cycles and greater difficulty collecting accounts receivable;

 

currency fluctuations, government-fixed foreign exchange rates, the effects of currency hedging activity, and the potential inability to hedge currency fluctuations;

 

political and economic instability, including wars, acts of terrorism, political unrest, boycotts, curtailments of trade and other business restrictions;

 

trade barriers such as export requirements, tariffs, taxes and other restrictions and expenses, which could increase the prices of our products and make the company less competitive in some countries; and

 

liabilities associated with compliance with laws (for example, the Foreign Corrupt Practices Act in the U.S. and similar laws outside of the U.S.).

 

We have an organizational structure involving entities globally. This increases the potential impact of adverse changes in laws, rules and regulations affecting the free flow of goods and personnel, and therefore heightens some of the risks noted above. Further, this structure requires us to manage our international inventory and warehouses effectively. If we fail to do so, our shipping movements may not correspond with product demand and flow. Unsettled intercompany balances between entities could result, if changes in law, regulations or related interpretations occur in adverse tax or other consequences that affect capital structure, intercompany interest rates and legal structure. If we are unable to successfully manage any such risks, any one or more could materially and negatively affect our business, financial condition and results of operations.

 

53

 

 

We have incurred losses and may be unable to achieve or sustain profitability in the future.

 

We have incurred net losses in the past and had an accumulated deficit of $364.5 million and $354.9 million as of March 31, 2024 and December 31, 2023, respectively. We will continue to incur net losses as spending increases to finance the expansion of operations, installation, engineering, administrative, sales and marketing staffs, spending increases on brand awareness and other sales and marketing initiatives and implement internal systems and infrastructure to support the company’s growth. We do not know whether revenue will grow rapidly enough to absorb these costs, and our limited operating history makes it difficult to assess the extent of these expenses or their impact on results of operations. Our ability to achieve profitability depends on a number of factors, including but not limited to:

 

Growing the customer base;

 

Maintaining or further lowering the cost of capital;

 

Reducing the cost of components for our solar service offerings;

 

Growing and maintaining our channel partner network;

 

Growing our direct-to-consumer business to scale; and

 

Reducing operating costs by lowering customer acquisition costs and optimizing our design and installation processes and supply chain logistics.

 

Even if we do achieve profitability, we may be unable to sustain or increase profitability in the future. 

 

A material drop in the retail price of utility-generated electricity or electricity from other sources could adversely impact our ability to attract customers, which would harm our business, financial condition, and results of operations.

 

We believe a homeowner’s decision to buy solar energy from us is primarily driven by a desire to lower electricity costs. Decreases in the retail prices of electricity from utilities or other energy sources would harm our ability to offer competitive pricing and could harm its business. The price of electricity from utilities could decrease as a result of:

 

the construction of a significant number of new power generation plants, including nuclear, coal, natural gas or renewable energy technologies;

 

the construction of additional electric transmission and distribution lines;

 

a reduction in the price of natural gas or other natural resources as a result of new drilling techniques or other technological developments, a relaxation of associated regulatory standards, or broader economic or policy developments;

 

energy conservation technologies and public initiatives to reduce electricity consumption;

 

subsidies impacting electricity prices, including in connection with electricity generation and transmission; and

 

development of new energy technologies that provide less expensive energy.

 

A reduction in utility electricity prices would make the purchase of our solar service offerings less attractive. If the retail price of energy available from utilities were to decrease due to any of these or other reasons, we would be at a competitive disadvantage. As a result, we may be unable to attract new homeowners and growth would be limited.

 

54

 

 

We face competition from both traditional energy companies and renewable energy companies.

 

The solar energy and renewable energy industries are both highly competitive and continually evolving as participants strive to distinguish themselves within their markets and compete with large utilities. Our primary competitors are the traditional utilities that supply energy to potential customers. We compete with these utilities primarily based on price, predictability of price and the ease by which customers can switch to electricity generated by our solar energy systems. If we cannot offer compelling value to its customers based on these factors, then our business will not grow. Utilities generally have substantially greater financial, technical, operational and other resources than us. As a result of their greater size, these competitors may be able to devote more resources to the research, development, promotion and sale of their products or respond more quickly to evolving industry standards and changes in market conditions than we can. Utilities could also offer other value- added products and services that could help them compete with us even if the cost of electricity they offer is higher than ours. In addition, a majority of utilities’ sources of electricity is non-solar, which may allow utilities to sell electricity more cheaply than electricity generated by our solar energy systems.

 

Our business is concentrated in certain markets including California, putting us at risk of region-specific disruptions.

 

As of March 31, 2024, a substantial portion of our installations were in California. We expect much of its near-term future growth to occur in California, further concentrating our customer base and operational infrastructure. Accordingly, our business and operations results are particularly susceptible to adverse economic, regulatory, pollical, weather, and other conditions in this market and other markets that may become similarly concentrated. We may not have adequate insurance, including business interruption insurance, to compensate for losses that may occur from any such significant events. A significant natural disaster could have a material adverse impact on our business, results of operations and financial condition. In addition, acts of terrorism or malicious computer viruses could cause disruptions in our business, our partners’ businesses or the economy as a whole. To the extent that these disruptions result in delays or cancellations of installations or the deployment of solar service offerings, our business, results of operations and financial condition would be adversely affected.

  

Our growth strategy depends on the widespread adoption of solar power technology.

 

The distributed residential solar energy market is at a relatively early stage of development compared to fossil fuel-based electricity generation. If additional demand for distributed residential solar energy systems fails to develop sufficiently or takes longer to develop than we anticipate, the company may be unable to originate additional solar service agreements and related solar energy systems and energy storage systems to grow the business. In addition, demand for solar energy systems and energy storage systems in our targeted markets may not develop to the extent it anticipates. As a result, we may need to successfully broaden our customer base through origination of solar service agreements and related solar energy systems and energy storage systems within its current markets or in new markets we may enter.

 

Many factors may affect the demand for solar energy systems, including, but not limited to, the following:

 

availability, substance and magnitude of solar support programs including government targets, subsidies, incentives, renewable portfolio standards and residential net metering rules;

 

the relative pricing of other conventional and non-renewable energy sources, such as natural gas, coal, oil and other fossil fuels, wind, utility-scale solar, nuclear, geothermal and biomass;

 

performance, reliability and availability of energy generated by solar energy systems compared to conventional and other non-solar renewable energy sources;

 

availability and performance of energy storage technology, the ability to implement such technology for use in conjunction with solar energy systems and the cost competitiveness such technology provides to customers as compared to costs for those customers reliant on the conventional electrical grid; and

 

general economic conditions and the level of interest rates.

 

The residential solar energy industry is constantly evolving, which makes it difficult to evaluate our prospects. We cannot be certain if historical growth rates reflect future opportunities or its anticipated growth will be realized. The failure of distributed residential solar energy to achieve, or its being significantly delayed in achieving, widespread adoption could have a material adverse effect on our business, financial condition and results of operations.

 

55

 

 

Our business could be adversely affected by seasonal trends, poor weather, labor shortages, and construction cycles.

 

Our business is subject to significant industry-specific seasonal fluctuations. In the U.S., many customers make purchasing decisions towards the end of the year in order to take advantage of tax credits. In addition, sales in the new home development market are often tied to construction market demands, which tend to follow national trends in construction, including declining sales during cold weather months. 

 

Natural disasters, terrorist activities, political unrest, economic volatility, and other outbreaks could disrupt our delivery and operations, which could materially and adversely affect our business, financial condition, and results of operations.

 

Global pandemics or fear of spread of contagious diseases, such as Ebola virus disease (EVD), coronavirus disease 2019 (COVID-19), Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), H1N1 flu, H7N9 flu, avian flu and monkeypox, as well as hurricanes, earthquakes, tsunamis, or other natural disasters could disrupt our business operations, reduce or restrict operations and services, incur significant costs to protect its employees and facilities, or result in regional or global economic distress, which may materially and adversely affect business, financial condition, and results of operations. Actual or threatened war, terrorist activities, political unrest, civil strife, future disruptions in access to bank deposits or lending commitments due to bank failures and other geopolitical uncertainty could have a similar adverse effect on our business, financial condition, and results of operations. On February 24, 2022, the Russian Federation launched an invasion of Ukraine that has had an immediate impact on the global economy resulting in higher energy prices and higher prices for certain raw materials and goods and services which in turn is contributing to higher inflation in the U.S. and other countries across the globe with significant disruption to financial markets. We have outsourced product development and software engineering in Ukraine and we may potentially indirectly be adversely impacted any significant disruption it has caused and may continue to escalate. Similarly, the current armed conflict in Israel and the Gaza Strip may impact our operations. Any one or more of these events may impede our operation and delivery efforts and adversely affect sales results, or even for a prolonged period of time, which could materially and adversely affect our business, financial condition, and results of operations. We cannot predict the full effects the supply chain constraints will have on our business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties.

 

We depend on a limited number of customers and sales contracts for a significant portion of revenues, and the loss of any customer or cancellation of any contract may cause significant fluctuations or declines in revenues.

 

In 2023, our top customer accounted for 55% of our total revenues, while in 2022 another customer accounted for 47% of our total revenues from continuing operations. We anticipate that our dependence on a limited number of customers may continue for the foreseeable future. As a result of customer concentration, our financial performance may fluctuate significantly from period to period based, among others, on exogenous circumstances related to its clients. In addition, any one of the following events may materially adversely affect cash flows, revenues and results of operations:

 

reduction, delay or cancellation of orders from one or more significant customers;

 

loss of one or more significant customers and failure to identify additional or replacement customers;

 

failure of any significant customers to make timely payment for our products; or

 

the customers becoming insolvent or having difficulties meeting their financial obligations for any reason.

  

We are exposed to the credit risk of customers and payment delinquencies on its accounts receivables.

 

While customer defaults have been immaterial to date, we expect that the risk of customer defaults may increase as we grow our business. If we experience increased customer credit defaults, our revenue and our ability to raise new investment funds could be adversely affected. If economic conditions worsen, certain of our customers may face liquidity concerns and may be unable to satisfy their payment obligations to us on a timely basis or at all, which could have a material adverse effect on our financial condition and results of operations.

 

56

 

 

We may not realize the anticipated benefits of past or future acquisitions, and integration of these acquisitions may disrupt our business.

 

In November 2022, we acquired The Solaria Corporation (“Solaria”), after which Complete Solar was renamed “Complete Solaria, Inc.” In October 2023, we subsequently sold solar panel assets of Solaria, including intellectual property and customer contracts, to Maxeon Solar Technologies, Ltd., which resulted in an impairment loss of $147.5 million and loss on disposal of $1.8 million. In the future, we may acquire additional companies, project pipelines, products, or technologies, or enter into joint ventures or other strategic initiatives. Our ability as an organization to integrate acquisitions is unproven. We may not realize the anticipated benefits of our acquisitions or any other future acquisition or the acquisition may be viewed negatively by customers, financial markets or investors.

 

Any acquisition has numerous risks, including, but not limited to, the following:

 

difficulty in assimilating the operations and personnel of the acquired company;

 

difficulty in effectively integrating the acquired technologies or products with current products and technologies;

 

difficulty in maintaining controls, procedures and policies during the transition and integration;

 

disruption of ongoing business and distraction of management and employees from other opportunities and challenges due to integration issues;

 

difficulty integrating the acquired company’s accounting, management information and other administrative systems;

 

inability to retain key technical and managerial personnel of the acquired business;

 

inability to retain key customers, vendors, and other business partners of the acquired business;

 

inability to achieve the financial and strategic goals for the acquired and combined businesses;

 

incurring acquisition-related costs or amortization costs for acquired intangible assets that could impact operating results;

 

failure of due diligence processes to identify significant issues with product quality, legal and financial liabilities, among other things;

 

inability to assert that internal controls over financial reporting are effective; and

 

inability to obtain, or obtain in a timely manner, approvals from governmental authorities, which could delay or prevent such acquisitions.

 

We depend on our intellectual property and may face intellectual property infringement claims that could be time-consuming and costly to defend and could result in the loss of significant rights.

 

From time to time, we and our customers, or the third parties with whom we work may receive letters, including letters from other third parties, and may become subject to lawsuits with such third parties alleging infringement of their patents. Additionally, we are required by contract to indemnify some customers and third-party intellectual property providers for certain costs and damages of patent infringement in circumstances where our products are a factor creating the customer’s or these third-party providers’ infringement liability. This practice may subject us to significant indemnification claims by customers and third-party providers. We cannot assure investors that indemnification claims will not be made or that these claims will not harm our business, operating results or financial condition. Intellectual property litigation is very expensive and time-consuming and could divert management’s attention from our business and could have a material adverse effect on our business, operating results or financial condition. If there is a successful claim of infringement against us, our customers or our third-party intellectual property providers, we may be required to pay substantial damages to the party claiming infringement, stop selling products or using technology that contains the allegedly infringing intellectual property, or enter into royalty or license agreements that may not be available on acceptable terms, if at all. Parties making infringement claims may also be able to bring an action before the International Trade Commission that could result in an order stopping the importation into the U.S. of our solar products. Any of these judgments could materially damage our business. We may have to develop non-infringing technology, and our failure in doing so or in obtaining licenses to the proprietary rights on a timely basis could have a material adverse effect on the business.

 

57

 

 

We may be required to file claims against other parties for infringing its intellectual property that may be costly and may not be resolved in its favor.

 

To protect our intellectual property rights and to maintain competitive advantage, we have filed, and may continue to file, suits against parties we believe infringe or misappropriate our intellectual property. Intellectual property litigation is expensive and time-consuming, could divert management’s attention from our business, and could have a material adverse effect on our business, operating results, or financial condition, and our enforcement efforts may not be successful. In addition, the validity of our patents may be challenged in such litigation. Our participation in intellectual property enforcement actions may negatively impact our financial results.

 

Developments in technology or improvements in distributed solar energy generation and related technologies or components may materially adversely affect demand for our offerings.

 

Significant developments in technology, such as advances in distributed solar power generation, energy storage solutions such as batteries, energy storage management systems, the widespread use or adoption of fuel cells for residential or commercial properties or improvements in other forms of distributed or centralized power production may materially and adversely affect demand for our offerings and otherwise affect our business. Future technological advancements may result in reduced prices to consumers or more efficient solar energy systems than those available today, either of which may result in current customer dissatisfaction. We may not be able to adopt these new technologies as quickly as its competitors or on a cost-effective basis.

 

Additionally, recent technological advancements may impact our business in ways not currently anticipated. Any failure by us to adopt or have access to new or enhanced technologies or processes, or to react to changes in existing technologies, could result in product obsolescence or the loss of competitiveness of and decreased consumer interest in its solar energy services, which could have a material adverse effect on its business, financial condition and results of operations.

 

Our business is subject to complex and evolving data protection laws. Many of these laws and regulations are subject to change and uncertain interpretation and could result in claims, increased cost of operations or otherwise harm its business.

 

Consumer personal privacy and data security have become significant issues and the subject of rapidly evolving regulation in the U.S. Furthermore, federal, state and local government bodies or agencies have in the past adopted, and may in the future adopt, more laws and regulations affecting data privacy. For example, the state of California enacted the California Consumer Privacy Act of 2018 (“CCPA”) and California voters recently approved the California Privacy Rights Act (“CPRA”). The CCPA creates individual privacy rights for consumers and places increased privacy and security obligations on entities handling the personal data of consumers or households. The CCPA went into effect in January 2020 and it requires covered companies to provide new disclosures to California consumers, provides such consumers, business-to-business contacts and employees new ways to opt-out of certain sales of personal information, and allows for a new private right of action for data breaches. The CPRA modifies the CCPA and imposes additional data protection obligations on companies doing business in California, including additional consumer rights processes and opt outs for certain uses of sensitive data. The CCPA and the CPRA may significantly impact Complete Solaria’s business activities and require substantial compliance costs that adversely affect its business, operating results, prospects and financial condition. To date, we have not experienced substantial compliance costs in connection with fulfilling the requirements under the CCPA or CPRA. However, we cannot be certain that compliance costs will not increase in the future with respect to the CCPA and CPRA or any other recently passed consumer privacy regulation.

 

58

 

 

Outside the U.S., an increasing number of laws, regulations, and industry standards may govern data privacy and security. For example, the European Union’s General Data Protection Regulation (“EU GDPR”) and the United Kingdom’s GDPR (“UK GDPR”) impose strict requirements for processing personal data. Under the EU GDPR, companies may face temporary or definitive bans on data processing and other corrective actions; fines of up to 20 million Euros or 4% of annual global revenue, whichever is greater; or private litigation related to processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law to represent their interests. Non-compliance with the UK GDPR may result in substantially similar adverse consequences to those in relation to the EU GDPR, including monetary penalties of up to £17.5 million or 4% of worldwide revenue, whichever is higher.

 

In addition, we may be unable to transfer personal data from Europe and other jurisdictions to the U.S. or other countries due to data localization requirements or limitations on cross-border data flows. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the European Economic Area (“EEA”) and the United Kingdom have significantly restricted the transfer of personal data to the U.S. and other countries whose privacy laws it believes are not adequate. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross- border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the U.S. in compliance with law, such as the EEA and UK’s standard contractual clauses, these mechanisms are subject to legal challenges, and there is no assurance that Complete Solaria can satisfy or rely on these measures to lawfully transfer personal data to the U.S. If there is no lawful manner for us to transfer personal data from the EEA, the UK, or other jurisdictions to the U.S., or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of its operations, the need to relocate part of or all of its business or data processing activities to other jurisdictions at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against its processing or transferring of personal data necessary to operate its business. Some European regulators have ordered certain companies to suspend or permanently cease certain transfers out of Europe for allegedly violating the EU GDPR’s cross-border data transfer limitations.

 

Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable privacy and data security laws, regulations and policies, could result in additional cost and liability to us damage our reputation, inhibit sales and adversely affect our business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations and policies that are applicable to our business may limit the use and adoption of, and reduce the overall demand for, its solutions. If we are not able to adjust to changing laws, regulations and standards related to privacy or security, our business may be harmed.

 

Any unauthorized access to or disclosure or theft of personal information we gather, store or use could harm our reputation and subject us to claims or litigation.

 

We receive, store and use personal information of customers, including names, addresses, e-mail addresses, and other housing and energy use information. We also store information of dealers, including employee, financial and operational information. We rely on the availability of data collected from customers and dealers in order to manage our business and market our offerings. We take certain steps in an effort to protect the security, integrity and confidentiality of the personal information collected, stored or transmitted, but there is no guarantee inadvertent or unauthorized use or disclosure will not occur or third parties will not gain unauthorized access to this information despite our efforts. Although we take precautions to provide for disaster recovery, our ability to recover systems or data may be expensive and may interfere with normal operations. Also, although we obtain assurances from such third parties that they will use reasonable safeguards to secure their systems, we may be adversely affected by unavailability of their systems or unauthorized use or disclosure or its data maintained in such systems. Because techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target, our suppliers or vendors and our dealers may be unable to anticipate these techniques or to implement adequate preventative or mitigation measures.

 

Cyberattacks in particular are becoming more sophisticated and include, but are not limited to, malicious software, attempts to gain unauthorized access to data and other electronic security breaches that could lead to disruptions in critical systems, disruption of customers’ operations, loss or damage to data delivery systems, unauthorized release of confidential or otherwise protected information, corruption of data and increased costs to prevent, respond to or mitigate cybersecurity events. In addition, certain cyber incidents, such as advanced persistent threats, may remain undetected for an extended period.

 

59

 

 

Unauthorized use, disclosure of or access to any personal information maintained by us or on the behalf of us, whether through breach of our systems, breach of the systems of our suppliers, vendors or dealers by an unauthorized party or through employee or contractor error, theft or misuse or otherwise, could harm our business. If any such unauthorized use, disclosure of or access to such personal information were to occur, our operations could be seriously disrupted and we could be subject to demands, claims and litigation by private parties and investigations, related actions and penalties by regulatory authorities.

 

In addition, we could incur significant costs in notifying affected persons and entities and otherwise complying with the multitude of federal, state and local laws and regulations relating to the unauthorized access to, use of or disclosure of personal information. Finally, any perceived or actual unauthorized access to, use of or disclosure of such information could harm our reputation, substantially impair our business, financial condition and results of operations. While we currently maintain cybersecurity insurance, such insurance may not be sufficient to cover against claims, and we cannot be certain that cyber insurance will continue to be available on economically reasonable terms, or at all, or that any insurer will not deny coverage as to any future claim.

 

If we fail to comply with laws and regulations relating to interactions by the company or its dealers with current or prospective residential customers could result in negative publicity, claims, investigations and litigation and adversely affect financial performance.

 

Our business substantially focuses on solar service agreements and transactions with residential customers. We offer leases, loans and other products and services to consumers by contractors in our dealer networks, who utilize sales people employed by or engaged as third-party service providers of such contractors. We and our dealers must comply with numerous federal, state and local laws and regulations that govern matters relating to interactions with residential consumers, including those pertaining to consumer protection, marketing and sales, privacy and data security, consumer financial and credit transactions, mortgages and refinancings, home improvement contracts, warranties and various means of customer solicitation, including under the laws described below in “As sales to residential customers have grown, we have increasingly become subject to substantial financing and consumer protection laws and regulations.” These laws and regulations are dynamic and subject to potentially differing interpretations and various federal, state and local legislative and regulatory bodies may initiate investigations, expand current laws or regulations, or enact new laws and regulations regarding these matters. Changes in these laws or regulations or their interpretation could dramatically affect how we and our dealers do business, acquire customers and manage and use information collected from and about current and prospective customers and the costs associated therewith. We and our dealers strive to comply with all applicable laws and regulations relating to interactions with residential customers. It is possible, however, these requirements may be interpreted and applied in a manner inconsistent from one jurisdiction to another and may conflict with other rules or our practices or the practices of our dealers.

 

Although we require dealers to meet consumer compliance requirements, we do not control dealers and their suppliers or their business practices. Accordingly, we cannot guarantee they follow ethical business practices such as fair wage practices and compliance with environmental, safety and other local laws. A lack of demonstrated compliance could lead us to seek alternative dealers or suppliers, which could increase costs and have a negative effect on business and prospects for growth. Violation of labor or other laws by our dealers or suppliers or the divergence of a dealer or supplier’s labor or other practices from those generally accepted as ethical in the U.S. or other markets in which the company does or intends to do business could also attract negative publicity and harm the business.

  

From time to time, we have been included in lawsuits brought by the consumer customers of certain contractors in our networks, citing claims based on the sales practices of these contractors. While we have paid only minimal damages to date, we cannot be sure that a court of law would not determine that we are liable for the actions of the contractors in our networks or that a regulator or state attorney general’s office may hold us accountable for violations of consumer protection or other applicable laws by. Our risk mitigation processes may not be sufficient to mitigate financial harm associated with violations of applicable law by our contractors or ensure that any such contractor is able to satisfy its indemnification obligations to us. Any significant judgment against us could expose it to broader liabilities, a need to adjust our distribution channels for products and services or otherwise change our business model and could adversely impact the business.

 

60

 

 

We may be unsuccessful in introducing new services and product offerings.

 

We intend to introduce new offerings of services and products to both new and existing customers in the future, including home automation products and additional home technology solutions. We may be unsuccessful in significantly broadening our customer base through the addition of these services and products within current markets or in new markets the company may enter. Additionally, we may not be successful in generating substantial revenue from any additional services and products introduced in the future and may decline to initiate new product and service offerings.

 

Damage to our brand and reputation or change or loss of use of our brand could harm our business and results of operations.

 

We depend significantly on our reputation for high-quality products, excellent customer service and the brand name “Complete Solaria” to attract new customers and grow our business. If we fail to continue to deliver solar energy systems or energy storage systems within the planned timelines, if our offerings do not perform as anticipated or if we damage any of our customers’ properties or delays or cancels projects, our brand and reputation could be significantly impaired. Future technological improvements may allow the company to offer lower prices or offer new technology to new customers; however, technical limitations in our current solar energy systems and energy storage systems may prevent us from offering such lower prices or new technology to existing customers.

 

In addition, given the sheer number of interactions our personnel or dealers operating on our behalf have with customers and potential customers, it is inevitable that some customers’ and potential customers’ interactions with us or dealers operating on our behalf will be perceived as less than satisfactory. This has led to instances of customer complaints, some of which have affected our digital footprint on rating websites and social media platforms. If we cannot manage hiring and training processes to avoid or minimize these issues to the extent possible, our reputation may be harmed and our ability to attract new customers would suffer.

 

In addition, if we were to no longer use, lose the right to continue to use or if others use the “Complete Solaria” brand, we could lose recognition in the marketplace among customers, suppliers and dealers, which could affect our business, financial condition, results of operations and would require financial and other investment and management attention in new branding, which may not be as successful.

 

Our success depends on the continuing contributions of key personnel.

 

We rely heavily on the services of our key executive officers and the loss of services of any principal member of the management team could adversely affect operations. There have been, and from time to time there may continue to be, changes in our management team resulting from the hiring or departure of executives and key employees, or the transition of executives within our business, which could disrupt our business.

 

We are investing significant resources in developing new members of management as we complete our restructuring and strategic transformation. We also anticipate that over time we will need to hire a number of highly skilled technical, sales, marketing, administrative, and accounting personnel. The competition for qualified personnel is intense in this industry. We may not be successful in attracting and retaining sufficient numbers of qualified personnel to support its anticipated growth. We cannot guarantee that any employee will remain employed with us for any definite period of time since all employees, including key executive officers, serve at-will and may terminate their employment at any time for any reason.

 

If we or our dealers or suppliers fail to hire and retain sufficient employees and service providers in key functions, our growth and ability to timely complete customer projects and successfully manage customer accounts would be constrained.

 

To support growth, we and our dealers need to hire, train, deploy, manage and retain a substantial number of skilled employees, engineers, installers, electricians and sales and project finance specialists. Competition for qualified personnel in this industry has increased substantially, particularly for skilled personnel involved in the installation of solar energy systems. We and our dealers also compete with the homebuilding and construction industries for skilled labor. These industries are cyclical and when participants in these industries seek to hire additional workers, it puts upward pressure on us and our dealers’ labor costs. Companies with whom our dealers compete to hire installers may offer compensation or incentive plans that certain installers may view as more favorable. As a result, our dealers may be unable to attract or retain qualified and skilled installation personnel. The further unionization of the industry’s labor force or the homebuilding and construction industries’ labor forces could also increase our dealers’ labor costs.

 

61

 

 

Shortages of skilled labor could significantly delay a project or otherwise increase dealers’ costs. Further, we need to continue to increase the training of the customer service team to provide high-end account management and service to homeowners before, during and following the point of installation of its solar energy systems. Identifying and recruiting qualified personnel and training them requires significant time, expense and attention. It can take several months before a new customer service team member is fully trained and productive at the standards established by us. If we are unable to hire, develop and retain talented customer service or other personnel, we may not be able to grow our business.

 

Our operating results and ability to grow may fluctuate from quarter to quarter and year to year, which could make future performance difficult to predict and could cause operating results for a particular period to fall below expectations.

 

Our quarterly and annual operating results and its ability to grow are difficult to predict and may fluctuate significantly. We have experienced seasonal and quarterly fluctuations in the past and expect to experience such fluctuations in the future. In addition to the other risks described in this “Risk Factors” section, the following factors could cause operating results to fluctuate:

 

expiration or initiation of any governmental rebates or incentives;

 

significant fluctuations in customer demand for our solar energy services, solar energy systems and energy storage systems;

 

our dealers’ ability to complete installations in a timely manner;

 

our and our dealers’ ability to gain interconnection permission for an installed solar energy system from the relevant utility;

 

the availability, terms and costs of suitable financing;

 

the amount, timing of sales and potential decreases in value of Solar Renewable Energy Certificates (“SRECs”);

 

our ability to continue to expand its operations and the amount and timing of expenditures related to this expansion;

  

announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital-raising activities or commitments;

 

changes in our pricing policies or terms or those of competitors, including centralized electric utilities;

 

actual or anticipated developments in competitors’ businesses, technology or the competitive landscape; and

 

natural disasters or other weather or meteorological conditions.

 

For these or other reasons, the results of any prior quarterly or annual periods should not be relied upon as indications of our future performance.

 

62

 

 

Our ability to obtain insurance on the terms of any available insurance coverage could be materially adversely affected by international, national, state or local events or company-specific events, as well as the financial condition of insurers.

 

Our insurance policies cover legal and contractual liabilities arising out of bodily injury, personal injury or property damage to third parties and are subject to policy limits.

 

However, such policies do not cover all potential losses and coverage is not always available in the insurance market on commercially reasonable terms. In addition, we may have disagreements with insurers on the amount of recoverable damages and the insurance proceeds received for any loss of, or any damage to, any of our assets may be claimed by lenders under financing arrangements or otherwise may not be sufficient to restore the loss or damage without a negative impact on its results of operations. Furthermore, the receipt of insurance proceeds may be delayed, requiring us to use cash or incur financing costs in the interim. To the extent our experiences covered losses under its insurance policies, the limit of our coverage for potential losses may be decreased or the insurance rates it has to pay increased. Furthermore, the losses insured through commercial insurance are subject to the credit risk of those insurance companies. While we believe our commercial insurance providers are currently creditworthy, we cannot assure such insurance companies will remain so in the future.

 

We may not be able to maintain or obtain insurance of the type and amount desired at reasonable rates. The insurance coverage obtained may contain large deductibles or fail to cover certain risks or all potential losses. In addition, our insurance policies are subject to annual review by insurers and may not be renewed on similar or favorable terms, including coverage, deductibles or premiums, or at all. If a significant accident or event occurs for which we are not fully insured or the company suffers losses due to one or more of its insurance carriers defaulting on their obligations or contesting their coverage obligations, it could have a material adverse effect on our business, financial condition and results of operations.

 

We may be subject to breaches of our information technology systems, which could lead to disclosure of internal information, damage to our reputation or relationships with dealers, suppliers, and customers, and disrupt access to online services. Such breaches could subject us to significant reputational, financial, legal, and operational consequences.

 

Our business requires the use and storage of confidential and proprietary information, intellectual property, commercial banking information, personal information concerning customers, employees, and business partners, and corporate information concerning internal processes and business functions. Malicious attacks to gain access to such information affects many companies across various industries, including ours.

 

Where appropriate, we use encryption and authentication technologies to secure the transmission and storage of data. These security measures may be compromised as a result of third-party security breaches, employee error, malfeasance, faulty password management, or other irregularity or malicious effort, and result in persons obtaining unauthorized access to data.

 

We devote resources to network security, data encryption, and other security measures to protect our systems and data, but these security measures cannot provide absolute security. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently, target end users through phishing and other malicious techniques, and/or may be difficult to detect for long periods of time, we may be unable to anticipate these techniques or implement adequate preventative measures. As a result, we may experience a breach of our systems in the future that reduces our ability to protect sensitive data. In addition, hardware, software, or applications we develop or procures from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving team members, contractors and temporary staff. If we experience, or are perceived to have experienced, a significant data security breach, fail to detect and appropriately respond to a significant data security breach, or fail to implement disclosure controls and procedures that provide for timely disclosure of data security breaches deemed material to our business, including corrections or updates to previous disclosures, we could be exposed to a risk of loss, increased insurance costs, remediation and prospective prevention costs, damage to our reputation and brand, litigation and possible liability, or government enforcement actions, any of which could detrimentally affect our business, results of operations, and financial condition.

 

63

 

 

We may also share information with contractors and third-party providers to conduct business. While we generally review and typically request or require such contractors and third-party providers to implement security measures, such as encryption and authentication technologies to secure the transmission and storage of data, those third-party providers may experience a significant data security breach, which may also detrimentally affect our business, results of operations, and financial condition as discussed above. See also under this section, “We may be required to file claims against other parties for infringing its intellectual property that may be costly and may not be resolved in our favor.” We rely substantially upon trade secret laws and contractual restrictions to protect our proprietary rights, and, if these rights are not sufficiently protected, our ability to compete and generate revenue could suffer.

 

As sales to residential customers have grown, we have increasingly become subject to consumer protection laws and regulations.

 

As we continue to seek to expand our retail customer base, our activities with customers are subject to consumer protection laws that may not be applicable to other businesses, such as federal truth-in-lending, consumer leasing, telephone and digital marketing, and equal credit opportunity laws and regulations, as well as state and local finance laws and regulations. Claims arising out of actual or alleged violations of law may be asserted against us by individuals or governmental entities and may expose the company to significant damages or other penalties, including fines. In addition, our affiliations with third-party dealers may subject the company to alleged liability in connection with actual or alleged violations of law by such dealers, whether or not actually attributable to us, which may expose us to significant damages and penalties, and we may incur substantial expenses in defending against legal actions related to third-party dealers, whether or not ultimately found liable.

 

The competitive environment in which we operate often requires the undertaking of customer obligations, which may turn out to be costlier than anticipated and, in turn, materially and adversely affect our business, results of operations and financial condition.

 

We are often required, at the request of our end customer, to undertake certain obligations such as:

 

system output performance warranties; and

 

system maintenance.

 

Such customer obligations involve complex accounting analyses and judgments regarding the timing of revenue and expense recognition, and in certain situations these factors may require us to defer revenue or profit recognition until projects are completed or until contingencies are resolved, which could adversely affect revenues and profits in a particular period.

 

We are subject to risks associated with construction, cost overruns, delays, regulatory compliance and other contingencies, any of which could have a material adverse effect on its business and results of operations.

 

We are a licensed contractor in certain communities that we service and are ultimately responsible as the contracting party for every solar energy system installation. A significant portion of our business depends on obtaining and maintaining required licenses in various jurisdictions. All such licenses are subject to audit by the relevant government agency. Our failure to obtain or maintain required licenses could result in the termination of certain of our contracts. For example, we hold a license with California’s Contractors State License Board (the “CSLB”) and that license is currently under probation with the CSLB. If we fail to comply with the CSLB’s law and regulations, it could result in termination of certain of our contracts, monetary penalties, extension of the license probation period or revocation of its license in California. In addition, we may be liable, either directly or through its solar partners, to homeowners for any damage we causes to them, their home, belongings or property during the installation of our systems. For example, we either directly or through its solar partners, frequently penetrate homeowners’ roofs during the installation process and may incur liability for the failure to adequately weatherproof such penetrations following the completion of construction. In addition, because the solar energy systems we or our solar partners deploy are high voltage energy systems, we may incur liability for failing to comply with electrical standards and manufacturer recommendations.

 

Further, we or our solar partners may face construction delays or cost overruns, which may adversely affect our or our solar partners’ ability to ramp up the volume of installation in accordance with our plans. Such delays or overruns may occur as a result of a variety of factors, such as labor shortages, defects in materials and workmanship, adverse weather conditions, transportation constraints, construction change orders, site changes, labor issues and other unforeseen difficulties, any of which could lead to increased cancellation rates, reputational harm and other adverse effects.

 

64

 

 

In addition, the installation of solar energy systems, energy storage systems, and other energy-related products requiring building modifications are subject to oversight and regulation in accordance with national, state, and local laws and ordinances relating to building, fire, and electrical codes, safety, environmental protection, utility interconnection and metering, and related matters. We also rely on certain employees to maintain professional licenses in many of the jurisdictions in which we operate, and the failure to employ properly licensed personnel could adversely affect our licensing status in those jurisdictions. It is difficult and costly to track the requirements of every individual authority having jurisdiction over our installations and to design solar energy systems to comply with these varying standards. Any new government regulations or utility policies pertaining to our systems may result in significant additional expenses to homeowners and us and, as a result, could cause a significant reduction in demand for solar service offerings.

 

While we have a variety of stringent quality standards that the company applies in the selection of its solar partners, we do not control our suppliers and solar partners or their business practices. Accordingly, we cannot guarantee that they follow our standards or ethical business practices, such as fair wage practices and compliance with environmental, safety and other local laws. A lack of demonstrated compliance could lead us to seek alternative suppliers or contractors, which could increase costs and result in delayed delivery or installation of our products, product shortages or other disruptions of its operations. Violation of labor or other laws by our suppliers and solar partners or the divergence of a supplier’s or solar partners’ labor or other practices from those generally accepted as ethical in the U.S. or other markets in which we do business could also attract negative publicity and harm our business, brand and reputation in the market.

  

Our management has identified conditions that raise substantial doubt about our ability to continue as a going concern.

 

Since our inception, we have incurred losses and negative cash flows from operations. We incurred net losses of $9.6 million and $23.5 million, during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, and had an accumulated deficit of $364.5 million and current debt of $65.2 million as of March 31, 2024. We had cash and cash equivalents of $1.8 million as of March 31, 2024, which were held for working capital expenditures. These conditions raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern requires that we obtain sufficient funding to meet our obligations and finance our operations.

 

If we are not able to secure adequate additional funding when needed, we will need to reevaluate our operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact our business, results of operations and future prospects. There can be no assurance that in the event we require additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on our ability to achieve our intended business objectives.

 

We expect that we will need to raise additional funding to finance our operations. This additional financing may not be available on acceptable terms or at all. Failure to obtain this necessary capital when needed may force us to curtail planned programs or cease operations entirely.

 

Our operations have consumed significant amounts of cash since inception. We expect to incur significant operating expenses as we continue to grow our business. We believe that our operating losses and negative operating cash flows will continue into the foreseeable future.

 

We had cash and cash equivalents of $1.8 million as of March 31, 2024. Our cash position raises substantial doubt regarding our ability to continue as a going concern for 12 months after the consolidated financial statements issuance. We will require substantial additional capital to continue operations. Such additional capital might not be available when we need it and our actual cash requirements might be greater than anticipated. We cannot be certain that additional capital will be available on attractive terms, if at all, when needed, which could be dilutive to stockholders, and our financial condition, results of operations, business and prospects could be materially and adversely affected.

 

65

 

 

We have identified material weaknesses in our internal controls over financial reporting. If we are unable to maintain effective internal controls over financial reporting and disclosure controls and procedures, the accuracy and timeliness of our financial and operating reporting may be adversely affected, and confidence in our operations and disclosures may be lost.

 

In connection with the preparation and audit of our financial statements for the years ended December 31, 2022 and 2021, and our consolidated financial statements for the year ended December 31, 2023, our management identified a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weakness is as follows:

 

We do not have sufficient full-time accounting personnel, (i) to enable appropriate reviews over the financial close and reporting process, (ii) to allow for appropriate segregation of duties, and (iii) with the requisite experience and technical accounting knowledge to identify, review and resolve complex accounting issues under generally accepted accounting principles in the U.S. (“GAAP”). Additionally, we did not adequately design and/or implement controls related to conducting a formal risk assessment process.

 

In connection with the preparation and audit of our consolidated financial statements for the year ended December 31, 2023, our management identified a material weakness in our internal control over financial reporting. The material weakness is as follows:

 

Inventory controls related to the completeness, existence, and cut-off of inventories held at third parties, and controls related to the calculation of adjustments to inventory for items considered excessive and obsolete.

 

Had such an evaluation been performed, additional control deficiencies may have been identified by the Company’s management, and those control deficiencies could have also represented one or more material weaknesses.

 

Complete Solaria was not required to evaluate internal control over financial reporting as of December 31, 2023 in accordance with the provisions of the Sarbanes-Oxley Act. Had such an evaluation been performed, Complete Solaria’s management may have identified additional control deficiencies, and those control deficiencies could have also represented one or more material weaknesses.

  

We have taken certain steps, such as recruiting additional personnel, in addition to utilizing third-party consultants and specialists, to supplement our internal resources, to enhance our internal control environment and plan to take additional steps to remediate the material weaknesses. Although we plan to complete this remediation process as quickly as possible, we cannot estimate how long it will take. We cannot assure that the measures we have taken to date, and may take in the future, will be sufficient to remediate the control deficiencies that led to our material weakness in internal control over financial reporting or that such measures will prevent or avoid potential future material weaknesses.

 

If we are not able to maintain effective internal control over financial reporting and disclosure controls and procedures, or if material weaknesses are discovered in future periods, a risk that is significantly increased in light of the complexity of our business, we may be unable to accurately and timely report our financial position, results of operations, cash flows or key operating metrics, which could result in late filings of the annual and quarterly reports under the Exchange Act, restatements of financial statements or other corrective disclosures, an inability to access commercial lending markets, defaults under its secured revolving credit facility and other agreements, or other material adverse effects on our business, reputation, results of operations, financial condition or liquidity.

 

Compliance with occupational safety and health requirements and best practices can be costly, and noncompliance with such requirements may result in potentially significant penalties, operational delays and adverse publicity.

 

The installation and ongoing operations and maintenance of solar energy systems and energy storage systems requires individuals hired by us, our dealers, or third-party contractors, potentially including employees, to work at heights with complicated and potentially dangerous electrical systems. The evaluation and modification of buildings as part of the installation process requires these individuals to work in locations that may contain potentially dangerous levels of asbestos, lead, mold or other materials known or believed to be hazardous to human health. There is substantial risk of serious injury or death if proper safety procedures are not followed. Our operations are subject to regulation by the Occupational Safety and Health Administration (“OSHA”) and the Department of Transportation (“DOT”) and equivalent state and local laws. Changes to OSHA or DOT requirements, or stricter interpretation or enforcement of existing laws or regulations, could result in increased costs. If we fail to comply with applicable OSHA or DOT regulations, even if no work-related serious injury or death occurs, we may be subject to civil or criminal enforcement and be required to pay substantial penalties, incur significant capital expenditures or suspend or limit operations. Because individuals hired by us or on our behalf to perform installation and ongoing operations and maintenance of the company’s solar energy systems and energy storage systems, including its dealers and third-party contractors, are compensated on a per project basis, they are incentivized to work more quickly than installers compensated on an hourly basis. While we have not experienced a high level of injuries to date, this incentive structure may result in higher injury rates than others in the industry and could accordingly expose the company to increased liability. Individuals hired by or on behalf of us may have workplace accidents and receive citations from OSHA regulators for alleged safety violations, resulting in fines. Any such accidents, citations, violations, injuries or failure to comply with industry best practices may subject us to adverse publicity, damage its reputation and competitive position and adversely affect the business.

 

66

 

 

Our business has benefited from the declining cost of solar energy system components, but it may be harmed if the cost of such components stabilizes or increases in the future.

 

Our business has benefited from the declining cost of solar energy system components and to the extent such costs stabilize, decline at a slower rate or increase, our future growth rate may be negatively impacted. The declining cost of solar energy system components and the raw materials necessary to manufacture them has been a key driver in the price of our solar energy systems, and the prices charged for electricity and customer adoption of solar energy. Solar energy system component and raw material prices may not continue to decline at the same rate as they have over the past several years or at all. In addition, growth in the solar industry and the resulting increase in demand for solar energy system components and the raw materials necessary to manufacture them may also put upward pressure on prices. An increase of solar energy system components and raw materials prices could slow growth and cause business and results of operations to suffer. Further, the cost of solar energy system components and raw materials has increased and could increase in the future due to tariff penalties, duties, the loss of or changes in economic governmental incentives or other factors.

 

Product liability claims against us could result in adverse publicity and potentially significant monetary damages.

 

It is possible our solar energy systems or energy storage systems could injure customers or other third parties or our solar energy systems or energy storage systems could cause property damage as a result of product malfunctions, defects, improper installation, fire or other causes. Any product liability claim we face could be expensive to defend and may divert management’s attention. The successful assertion of product liability claims against us could result in potentially significant monetary damages, potential increases in insurance expenses, penalties or fines, subject the company to adverse publicity, damage our reputation and competitive position and adversely affect sales of solar energy systems or energy storage systems. In addition, product liability claims, injuries, defects or other problems experienced by other companies in the residential solar industry could lead to unfavorable market conditions to the industry as a whole and may have an adverse effect on our ability to expand its portfolio of solar service agreements and related solar energy systems and energy storage systems, thus affecting our business, financial condition and results of operations.

 

Our warranty costs may exceed the warranty reserve.

 

We provide warranties that cover parts performance and labor to purchasers of our solar modules. We maintain a warranty reserve on our financial statements, and our warranty claims may exceed the warranty reserve. Any significant warranty expenses could adversely affect our financial condition and results of operations. Significant warranty problems could impair our reputation which could result in lower revenue and a lower gross margin.

 

We are subject to legal proceedings and regulatory inquiries and may be named in additional claims or legal proceedings or become involved in regulatory inquiries, all of which are costly, distracting to our core business and could result in an unfavorable outcome or harm our business, financial condition, results of operations or the trading price for our securities.

 

We are involved in claims, legal proceedings that arise from normal business activities. In addition, from time to time, third parties may assert claims against us. We evaluate all claims, lawsuits and investigations with respect to their potential merits, our potential defenses and counter claims, settlement or litigation potential and the expected effect on us. In the event that we are involved in significant disputes or are the subject of a formal action by a regulatory agency, we could be exposed to costly and time-consuming legal proceedings that could result in any number of outcomes. Although outcomes of such actions vary, any claims, proceedings or regulatory actions initiated by or against us whether successful or not, could result in expensive costs of defense, costly damage awards, injunctive relief, increased costs of business, fines or orders to change certain business practices, significant dedication of management time, diversion of significant operational resources or some other harm to the business. In any of these cases, our business, financial condition or results of operations could be negatively impacted. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. Depending on the nature and timing of any such controversy, an unfavorable resolution of a matter could materially affect our future business, financial condition or results of operations, or all of the foregoing, in a particular quarter.

 

67

 

 

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain qualified directors and officers.

 

We will face increased legal, accounting, administrative and other costs and expenses as a public company that we did not incur as a private company. The Sarbanes-Oxley Act, including the requirements of Section 404, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements will increase costs and make certain activities more time- consuming. A number of those requirements will require us to carry out activities we had not done previously.

 

If any issues in complying with those requirements are identified (for example, if we or the auditors identify a material weakness or significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of it. It may also be more expensive to obtain director and officer liability insurance. Risks associated with our status as a public company may make it more difficult to attract and retain qualified persons to serve on our board of directors or as executive officers. The additional reporting and other obligations imposed by these rules and regulations will increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. These increased costs will require us to divert a significant amount of money that could otherwise be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further increase costs.

 

Our ability to use net operating loss carryforwards and certain other tax attributes may be limited.

 

We have incurred substantial losses during our history and do not expect to become profitable in the near future and may never achieve profitability. Under current U.S. federal income tax law, unused losses for the tax year ended December 31, 2017 and prior tax years will carry forward to offset future taxable income, if any, until such unused losses expire, and unused federal losses generated after December 31, 2017 will not expire and may be carried forward indefinitely but will be only deductible to the extent of 80% of current year taxable income in any given year. Many states have similar laws.

 

In addition, both current and future unused net operating loss (“NOL”) carryforwards and other tax attributes may be subject to limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”), if a corporation undergoes an “ownership change,” generally defined as a greater than 50 percentage point change (by value) in equity ownership by certain stockholders over a three-year period. The Business Combination may have resulted in an ownership change for us and, accordingly, our NOL carryforwards and certain other tax attributes may be subject to limitations (or disallowance) on their use after the Business Combination. Our NOL carryforwards may also be subject to limitation as a result of prior shifts in equity ownership. Additional ownership changes in the future could result in additional limitations on our NOL carryforwards. Consequently, even if we achieve profitability, we may not be able to utilize a material portion of our NOL carryforwards and other tax attributes, which could have a material adverse effect on cash flow and results of operations.

 

The trading price of our common stock may be volatile, and you could lose all or part of your investment.

 

Fluctuations in the price of our securities could contribute to the loss of all or part of your investment. Prior to the Business Combination, there was no public market for Solaria’s stock and trading in the shares of our common stock (prior to consummation of the Business Combination, “FACT Common Stock”) was not active. Accordingly, the valuation ascribed to Solaria and FACT Common Stock in the Business Combination may not have been indicative of the price that will prevail in the trading market following the Business Combination. If an active market for our securities develops and continues, the trading price of our securities could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment in our securities and our securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience a further decline.

 

68

 

 

Factors affecting the trading price of our securities:

 

actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us;

 

changes in the market’s expectations about our operating results;

 

success of competitors;

 

our operating results failing to meet the expectation of securities analysts or investors in a particular period;

 

changes in financial estimates and recommendations by securities analysts concerning us or the market in general;

 

operating and stock price performance of other companies that investors deem comparable to us;

 

our ability to develop product candidates;

 

changes in laws and regulations affecting our business;

 

commencement of, or involvement in, litigation involving us;

 

changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;

 

the volume of shares of our securities available for public sale

 

any major change in our board of directors or management;

 

sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; and

 

general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism.

 

If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our securities adversely, the price and trading volume of our securities could decline.

 

The trading market for our securities is influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. If any of the analysts who currently cover us change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our securities would likely decline. If any analyst who currently cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline. If we obtain additional coverage and any new analyst issues, an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our operating results fail to meet the expectations of analysts, our stock price could decline.

 

A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.

 

The price of our securities may fluctuate significantly due to general market and economic conditions and an active trading market for our securities may not be sustained. In addition, the price of our securities can vary due to general economic conditions and forecasts, our general business condition and the release of our financial reports. If our securities are not listed on, or become delisted from Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

 

69

 

 

There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.

 

If Nasdaq delists our securities from trading on its exchange for failure to meet the listing standards, we and our stockholders could face significant material adverse consequences including:

 

a limited availability of market quotations for our securities;

 

a determination that our common stock is a “penny stock” which will require brokers trading in our common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our common stock;

 

a limited amount of analyst coverage; and a decreased ability to issue additional securities or obtain additional financing in the future.

  

Sales of a substantial number of our common stock in the public market by our shareholders could cause the price of our common stock to decline.

 

Sales of a substantial number of shares of our common stock in the public market could occur at any time. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of our common stock in the public market, the market price of our common stock could decline.

 

Provisions in our Certificate of Incorporation and Bylaws and provisions of the Delaware General Corporation Law may delay or prevent an acquisition by a third party that could otherwise be in the interests of shareholders.

  

Our Certificate of Incorporation and Bylaws contain several provisions that may make it more difficult or expensive for a third party to acquire control of us without the approval of our board. These provisions, which may delay, prevent or deter a merger, acquisition, tender offer, proxy contest, or other transaction that stockholders may consider favorable, include the following:

 

advance notice requirements for stockholder proposals and director nominations;

 

provisions limiting stockholders’ ability to call special meetings of stockholders and to take action by written consent;

 

restrictions on business combinations with interested stockholders;

 

no cumulative voting; and

 

the ability of the board of directors to designate the terms of and issue new series of preferred stock without stockholder approval, which could be used, among other things, to institute a rights plan that would have the effect of significantly diluting the stock ownership of a potential hostile acquirer, likely preventing acquisitions by such acquirer.

 

These provisions of our Certificate of Incorporation and Proposed Bylaws could discourage potential takeover attempts and reduce the price that investors might be willing to pay for the shares of our common stock in the future, which could reduce the market price of our common stock. 

 

The provision of our Certificate of Incorporation requiring exclusive venue in the Court of Chancery in the State of Delaware and the federal district courts of the U.S. for certain types of lawsuits may have the effect of discouraging lawsuits against directors and officers.

  

Our Certificate of Incorporation provides that, unless otherwise consented to by us in writing, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) will, to the fullest extent permitted by law, be the sole and exclusive forum for the following types of actions or proceedings:

 

any derivative action or proceeding brought on behalf of us;

 

any action asserting a claim of breach of a duty (including any fiduciary duty) owed by any of our current or former directors, officers, stockholders, employees or agents to us or our stockholders;

 

any action asserting a claim against us or any of our current or former directors, officers, stockholders, employees or agents relating to any provision of the Delaware General Corporation Law (“DGCL”) or our Certificate of Incorporation or the Bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; and

 

70

 

 

any action asserting a claim against us or any of our current or former directors, officers, stockholders, employees or agents governed by the internal affairs doctrine of the State of Delaware, in each such case unless the Court of Chancery (or such other state or federal court located within the State of Delaware, as applicable) has dismissed a prior action by the same plaintiff asserting the same claims because such court lacked personal jurisdiction over an indispensable party named as a defendant therein.

 

Our Certificate of Incorporation will further provide that, unless otherwise consented to by us in writing to the selection of an alternative forum, the federal district courts of the U.S. will, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint against any person in connection with any offering of our securities, asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in our securities will be deemed to have notice of and consented to this provision.

 

Although our Certificate of Incorporation contains the choice of forum provisions described above, it is possible that a court could rule that such provisions are inapplicable for a particular claim or action or that such provisions are unenforceable. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. In addition, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and, therefore, the exclusive forum provisions described above do not apply to any actions brought under the Exchange Act.

 

Although we believe these provisions will benefit us by limiting costly and time-consuming litigation in multiple forums and by providing increased consistency in the application of applicable law, these exclusive forum provisions may limit the ability of our shareholders to bring a claim in a judicial forum that such shareholders find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and other employees.

 

We may be required to repurchase up to 6,720,000 shares of common stock from the investors with whom we entered into Forward Purchase Agreements in connection with the closing of the Business Combination, which would reduce the amount of cash available to us to fund our growth plan.

 

On and around July 13, 2023, FACT entered into separate Forward Purchase Agreements with certain investors (together, the “FPA Investors”), pursuant to which FACT (now Complete Solaria following the Closing) agreed to purchase in the aggregate, on the date that is 24 months after the Closing Date (the “Maturity Date”), up to 6,720,000 shares of common stock then held by the FPA Investors (subject to certain conditions and purchase limits set forth in the Forward Purchase Agreements). Pursuant to the terms of the Forward Purchase Agreements, each FPA Investor further agreed not to redeem any of the FACT Class A Ordinary Shares owned by it at such time. The per price at which the FPA Investors have the right to sell the shares to us on the Maturity Date will not be less than $5.00 per share.

 

If the FPA Investors hold some or all of the 6,720,000 forward purchase agreement shares on the Maturity Date, and the per share trading price of our common stock is less than the per share price at which the FPA Investors have the right to sell the common stock to us on the Maturity Date, we would expect that the FPA Investors will exercise this repurchase right with respect to such shares. In the event that we are required to repurchase these forward purchase agreement shares, or in the event that the forward purchase agreements are terminated the amount of cash arising from the Business Combination that would ultimately be available to fund our liquidity and capital resource requirements would be reduced accordingly, which would adversely affect our ability to fund our growth plan in the manner we had contemplated when entering into the forward purchase agreements.

 

Warrants to purchase shares of our common stock may not be exercised at all or may be exercised on a cashless basis and we may not receive any cash proceeds from the exercise of such warrants.

 

The exercise price of warrants to purchase shares of our common stock may be higher than the prevailing market price of the underlying shares of common stock. The exercise price of such warrants is subject to market conditions and may not be advantageous if the prevailing market price of the underlying shares of common stock is lower than the exercise price. The cash proceeds associated with the exercise of such warrants to purchase our common stock are contingent upon our stock price. The value of our common stock will fluctuate and may not align with the exercise price of such warrants at any given time. If such warrants are “out of the money,” meaning the exercise price is higher than the market price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we may not receive any proceeds from the exercise of such warrants.

 

Furthermore, with regard to certain warrants to purchase shares of our common stock that were issued in a private placement at the time of FACT’s IPO and warrants issued to certain selling securityholders in connection with conversion of working capital loans, it is possible that we may not receive cash upon their exercise, since these warrants may be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock without the need for a cash payment. Instead of paying cash upon exercise, the warrant holder would receive a reduced number of shares based on a predetermined formula. As a result, the number of shares issued through a cashless exercise will be lower than if the warrants were exercised on a cash basis, which could impact the cash proceeds we receive from the exercise of such warrants.

 

71

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit Number   Exhibit Description   Form   File Number   Exhibit   Filing Date
2.1   Amended and Restated Business Combination Agreement, dated as of May 26, 2023, by and among Freedom Acquisition I Corp., Jupiter Merger Sub I Corp., Jupiter Merger Sub II LLC, Complete Solar Holding Corporation, and The Solaria Corporation   S-4   333-269674   2.1   May 31, 2023
2.2   Agreement and Plan of Merger, dated as of October 3, 2022, by and between Complete Solar Holding Corporation, Complete Solar Midco, LLC, Complete Solar Merger Sub, Inc., The Solaria Corporation, and Fortis Advisors LLC   S-4   333-269674   2.4   February 10, 2023
2.3   Asset Purchase Agreement dated September 19, 2023, by and among Complete Solaria, Inc., SolarCA, LLC, and Maxeon Solar Technologies, Ltd.   8-K   001-40117   2.1   2023-09-21
3.1   Certificate of Incorporation of Complete Solaria   8-K   001-40017   3.1   2023-07-21
3.2   Bylaws of Complete Solaria   8-K   001-40017   3.2   2023-07-21
4.1   Form of Replacement Warrant   8-K   001-40117   4.1   2023-10-12
4.2   Form of First Amendment to Replacement Warrant   8-K   001-40117   4.2   2023-10-12
4.3   Amended and Restated Registration Rights Agreement, dated July 18, 2023, by and among the Company and certain other stockholders party thereto   8-K   001-40117   4.1   2023-07-24
4.4   Warrant Agreement, dated February 25, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent   8-K   001-40117   4.1   2021-03-2
10.1   Form of SAFE (2024)   8-K   001-40017   10.1   2024-02-16
31.1*   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                
31.2*   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                
32.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                
32.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                
101*   Inline XBRL Document Set for the unaudited consolidated condensed financial statements and accompanying notes in Consolidated Condensed Financial Statements and Supplemental Details                
104*   Cover Page Interactive Data File - formatted in Inline XBRL and included as Exhibit 101                

 

*Filed herewith

 

**Furnished herewith

 

72

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Complete Solaria, Inc.
     
Date: May 15, 2024 By: /s/ THURMAN J. RODGERS
    Thurman J. Rodgers
    Chief Executive Officer and Executive Chairman
     
Date: May 15, 2024 By: /s/ BRIAN WUEBBELS
    Brian Wuebbels
    Chief Operating Officer

 

 

73

 

 

277965000 0.20 0.62 0.31 0.20 0.93 25200347 49077330 25200347 49077330 0.20 0.62 0.31 0.20 0.93 false --12-31 Q1 0001838987 0001838987 2024-01-01 2024-03-31 0001838987 cslr:CommonStockParValue00001PerShareMember 2024-01-01 2024-03-31 0001838987 cslr:RedeemableWarrantsEachWholeWarrantExercisableForOneCommonStockMember 2024-01-01 2024-03-31 0001838987 2024-05-13 0001838987 2024-03-31 0001838987 2023-12-31 0001838987 2023-01-01 2023-04-02 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001838987 us-gaap:CommonStockMember 2023-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001838987 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2024-01-01 2024-03-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001838987 us-gaap:CommonStockMember 2024-03-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2024-03-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-01-01 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-01-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-01-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-01-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-01-01 0001838987 2023-01-01 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0001838987 cslr:AdjustedMember 2023-01-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-04-02 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-04-02 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-04-02 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-02 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-04-02 0001838987 us-gaap:CommonStockMember 2023-04-02 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-04-02 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0001838987 2023-04-02 0001838987 cslr:SolariaMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001838987 cslr:SolariaMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEInvestorsMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEFinancingMember 2024-01-01 2024-03-31 0001838987 cslr:SubscriptionAgreementsMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEFinancingMember 2024-03-31 0001838987 cslr:NewMoneyPIPEInvestorsMember 2024-01-01 2024-03-31 0001838987 cslr:NewMoneyPIPESubscriptionAgreementMember 2024-01-01 2024-03-31 0001838987 cslr:SolariaMember us-gaap:CommonStockMember 2024-03-31 0001838987 2023-03-31 0001838987 us-gaap:CommonClassAMember 2023-03-31 0001838987 cslr:FACTInvestorsMember us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 2023-03-31 2023-03-31 0001838987 cslr:SolariaMember us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 cslr:SolariaMember us-gaap:CommonClassBMember 2023-03-31 2023-03-31 0001838987 cslr:DisposalAgreementMember 2023-10-31 2023-10-31 0001838987 cslr:MaxeonMember us-gaap:CommonStockMember 2023-10-31 0001838987 cslr:DisposalAgreementMember 2023-01-01 2023-12-31 0001838987 cslr:LiquidityAndGoingConcernMember 2024-01-01 2024-03-31 0001838987 cslr:LiquidityAndGoingConcernMember 2023-04-02 2023-04-02 0001838987 cslr:LiquidityAndGoingConcernMember 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001838987 cslr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-12-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 cslr:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 cslr:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:OneSupplierMember 2023-01-08 2023-04-02 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:OneSupplierMember 2023-01-01 2023-12-31 0001838987 2023-04-01 2024-03-31 0001838987 2022-04-01 2023-04-02 0001838987 cslr:SolarEnergySystemInstallationsMember 2024-01-01 2024-03-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-04-02 2023-04-02 0001838987 cslr:SoftwareServicesMember 2024-01-01 2024-03-31 0001838987 cslr:SoftwareServicesMember 2023-04-02 2023-04-02 0001838987 2023-04-02 2023-04-02 0001838987 us-gaap:FairValueInputsLevel1Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PublicWarrantsMember 2023-12-31 0001838987 cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember cslr:MeasurementInputVolatilityMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember cslr:MeasurementInputVolatilityMember 2023-01-01 2023-12-31 0001838987 2023-01-01 2023-12-31 0001838987 2023-01-01 2023-07-31 0001838987 cslr:LegacyCompleteSolariaMember us-gaap:CommonClassAMember 2024-03-31 0001838987 srt:MaximumMember 2024-03-31 0001838987 srt:MinimumMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2023-12-31 0001838987 us-gaap:CommonClassBMember 2023-12-31 0001838987 cslr:SponsorMember 2023-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-01-01 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-01-01 2023-12-31 0001838987 cslr:FPASMember 2024-01-01 2024-03-31 0001838987 cslr:FPASMember 2024-03-31 0001838987 cslr:CompleteSolariaCommonStockMember 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2023-12-31 0001838987 cslr:FPASMember 2023-12-18 2023-12-18 0001838987 2023-12-18 2023-12-18 0001838987 2023-12-18 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-04-02 0001838987 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001838987 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001838987 cslr:ManufacturingEquipmentMember 2024-03-31 0001838987 cslr:ManufacturingEquipmentMember 2023-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001838987 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001838987 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001838987 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-04-02 0001838987 us-gaap:PreferredStockMember 2023-12-31 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001838987 cslr:CarlyleWarrantsMember 2022-02-28 0001838987 cslr:BlackScholesModelMember 2024-01-01 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-31 0001838987 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 cslr:CompleteSolariaMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember cslr:BlackScholesModelMember 2024-01-01 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember 2022-11-30 0001838987 cslr:SeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:SeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:SeriesD7WarrantsMember 2024-03-31 0001838987 cslr:SecondTrancheSeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:MergerTransactionMember 2024-03-31 0001838987 cslr:SeriesD7WarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2023-07-18 2023-07-18 0001838987 cslr:CommonStockForTheFirstTrancheMember 2023-07-18 0001838987 cslr:CommonStockForTheSecondTrancheMember 2023-07-18 0001838987 cslr:SeriesD7PreferredStockConvertedIntoWarrantsToPurchaseMember 2023-10-31 0001838987 cslr:ReplacementWarrantsMember 2023-10-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember cslr:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:SeriesBPreferredStockMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember us-gaap:CommonClassAMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesBWarrantsMember 2022-12-01 2022-12-31 0001838987 cslr:SeriesCWarrantsMember 2016-07-30 0001838987 us-gaap:SeriesCPreferredStockMember 2016-07-30 0001838987 cslr:SeriesCWarrantsMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 2020-01-31 0001838987 cslr:SeriesCWarrantsMember 2020-01-31 2020-01-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-05-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-08-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-08-31 2021-08-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-05-31 2021-05-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 2021-10-31 0001838987 cslr:November2022CommonStockWarrantsMember 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-31 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-01 2023-05-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:ClassACommonStockEqualsOrExceedsThresholdTwoMember us-gaap:PrivatePlacementMember 2023-07-31 0001838987 cslr:WarrantConsiderationMember 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember 2023-12-31 0001838987 cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PublicWarrantsMember 2023-12-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 cslr:ConvertibleSecuredNoteMember cslr:TwoZeroOneEightBridgeNotesMember 2018-12-31 0001838987 cslr:ConvertibleNotesEmbeddedDerivativeLiabilityMember 2022-01-01 2022-12-31 0001838987 cslr:ConvertibleSecuredNoteMember 2018-12-31 0001838987 srt:MinimumMember 2018-12-31 2022-12-31 0001838987 srt:MaximumMember 2018-12-31 2022-12-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-01-01 2023-12-31 0001838987 cslr:RevolvingLoanMember 2023-01-01 2023-12-31 0001838987 cslr:RevolvingLoanMember 2024-01-01 2024-03-31 0001838987 cslr:RevolvingLoanMember 2024-03-31 0001838987 cslr:RevolvingLoanMember 2023-04-02 2023-04-02 0001838987 cslr:RodgersMasseyMember 2023-10-31 2023-10-31 0001838987 2022-01-01 2022-12-31 0001838987 2023-09-30 2023-09-30 0001838987 cslr:DebtInCSSolisMember 2024-01-01 2024-03-31 0001838987 2023-10-01 2023-10-01 0001838987 cslr:CSSoilsMember 2024-03-31 0001838987 cslr:CSSoilsMember 2023-04-02 0001838987 us-gaap:InterestExpenseMember 2023-04-02 2023-04-02 0001838987 cslr:PromissoryNoteMember cslr:CurrentInsightPromissoryNoteMember 2024-01-31 2024-01-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2024-01-31 2024-01-31 0001838987 2024-01-31 2024-01-31 0001838987 us-gaap:InterestExpenseMember 2024-01-31 2024-01-31 0001838987 cslr:CSSoilsMember 2024-01-31 2024-01-31 0001838987 cslr:SAFEPriceMember 2024-01-31 0001838987 2024-02-15 2024-02-15 0001838987 cslr:ConvertibleNoteMember cslr:TwoThousandNineteenAConvertibleNotesMember 2024-02-15 2024-02-15 0001838987 cslr:CSSoilsMember 2024-02-15 2024-02-15 0001838987 cslr:SecondSAFEMember 2024-02-15 0001838987 cslr:SecondSAFEMember 2024-02-15 2024-02-15 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2024-03-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-12-31 0001838987 cslr:RevolverLoanMember 2024-03-31 0001838987 cslr:RevolverLoanMember 2023-12-31 0001838987 cslr:SecuredCreditFacilityMember 2024-03-31 0001838987 cslr:SecuredCreditFacilityMember 2023-12-31 0001838987 cslr:PolarSettlementAgreementMember 2024-03-31 0001838987 cslr:PolarSettlementAgreementMember 2023-12-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-07-31 0001838987 cslr:ISOsUnderThe2023PlanMember 2023-07-31 2023-07-31 0001838987 cslr:ServiceBasedOptioMember 2024-03-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001838987 cslr:ServiceBasedOptioMember 2024-01-01 2024-03-31 0001838987 2023-12-31 2023-12-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember 2023-01-01 2023-04-02 0001838987 cslr:SolarParkKoreaCoLTDMember 2023-01-31 2023-01-31 0001838987 2023-02-28 2023-02-28 0001838987 2023-03-16 2023-03-16 0001838987 2021-07-22 0001838987 2024-02-01 2024-02-22 0001838987 2023-08-24 2023-08-24 0001838987 cslr:ChinaBridgeMember 2023-08-24 2023-08-24 0001838987 cslr:CommonStockWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:CommonStockWarrantsMember 2023-01-01 2023-12-31 0001838987 cslr:PreferredStockWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:PreferredStockWarrantsMember 2023-01-01 2023-12-31 0001838987 cslr:StockOptionsAndRSUsIssuedAndOutstandingMember 2024-01-01 2024-03-31 0001838987 cslr:StockOptionsAndRSUsIssuedAndOutstandingMember 2023-01-01 2023-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember cslr:ConvertiblePromissoryNotesMember 2022-10-01 2023-06-30 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-10-01 2023-06-30 0001838987 2022-10-01 2023-06-30 0001838987 srt:MaximumMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001838987 srt:MinimumMember us-gaap:RelatedPartyMember 2023-04-02 2023-04-02 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 2020-01-01 2020-12-31 0001838987 us-gaap:RelatedPartyMember cslr:ConvertiblePromissoryNotesMember 2023-07-31 0001838987 cslr:FPAMember 2023-01-01 2023-12-31 0001838987 us-gaap:RelatedPartyMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001838987 2022-03-01 2022-03-31 0001838987 2022-03-31 0001838987 cslr:SettlementAgreementMember 2023-01-01 2023-12-31 0001838987 us-gaap:SubsequentEventMember 2024-04-19 2024-04-19 0001838987 cslr:FirstSAFEMember us-gaap:SubsequentEventMember 2024-04-19 0001838987 cslr:FirstSAFEMember 2024-01-01 2024-03-31 0001838987 cslr:SecondSAFEMember 2024-01-01 2024-03-31 0001838987 us-gaap:SubsequentEventMember 2024-04-16 2024-04-16 0001838987 2024-04-19 2024-04-19 0001838987 srt:ScenarioForecastMember 2024-05-01 0001838987 srt:ScenarioForecastMember 2024-05-01 2024-05-01 0001838987 2024-05-01 2024-05-01 0001838987 srt:ScenarioForecastMember cslr:KlineHillMember 2024-04-19 0001838987 cslr:KlineHillMember 2024-04-19 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 ea020562901ex31-1_complete.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, Thurman J. Rodgers, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Complete Solaria, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024   By: /s/ Thurman J. Rodgers
        Thurman J. Rodgers and Executive Chairman
        Chief Executive Officer
        (Principal Executive Officer)

 

 

EX-31.2 3 ea020562901ex31-2_complete.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Brian Wuebbels, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Complete Solaria, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2024   By: /s/ Brian Wuebbels
        Brian Wuebbels
        Chief Operating Officer
        (Principal Financial Officer and
        Principal Accounting Officer)

EX-32.1 4 ea020562901ex32-1_complete.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Complete Solaria, Inc. (the “Company”) for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024 /s/ Thurman J. Rodgers
  Thurman J. Rodgers and Executive Chairman
  Chief Executive Officer
  (Principal Executive Officer)

 

 

EX-32.2 5 ea020562901ex32-2_complete.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION OF CHIEF OPERATING OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Complete Solaria, Inc. (the “Company”) for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2024 /s/ Brian Wuebbels
  Brian Wuebbels
  Chief Operating Officer
  (Principal Financial Officer and
  Principal Accounting Officer)

 

 

 

EX-101.SCH 6 cslr-20240331.xsd XBRL SCHEMA FILE 995301 - Statement - Unaudited Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 995302 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 995303 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 995304 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 995305 - Statement - Unaudited Condensed Consolidated Statements of Stockholders’ Deficit link:presentationLink link:definitionLink link:calculationLink 995306 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 995307 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 995308 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 995309 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 995310 - Disclosure - Reverse Recapitalization link:presentationLink link:definitionLink link:calculationLink 995311 - Disclosure - Forward Purchase Agreements link:presentationLink link:definitionLink link:calculationLink 995312 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 995313 - Disclosure - Divestiture link:presentationLink link:definitionLink link:calculationLink 995314 - Disclosure - Property and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 995315 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:definitionLink link:calculationLink 995316 - Disclosure - Other Expense, Net link:presentationLink link:definitionLink link:calculationLink 995317 - Disclosure - Common Stock link:presentationLink link:definitionLink link:calculationLink 995318 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 995319 - Disclosure - Borrowings and SAFE Agreements link:presentationLink link:definitionLink link:calculationLink 995320 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 995321 - Disclosure - Employee Stock Purchase Plan link:presentationLink link:definitionLink link:calculationLink 995322 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 995323 - Disclosure - Basic and Diluted Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 995324 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 995325 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 996000 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 996001 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 996002 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 996003 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:definitionLink link:calculationLink 996004 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 996005 - Disclosure - Divestiture (Tables) link:presentationLink link:definitionLink link:calculationLink 996006 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 996007 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 996008 - Disclosure - Other Expense, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 996009 - Disclosure - Common Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 996010 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 996011 - Disclosure - Borrowings and SAFE Agreements (Tables) link:presentationLink link:definitionLink link:calculationLink 996012 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 996013 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 996014 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 996015 - Disclosure - Organization (Details) link:presentationLink link:definitionLink link:calculationLink 996016 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash link:presentationLink link:definitionLink link:calculationLink 996018 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services link:presentationLink link:definitionLink link:calculationLink 996019 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 996020 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis link:presentationLink link:definitionLink link:calculationLink 996021 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method link:presentationLink link:definitionLink link:calculationLink 996022 - Disclosure - Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility link:presentationLink link:definitionLink link:calculationLink 996023 - Disclosure - Reverse Recapitalization (Details) link:presentationLink link:definitionLink link:calculationLink 996024 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding link:presentationLink link:definitionLink link:calculationLink 996025 - Disclosure - Forward Purchase Agreements (Details) link:presentationLink link:definitionLink link:calculationLink 996026 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 996027 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 996028 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:definitionLink link:calculationLink 996029 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 996030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities link:presentationLink link:definitionLink link:calculationLink 996031 - Disclosure - Other Expense, Net (Details) link:presentationLink link:definitionLink link:calculationLink 996032 - Disclosure - Other Expense, Net (Details) - Schedule of Other Expense, Net link:presentationLink link:definitionLink link:calculationLink 996033 - Disclosure - Common Stock (Details) link:presentationLink link:definitionLink link:calculationLink 996034 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock link:presentationLink link:definitionLink link:calculationLink 996035 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 996036 - Disclosure - Warrants (Details) - Schedule of Liability-Classified Warrants link:presentationLink link:definitionLink link:calculationLink 996037 - Disclosure - Borrowings and SAFE Agreements (Details) - Part-1 link:presentationLink link:definitionLink link:calculationLink 996038 - Disclosure - Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes link:presentationLink link:definitionLink link:calculationLink 996039 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 996040 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity link:presentationLink link:definitionLink link:calculationLink 996041 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity link:presentationLink link:definitionLink link:calculationLink 996042 - Disclosure - Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 996043 - Disclosure - Employee Stock Purchase Plan (Details) link:presentationLink link:definitionLink link:calculationLink 996044 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 996045 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company’s Warranty Provision link:presentationLink link:definitionLink link:calculationLink 996046 - Disclosure - Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 996047 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:definitionLink link:calculationLink 996048 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 996049 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 996050 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 996051 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 cslr-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cslr-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cslr-20240331_lab.xml XBRL LABEL FILE EX-101.PRE 10 cslr-20240331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 13, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name COMPLETE SOLARIA, INC.  
Entity Central Index Key 0001838987  
Entity File Number 001-40117  
Entity Tax Identification Number 93-2279786  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 45700 Northport Loop East  
Entity Address, City or Town Fremont  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94538  
Entity Phone Fax Numbers [Line Items]    
City Area Code (510)  
Local Phone Number 270-2507  
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   49,096,537
Common stock, par value $0.0001 per share    
Entity Listings [Line Items]    
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol CSLR  
Security Exchange Name NASDAQ  
Redeemable warrants, each whole warrant exercisable for one common stock    
Entity Listings [Line Items]    
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one common stock  
Trading Symbol CSLRW  
Security Exchange Name NASDAQ  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,786 $ 2,593
Accounts receivable, net 20,939 26,281
Inventories 2,773 3,058
Prepaid expenses and other current assets 5,776 5,817
Total current assets 31,274 37,749
Restricted cash 3,829 3,823
Property and equipment, net 4,495 4,317
Operating lease right-of-use assets 1,054 1,235
Other noncurrent assets 198 198
Total assets 40,850 47,322
Current liabilities:    
Accounts payable 10,521 13,122
Accrued expenses and other current liabilities 24,893 27,870
Notes payable, net 29,365 28,657
Deferred revenue, current 2,010 2,423
Short-term debt with CS Solis 35,840 33,280
SAFE Agreements 5,000
Forward purchase agreement liabilities 9,409 3,831
Total current liabilities 117,038 109,183
Warranty provision, noncurrent 3,416 3,416
Warrant liability 3,877 9,817
Deferred revenue, noncurrent 1,055 1,055
Operating lease liabilities, net of current portion 543 664
Total liabilities 125,929 124,135
Commitments and contingencies (Note 16)
Stockholders’ (deficit) equity:    
Common stock, $0.0001 par value; Authorized 1,000,000,000 and 1,000,000,000 shares as of March 31, 2024 and December 31, 2023, respectively; issued and outstanding 49,096,537 and 49,065,361 shares as of March 31, 2024 and December 31, 2023, respectively 7 7
Additional paid-in capital 279,332 277,965
Accumulated other comprehensive loss 98 143
Accumulated deficit (364,516) (354,928)
Total stockholders’ (deficit) equity (85,079) (76,813)
Total liabilities and stockholders’ equity $ 40,850 $ 47,322
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stocks, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 49,096,537 49,065,361
Common stock, shares outstanding 49,096,537 49,065,361
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Income Statement [Abstract]    
Revenues $ 10,040 $ 16,677
Cost of revenues 7,757 13,827
Gross profit 2,283 2,850
Operating expenses:    
Sales commissions 3,116 5,677
Sales and marketing 1,618 683
General and administrative 5,093 8,913
Total operating expenses 9,827 15,273
Loss from continuing operations (7,544) (12,423)
Interest expense(1) (3,568) (3,611)
Interest income 6 8
Other income, net 1,519 317
Total Other expense (2,043) (3,286)
Loss from continuing operations before income taxes (9,587) (15,709)
Income tax benefit (provision) (1)
Net loss from continuing operations (9,588) (15,709)
Loss from discontinued operations, net of tax (7,805)
Net loss from discontinued operations, net of taxes (7,805)
Net loss (9,588) (23,514)
Other Comprehensive (loss) income:    
Foreign currency translation adjustment (45) 1
Comprehensive loss (net of tax) $ (9,633) $ (23,513)
Net loss from continuing operations per share attributable to common stockholders, basic (in Dollars per share) $ (0.2) $ (0.62)
Net loss from discontinued operations per share attributable to common stockholders, basic (in Dollars per share) (0.31)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.2) $ (0.93)
Weighted-average shares used to compute net loss per share attributable to common stockholders’, basic (in Shares) 49,077,330 25,200,347
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Income Statement [Abstract]    
Net loss from continuing operations per share attributable to common stockholders, diluted $ (0.20) $ (0.62)
Net loss from discontinued operations per share attributable to common stockholders, diluted (0.31)
Net loss per share attributable to common stockholders, diluted $ (0.20) $ (0.93)
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in Shares) 49,077,330 25,200,347
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
$ in Thousands
Preferred Stock
Redeemable Convertible
Adjusted
Preferred Stock
Redeemable Convertible
Common Stock
Adjusted
Common Stock
Additional Paid-in Capital
Adjusted
Additional Paid-in Capital
Accumulated Deficit
Adjusted
Accumulated Deficit
Accumulated Other Comprehensive Income
Adjusted
Accumulated Other Comprehensive Income
Adjusted
Total
Balance at Dec. 31, 2022   $ 155,630     $ 34,997   $ (85,373)   $ 27   $ (50,349)
Balance (in Shares) at Dec. 31, 2022   34,311,133   6,959,618                
Retroactive application of recapitalization   $ (155,630)   $ 3   155,627       155,630
Retroactive application of recapitalization (in Shares)   (34,311,133)   12,972,811                
Balance at Jan. 01, 2023   $ 3   $ 190,624   $ (85,373)   $ 27   $ (105,281)  
Balance (in Shares) at Jan. 01, 2023     19,932,429                  
Balance at Dec. 31, 2022   $ 155,630     34,997   (85,373)   27   (50,349)
Balance (in Shares) at Dec. 31, 2022   34,311,133   6,959,618                
Exercise of common stock options       55       55
Exercise of common stock options (in Shares)       137,452                
Stock-based compensation       1,022       1,022
Net loss         (23,514)     (23,514)
Foreign currency translation adjustment           1   1
Balance at Apr. 02, 2023     $ 3   191,701   (108,887)   28   82,845
Balance (in Shares) at Apr. 02, 2023     20,069,881                
Balance at Dec. 31, 2023     $ 7   277,965   (354,928)   143   (76,813)
Balance (in Shares) at Dec. 31, 2023     49,065,361                
Exercise of common stock options       26       $ 26
Exercise of common stock options (in Shares)       31,176               31,176
Stock-based compensation       1,341       $ 1,341
Net loss         (9,588)     (9,588)
Foreign currency translation adjustment           (45)   (45)
Balance at Mar. 31, 2024     $ 7   $ 279,332   $ (364,516)   $ 98   $ (85,079)
Balance (in Shares) at Mar. 31, 2024       49,096,537                
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Cash flows from operating activities from continuing operations    
Net loss $ (9,588) $ (23,514)
Loss from discontinued operations, net of income taxes (7,805)
Net loss from continuing operations, net of tax (9,588) (15,709)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:    
Stock-based compensation expense 1,341 270
Non-cash interest expense 1,008 1,248
Non-cash lease expense 181 248
Depreciation and amortization 357 189
Provision for credit losses 62 2,117
Change in reserve for excess and obsolete inventory (344) 791
Change in fair value of forward purchase agreement liabilities 5,578
Change in fair value of warrant liabilities (7,246) (209)
Accretion of debt in CS Solis 2,560 752
Changes in operating assets and liabilities:    
Accounts receivable, net 5,280 (3,197)
Inventories 629 (570)
Prepaid expenses and other current assets 41 (1,857)
Other noncurrent assets (848)
Accounts payable (2,599) 2,132
Accrued expenses and other current liabilities (1,613) (581)
Operating lease liabilities (180) (86)
Warranty provision, noncurrent 100
Deferred revenue (413) (906)
Net cash used in operating activities from continuing operations (4,946) (16,116)
Net cash used in operating activities from discontinued operations (162)
Net cash used in operating activities (4,946) (16,278)
Cash flows from investing activities from continuing operations    
Purchase of property and equipment (30)
Capitalization of internal-use software costs (536) (457)
Proceeds from sale of property and equipment 1
Net cash used in investing activities from continuing operations (536) (486)
Cash flows from financing activities from continuing operations    
Proceeds from issuance of notes payable, net 14,102
Principal repayment of notes payable (300) (9,603)
Proceeds from issuance of convertible notes, net of issuance cost 11,000
Proceeds from exercise of common stock options 26 55
Proceeds from issuance of SAFE agreements 5,000
Net cash provided by financing activities from continuing operations 4,726 15,554
Effect of exchange rate changes (45) 1
Net decrease in cash, cash equivalents and restricted cash (801) (1,209)
Cash, cash equivalents, and restricted cash at beginning of period 6,416 8,316
Cash, cash equivalents, and restricted cash at end of period 5,615 7,107
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest $ 1,608
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Organization
3 Months Ended
Mar. 31, 2024
Organization [Abstract]  
Organization
(1)Organization

 

(a) Description of Business

 

Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”).

 

Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. were transferred to Complete Solar Holdings at their carrying value, and there were no changes to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application.

 

In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.

 

The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”

 

As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT effected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).

 

In connection with the closing of the Mergers:

 

Each share of the Company’s capital stock, inclusive of shares converted from the 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.

 

In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.

 

All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.

 

On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.

 

Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.

 

In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.

 

Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.

 

In November 2022, Complete Solar Holdings acquired Solaria and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. Refer to Note 1(b) – Divestiture and Note 7 – Divestiture.

 

(b) Divestiture

 

In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. As of December 31, 2023, the Company sold all its Maxeon shares and recorded a loss of $4.2 million in its unaudited condensed consolidated statements of operations and comprehensive loss within loss from continuing operations.

 

This divestiture represented a strategic shift in Complete Solaria’s business and qualified as held for sale and as a discontinued operation. Based on the held for sale classification of the assets, the Company reduced the carrying value of the disposal group to its fair value, less its cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive loss for all periods presented. The cash flows related to discontinued operations were segregated from continuing operations within the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 7 – Divestiture for additional information.

 

(c) Liquidity and Going Concern

 

Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $9.6 million and $23.5 million, during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, and had an accumulated deficit of $364.5 million and current debt of $65.2 million as of March 31, 2024. The Company had cash and cash equivalents of $1.8 million as of March 31, 2024. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

 

Management plans to obtain additional funding and restructure its current debt. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.

 

Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
(2)Summary of Significant Accounting Policies

 

(a)Basis of Presentation

 

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the Unites States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

(b)Use of Estimates

 

The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:

 

The allocation of the transaction price to identified performance obligations;

 

Fair value of warrant liabilities;

 

The reserve methodology for inventory obsolescence;

 

The reserve methodology for product warranty;

 

The reserve methodology for the allowance for credit losses;

 

The fair value of the forward purchase agreements; and

 

The measurement of stock-based compensation.

 

To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.

 

(c)Segment Information

 

The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated Company. All the Company’s long-lived assets are maintained in the United States of America.

 

(d)Concentration of Risks

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of March 31, 2024, two customers had an outstanding balance that represented 36% and 19% of the total accounts receivable balance. As of December 31, 2023, two customers had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.

 

Concentration of customers

 

For the thirteen-weeks ended March 31, 2024, one customer represented 76% of gross revenues. For the thirteen-weeks ended and April 2, 2023, three customers represented 29%, 23% and 12% of gross revenues.

 

Concentration of suppliers

 

For the thirteen-weeks ended March 31, 2024, and December 31, 2023, one supplier represented 34% and 40% of the Company’s inventory purchases, respectively.

 

(e)Cash and Cash Equivalents

 

The Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.

 

(f)Restricted Cash

 

The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. The restricted cash balance was $3.8 million at each of March 31, 2024 and December 31, 2023. Restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in its unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Cash and cash equivalents  $1,786   $2,593 
Restricted cash   3,829    3,823 
Total cash, cash equivalents and restricted cash  $5,615   $6,416 

 

(g)Revenue Recognition

 

Disaggregation of revenue

 

Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):

 

   Thirteen-weeks Ended 
   March 31,   April 2, 
   2024   2023 
Solar energy system installations  $9,922   $15,843 
Software enhanced services   118    834 
Total revenue  $10,040   $16,677 

 

All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was in the United States.

 

Remaining performance obligations

 

The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of March 31, 2024, the Company has deferred $1.1 million associated with a long-term service contract. As of December 31, 2023, the Company has deferred $1.2 million associated with a long-term service contract, which will be recognized evenly through 2028.

 

Incremental costs of obtaining customer contracts

 

Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. As of March 31, 2024 and December 31, 2023, deferred commissions were $5.1 million and $4.2 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.

 

Deferred revenue

 

The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within 12-months, the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirteen-week periods ended March 31, 2024 and April 2, 2023 that was included in deferred revenue at the beginning of each period was $1.3 million and $1.9 million, respectively.

 

(h)Fair Value Measurements

 

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.

 

When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

 

Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

 

Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

 

Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

 

Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities, SAFE Agreements and FPA liabilities.

 

The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).

 

The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.

 

(i)Direct Offering Costs

 

Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional paid-in capital and netted against the Mergers proceeds received upon close. As of March 31, 2024 and December 31, 2023, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.

 

(j)Warrant Liabilities

 

The Company accounts for its warrant liabilities in accordance with the guidance in ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 12 – Warrants.

 

(k)Forward Purchase Agreements

 

The Company accounts for its FPAs in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.

 

(l)Net Loss Per Share

 

The Company computes net loss per share following ASC 260, Earnings Per Share. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.

 

(m)Accounting Pronouncements Not Yet Adopted

 

In November 2023, the FASB issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. The Company is currently evaluating ASU 2023-07,but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements. 

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. The Company is currently evaluating ASU 2023-09 but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements
3 Months Ended
Mar. 31, 2024
Fair Value Measurements [Abstract]  
Fair Value Measurements
(3)Fair Value Measurements

 

The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):

 

   As of March 31, 2024 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                
Carlyle warrants  $   $   $3,086   $3,086 
Public warrants   437            437 
Private placement warrants       318        318 
Working capital warrants       36        36 
Replacement warrants           5    5 
Forward purchase agreement liabilities           9,409    9,409 
SAFE Agreements           5,000    5,000 
Total  $437   $354   $17,500   $18,291 

 

   As of December 31, 2023 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                    
Carlyle warrants  $
   $
   $9,515   $9,515 
Public warrants   167    
    
    167 
Private placement warrants   
    122    
    122 
Working capital warrants   
    14    
    14 
Replacement warrants   
    
    1,310    1,310 
Forward purchase agreement liabilities   
    
    3,831    3,831 
Total  $167   $136   $14,656   $14,959 

 

Carlyle Warrants

 

As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC and its affiliates (“Carlyle”), the Company issued Carlyle a warrant to purchase shares of Complete Solaria Common Stock at a price per share of $0.01. Refer to Note 12 – Warrants for further details. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:

 

   March 31,
2024
   December 31,
2023
 
Expected term   7.0 years    7.0 years 
Expected volatility   77.0%   77.0%
Risk-free interest rate   3.92%   3.92%
Expected dividend yield   0.0%   0.0%

 

Public, Private Placement and Working Capital Warrants

 

The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly-traded instruments.

 

Forward Purchase Agreement Liabilities

 

The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:

 

   March 31,
2024
   December 31,
2023
 
Common stock trading price  $0.59   $1.66 
Simulation period   1.30 years    1.55 years 
Risk-free interest rate   4.90%   4.48%
Volatility   112.0%   95.0%

 

Replacement Warrants

 

   March 31,
2024
   December 31,
2023
 
Expected term  0.8 years   0.3 years 
Expected volatility   78.5%   78.5%
Risk-free interest rate   5.49%   5.4%
Volatility   0.0%   0.0%

 

The Series D-7 redeemable convertible preferred stock warrants were initially accounted for as liabilities and measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 12 – Warrants, the redeemable convertible preferred stock warrants were reclassified to additional paid-in capital upon the closing of the Mergers. In October 2023, in connection with the Assignment and Acceptance Agreement as further described in Note 12 – Warrants, these warrants were replaced (“Replacement Warrants”), and the Replacement Warrants are classified as liabilities. Refer to Note 13 – Borrowings and SAFE Agreements.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Reverse Recapitalization
3 Months Ended
Mar. 31, 2024
Reverse Recapitalization [Abstract]  
Reverse Recapitalization
(4)Reverse Recapitalization

 

As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria was determined to be the accounting acquirer based on an evaluation of the following facts and circumstances:

 

Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post- merged company;

 

Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;

 

Legacy Complete Solaria’s management team is considered the management team of the post-merged company;

 

Legacy Complete Solaria’s prior operations are comprised of the ongoing operations of the post-merged company;

 

Complete Solaria is the larger entity based on historical revenues and business operations; and

 

the post-merged company has assumed Complete Solaria’s operating name.

 

Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The unaudited condensed consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.

 

Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million less non-cash net liabilities assumed from FACT of $10.1 million.

  

Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:

 

   Recapitalization 
FACT Class A Ordinary Shares, outstanding prior to Mergers   34,500,000 
FACT Class B Ordinary Shares, outstanding prior to Mergers   8,625,000 
Bonus shares issued to sponsor   193,976 
Bonus shares issued to PIPE investors   120,000 
Bonus shares issued to FPA investors   150,000 
Shares issued from PIPE financing   1,690,000 
Shares issued from FPA agreements, net of recycled shares   5,558,488 
Less: redemption of FACT Class A Ordinary Shares   (31,041,243)
Total shares from the Mergers and PIPE Financing   19,796,221 
Legacy Complete Solaria shares   20,034,257 
2022 Convertible Note Shares   5,460,075 
Shares of Complete Solaria Common stock immediately after Mergers   45,290,553 

 

In connection with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. The Company did not make any cash payments to settle transaction costs in the thirteen-weeks ended March 31, 2024. As of December 31, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Forward Purchase Agreements
3 Months Ended
Mar. 31, 2024
Forward Purchase Agreements [Abstract]  
Forward Purchase Agreements
(5)Forward Purchase Agreements

 

In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).

 

Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.

 

The key terms of the forward contracts are as follows:

 

The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the Seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.

 

The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.

 

The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to the Counterparty at the Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading day-period (the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price.

 

The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815, Derivatives and Hedging, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.

 

Additionally, in accordance with ASC 480, Distinguishing Liabilities from Equity, the Company has determined that the forward contracts are financial instruments other than shares that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the forward purchase liabilities at fair value and has subsequently remeasured them at fair value with changes in fair value recognized in earnings.

 

Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock in association with the FPAs.

 

As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss. Subsequently, the change of fair value of the forward purchase liabilities amounted to an expense of $5.6 million for the thirteen-weeks ended March 31, 2024. As of March 31, 2024, and December 31, 2023, the forward purchase liabilities amounted to $9.4 million and $3.8 million, respectively. Of the balances as of March 31, 2024 and December 31, 2023, $7.9 million and $3.2 million, respectively, are due to related parties Refer to Note 19 – Related Party Transactions for further details.

 

On December 18, 2023, the Company and the FPA Sellers entered into separate amendments to the FPAs (the “Amendments”). The Amendments lower the reset floor price of each FPA from $5.00 to $3.00 and allow the Company to raise up to $10.0 million of equity from existing stockholders without triggering certain anti-dilution provisions contained in the FPAs; provided, the insiders pay a price per share for their initial investment equal to the closing price per share as quoted on the Nasdaq on the day of purchase; provided, further, that any subsequent investments are made at a price per share equal to the greater of (a) the closing price per share as quoted by Nasdaq on the day of the purchase or (b) the amount paid in connection with the initial investment.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets
3 Months Ended
Mar. 31, 2024
Prepaid Expenses and Other Current Assets [Abstract]  
Prepaid Expenses and Other Current Assets
(6)Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

   As of 
   March 31,
2024
   December 31,
2023
 

Deferred commissions

  $5,098   $4,185 
Inventory deposits   -    616 
Other   678    1,016 
Total prepaid expenses and other current assets  $5,776   $5,817 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Divestiture
3 Months Ended
Mar. 31, 2024
Divestiture [Abstract]  
Divestiture
(7)Divestiture

 

Discontinued operations

 

As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement Disposal Agreement.

 

The components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive loss related to discontinued operations are presented in the table, as follows (in thousands):

 

   Thirteen-Weeks 
   Ended April 2,
2023
 
Revenues  $18,721 
Cost of revenues   19,479 
Gross loss   (758)
Operating expenses:     
Sales and marketing   2,866 
General and administrative   4,185 
Total operating expenses   7,051 
Loss from discontinued operations   (7,809)
Other income (expense), net   
 
Loss from discontinued operations before income taxes   (7,809)
Income tax benefit   4
Net loss from discontinued operations  $(7,805)
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net
3 Months Ended
Mar. 31, 2024
Property and Equipment, Net [Abstract]  
Property and Equipment, Net
(8)Property and Equipment, Net

 

Property and equipment, net consists of the following (in thousands, except year data):

 

   Estimated   As of 
     Useful Lives
(Years)
   March 31,
2024
   December 31,
2023
 
Developed software  5   $7,529   $6,993 
Manufacturing equipment  3    131    131 
Furniture and equipment  3    90    96 
Leasehold improvements  5    708    708 
Total property and equipment       8,464    7,928 
Less: accumulated depreciation and amortization               (3,969)   (3,611)
Total property and equipment, net      $4,495   $4,317 

 

Depreciation and amortization expense from continuing operations totaled $0.4 million and $0.2 million for the thirteen-week periods ended March 31, 2024 and April 2, 2023.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities
3 Months Ended
Mar. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities
(9)Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of the following (in thousands):

 

   As of 
   March 31,
2024
   December 31,
2023
 
Accrued compensation and benefits  $3,715   $3,969 
Customer deposits   296    544 
Uninvoiced contract costs   80    671 
           
Accrued term loan and revolving loan amendment and final payment fees   2,400    2,400 
Accrued legal settlements   7,700    7,700 
Accrued taxes   930    931 
Accrued rebates and credits   32    677 
Operating lease liabilities, current   548    607 
Accrued warranty, current   1,449    1,433 
Other accrued liabilities   7,743    8,938 
Total accrued expenses and other current liabilities  $24,893   $27,870 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other Expense, Net
3 Months Ended
Mar. 31, 2024
Other Expense, Net [Abstract]  
Other Expense, Net
(10)Other Expense, Net

 

Other expense, net consists of the following (in thousands):

 

  

Thirteen-Weeks
Ended

 
   March 31,
2024
   April 2,
2023
 
Change in fair value of redeemable convertible preferred stock warrant liability  $1,305   $209 
Change in fair value of Carlyle warrants   6,429    
 
Change in fair value of FACT public, private placement and working capital warrants   (489)   
 
Change in fair value of forward purchase agreement liabilities(1)   (5,578)   
 
Loss on discontinued Solaria business and other, net   (148)   108 
Total other income (expense), net  $1,519   $317 

 

(1)Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock
3 Months Ended
Mar. 31, 2024
Common Stock [Abstract]  
Common Stock
(11)Common Stock

 

The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of March 31, 2024. No preferred stock has been issued.

 

Common Stock Purchase Agreements

 

On December 18, 2023, the Company entered into separate common stock purchase agreements (the “Purchase Agreements”) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a “Purchaser”, and together, the “Purchasers”). Pursuant to the terms of the Purchase Agreements, each Purchaser purchased 1,838,235 shares of common stock of the Company, par value $0.0001, (the “Shares”), at a price per share of $1.36, representing an aggregate purchase price of $4,999,999.20. The Purchasers paid for the Shares in cash. Thurman J. Rodgers is a trustee of each Purchaser and is the Executive Chairman of the board of directors of the Company.

 

The Company has reserved shares of common stock for issuance related to the following:

 

   As of
March 31,
2024
 
Common stock warrants   27,637,266 
Employee stock purchase plan   2,628,996 
Stock options and RSUs, issued and outstanding   11,436,369 
Stock options and RSUs, authorized for future issuance   3,850,462 
Total shares reserved   45,553,093 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants
3 Months Ended
Mar. 31, 2024
Warrants [Abstract]  
Warrants
(12)Warrants

 

Liability-classified warrants

 

    As of  
    March 31,     December 31,  
    2024     2023  
Carlyle warrants   $ 3,086     $ 9,515  

Replacement warrants

    5       1,310  
Public warrants     437       167  
Private placements warrants     318       122  
Working capital warrants     36       13  
    $ 3,882     $ 11,127  

 

Carlyle Warrants

 

In February 2022, as part of a debt financing from Carlyle (Refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with long-term debt issued to Carlyle (“CS Solis Debt”). The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, expired on December 31, 2022 prior to becoming exercisable. In December 2023, Carlyle was issued an additional warrant to purchase an additional 2,190,604 shares of the Company’s common stock related to an anti-dilution provision within the CS Solis Debt that provides for such additional warrants under such circumstances as provided within the CS Solis Debt.

 

At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and no dividend yield. The fair value of the warrant was initially recorded within additional paid-in capital as it met the conditions for equity classification.

 

In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of December 31, 2023.

 

The modification of the warrant resulted in the reclassification of previously equity-classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718, Compensation – Stock Compensation. The Company recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the pre-modification fair value of the warrants as a reduction to additional paid-in capital of $10.9 million and an expense of $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be $20.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and no dividend yield. As of March 31, 2024, the fair value of the warrant was $3.1 million, and the Company recorded an income of $6.4 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.

 

Series D-7 Warrants (Converted to common stock warrants “Replacement Warrants”)

 

In November 2022, the Company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series D-7 warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers.

 

In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), (Refer to Note 13 – Borrowings and SAFE Agreements). In connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series D-7 warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series D-7 preferred stock converted into warrants to purchase 656,630 shares of common stock, the Replacement Warrants. As a result of the warrant amendment, the Company reclassified the Replacement Warrants from equity to liability. The Replacement Warrants were remeasured to their fair value on the amendment effective date, and the Company has recorded subsequent changes in fair value in other income (expense), net on its unaudited condensed consolidated statements of operations and comprehensive loss. The Replacement Warrants remain outstanding as of March 31, 2024.

 

Public, Private Placement, and Working Capital Warrants

 

In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, the Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the Company’s unaudited condensed consolidated balance sheets.

 

The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.7 million. The fair value of these warrants was $0.8 million as of March 31, 2024, and the Company recorded the change in fair value of $0.5 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.

 

Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of March 31, 2024, the Working Capital warrants had a fair value of $0.03 million, and the Company recorded the change in fair value of $0.02 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.

 

Equity Classified Warrants

 

Series B Warrants (Converted to Common Stock Warrants)

 

In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other non-current liabilities upon issuance. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. Prior to its reclassification from equity to a liability during 2023, the changes in fair value were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023.

 

Series C Warrants (Converted to Common Stock Warrants)

 

In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability and changes in the fair value of the warrant were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock.

 

Series C-1 Warrants (Converted to Common Stock Warrants)

 

In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series C-1 preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

SVB Common Stock Warrants

 

In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of March 31, 2024. At issuance, the relative fair value of the warrants was determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and no dividend yield. The fair value of the warrant was recorded within additional paid-in-capital on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.

 

Promissory Note Common Stock Warrants

 

In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

November 2022 Common Stock Warrants

 

In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying (i) the shares of common stock to be purchased to 31,680, (ii) the exercise price to $0.01, and (iii) the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and no dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock.

 

July 2023 Common Stock Warrants

 

In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of the Company’s common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

 

Warrant Consideration

 

In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional paid-in capital, net of the issuance costs of the Mergers. As of March 31, 2024, all warrants issued as warrant consideration remain outstanding.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Borrowings and SAFE Agreements
3 Months Ended
Mar. 31, 2024
Borrowings and SAFE Agreements [Abstract]  
Borrowings and SAFE Agreements
(13)Borrowings and SAFE Agreements

 

The Company’s borrowings consisted of the following (in thousands):

 

   As of 
   March 31,   December 31, 
   2024   2023 
2018 Bridge Notes  $11,376   $11,031 
Revolver Loan   5,290    5,168 
Secured Credit Facility   12,699    12,158 
Polar Settlement Agreement   
    300 
Total Notes payable   29,365    28,657 
Debt in CS Solis   35,840    33,280 
Total notes payable and convertible notes, net   65,205    61,937 
Less current portion   (65,205)   (61,937)
Notes payable and convertible notes, net of current portion  $
   $
 

 

Notes Payable

 

2018 Bridge Notes

 

In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice the face value of the 2018 Notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria. The 2018 Notes are secured by substantially all of the assets of Complete Solaria.

 

In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023, and the 2018 Notes remain outstanding as of March 31, 2024. In connection with the amendment, the 2018 Notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.

 

The Company concluded that the amendment represented a troubled debt restructuring as the Company was experiencing financial difficulty, and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of March 31, 2024 and December 31, 2023, the carrying value of the 2018 Notes was $11.4 million and $11.0 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.3 million and $0.3 million, respectively. As of March 31, 2024, the carrying value of the 2018 Notes approximates their fair value.

 

Revolver Loan

 

In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).

 

The SCI Loan Agreement is comprised of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination.

 

The Revolving Loan has a term of thirty-six months, with the principal due at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement requires the Company to meet certain financial covenants relating to the maintenance of specified restricted cash balance, achieve specified revenue targets and maintain specified contribution margins (“Financial Covenants”) over the term of the Revolving Loan. The Revolving Loan is collateralized by substantially all assets and property of the Company.

 

In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements with SCI to forbear SCI from exercising any rights and remedies available to it as a result of the Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendments changes were made to the Financial Covenants, and Solaria recorded a total of $1.9 million in amendment fees which amount was recorded in Other Liabilities, and this liability was included in the assumed liabilities for purchase price accounting.

 

Solaria had historically issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria (“SCI Series E-1 warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series E-1 warrants were assumed by the parent company, Complete Solaria.

 

The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting. The Revolving Loan principal balance at March 31, 2024 and December 31, 2023 amounted to $5.3 million and $5.1 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.1 million and $0.1 million, respectively. The Company was in compliance with all the Financial Covenants as of March 31, 2024.

 

In October 2023, the Company entered into an Assignment Agreement whereby Structural Capital Investments III, LP assigned the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, (collectively “Kline Hill”) and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this arrangement as a related party transaction, as discussed in Note 18 – Related Party Transactions. The SCI Revolving Loan continued to remain outstanding as of March 31, 2024 and is currently being renegotiated. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 1 - Subsequent Events for further details.

 

Secured Credit Facility

 

In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC (“Secured Credit Facility”). The Secured Credit Facility agreement allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as collateral. The amounts drawn under the Secured Credit Facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the Secured Credit Facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the Secured Credit Facility agreement was due to mature in April 2023. The Company is in the process of amending the Secured Credit Facility agreement to extend its maturity date.

 

At March 31, 2024, the balance outstanding was $12.7 million, including accrued financing cost of $5.0 million, and as of December 31, 2023, the balance outstanding was $12.2 million, including accrued financing cost of $4.5 million. The Company recognized interest expense of $0.5 million and $1.7 million related to the Secured Credit Facility during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively. As of March 31, 2024, the total estimated fair value of the Secured Credit Facility approximated its carrying value. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 19 - Subsequent Events for further details.

 

Polar Settlement Agreement

 

In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. The settlement agreement required the Company to pay Polar $0.5 million in ten equal monthly installments and did not accrue interest. As of December 31, 2023, the balance owed to Polar was $0.3 million all of which was paid in the period ended March 31, 2024.

 

Debt in CS Solis

 

As part of the Reorganization described in Note 1(a) Organization - Description of Business and Note 12 - Warrants, the Company received cash and recorded debt for an investment by Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment by Carlyle, the Company issued Carlyle a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, the purchase of 4,132,513 shares of the Company’s common stock is immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 11 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units.

 

On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.

 

The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is now March 31, 2024 subsequent to the modification. The acceleration of the redemption date of the investment, resulted in the total redemption amount to be 1.3 times the principal at December 31, 2023. The redemption amount will increase to 1.4 times the original investment at March 31, 2024. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the Company’s unaudited condensed consolidated statements of operations and comprehensive loss.

 

The Company accounted for the modification of the debt due with CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million in the thirteen-week period ended October 1, 2023. As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt with CS Solis. As of March 31, 2024, the debt has a redemption obligation of $35.8 million under the Carlyle Debt Modification Agreement. The debt in CS Solis is currently under negotiation.

 

The Company has recorded a liability of $35.8 million and $33.3 million included in short-term debt with CS Solis on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recorded accretion of the liability as interest expense of $2.5 million and $0.8 million, respectively, and made no payments of interest expense. For the thirteen-week periods ended March 31, 2024 and April 2, 2023 the Company recorded amortization of issuance costs as interest expense of zero and $0.3 million, respectively. As of March 31, 2024, the total estimated fair value of the Company’s debt with CS Solis was $35.8 million, which was estimated based on Level 3 inputs.

 

SAFE Agreements

 

First SAFE

 

On January 31, 2024, the Company entered into a simple agreement for future equity (the “First SAFE”) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the “Purchaser”), a related party, in connection with the Purchaser investing $1.5 million in the Company. The First SAFE does not accrued interest. The First SAFE was initially convertible into shares of the Company’s common stock, par value $0.0001 per share, upon the initial closing of a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company would have issued and sold shares of its common stock at a fixed valuation (an “Equity Financing”), at a per share conversion price which was equal to the lower of (i)(a) $53.54 million divided by (b) the Company’s capitalization immediately prior to such Equity Financing (such conversion price, the “SAFE Price”), and (ii) 80% of the price per share of its common stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the First SAFE, the Purchaser would have been automatically entitled to receive a portion of the proceeds of such liquidity event equal to the greater of (i) $1.5 million and (ii) the amount payable on the number of shares of common stock equal to (a) $1.5 million divided by (b)(1) $53.54 million divided by (2) the Company’s capitalization immediately prior to such liquidity event (the “Liquidity Price”), subject to certain adjustments as set forth in the First SAFE. The First SAFE was convertible into a maximum of 1,431,297 shares of the Company’s common stock, assuming a per share conversion price of $1.05, which is the product of (i) $1.31, the closing price per share of the Company’s common stock on January 31, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the First SAFE which resulted in the First SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.

 

Second SAFE

 

On February 15, 2024, the Company entered into a simple agreement for future equity (the “Second SAFE” and together with the First SAFE, the “SAFEs”) with the Purchaser, a related party, in connection with the Purchaser investing $3.5 million in the Company. The First SAFE does not accrued interest. The Second SAFE was initially convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing at a per share conversion price which was equal to the lower of (i) the SAFE Price, and (ii) 80% of the price per share of Common Stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the Second SAFE, the Purchaser would have been automatically entitled to receive an amount equal to the greater of (i) $3.5 million and (ii) the amount payable on the number of shares of Common Stock equal to $3.5 million divided by the Liquidity Price, subject to certain adjustments as set forth in the Second SAFE. The Second SAFE was convertible into a maximum of 3,707,627 shares of the Company’s common stock, assuming a per share conversion price of $0.94, which is the product of (i) $1.18, the closing per share price of its common stock on February 15, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the Second SAFE which resulted in the conversion of the Second SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
(14)Stock-Based Compensation

 

In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria common stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria common stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s common stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s board of directors prior to the date of the increase. The maximum number of shares of Complete Solaria common stock that may be issued on the exercise of incentive stock options (“ISOs”) under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares).

 

Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction.

 

Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”).

 

A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:

 

    Options Outstanding  
    Number of
Shares
    Weighted Average
Exercise Price per Share
    Weighted Average
Contractual Term (Years)
    Aggregate
Intrinsic Value
(in thousands)
 
Outstanding—December 31, 2023     11,716,646     $ 3.48       8.53     $ 2,756  
Options granted    
––
     
––
                 
Options exercised     (31,176 )     0.83                  
Options canceled     (307,198 )     2.86                  
Outstanding—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and expected to vest—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and exercisable—March 31, 2024     4,536,233     $ 4.38       4.78     $ 139  

 

A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:

 

   Number of RSUs   Weighted
Average
Grant Date
Fair Value
 
Unvested at December 31, 2023   58,097   $2.07 
Granted   
––
   $
––
 
Vested and released   
––
   $
––
 
Cancelled or forfeited   
––
   $
––
 
Unvested at March 31, 2024   58,097   $2.07 

 

Stock-based compensation expense

 

The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):

 

   Thirteen-
Weeks
Ended
   Thirteen-
Weeks
Ended
 
   March 31,
2024
   April 2,
2023
 
Cost of revenues  $27   $11 
Sales and marketing   216    94 
General and administrative   1,098    165 

Total stock-based compensation expense from continuing operations

  $1,341   $270 

 

As of March 31, 2024, there was a total of $18.8 million and zero unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.16 years for service-based options.

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Employee Stock Purchase Plan
3 Months Ended
Mar. 31, 2024
Employee Stock Purchase Plan [Abstract]  
Employee Stock Purchase Plan
(15) Employee Stock Purchase Plan

 

The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase shares of the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of March 31, 2024, 2,628,996 shares were reserved for future issuance under the ESPP Plan.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
(16)Commitments and Contingencies

 

Warranty Provision

 

The Company typically provides a 10-year warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a 30-year warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business.

 

The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.

 

Activity by period relating to the Company’s warranty provision was as follows (in thousands):

 

   Thirteen-
Weeks
Ended
March 31,
2024
   Year Ended
December 31,
2023
 
Warranty provision, beginning of period  $4,849   $3,981 
Accruals for new warranties issued   265    2,968 
Settlements   (250)   (2,100)
Warranty provision, end of period  $4,864   $4,849 
Warranty provision, current  $1,448   $1,433 
Warranty provision, noncurrent  $3,416   $3,416 

 

Indemnification Agreements

 

From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.

 

Legal Matters

 

The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that may have a material adverse effect on its business, financial position, results of operations, or cash flows. The Company has recorded zero and $7.9 million as a loss contingency in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively, primarily associated with the pending settlement of the following legal matters.

 

SolarPark Litigation

 

In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the U.S. District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages.

 

On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, the Company filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

Siemens Litigation

 

On July 22, 2021, Siemens filed a lawsuit in which Siemens alleged that the Company breached express and implied warranties under a purchase order that Siemens placed with the Company for a solar module system. Siemens claimed damages of approximately $6.9 million, inclusive of amounts of the Company’s indemnity obligations to Siemens, plus legal fees.

 

On February 22, 2024, the Court issued an order against the Company which awarded Siemens approximately $6.9 million, inclusive of the Company’s indemnity obligations to Siemens, plus legal fees, the amount of which will be determined at a later hearing. On March 15, 2024, Siemens filed a motion seeking to recover $2.67 million for attorneys’ fees, expenses, and pre-judgment interest. The Court will conduct a hearing on Siemens’ motion in late May 2024. Pending entry of a final judgment by the Court, the Company intends to appeal such judgment. The Company has recorded $6.9 million as a legal loss related to this litigation, excluding the $2.67 million for attorneys’ fees, expenses, and pre-judgment interest, in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023.

 

China Bridge Litigation

 

On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

 

Letters of Credit

 

The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of March 31, 2024. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.8 million as of March 31, 2024 and December 31, 2023, respectively.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share
3 Months Ended
Mar. 31, 2024
Basic and Diluted Net Loss Per Share [Abstract]  
Basic and Diluted Net Loss Per Share
(17)Basic and Diluted Net Loss Per Share

 

The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid for the thirteen-week periods ended March 31, 2024 and April 2, 2023. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. The Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.

 

The unaudited basic and diluted shares and net loss per share for the thirteen-week period ended April 2, 2023 has been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit.

 

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen-week periods ended March 31, 2024 and April 2, 2023 (in thousands, except share and per share amounts):

 

   Thirteen-
Weeks
Ended
March 31,
2024
   Thirteen- Weeks
Ended
April 2,
2023
 
Numerator:        
Net loss from continuing operations  $(9,588)  $(15,709)
Net loss from discontinued operations   
––
    (7,805)
Net loss  $(9,588)  $(23,514)
Denominator:          
Weighted average common shares outstanding, basic and diluted
   49,077,330    25,200,347 
Net loss per share:          
Continuing operations – basic and diluted
  $(0.20)  $(0.62)
Discontinued operations – basic and diluted
  $
––
   $(0.31)
Net loss per share – basic and diluted
  $(0.20)  $(0.93)

 

The computation of basic and diluted net loss per share attributable to common stockholders is the same for the thirteen-week periods ended March 31, 2024 and April 2, 2023 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.

 

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:

 

   As of 
   March 31,
2024
   April 2,
2023
 
Common stock warrants   23,024,556    89,313 
Preferred stock warrants   
    2,386,879 
Stock options and RSUs issued and outstanding   11,436,369    9,714,894 
Potential common shares excluded from diluted net loss per share   34,460,924    12,191,086 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions
(18)Related Party Transactions

 

From October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recognized zero and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Notes.

 

In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp. In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million. In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. Refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization for further discussion.

 

In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for the fiscal year ended December 31, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of March 31, 2024, the Company has recognized a liability associated with the FPAs of $7.9 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $4.7 million in its unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.

 

In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. The Company paid $0.2 million in 2023 and the remaining balance of $0.3 million was paid in the thirteen-week period ended March 31, 2024.

 

The SAFEs, as described in Note 13 – Borrowing Arrangements, entered into in January 2024 and February 2024 were with the Rodgers Massey Freedom and Free Markets Charitable Trust, a related party. The Company received proceeds from the SAFEs totaling $5.0 million in exchange for debt that was subsequently converted into shares of the Company’s common stock as discussed in Note 19 – Subsequent Events.

 

There were no other material related party transactions during the thirteen-week periods ended March 31, 2024 and April 2, 2023.

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events
(19)Subsequent Events

 

Amendment to SAFEs Agreements

 

As described in Note 13 – Borrowing Arrangements, the Company’s SAFEs were convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing. On April 21, 2024, the Company entered into an amendment for each of its First SAFE and Second SAFE to convert the invested amounts into shares of the Company’s common stock.

 

The conversion share price was $0.36, calculated as the product of (i) $0.45, the closing price of the Common Stock on April 19, 2024, multiplied by (ii) 80%. The First SAFE and Second SAFE converted into 4,166,667 and 9,722,222 shares of the Company’s common stock, respectively.

 

Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Bid Price Requirement

 

On April 16, 2024, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.

 

The Notice does not impact the listing of the Company’s common stock on The Nasdaq Global Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days before October 14, 2024. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period by effecting a reverse stock split if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.

 

The Company intends to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the minimum bid price requirement.

 

Amendments to Forward Purchase Agreements

 

On May 7 and 8, 2024, respectively, the Company entered into separate amendments to the Forward Purchase Agreements (the collectively the “Second Amendments”) with Sandia (the “Sandia Second Amendment”) and Polar (the “Polar Second Amendment”). The Second Amendments lower the reset price of each Forward Purchase Agreement from $3.00 to $1.00 per share and amend the VWAP Trigger Event provision to read as “After December 31, 2024, an event that occurs if the VWAP Price, for any 20 trading days during a 30 consecutive trading day-period, is below $1.00 per Share.”. The Sandia Second Amendment is not effective until the Company executes similar amendments with both Polar and Meteora.

 

Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Market Value of Listed Securities

 

On April 16, 2024, the Company received a letter (the “Letter”) from the staff at Nasdaq notifying the Company that, for the 30 consecutive trading days prior to the date of the Letter, the Company’s common stock had traded at a value below the minimum $50,000,000 “Market Value of Listed Securities” (“MVLS”) requirement set forth in Nasdaq Listing Rule 5450(b)(2)(A), which is required for continued listing of the Company’s common stock on The Nasdaq Global Market. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq.

 

In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until October 14, 2024, to regain compliance. The Letter notes that to regain compliance, the Company’s common stock must trade at or above a level such that the Company’s MVLS closes at or above $50,000,000 for a minimum of ten consecutive business days during the compliance period, which ends October 14, 2024. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Capital Market (provided that the Company then satisfies the requirements for continued listing on that market).

 

If the Company does not regain compliance by October 14, 2024, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.

 

The Company intends to actively monitor the Company’s MVLS between now and October 14, 2024, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

 

Entry into a Definitive Agreement to Cancel Debt in Exchange for Equity and Other Consideration

 

On May 1, 2024, the Company entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) with Kline Hill providing for (a) the cancellation of all indebtedness owed to Kline Hill by the Company, termination of all debt instruments by and between the Company and Kline Hill, and the satisfaction of all obligations owed to Kline Hill by the Company under the terminated debt instruments, (b) the issuance of 9,800,000 shares of the Company’s common stock to Kline Hill, (c) the issuance of warrants (the “Kline Hill Warrants” and the shares issuable therefrom, the “Warrant Shares”) to Kline Hill to purchase up to 3,700,000 shares of the Company’s common stock, with an exercise price per share of $0.62 (the closing price per share of the Company’s common stock as reported on the Nasdaq Capital Market of the date of the Agreement), and (d) a one-time $3,750,000 cash payment to Kline Hill upon the earlier of (i) the Company achieving $100,000,000 of trailing twelve month revenue, or (ii) the Company achieving $10,000,000 of trailing twelve month EBITDA. The Kline Hill Warrants will be sold to Kline Hill at a price of $0.125 per Warrant Share. The closing of the foregoing transactions will occur when the following conditions are met: Carlyle executes an agreement to cancel all debt owed to Carlyle by the Company, and all debt owed to Carlyle and its affiliates by the Company is no longer outstanding.

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (9,588) $ (23,514)
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies [Abstract]  
Basis of Presentation
(a)Basis of Presentation

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the Unites States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates
(b)Use of Estimates

The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:

The allocation of the transaction price to identified performance obligations;
Fair value of warrant liabilities;
The reserve methodology for inventory obsolescence;
The reserve methodology for product warranty;
The reserve methodology for the allowance for credit losses;
The fair value of the forward purchase agreements; and
The measurement of stock-based compensation.

To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.

Segment Information
(c)Segment Information

The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated Company. All the Company’s long-lived assets are maintained in the United States of America.

Concentration of Risks
(d)Concentration of Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of March 31, 2024, two customers had an outstanding balance that represented 36% and 19% of the total accounts receivable balance. As of December 31, 2023, two customers had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.

 

Concentration of customers

For the thirteen-weeks ended March 31, 2024, one customer represented 76% of gross revenues. For the thirteen-weeks ended and April 2, 2023, three customers represented 29%, 23% and 12% of gross revenues.

Concentration of suppliers

For the thirteen-weeks ended March 31, 2024, and December 31, 2023, one supplier represented 34% and 40% of the Company’s inventory purchases, respectively.

Cash and Cash Equivalents
(e)Cash and Cash Equivalents

The Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.

Restricted Cash
(f)Restricted Cash

The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. The restricted cash balance was $3.8 million at each of March 31, 2024 and December 31, 2023. Restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in its unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):

   March 31,
2024
   December 31,
2023
 
Cash and cash equivalents  $1,786   $2,593 
Restricted cash   3,829    3,823 
Total cash, cash equivalents and restricted cash  $5,615   $6,416 
Revenue Recognition
(g)Revenue Recognition

Disaggregation of revenue

Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):

   Thirteen-weeks Ended 
   March 31,   April 2, 
   2024   2023 
Solar energy system installations  $9,922   $15,843 
Software enhanced services   118    834 
Total revenue  $10,040   $16,677 

All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was in the United States.

Remaining performance obligations

The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of March 31, 2024, the Company has deferred $1.1 million associated with a long-term service contract. As of December 31, 2023, the Company has deferred $1.2 million associated with a long-term service contract, which will be recognized evenly through 2028.

 

Incremental costs of obtaining customer contracts

Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. As of March 31, 2024 and December 31, 2023, deferred commissions were $5.1 million and $4.2 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.

Deferred revenue

The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within 12-months, the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirteen-week periods ended March 31, 2024 and April 2, 2023 that was included in deferred revenue at the beginning of each period was $1.3 million and $1.9 million, respectively.

Fair Value Measurements
(h)Fair Value Measurements

The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.

When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities, SAFE Agreements and FPA liabilities.

The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).

 

The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.

Direct Offering Costs
(i)Direct Offering Costs

Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional paid-in capital and netted against the Mergers proceeds received upon close. As of March 31, 2024 and December 31, 2023, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.

Warrant Liabilities
(j)Warrant Liabilities

The Company accounts for its warrant liabilities in accordance with the guidance in ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 12 – Warrants.

Forward Purchase Agreements
(k)Forward Purchase Agreements

The Company accounts for its FPAs in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.

Net Loss Per Share
(l)Net Loss Per Share

The Company computes net loss per share following ASC 260, Earnings Per Share. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.

Accounting Pronouncements Not Yet Adopted
(m)Accounting Pronouncements Not Yet Adopted

In November 2023, the FASB issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. The Company is currently evaluating ASU 2023-07,but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements. 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. The Company is currently evaluating ASU 2023-09 but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements.

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies [Abstract]  
Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):
   March 31,
2024
   December 31,
2023
 
Cash and cash equivalents  $1,786   $2,593 
Restricted cash   3,829    3,823 
Total cash, cash equivalents and restricted cash  $5,615   $6,416 
Schedule of Revenue Recognized By Product and Services Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
   Thirteen-weeks Ended 
   March 31,   April 2, 
   2024   2023 
Solar energy system installations  $9,922   $15,843 
Software enhanced services   118    834 
Total revenue  $10,040   $16,677 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Measurements [Abstract]  
Schedule of Assets that are Measured at Fair Value on a Recurring Basis The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):
   As of March 31, 2024 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                
Carlyle warrants  $   $   $3,086   $3,086 
Public warrants   437            437 
Private placement warrants       318        318 
Working capital warrants       36        36 
Replacement warrants           5    5 
Forward purchase agreement liabilities           9,409    9,409 
SAFE Agreements           5,000    5,000 
Total  $437   $354   $17,500   $18,291 
   As of December 31, 2023 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                    
Carlyle warrants  $
   $
   $9,515   $9,515 
Public warrants   167    
    
    167 
Private placement warrants   
    122    
    122 
Working capital warrants   
    14    
    14 
Replacement warrants   
    
    1,310    1,310 
Forward purchase agreement liabilities   
    
    3,831    3,831 
Total  $167   $136   $14,656   $14,959 

 

Schedule of Warrants Based on a Black Scholes Option Pricing Method The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:
   March 31,
2024
   December 31,
2023
 
Expected term   7.0 years    7.0 years 
Expected volatility   77.0%   77.0%
Risk-free interest rate   3.92%   3.92%
Expected dividend yield   0.0%   0.0%
   March 31,
2024
   December 31,
2023
 
Expected term  0.8 years   0.3 years 
Expected volatility   78.5%   78.5%
Risk-free interest rate   5.49%   5.4%
Volatility   0.0%   0.0%
Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
   March 31,
2024
   December 31,
2023
 
Common stock trading price  $0.59   $1.66 
Simulation period   1.30 years    1.55 years 
Risk-free interest rate   4.90%   4.48%
Volatility   112.0%   95.0%
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Reverse Recapitalization (Tables)
3 Months Ended
Mar. 31, 2024
Reverse Recapitalization [Abstract]  
Schedule of Common Stock Outstanding The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
   Recapitalization 
FACT Class A Ordinary Shares, outstanding prior to Mergers   34,500,000 
FACT Class B Ordinary Shares, outstanding prior to Mergers   8,625,000 
Bonus shares issued to sponsor   193,976 
Bonus shares issued to PIPE investors   120,000 
Bonus shares issued to FPA investors   150,000 
Shares issued from PIPE financing   1,690,000 
Shares issued from FPA agreements, net of recycled shares   5,558,488 
Less: redemption of FACT Class A Ordinary Shares   (31,041,243)
Total shares from the Mergers and PIPE Financing   19,796,221 
Legacy Complete Solaria shares   20,034,257 
2022 Convertible Note Shares   5,460,075 
Shares of Complete Solaria Common stock immediately after Mergers   45,290,553 

 

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets (Tables)
3 Months Ended
Mar. 31, 2024
Prepaid Expenses and Other Current Assets [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands):
   As of 
   March 31,
2024
   December 31,
2023
 

Deferred commissions

  $5,098   $4,185 
Inventory deposits   -    616 
Other   678    1,016 
Total prepaid expenses and other current assets  $5,776   $5,817 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Divestiture (Tables)
3 Months Ended
Mar. 31, 2024
Divestiture [Abstract]  
Schedule of Operations and Comprehensive Income Related to Discontinued Operations The components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive loss related to discontinued operations are presented in the table, as follows (in thousands):
   Thirteen-Weeks 
   Ended April 2,
2023
 
Revenues  $18,721 
Cost of revenues   19,479 
Gross loss   (758)
Operating expenses:     
Sales and marketing   2,866 
General and administrative   4,185 
Total operating expenses   7,051 
Loss from discontinued operations   (7,809)
Other income (expense), net   
 
Loss from discontinued operations before income taxes   (7,809)
Income tax benefit   4
Net loss from discontinued operations  $(7,805)
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net (Tables)
3 Months Ended
Mar. 31, 2024
Property and Equipment, Net [Abstract]  
Schedule of Property and Equipment, Net Property and equipment, net consists of the following (in thousands, except year data):
   Estimated   As of 
     Useful Lives
(Years)
   March 31,
2024
   December 31,
2023
 
Developed software  5   $7,529   $6,993 
Manufacturing equipment  3    131    131 
Furniture and equipment  3    90    96 
Leasehold improvements  5    708    708 
Total property and equipment       8,464    7,928 
Less: accumulated depreciation and amortization               (3,969)   (3,611)
Total property and equipment, net      $4,495   $4,317 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities (Tables)
3 Months Ended
Mar. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands):
   As of 
   March 31,
2024
   December 31,
2023
 
Accrued compensation and benefits  $3,715   $3,969 
Customer deposits   296    544 
Uninvoiced contract costs   80    671 
           
Accrued term loan and revolving loan amendment and final payment fees   2,400    2,400 
Accrued legal settlements   7,700    7,700 
Accrued taxes   930    931 
Accrued rebates and credits   32    677 
Operating lease liabilities, current   548    607 
Accrued warranty, current   1,449    1,433 
Other accrued liabilities   7,743    8,938 
Total accrued expenses and other current liabilities  $24,893   $27,870 
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other Expense, Net (Tables)
3 Months Ended
Mar. 31, 2024
Other Expense, Net [Abstract]  
Schedule of Other Expense, Net Other expense, net consists of the following (in thousands):
  

Thirteen-Weeks
Ended

 
   March 31,
2024
   April 2,
2023
 
Change in fair value of redeemable convertible preferred stock warrant liability  $1,305   $209 
Change in fair value of Carlyle warrants   6,429    
 
Change in fair value of FACT public, private placement and working capital warrants   (489)   
 
Change in fair value of forward purchase agreement liabilities(1)   (5,578)   
 
Loss on discontinued Solaria business and other, net   (148)   108 
Total other income (expense), net  $1,519   $317 
(1)Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock (Tables)
3 Months Ended
Mar. 31, 2024
Common Stock [Abstract]  
Schedule of Reserved Shares of Common Stock The Company has reserved shares of common stock for issuance related to the following:
   As of
March 31,
2024
 
Common stock warrants   27,637,266 
Employee stock purchase plan   2,628,996 
Stock options and RSUs, issued and outstanding   11,436,369 
Stock options and RSUs, authorized for future issuance   3,850,462 
Total shares reserved   45,553,093 
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants (Tables)
3 Months Ended
Mar. 31, 2024
Warrants [Abstract]  
Schedule of Liability-Classified Warrants Liability-classified warrants
    As of  
    March 31,     December 31,  
    2024     2023  
Carlyle warrants   $ 3,086     $ 9,515  

Replacement warrants

    5       1,310  
Public warrants     437       167  
Private placements warrants     318       122  
Working capital warrants     36       13  
    $ 3,882     $ 11,127  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Borrowings and SAFE Agreements (Tables)
3 Months Ended
Mar. 31, 2024
Borrowings and SAFE Agreements [Abstract]  
Schedule of Convertible Notes The Company’s borrowings consisted of the following (in thousands):
   As of 
   March 31,   December 31, 
   2024   2023 
2018 Bridge Notes  $11,376   $11,031 
Revolver Loan   5,290    5,168 
Secured Credit Facility   12,699    12,158 
Polar Settlement Agreement   
    300 
Total Notes payable   29,365    28,657 
Debt in CS Solis   35,840    33,280 
Total notes payable and convertible notes, net   65,205    61,937 
Less current portion   (65,205)   (61,937)
Notes payable and convertible notes, net of current portion  $
   $
 
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Summary of Stock Option Activity A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:
    Options Outstanding  
    Number of
Shares
    Weighted Average
Exercise Price per Share
    Weighted Average
Contractual Term (Years)
    Aggregate
Intrinsic Value
(in thousands)
 
Outstanding—December 31, 2023     11,716,646     $ 3.48       8.53     $ 2,756  
Options granted    
––
     
––
                 
Options exercised     (31,176 )     0.83                  
Options canceled     (307,198 )     2.86                  
Outstanding—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and expected to vest—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and exercisable—March 31, 2024     4,536,233     $ 4.38       4.78     $ 139  
Schedule of Summary of RSU Activity A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:
   Number of RSUs   Weighted
Average
Grant Date
Fair Value
 
Unvested at December 31, 2023   58,097   $2.07 
Granted   
––
   $
––
 
Vested and released   
––
   $
––
 
Cancelled or forfeited   
––
   $
––
 
Unvested at March 31, 2024   58,097   $2.07 

 

Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
   Thirteen-
Weeks
Ended
   Thirteen-
Weeks
Ended
 
   March 31,
2024
   April 2,
2023
 
Cost of revenues  $27   $11 
Sales and marketing   216    94 
General and administrative   1,098    165 

Total stock-based compensation expense from continuing operations

  $1,341   $270 
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
Schedule of Activity by Period Relating to the Company’s Warranty Provision Activity by period relating to the Company’s warranty provision was as follows (in thousands):
   Thirteen-
Weeks
Ended
March 31,
2024
   Year Ended
December 31,
2023
 
Warranty provision, beginning of period  $4,849   $3,981 
Accruals for new warranties issued   265    2,968 
Settlements   (250)   (2,100)
Warranty provision, end of period  $4,864   $4,849 
Warranty provision, current  $1,448   $1,433 
Warranty provision, noncurrent  $3,416   $3,416 

 

XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Basic and Diluted Net Loss Per Share (Tables) [Line Items]  
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen-week periods ended March 31, 2024 and April 2, 2023 (in thousands, except share and per share amounts):
   Thirteen-
Weeks
Ended
March 31,
2024
   Thirteen- Weeks
Ended
April 2,
2023
 
Numerator:        
Net loss from continuing operations  $(9,588)  $(15,709)
Net loss from discontinued operations   
––
    (7,805)
Net loss  $(9,588)  $(23,514)
Denominator:          
Weighted average common shares outstanding, basic and diluted
   49,077,330    25,200,347 
Net loss per share:          
Continuing operations – basic and diluted
  $(0.20)  $(0.62)
Discontinued operations – basic and diluted
  $
––
   $(0.31)
Net loss per share – basic and diluted
  $(0.20)  $(0.93)
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:
   As of 
   March 31,
2024
   April 2,
2023
 
Common stock warrants   23,024,556    89,313 
Preferred stock warrants   
    2,386,879 
Stock options and RSUs issued and outstanding   11,436,369    9,714,894 
Potential common shares excluded from diluted net loss per share   34,460,924    12,191,086 
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Organization (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 31, 2023
Apr. 02, 2023
Mar. 31, 2023
Mar. 31, 2024
Apr. 02, 2023
Dec. 31, 2023
Organization and Business Operations [Line Items]            
Capital stock, shares       45,553,093    
Purchase price per share (in Dollars per share)       $ 10    
Shares issued       193,976    
Originally issued shares     23,256,504 45,290,553    
Shares exercised       31,176    
Aggregate amount (in Dollars)     $ 82,200,000      
Aggregate purchase price (in Dollars)           $ 4,999,999.2
Net losses (in Dollars)       $ (9,588,000) $ (23,514,000)  
Accumulated deficit (in Dollars)       (364,516,000)   (354,928,000)
Current debt (in Dollars)       65.2    
Cash and cash equivalents (in Dollars)       $ 1,800,000    
Solaria [Member]            
Organization and Business Operations [Line Items]            
Capital stock, shares       25,494,332    
Shares issued       60,000    
PIPE Investors [Member]            
Organization and Business Operations [Line Items]            
Aggregate shares       1,570,000    
PIPE Financing [Member]            
Organization and Business Operations [Line Items]            
Aggregate gross proceeds (in Dollars)       $ 15,700,000    
Shares issued       60,000    
Subscription Agreements [Member]            
Organization and Business Operations [Line Items]            
Aggregate gross proceeds (in Dollars)       $ 3,500,000    
New Money PIPE Investors [Member]            
Organization and Business Operations [Line Items]            
Aggregate shares       120,000    
Purchase price per share (in Dollars per share)       $ 5    
New Money PIPE Subscription Agreement [Member]            
Organization and Business Operations [Line Items]            
Aggregate gross proceeds (in Dollars)       $ 600,000    
Disposal Agreement [Member]            
Organization and Business Operations [Line Items]            
Aggregate purchase price (in Dollars) $ 11,000,000          
Loss from discontinued operations (in Dollars)           $ 4,200,000
Liquidity and Going Concern [Member]            
Organization and Business Operations [Line Items]            
Net losses (in Dollars)   $ 23,500,000   9,600,000    
Accumulated deficit (in Dollars)       $ 364,500,000    
Class A Ordinary Shares [Member]            
Organization and Business Operations [Line Items]            
Capital stock, shares       6,300,000    
Forward purchase agreements, shares       1,161,512    
Originally issued shares     34,500,000      
Shares exercised     7,784,739      
Class A Ordinary Shares [Member] | Solaria [Member]            
Organization and Business Operations [Line Items]            
Converted shares     1      
Class A Ordinary Shares [Member] | FACT Investors [Member]            
Organization and Business Operations [Line Items]            
Remaining shares outstanding     11,243,496      
Class B Ordinary Share [Member] | Solaria [Member]            
Organization and Business Operations [Line Items]            
Converted shares     1      
Common Stock [Member]            
Organization and Business Operations [Line Items]            
Shares exercised       31,176 137,452  
Net losses (in Dollars)        
Common Stock [Member] | Solaria [Member]            
Organization and Business Operations [Line Items]            
Sale of aggregate shares       420,000    
Shares issued       150,000    
Common Stock [Member] | Maxeon [Member]            
Organization and Business Operations [Line Items]            
Shares issued 1,100,000          
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Mar. 31, 2024
Dec. 31, 2023
Apr. 02, 2023
Significant Accounting Policies [Line Items]          
Restricted cash balance (in Dollars) $ 3.8   $ 3.8 $ 3.8  
Deferred long-term service contract (in Dollars) 1.1   1.1 1.2  
Deferred commissions (in Dollars) $ 5.1   5.1 $ 4.2  
Deferred revenue (in Dollars)     $ 1.3   $ 1.9
Direct offering costs (in Dollars)         $ 5.7
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | One Supplier [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge   34.00%   40.00%  
Customer Concentration Risk [Member] | Customer One [Member] | Accounts Receivable [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge 36.00%     38.00%  
Customer Concentration Risk [Member] | Customer One [Member] | Revenue Benchmark [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge 76.00% 29.00%      
Customer Concentration Risk [Member] | Customer Two [Member] | Accounts Receivable [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge 19.00%        
Customer Concentration Risk [Member] | Customer Two [Member] | Revenue Benchmark [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge   23.00%      
Customer Concentration Risk [Member] | Customer Three [Member] | Revenue Benchmark [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge   12.00%      
Credit Concentration Risk [Member] | Customer Two [Member] | Accounts Receivable [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk percenatge       16.00%  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 1,786 $ 2,593
Restricted cash 3,829 3,823
Total cash, cash equivalents and restricted cash $ 5,615 $ 6,416
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services - USD ($)
$ in Thousands
3 Months Ended
Apr. 02, 2023
Mar. 31, 2024
Apr. 02, 2023
Schedule of Revenue Recognized By Product and Services [Line Items]      
Total revenue $ 16,677 $ 10,040 $ 16,677
Solar energy system installations [Member]      
Schedule of Revenue Recognized By Product and Services [Line Items]      
Total revenue 15,843 9,922  
Software enhanced services [Member]      
Schedule of Revenue Recognized By Product and Services [Line Items]      
Total revenue $ 834 $ 118  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Details)
3 Months Ended
Mar. 31, 2024
$ / shares
Fair Value Measurements [Line Items]  
Price per share $ 0.01
Description warrant expires The Series D-7 redeemable convertible preferred stock warrants were initially accounted for as liabilities and measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 12 – Warrants, the redeemable convertible preferred stock warrants were reclassified to additional paid-in capital upon the closing of the Mergers. In October 2023, in connection with the Assignment and Acceptance Agreement as further described in Note 12 – Warrants, these warrants were replaced (“Replacement Warrants”), and the Replacement Warrants are classified as liabilities. Refer to Note 13 – Borrowings and SAFE Agreements.
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities $ 18,291 $ 14,959
Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 437 167
Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 354 136
Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 17,500 14,656
Carlyle warrants [Member[    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 3,086 9,515
Carlyle warrants [Member[ | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Carlyle warrants [Member[ | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Carlyle warrants [Member[ | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 3,086 9,515
Public warrants [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 437 167
Public warrants [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 437 167
Public warrants [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Public warrants [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Private placement warrants [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 318 122
Private placement warrants [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Private placement warrants [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 318 122
Private placement warrants [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Working capital warrants [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 36 14
Working capital warrants [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Working capital warrants [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 36 14
Working capital warrants [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Replacement warrants [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 5 1,310
Replacement warrants [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Replacement warrants [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Replacement warrants [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 5 1,310
Forward purchase agreement liabilities [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 9,409 3,831
Forward purchase agreement liabilities [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Forward purchase agreement liabilities [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities
Forward purchase agreement liabilities [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 9,409 $ 3,831
SAFE Agreements [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities 5,000  
SAFE Agreements [Member] | Level 1 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities  
SAFE Agreements [Member] | Level 2 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities  
SAFE Agreements [Member] | Level 3 [Member]    
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]    
Financial liabilities $ 5,000  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Expected term [Member] | Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Expected term 7 years 7 years
Expected term [Member] | Replacements Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Expected term 9 months 18 days 3 months 18 days
Expected volatility [Member] | Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 77.00% 77.00%
Expected volatility [Member] | Replacements Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 78.50% 78.50%
Risk-free interest rate [Member] | Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 3.92% 3.92%
Risk-free interest rate [Member] | Replacements Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 5.49% 5.40%
Expected dividend yield [Member] | Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 0.00% 0.00%
Volatility [Member] | Replacements Warrants [Member]    
Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]    
Fair value measurement input 0.00% 0.00%
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility [Line Items]    
Common stock trading price (in Dollars per share) $ 0.59 $ 1.66
Simulation period 1 year 3 months 18 days 1 year 6 months 18 days
Risk-free interest rate 4.90% 4.48%
Volatility 112.00% 95.00%
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Reverse Recapitalization (Details) - USD ($)
$ in Thousands
3 Months Ended 7 Months Ended
Mar. 31, 2024
Jul. 31, 2023
Dec. 31, 2023
Mar. 31, 2023
Reverse Recapitalization (Details) [Line Items]        
Net cash proceeds   $ 19,700    
Non-cash net liabilities assumed   $ 10,100    
Common shares issued (in Shares) 45,290,553     23,256,504
Professional fees $ 15,800      
Additional paid in capital 279,332   $ 277,965  
Incurred amount 10,600      
Cash payments     $ 5,400  
Maximum [Member]        
Reverse Recapitalization (Details) [Line Items]        
Additional paid in capital 15,800      
Minimum [Member]        
Reverse Recapitalization (Details) [Line Items]        
Additional paid in capital $ 5,200      
Common Class A [Member]        
Reverse Recapitalization (Details) [Line Items]        
Common shares issued (in Shares)       34,500,000
Common Class A [Member] | Legacy Complete Solaria [Member]        
Reverse Recapitalization (Details) [Line Items]        
Common shares outstanding (in Shares) 45,290,553      
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding
12 Months Ended
Dec. 31, 2023
shares
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Less: Redemption of FACT Class A Ordinary Shares (31,041,243)
Total shares from the Mergers and PIPE Financing 19,796,221
Legacy Complete Solaria shares 20,034,257
2022 Convertible Note Shares 5,460,075
Shares of Complete Solaria Common stock immediately after Mergers 45,290,553
Sponsor [Member]  
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Bonus shares issued 193,976
PIPE [Member]  
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Bonus shares issued 120,000
Shares issued 1,690,000
FPA [Member]  
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Bonus shares issued 150,000
Shares issued 5,558,488
Class A Ordinary Shares [Member]  
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Ordinary Shares, outstanding prior to Mergers 34,500,000
Class B Ordinary Shares [Member]  
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]  
Ordinary Shares, outstanding prior to Mergers 8,625,000
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Forward Purchase Agreements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 18, 2023
Mar. 31, 2024
Dec. 31, 2023
Forward Purchase Agreements [Line Items]      
Ordinary shares, par value (in Dollars per share)   $ 0.0001 $ 0.0001
Purchase percentage   9.90%  
Price on floor (in Dollars per share)   $ 5  
Issuance of shares (in Shares)   193,976  
Fair value of prepaid forward purchase agreements   $ 100  
Prepaid forward purchase liability   5,600  
Purchase liabilities   9,400 $ 3,800
Reset floor price (in Dollars per share) $ 3    
Anti-dilution provisions $ 10,000 7 7
Related Party [Member]      
Forward Purchase Agreements [Line Items]      
Purchase liabilities   $ 7,900 $ 3,200
Complete Solaria Common Stock [Member]      
Forward Purchase Agreements [Line Items]      
Issuance of shares (in Shares)   6,720,000  
FPA'S [Member]      
Forward Purchase Agreements [Line Items]      
Aggregate shares (in Shares)   6,720,000  
Reset price per share (in Dollars per share)   $ 10.56  
Number of shares (in Shares)   2  
Issuance of shares (in Shares)   6,300,000  
Other income expense   $ 35,500  
Reset floor price (in Dollars per share) $ 5    
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Prepaid Expenses and Other Current Assets [Abstract]    
Deferred commissions $ 5,098 $ 4,185
Inventory deposits   616
Other 678 1,016
Total prepaid expenses and other current assets $ 5,776 $ 5,817
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations - Discontinued Operations [Member]
$ in Thousands
3 Months Ended
Apr. 02, 2023
USD ($)
Condensed Statement of Income Captions [Line Items]  
Revenues $ 18,721
Cost of revenues 19,479
Gross loss (758)
Sales and marketing 2,866
General and administrative 4,185
Total operating expenses 7,051
Loss from discontinued operations (7,809)
Other income (expense), net
Loss from discontinued operations before income taxes (7,809)
Income tax benefit 4
Net loss from discontinued operations $ (7,805)
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Property and Equipment, Net [Abstract]    
Depreciation and amortization expense $ 0.4 $ 0.2
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 8,464 $ 7,928
Less: accumulated depreciation and amortization (3,969) (3,611)
Total property and equipment, net $ 4,495 4,317
Developed software [Member]    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives 5 years  
Total property and equipment, gross $ 7,529 6,993
Manufacturing equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives 3 years  
Total property and equipment, gross $ 131 131
Furniture and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives 3 years  
Total property and equipment, gross $ 90 96
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives 5 years  
Total property and equipment, gross $ 708 $ 708
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]    
Accrued compensation and benefits $ 3,715 $ 3,969
Customer deposits 296 544
Uninvoiced contract costs 80 671
Accrued term loan and revolving loan amendment and final payment fees 2,400 2,400
Accrued legal settlements 7,700 7,700
Accrued taxes 930 931
Accrued rebates and credits 32 677
Operating lease liabilities, current 548 607
Accrued warranty, current 1,449 1,433
Other accrued liabilities 7,743 8,938
Total accrued expenses and other current liabilities $ 24,893 $ 27,870
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other Expense, Net (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Related Party [Member]    
Other Expense, Net (Details) [Line Items]    
Other income $ 4,700 $ 0
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other Expense, Net (Details) - Schedule of Other Expense, Net - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Schedule of Other Income (Expense), Net [Abstract]    
Change in fair value of redeemable convertible preferred stock warrant liability $ 1,305 $ 209
Change in fair value of Carlyle warrants 6,429
Change in fair value of FACT public, private placement and working capital warrants (489)
Change in fair value of forward purchase agreement liabilities [1] (5,578)
Loss on discontinued Solaria business and other, net (148) 108
Total other income (expense), net $ 1,519 $ 317
[1] Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Common Stock [Line Items]    
Common stock, shares authorized 1,000,000,000 1,000,000,000
Preferred stock issued  
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Price per share (in Dollars per share) $ 1.36  
Aggregate purchase price (in Dollars) $ 4,999,999.2  
Common Stock [Member]    
Common Stock [Line Items]    
Common stock, shares authorized 1,000,000,000  
Purchase shares 1,838,235  
Common stock, par value (in Dollars per share) $ 0.0001  
Preferred Stock [Member]    
Common Stock [Line Items]    
Preferred stock, shares authorized 10,000,000  
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Common Stock (Details) - Schedule of Reserved Shares of Common Stock
Mar. 31, 2024
shares
Schedule of Reserved Shares of Common Stock [Abstract]  
Common stock warrants 27,637,266
Employee stock purchase plan 2,628,996
Stock options and RSUs, issued and outstanding 11,436,369
Stock options and RSUs, authorized for future issuance 3,850,462
Total shares reserved 45,553,093
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 18, 2023
Oct. 31, 2021
Aug. 31, 2021
May 31, 2021
Jan. 31, 2020
Jul. 31, 2023
Jul. 18, 2023
May 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Apr. 02, 2023
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2023
Nov. 30, 2022
Feb. 28, 2022
Jul. 30, 2016
Feb. 29, 2016
Warrants [Line Items]                                    
Warrant to purchase shares                   8,625,000   2,190,604            
Fair value of warrant (in Dollars)                   $ (7,246,000) $ (209,000)              
Expected volatility, percentage                   112.00%   95.00%            
Risk free interest rate                   1.90%                
Dividend yield (in Dollars)                                  
Outstanding warrants                   27,637,266                
Number of shares issued                   350,000                
Common stock issued and outstanding percentage                   2.795%                
Common stock trading days.                   10 days                
Warrant vesting shares                   350,000                
Warrant vesting agreement exercisable shares.                   150,000                
Warrant liability (in Dollars)                   $ 3,877,000   $ 9,817,000            
Reduction to additional paid-in capital (in Dollars)                   9,500,000                
Other income (expense) (in Dollars)                   $ 1,519,000 $ 317,000              
Warrant exercise price (in Dollars per share)                   $ 0.01                
Other income and expense (in Dollars)                   $ 20,000.00                
Risk free interest rate, percentage                   4.90%   4.48%            
Carlyle Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares           1,995,879                   2,886,952    
Number of share exercisable                               1,995,879    
Fair value of warrant (in Dollars)                   $ 3,100,000                
Risk free interest rate                   3.90%                
Dividend yield (in Dollars)                                  
Outstanding warrants           1,995,879                        
Other income (expense) (in Dollars)                   $ 6,400,000                
Warrants                                    
Warrants [Line Items]                                    
Warrant to purchase shares                             656,630      
Warrant expired term                   Jul. 18, 2030                
Number of shares issued                   1,995,879                
Warrant liability (in Dollars)                   $ 20,400,000                
Reduction to additional paid-in capital (in Dollars)                   $ 10,900,000                
Series D-7 Preferred Stock [Member]                                    
Warrants [Line Items]                                    
Warrant exercise price (in Dollars per share)                   $ 2.5                
Series D-7 Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars) $ 2,400,000                       $ 7.8          
Warrant exercise price (in Dollars per share)                   $ 2.04                
Replacement warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                           656,630        
Public, Private Placement, and Working Capital Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                   6,266,667                
Fair value of warrant (in Dollars)                   $ 800,000                
Other income (expense) (in Dollars)                   $ 500,000                
Warrant exercise price (in Dollars per share)                   $ 11.5                
Private Placement Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)                   $ 6,700,000                
Series B Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)                 $ 100,000                  
Warrant exercise price (in Dollars per share)                                   $ 4.3
Series C Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                                 148,477  
Fair value of warrant (in Dollars)             $ 2,300,000                      
Expected volatility, percentage         62.50%                          
Dividend yield (in Dollars)                                  
Warrant exercise price (in Dollars per share)                                 $ 1  
Risk free interest rate, percentage         1.50%                          
Series C-1 Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares         173,067                          
Fair value of warrant (in Dollars)         $ 100,000                          
Expected term         10 years                          
Warrant exercise price (in Dollars per share)         $ 0.01                          
SVB Common Stock Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares     2,525 2,473                            
Fair value of warrant (in Dollars)     $ 100,000 $ 100,000                            
Expected term     12 years 12 years                            
Expected volatility, percentage     73.00% 73.00%                            
Dividend yield (in Dollars)                                
Warrant exercise price (in Dollars per share)     $ 0.62 $ 0.38                            
Risk free interest rate, percentage     1.30% 1.70%                            
Promissory Note Common Stock Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares   24,148                                
Fair value of warrant (in Dollars)   $ 100,000                                
Expected term   10 years                                
Expected volatility, percentage   73.00%                                
Dividend yield (in Dollars)                                  
Warrant exercise price (in Dollars per share)   $ 0.01                                
Risk free interest rate, percentage   1.50%                                
November 2022 Common Stock Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares               31,680             78,962      
Fair value of warrant (in Dollars)               $ 100,000                    
Expected term               1 year 6 months                    
Expected volatility, percentage               78.50%                    
Dividend yield (in Dollars)                                  
Warrant exercise price (in Dollars per share)               $ 0.01             $ 8      
Risk free interest rate, percentage               4.70%                    
Warrant exercised               31,680                    
July 2023 Common Stock Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares           38,981                        
Warrant exercise price (in Dollars per share)           $ 0.01                        
Warrant Consideration [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares           6,266,572                        
Warrant exercise price (in Dollars per share)           $ 11.5                        
Warrant term           10 years                        
Common Stock [Member]                                    
Warrants [Line Items]                                    
Common stock price (in Dollars per share)                   $ 0.01                
Common Stock [Member] | Warrants                                    
Warrants [Line Items]                                    
Number of shares issued                   150,000                
Black-Scholes model [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)                   $ 3,400,000                
Expected term                   7 years                
Expected volatility, percentage                   73.00%                
Black-Scholes model [Member] | Carlyle Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)                   $ 20,400,000                
Expected term                   7 years                
Expected volatility, percentage                   77.00%                
Complete Solaria [Member]                                    
Warrants [Line Items]                                    
Number of shares issued                   250,000                
Series D-7 Preferred Stock [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                   518,752                
Warrant exercise price (in Dollars per share)                   $ 5                
Second Tranche Series D-7 preferred stock [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                   137,878                
Common Stock for the First Tranche [Member]                                    
Warrants [Line Items]                                    
Common stock price (in Dollars per share) $ 2.5           $ 2.5                      
Common Stock for the Second Tranche [Member]                                    
Warrants [Line Items]                                    
Common stock price (in Dollars per share) $ 5           $ 5                      
Series D-7 Preferred Stock Converted into Warrants to Purchase [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                           1,376,414        
Series B Preferred Stock [Member]                                    
Warrants [Line Items]                                    
Warrant to purchase shares                                   5,054
Common Class A [Member] | Series B Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)             $ 100,000                      
Series C Preferred Stock [Member]                                    
Warrants [Line Items]                                    
Number of share exercisable                                 482,969  
Merger Transaction [Member]                                    
Warrants [Line Items]                                    
Warrant exercise price (in Dollars per share)                   $ 4.09                
Public Warrants [Member] | Public, Private Placement, and Working Capital Warrants [Member]                                    
Warrants [Line Items]                                    
Warrant exercise price (in Dollars per share)                   $ 11.5                
Private Placement Warrants [Member]                                    
Warrants [Line Items]                                    
Working capital warrants                   716,668                
Private Placement Warrants [Member] | Warrants                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)                   $ 300,000                
Private Placement Warrants [Member] | July 2023 Common Stock Warrants [Member]                                    
Warrants [Line Items]                                    
Fair value of warrant (in Dollars)           $ 200,000                        
Private Placement Warrants [Member] | Class A Common Stock Equals or Exceeds Threshold Two [Member]                                    
Warrants [Line Items]                                    
Warrant exercise price (in Dollars per share)           $ 0.01                        
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants (Details) - Schedule of Liability-Classified Warrants - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants $ 3,882 $ 11,127
Carlyle warrants [Member]    
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants 3,086 9,515
Replacements Warrants [Member]    
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants 5 1,310
Public warrents [Member]    
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants 437 167
Private placements warrants [Member]    
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants 318 122
Working capital warrents [Member]    
Schedule of Liability-Classified Warrants [Line Items]    
Total liability classified warrants $ 36 $ 13
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Borrowings and SAFE Agreements (Details) - Part-1 - USD ($)
3 Months Ended 12 Months Ended 48 Months Ended
Apr. 19, 2024
Feb. 15, 2024
Jan. 31, 2024
Oct. 31, 2023
Oct. 01, 2023
Sep. 30, 2023
Apr. 02, 2023
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2018
Borrowings and SAFE Agreements [Line Items]                        
Carrying value               $ 11,400,000        
Interest expense recognized             $ 300,000 300,000        
Prime rate plus                 4.50%      
Total amendment fees                 $ 1,900,000      
Principal balance                 5,100,000      
Borrow, percentage                   70.00%    
Vendor purchase net amount                   $ 10,000,000    
Borrowing                   20,000,000 $ 20,000,000  
Outstanding net debt               12,700,000 12,200,000      
Accrued financing cost               5,000,000 4,500,000      
Recognized interest expense             1,700,000 500,000        
Pay return capital           $ 500,000            
Balance owed amount               300,000        
Contributed               $ 25,600,000        
Redemption price percentage   80.00%                    
Investment dividend payable percentage               25.00%        
Warrant to purchase shares (in Shares)               5,978,960        
Exercisable shares (in Shares)               4,132,513        
Investment description               The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is now March 31, 2024 subsequent to the modification. The acceleration of the redemption date of the investment, resulted in the total redemption amount to be 1.3 times the principal at December 31, 2023. The redemption amount will increase to 1.4 times the original investment at March 31, 2024. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the Company’s unaudited condensed consolidated statements of operations and comprehensive loss.        
Loss on extinguishment         $ 10,300,000              
Fair value of short term debt               $ 28,400,000        
Redemption amount               35,800,000        
Short term debt               35,800,000 33,300,000      
Interest expense               0        
Long term debt fair value               $ 35,800,000        
Dividend cash     $ 1,500,000                  
Convertible conversion price (in Dollars per share)     $ 1,431,297         $ 0.36        
Closing price per share (in Dollars per share)     1.31                  
Purchaser investing $ 50,000,000 $ 3,500,000                    
Amount equal to the greater   $ 3,500,000                    
Convertible shares (in Shares)   3,707,627                    
Convertible Secured Note [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Simple interest rate                       8.00%
SCI Term Loan and Revolver Loan [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Revolving loan                 $ 5,000,000      
Maturity date                 Oct. 31, 2023      
Debt in CS Solis [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Redemption price percentage               10.50%        
SAFE Price [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Conversion price (in Dollars per share)     $ 1.05                  
Second SAFE {Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Conversion price (in Dollars per share)   $ 0.94                    
Minimum [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Increased repayment premium, percentage                     110.00%  
Maximum [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Increased repayment premium, percentage                     120.00%  
Common Stock [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Price per share (in Dollars per share)               $ 0.01        
Convertible Notes Embedded Derivative Liability [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Other expense                   $ 0    
2018 Bridge Notes [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Carrying value                 $ 11,000,000      
2018 Bridge Notes [Member] | Convertible Secured Note [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Simple interest rate                       8.00%
Current Insight Promissory Note [Member] | Promissory Note [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Total Principal amount     $ 1,500,000                  
2022 Convertible Notes [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Redemption price percentage     80.00%                  
Two Thousand Nineteen A Convertible Notes [Member] | Convertible Note [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Conversion rate   80.00%                    
CS Soils [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Long-term debt with CS Solis             800,000 $ 2,500,000        
Dividend cash     $ 53,540,000                  
Amount equal to the greater   $ 3,500,000                    
Revolving Loan [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Interest expense recognized             100,000 100,000        
Interest rate                 7.75%      
Revolving loan amount               5,000,000        
Principal balance               $ 5,300,000        
Rodgers Massey [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Interest expense recognized       $ 5,000,000                
Interest Expense [Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Interest expense             $ 300,000          
Dividend cash     $ 1,500,000                  
Second SAFE {Member]                        
Borrowings and SAFE Agreements [Line Items]                        
Closing price per share (in Dollars per share)   $ 1.18                    
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]    
Total Notes payable $ 29,365 $ 28,657
Debt in CS Solis 35,840 33,280
Total notes payable and convertible notes, net 65,205 61,937
Less current portion (65,205) (61,937)
Notes payable and convertible notes, net of current portion
2018 Bridge Notes [Member]    
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]    
Total Notes payable 11,376 11,031
Revolver Loan [Member]    
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]    
Total Notes payable 5,290 5,168
Secured Credit Facility [Member]    
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]    
Total Notes payable 12,699 12,158
Polar Settlement Agreement [Member]    
Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]    
Total Notes payable $ 300
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Details) - USD ($)
$ in Millions
3 Months Ended
Jul. 31, 2023
Mar. 31, 2024
Dec. 31, 2023
Stock-Based Compensation (Details) [Line Items]      
Common stock, share issued   49,096,537 49,065,361
Issuance shares   350,000  
service-based options [Member]      
Stock-Based Compensation (Details) [Line Items]      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount   $ 18.8  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   2 years 1 month 28 days  
RSU [Member]      
Stock-Based Compensation (Details) [Line Items]      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount    
Two Thousand Twenty Three Equity Incentive Plan [Member]      
Stock-Based Compensation (Details) [Line Items]      
Common stock, share issued 8,763,322    
ISOs under the 2023 Plan [Member]      
Stock-Based Compensation (Details) [Line Items]      
Issuance shares 26,289,966    
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Summary of Summary of Stock Option Activity [Abstract]    
Number of shares, outstanding, 11,716,646 11,378,272
Weighted average exercise price per share, outstanding, $ 3.48 $ 3.5
Weighted Average Contractual Term (Years), outstanding, 8 years 6 months 10 days 8 years 3 months
Aggregate Intrinsic Value, outstanding $ 2,756 $ 215
Number of shares, Vested and expected to vest   11,378,272
Weighted average exercise price per share, Vested and expected to vest   $ 3.5
Weighted Average Contractual Term (Years), Vested and expected to vest   8 years 3 months
Aggregate Intrinsic Value, Vested and expected to vest   $ 215
Number of Shares, Vested and exercisable   4,536,233
Weighted Average Exercise Price per Share, Vested and exercisable   $ 4.38
Weighted Average Contractual Term (Years), Vested and exercisable   4 years 9 months 10 days
Aggregate Intrinsic Value , Vested and exercisable   $ 139
Number of shares, Options granted  
Weighted average exercise price per share, Options granted  
Number of shares, Options exercised   (31,176)
Weighted average exercise price per share, Options exercised   $ 0.83
Number of shares, Options canceled   (307,198)
Weighted average exercise price per share, Options canceled   $ 2.86
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity - Restricted Stock Units (RSUs) [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity [Line Items]  
Number of RSUs, Unvested, Beginning balance | shares 58,097
Weighted average grant date fair value, Unvested, Beginning balance | $ / shares $ 2.07
Number of RSUs, Unvested , Ending balance | shares 58,097
Weighted average grant date fair value, Unvested, Ending balance | $ / shares $ 2.07
Number of RSUs, Granted | shares
Weighted average grant date fair valuem, Granted | $ / shares
Number of RSUs, Vested and released | shares
Weighted average grant date fair value, Vested and released | $ / shares
Number of RSUs, Cancelled or forfeited | shares
Weighted average grant date fair value, Cancelled or forfeited | $ / shares
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) - Share-Based Payment Arrangement [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense from continuing operations $ 1,341 $ 270
Cost of revenues [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share based compensation expense gross 27 11
Sales and marketing [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share based compensation expense gross 216 94
General and administrative [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share based compensation expense gross $ 1,098 $ 165
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Employee Stock Purchase Plan (Details)
3 Months Ended
Mar. 31, 2024
shares
Employee Stock Purchase Plan [Abstract]  
Market fair value offering proceeds percentage 85.00%
Reserved for future issuance 2,628,996
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 24, 2023
Mar. 16, 2023
Feb. 28, 2023
Jan. 31, 2023
Feb. 22, 2024
Mar. 31, 2024
Dec. 31, 2023
Jul. 22, 2021
Commitments and Contingencies [Line Items]                
Total lease expense           $ 7,900  
Demanded approximately     $ 26,400          
Damages amount   $ 220,000            
Siemens claimed damages               $ 6,900
Inclusive amounts of indemnity         $ 6,900      
Attorneys’ fees, expenses, and pre-judgement interest         $ 2,670      
Operating leases payments           2,670 6,900  
Breach of contract $ 6,000              
Advisory fee 6,000              
Letters of credit           3,500    
Restricted cash accounts           $ 3,800 $ 3,800  
SolarPark Korea Co., LTD [Member]                
Commitments and Contingencies [Line Items]                
Demanded approximately       $ 80,000        
China Bridge [Member]                
Commitments and Contingencies [Line Items]                
Advisory fee $ 6,000              
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company’s Warranty Provision - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Activity by Period Relating to the Company’s Warranty Provision [Abstract]    
Warranty provision, beginning of period $ 4,849 $ 3,981
Accruals for new warranties issued 265 2,968
Settlements (250) (2,100)
Warranty provision, end of period 4,864 4,849
Warranty provision, current 1,448 1,433
Warranty provision, noncurrent $ 3,416 $ 3,416
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share (Details) - $ / shares
Mar. 31, 2024
Apr. 02, 2023
Basic and Diluted Net Loss Per Share [Abstract]    
Dividend paid
XML 87 R76.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]    
Net loss from continuing operations $ (9,588) $ (15,709)
Net loss from discontinued operations (7,805)
Net loss $ (9,588) $ (23,514)
Weighted average common shares outstanding, basic 49,077,330 25,200,347
Continuing operations - basic $ (0.2) $ (0.62)
Discontinued operations - basic (0.31)
Net loss per share - basic $ (0.2) $ (0.93)
XML 88 R77.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]    
Diluted weighted average shares outstanding (in Shares) 49,077,330 25,200,347
Continuing operations diluted $ (0.20) $ (0.62)
Discontinued operations diluted (0.31)
Net loss per share diluted $ (0.20) $ (0.93)
XML 89 R78.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share - shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share 34,460,924 12,191,086
Common stock warrants [Member]    
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share 23,024,556 89,313
Preferred stock warrants [Member]    
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share 2,386,879
Stock options and RSUs Issued and Outstanding [Member]    
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share 11,436,369 9,714,894
XML 90 R79.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 02, 2023
Mar. 31, 2022
Mar. 31, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2020
Jul. 31, 2023
Related Party Transaction [Line Items]              
Related party issued           $ 12.1  
Fair value acquisition       $ 6.7      
Accrued interest percentage       5.00%      
Share issued (in Shares)     193,976        
Recognized a liability   $ 7.9          
Due to related parties   $ 4.7          
Outstanding remains     $ 0.3   $ 0.2    
Received proceeds     5.0        
Related Party [Member] | Common Stock [Member]              
Related Party Transaction [Line Items]              
Issuance of common stock (in Shares)         5,670,000    
2022 Convertible Notes [Member]              
Related Party Transaction [Line Items]              
Related party issued       $ 12.1      
Related Party [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Interest expense related party     $ 0.0        
Related Party [Member] | Minimum [Member]              
Related Party Transaction [Line Items]              
Interest expense related party $ 0.4            
2020-A Convertible Notes [Member]              
Related Party Transaction [Line Items]              
Related party issued           $ 3.5  
FPA [Member]              
Related Party Transaction [Line Items]              
Other expenses         $ 30.7    
Other income (expense)         0.3    
Settlement Agreement [Member]              
Related Party Transaction [Line Items]              
Agreed related party         $ 0.5    
Convertible Promissory Notes [Member] | 2022 Convertible Notes [Member]              
Related Party Transaction [Line Items]              
Related party issued       $ 33.3      
Convertible Promissory Notes [Member] | Related Party [Member]              
Related Party Transaction [Line Items]              
Share issued (in Shares)             120,000
XML 91 R80.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details) - USD ($)
3 Months Ended
May 01, 2024
Apr. 19, 2024
Apr. 16, 2024
Feb. 15, 2024
Jan. 31, 2024
Mar. 31, 2024
Subsequent Events (Details) [Line Items]            
Conversion share price         $ 1,431,297 $ 0.36
Least per price           1
Per share           $ 1
Purchaser investing (in Dollars)   $ 50,000,000   $ 3,500,000    
Received amount (in Dollars)           $ 50,000,000
Issuance share (in Shares)           45,553,093
Exercise price per share $ 0.62          
Cash Payment (in Dollars) $ 3,750,000          
Kline Hill [Member]            
Subsequent Events (Details) [Line Items]            
Least per price   $ 0.125        
Subsequent Event [Member]            
Subsequent Events (Details) [Line Items]            
Common Stock Issued Price   $ 0.45        
Bid Price Per Share     $ 1      
Subsequent Event [Member] | First SAFE [Member]            
Subsequent Events (Details) [Line Items]            
Equity financing percentage   80.00%        
First SAFE [Member]            
Subsequent Events (Details) [Line Items]            
Convertible shares (in Shares)           4,166,667
Second SAFE {Member]            
Subsequent Events (Details) [Line Items]            
Convertible shares (in Shares)           9,722,222
Forecast [Member]            
Subsequent Events (Details) [Line Items]            
Issuance share (in Shares) 9,800,000          
Purchase shares (in Shares) 3,700,000          
Revenue (in Dollars) $ 100,000,000          
Forecast [Member] | Kline Hill [Member]            
Subsequent Events (Details) [Line Items]            
Revenue (in Dollars)   $ 10,000,000        
EXCEL 92 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

)-O./" MCA:EM@M^&M>X@$?0/^JM-#-_H!!: 5=4<"0A3[S59+E>V'@7\)-"JT[&R%:R M%^+93C8D\0(K! PR;0G8/ YP#XQ9D-'XW3.]84N;>#H^TK^ZVDTM>ZS@7K!? ME.@R\3YXB$".&Z9WHOT&?3TSR\L$4^X7M5UL]-%#6:.TJ/ID8U!1WCWQ2W\. M)PF&4I.GTXTY M7@(2/4E,*"_02DK,"S#'KE7L:[.#C?.SGK;N:.$%6H0>!->E0E\X ?)OOF_, M!KWPJ+<.1X$/6-ZA:'*#PB"LV>Z%-[W+#TGPL0-H \SX70A\G=H/A\Y/^ 5!+ M P04 " "(?*]875&!JO86 #61P &0 'AL+W=OO0#F3E%VED2UYGZW*LYV36YG,5#PYJ5NW[@-% M0A(RW$*0MI5??[]N+ 0EBIY)CEZT9#+^[+^HM>2]F(ASPK],N# M==-4SXZ/=;*6>:RG924+?+,LZSQN\+9>'>NJEG'*@_+L>'YR/6" M/_M4OWI1MDVF"OFI%KK-\[C>O)99>?_R8';@/OA%K=8-?7#\ZD45K^2M;'ZM M/M5X=^RII"J7A59E(6JY?'EP,WOV>G9! _B)_RAYKX/7@I:R*,LO].;'].7! M"7$D,YDT1"+&OSOY1F8940(??UBB!WY.&AB^=M3?\^*QF$6LY9LR^TVES?KE MP=6!2.4R;K/FE_+^W](NZ)SH)66F^:^X-\^>G1Z(I-5-F=O!X"!7A?D?/UA! M! .N3O8,F-L!<^;;3,1[R%]*CZ4 M1;/6XEV1RK0__AAL>E[GCM?7\U&"'^)Z*DYG$S$_F9^-T#OU:S]E>J=[Z-VJ M5:&6*HF+1@S(0?S/S4(W-?3F?X<6;VB?#=,F8WJFJSB1+P]@+5K6=_+@U0_? MS2Y.GH]P?N8Y/QNC_NIUK)46Y5)\(MI%$Y.&#S$Y2F:8RPO*?,J+C8DXZ)L M(.!U?"?%0LI"8/HJKC%<%?Q@G8*(A"TT:[&2A:SC+-O0-[*B2>)NMZI:8;HJ M SF,;<#BKX4BXKW4_&OFYM/_'[V_(CY MJ]I:MZ0*3U7+49BX!E0E_>RJ2M5:/L$^\>DG52)#;4DN26!%$ ,<2V8G <6:5A2GO\/NC>":=8PG:SEQBRLK51!U M\)''!?PF/3<1A4RDUG"K HY:Q&(9JUI4X>99QO$1_)6.Z#%ZKXH&PLE%A;]E MJMT8F4Z_<;M%L-W8D:Q-)4]@M\I+[HU1 EZS B/WZQ);^[2\+T!-MPNM4A77 M$.Q4W$!".K!1YM4J$5QQ1BIBY \K+72T1G^E_+C%>0*IUD MI6YKEA#X)I,GS@Q-9B<@.Q6!2X_V] *J& K%%F6YY%/WQW?7%Y_9RW# 9=)KT="]22_!0<&B2JL%4-> 1=&!WC M*NAQ5"XRM3).YKDG^Y[,^"[.6E[_?5S79 ?!BI_W.+ ^7.2R69=IF94KXP]4 M 6$W);Q#N8!Z2)U(3/EU8ZNZ3%NX*SOYYNM&-58>]^S&Z9,$WEV!]Q([M\7V MLK=*&HH!F(]],APK["->U=(H\'/:S=[P7,:D(;R-& _(E'QY2DB-S"$G[;(6 M_]DX=OG0L'*3ZN(]]IKVFS2E)EM)%=2Y)@'I:"&;>W(D>$SOF$'2M'C<.M3) MH(EV%D@FJHQNU'#BDDP;OMZ.AAU"\1?2FI+SOI9<1(O1Y"T#%DBE8MVP_==P"W"^C0O&TA>ET6\R,C7I]+L7*+JI,WA-$@($^-AUS)R M!"3M%3.Q+1>"V5AAL2II<0M"$;V5P#=KMEU-N\/Q!Y]3,,04H35JMK_X/C:6 M3T-U)1,R[8@\!WF6NL^G6:AU8RGQT5;D!UT\W]Z;_>X!E)TV$.BP6V(D RL@ M !/UU'6;M/5.H!.8*ODU^SRSA== "BT;"'^NM'6?++*>7/-X(RS" )4"N8X1 M0E0F0 UF :G1+^B:*DRV1MI&,&[1(#N#3HU$O L?\2Y&X]6M7/$&_=A-,13T MQHD<)D=B@%!/4X':,UB]:#1*:@U=9R,Y^(FW)\-[#5=W!NVJ;-PFXNKBF MOZVSA+IL5VO (U*9% Y&_4E>&+&&F&#GW- F:..C*7 R"4NX-JIB$ CM* 8L MXX3V%[O$\4_'F;%#56".+//AP! B) L/J3<:X5A;BP,[6$HFO:M=@ ML]ZLE014> !8I&Q6?%S"(D##@\M&[G+&.K;T0+M"!(TLM52V,YP7]+A,(%=(#3'86?< 2. S( M8@FQLO%L]ME93V#>:?@P37QA?QJ.@)$+S\;K!DMIW%K34AH2SL%M<;&@&@8_ MGL'\,L=5;PF610->!WB.,GC'IQGV+O4@AJ,/P"U;:2^+26T6([HL9LR*+[T5 M7XX:X)L23J=H.GCYB])?!M'K.)W#]$@,TQ+O?>0C2ZC;()VIRL98%YPK /_O M#CLZTX=5)2%17KV%#S6(L\"5)GN'>ZQ5QOJ1Q'IMS)->4!3 )O:23\:C2+,D MOD&\&S2P:(0,A:("RE65&IPP"SXF@U9@EUL%HV@B( M)YUX6<$UPB5M)A&94=[F/?G+!TA?&PG E"K*9DV01=!R>=ENW&?+\F@EY:!N MX*!(6P.-NT5@28"%&2/_&@"H^%*W59-L^F0M@-:./6NX3FE(IB86.-_=U1*\ ML5O$ *TB=TW?,EXE3\Z QI#F>3T"0O9"Y<$AM>H24RS(>2)LNP$QW7,6\X7& ML" ,1FQ0Q7+A PDG)IJ'VZPJ)N9?+&AE1P%RX\OGU]WCLU"Y_/CC?SCIU6U7P M+]^X3BYI#6P;+=]1[._*F6'K[.3[?6&]2U==_L<% W8T")S99BP&7OD8>#4> M YVCYQ?O.D<_% ;'21W*([&7W#:JU19(PO;7:K6&V6<*3Z="^Y*B467@)?)^ MY&79C&F[;G9CJ"H7\Q5IFIDZW MELD7IH!$7\=W>!EX6@:?T"YBN_XBF^X;"PMH)%C?)URS B\PEC*!N]3AK"%) M1X]+>DPGK[U.7H\JTB^0'S >XTA(9$@31PGL*>@OC\06Y;Y29@"B5) R6LE[ M07'B?JU@Z:U&4DZYA"N&+5B-^5R$ZA^<&QGDSX4[/P_1F;HB4?BA4R9QCP%/ M3J=7(D(2*.L_8 MQT\V.=R2'5=)8\%)!$5^DT-,(C+ 1C]>KG>BYP/#+6X0#1$3%$$3,]6VN4[L M045?YK[DBQRK^9HC@SX/MH2\6M5R%51K%A)F5E@O0*$G"/4:0\O[PJ&;@0FC MWH1!]=LE"DL (E;899GQRT,F5D+;BU0?/8LZ_0N#6[3?E3T1L\GEU07^SR?G MUZ?1MFJ>3J[FU_SW-/K,,&18R(,R?B+.)Q>S<_R_F)S-+L;.+F8GW MAK$ C"@I5X7:5\MYA,KABKS+#B7Q5FFWJ19@U/ZI)=49S3XW!GUQ9NT*Q]LY MF1M8&_)_&B?DDG^2%WDZ+J]O*KFSE9_[,(9/HX/]=;@J8D=#?B6ZW2W6] HZ MM-O7D^OYG';]?')U1D.6#5[P).= M=J]$$9D2!3EC A)\)MN=:XC@7&/']W%OAJVL5A105 ()48Z8(D=L(DK/*(LR MIT"T_,=FX/S&1J?N]-2@);PSY<,-$ JM ?:V:M9[,Z"@ $_,IJ2VE*P_F4UG M7!>B3KI?O.(R!5N*-O@]#KQQ^4^&L>SJ >W(> MFA1@_Y.S3NW[N9_7:QIG\P=.&_C$'!KC#I2#XS#JK A.C;]2,M$H2K3,3ZCUG$O;8),IXOAB-]0W61?JC]:=#>3Q \+-GZ8#J^7^HJA< MD!W$IBQ:P( ]6 108^)GD2F18421W/$Z!];*S@NZ/J&,"M5HEH%6P*^ ML'TD@5Q)^ ."[L$@&.6JK!FSN9-OUQ]C)X_X)%)WC4@_\Y9_,@QFM'Y-HN=,^!!T(]G,8<06*^NV, MV$*E:G;;E@9LV;:LQ7>QRNB+B>EM K*-O:+2*E7C#L@@5:-KI@D*H1:<-#32 M'%9-NH(9](2V=C__>W<]. @>[MDS9=\^ (\LF93(AMUAU#'0-W/;Y$7 &%/' ;$;$(48:N62:Q]?GF.[V& M+9M\LC#'#X>^.LQIAG4OMD-D8+U#RS,=#H-;&K6,0?O&LUN6)+Q%]HFM8AP? M=DB7OJ.:^\DH*:6##VAG*NUK.G.WO51IN'Y;;XXZ'\95?7_D\A7%S&](F, : M<*4XI,3IR-1QZ0&X=<97D4>#XE)!Y7JK$-_06=&4#=5W2RUH0\4&*02)DZ>W89&1>Y>BEU M]%A*W:\;8=*R@\U;*_31U*KW5^?+?_5P84QGNRLZL]%[-*]^LR[FI\Z=#&KL M.)7#WX_$ *6>G_'^E'$00=$![[9;W&$P")R7VA1;W-R^$5>S\Z=G)W1V4,-= M-YSTDGC_+=,5[0CG=K/G= AORU08^([QDT_[/MX7?(Y,\,4DJCY:.]8L#DI+ MKI3F=(F/\]M:5G\0= MZ6VYV#U%LATYSB'$X9QH8DN@Q2:,#*9)EE4V\/-![9-P]'X_ZTKH_Z#;CWIN M?]J=?OP,J(N0YU1A7^9'!/G1V=P_:U5YW,2ZNV2S\EMZ*X1"'C2 M,MUP,Y$_/^!P0WO1T9_PT3.W:/1B :.&DUW\VLV?G'K9TCB)^JH^@16;]?8[T%;>>3V5W8D M=@EM=0SE@,34JBA-RQZ5UA!AN7_35P%($>87L(=W<5UPOXRG-N7+G,G0>"1/ MG8YJ!Y]I)RBUHV=]-FF:WK_EF#IZXN?T5CTSYVZB1]S:HJ2/C\UC[$9N9%O_<5&;2]=^(L8-*>=KW\? M@[Z *Z:NAJAJ$;024W(+6HW<=9CNWB2?;9H.)(XLO0N5X>5:-]2G [[$9JX_ MU]G&W8-Q:5ED;HAT3[$LF(N-(,DNYFIKBV252V[]UU0LI8X"NBWH>Y:68*++UV;G+E\+.71G)%9F(2GQ&*DS MUXME+^W6LJE+=[01Q:GQ4OU"BM(NLUU_/KWF_;1JVKR?4BT#^[W/\ -:,,4:79T/&V#T9 M&J&15,F746AOZ;Y-1Y]$AZ&VM:JI[ILSL["^*V[;14O$'/M\(@YXUK%='MU M?:VVWJ6[Z(:=,7Z.0&E1<-^GU=Y'-75;":-'E/!:_.-*^#A8'53"H7!W'/S4 M2D[E'/I!&7)/\%WF5U?\I_Y':V[,3[5TCYM?O/D0URMJNL[D$D-/II< B[7Y M$1GSIBDK_N&61=DT9&PO=V]R:W-H965T]L>BAYH:6012Y$*2:WC M_OH.*5GK;&P7O8BO>7PSWY"CV5[I)U,@6OA>"FGF06%M=1=%)BVP9.9&52CI M)%>Z9):6>A>92B/+O%(IHKC?'T2B]FJK:"2UQI,'59,GVX1Z'V M\V 0'#?6?%=8MQ$M9A7;X0;M[]5*TRKJK&2\1&FXDJ QGP?+P=W]R,E[@3\X M[LW)'%PD6Z6>W.)+-@_Z#A *3*VSP&AXQ@<4PADB&-]:FT'GTBF>SH_6?_6Q M4RQ;9O!!B3]Y9HMY, T@PYS5PJ[5_C=LX_$ 4R6,_\*^D1U/ DAK8U79*A." MDLMF9-_;/)PH3/L7%.)6(?:X&T<>Y2=FV6*FU1ZTDR9K;N)#]=H$CDM'RL9J M.N6D9Q>;A@Q0.6SX3O*7G(I"_\1^E_+K;&:*NCO<\$WMH?G;;M;=6V I!Z(^P*^!J)?@'@!C972;L5ESY*Y M6K(ZX_Y84>%(T\P,L9(QM[UE@LD4P9>_ 5LP"VRWT[BC8[ *G)4M[KB4CD[G M$V7FIJVF(56UE^00+CCL_>#06!I*%X'+MP>=T[-F@!G(E?#3]]Z8J@VY,Q_N M>E2K:>&+]1.F6&Y1NT7/<^,0OT(;*A5/FSY7=53_GRVZ-.26TI=JZ!XH()QZ(#NWWVII\]V8:#R8?34^W M"/4+PNT!JA.$ID$(]E#A3VP^%IQ*%.4O>\2G]D$[H7A9:2Z(MYY[F-SKE/0V M2C!-=8=Z=P!S,%1 5&]424(PUY@NZ1C=;M=OETV; M>1%OFC5%3+?*@,"<5/LW$Z).-PVP65A5^::S599:F)\6],^ V@G0>:Z4/2Z< M@^XO9/$O4$L#!!0 ( (A\KUC!%<7_+@4 /0- 9 >&PO=V]R:W-H M965T&0/-T)^:PV )K\2'FF MS@8;K?/CT4C%&TBI=-1BEEV6!^:K_= MROFI*#1G&=Q*HHHTI7)_#ESLS@;^H/YPQ]8;;3Z,YJ6DQ>,-B2&Y$IC>*7&4))"_U1XBN@1C4$,^#7H,W5+HD](^$O4OY[L51:8IK\-QG?7Z/6S$I.!"Q(@NE ,'J#=6$RH9"0G#>8682GMQ!7$C) MLC4YIXJI0[1Z%SY,ZV$#9"4X;F=C69L\(183E@B]061 +D2:TVS_\<,T\(]. ME+-B&A'/00YDN\:1+&^09;X(Y/RCZH^I \"$VY<]T@^];"<2ZHY'NDM:-2 M4I,;OQ'+)3AY,0J'WG12]\YML>0L;G7&X5$C6_?XS;F5;$LUD)RC8TWJM2JU M6.A/NV/G"2N;H1W3G"'J PJ3SM"Y@Q[;=1^1R,'"AO\3DA?H,JQMA*XE6#VG M&YW7JK/AV)N5K7._N+YR%K7:@66&GN>5K6-=COXRGD&O16-L_:-AA (XF Z# MF8\Q-%E^"0A_";(.8UB&D51A)%48R?\2QMDP\J.Z_RF,_N3G,.*W]X31#X+N M^+_#Z(\[PYXP^B=-[P]#WRO;GG"2OG"&PVGHEVT3(L,:V]"DMS\>3J)J,(MF MI*>B14U%B]Y=T9YJ:EBD<./;G7Z.Q)\)2@D\A,B?N3W!T>.Q<=\-X*9/#E6S M_D4?VLI4EI7$,<6J<>WRU?I?>M8K1 IN3(]<@>J%3MJ)78"DZUB=V>')G?OU>=<\?4\Y<5 M1A@70S.@-)$F(T-W%J!4V;5V$K9E"6#AW3/@"?&L*=LZ;7>>-5@[J^$A<@F&'>HE M;0*:4'YE>/G"B.-VN/I>&.%6[U#N]0,QN7=]NWBQ#P^==\ZV/;Y?'W>%,F-J M[U>8R5CNF: IQ8FG BUIB M='+$#%B:/!<+$U8H=S)Q[E^OBY_#>H/Y;A15R?M6:H[=FOLQ-WP]L M=LZBM])SU+F)IR#7]KVAT&5%ILM+>?.U>=(LRIM\*UZ^A] +:Y8IPF&%JIY[ MA,5-EF^,N$=C:EF0:"S(Y14W\@* M!)X44I74X%(= ETIH+DS*GD0A>$H*"D3WG+N]K9J.9>UX4S 5A%=ER55SVO@ M\K3PAEZW<<\.1V,W@N6\H@?8@?FKVBI6G)4@-)."*"@6WFHX6R<6[P!_ M,SCIWC>QGNRE?+2+S_G""ZT@X) 9RT#Q[PDVP+DE0AG?6D[O?*4U[']W[+?. M=_1E3S5L)/^'Y>:X\"8>R:&@-3?W\O0)6G]2RY=)KMTO.378>.R1K-9&EJTQ M*BB9:/[I]S8./8-)^(9!U!I$3G=SD5/Y@1JZG"MY(LJBD=-8ICPB9E M9Q2>,K0SRWMX J6!W$-&*V8H9S^H"]>[![KGH-_/ X/76'"0M93KAC)Z@S(F M=U*8HR8?10[Y:_L Y9TU1IW&=725\(ZJ&Q(/?1*%47*%+S[['#N^^%=]_G>U MUT9AH?QWR>N&-+E,:A_/3%@)O^?MOPU'XQQ7)R5ERBKK<@[)*])'B0:NIXF!@L).<*D9?BY0O(@DK2\@9-<"?^]<@;R:%:PTN M%)Y#677INI80\@Z?;Y@,_2B)R?O! M@\1$=JQ.02_7! />J+]]43_UQ].1'T5#O/I L^=SP9&NX%HV&SW,;Y2.!]@M M(L1AL)1AMHK_E!;?^9*,$#I.NWCTBIC\5,3:%7&_<&EA\ 5T@I/4CS"X:1J3 M2T\]Z'7GTIK8&:2QW&MAFD9]WCV/N573W5_@S8S$3GA@0A,.!9J&-^/4(ZJ9 M.\W"R,KU^KTT.#G&ULI53; M;MLP#'W/5PC>,*Q 5E_B7)8E!I*VP_I0+&B[[6'8@V+3L5!=/$ENVK\?)2=> M!J1!@;U8HD2>PT.9G&V5?C 5@"5/@DLS#RIKZVD8FKP"0J71"CN4@@F0ABE)-)3S8!%/EZGS]P[?&6S-P9XX)6NE M'IQQ7;=$/LM+:FDVTVI+M/-&-+?Q4GTT)L>D>Y0[J_&689S-5AIJ MR@IR]83/;, 0*@ORU5:@R46C-4A+%L: ->3]/5US,&>ST"*OBP[S'<>RY4A> MX!B0&R5M9D)O$%7A(''&_QW M$7XNUL9J_)5^'2M#RY(>9W'M-34US6$>8/\8T(\09._>Q*/HTPD-:: MW6&[%@T'HDKR:CW'1)RD.2YBSP>'?,KSY3L^VM8O5]C.QO8P2;PFI>(X%9C< MD/=,XHEJ#(::LVEO85!(#Q\ZK_Q+7T(.8HV :/0NH02$+1!."&;<@##D+1GV MHX\37--^/!GVKN4C$BO]C$U:*\.0_0,9Q:->6XC1>$+B?H3VO;*4D_K5&AS1 M>#SRZR0>DV./%QYTI "]\7/'R6^D;9NS.^U&VZ+MZ+_N[5S$&FP8ZN-08FAT M/AX&1+>SIC6LJGU_KY7%:>&W%8YGT,X![TNE[-YP!-W S_X 4$L#!!0 ( M (A\KUBS)F1L10, #L' 9 >&PO=V]R:W-H965T,.0 +[Z)4F39DF OMRV MNN:+OMP^$^*#83"Y4EGR0W MO7]_E.QX*:[+]8OU0O+A0YJD%CNE'TR):.&I$M(LP]+:>A[')B^Q8N9$U2A) MLE&Z8I:.>AN;6B,KO%$EXBQ)3N.*<1FN%O[N1J\6JK&"2[S18)JJ8OJ?"Q1J MMPS3<']QR[>E=1?Q:E&S+=ZA_5;?:#K%/4K!*Y2&*PD:-\OP/)U?C)V^5_C. M<6<.]N B62OUX [7Q3),'"$4F%N'P&AYQ$L4P@$1C;\[S+!WZ0P/]WOT#SYV MBF7-#%XJ\8,7MER&LQ *W+!&V%NU^X1=/!.'ERMA_!=VG6X20MX8JZK.F!A4 M7+8K>^KR\!J#K#/(/._6D6=YQ2Q;+;3:@7;:A.8V/E1O3>2X=#_ESFJ2UI761' ;\P?0*C-((LR<9'\$9]F"./-WI%F'^>KXW55 Y_O11HBS-^&<>U MR-S4+,=E2#U@4#]BN'KW)CU-WA]A.>Y9CH^AK^ZHY8I&(*@-_%&C9JYP#3!9 MP*6JR&'INN$1X5KFJD*X1<$L%F 57'&3TR_@LJ'S3]N7(CS.X;Y$(/!:2936 M.":L4HW;4KNX7B)\+L&26B-94W!W0:X+HM;NC!*\<+P"8VFI]CCJ>43YLXB$ M,LY#'T]Q&,^A)?U GWEY0,2ZNHV &=@H06/&P,!+5&/(DQG.@_N2:XLH?_N! M^& "7Z;!>:VY@"P*;O$1R9&!MY#.HFF6!I?*6,=9[R7I632>G@4?M>/IR0ZF MDQD,@R[7<@OX5+L\,#%=7]+>A(WW,(X^$KXXG]QW[8H$QB^U#?Q MP4"K4&_]V#94,E2([6SK;_N7X;P=B#_5VV>%)LF6DT.!&S)-3J:3$'0[JMN# M5;4?CVME:=CZ;4FO&VJG0/*-4G9_< [Z]W+U+U!+ P04 " "(?*]8,^^E M4OL" "%!@ &0 'AL+W=O:&ED$:%(E:3BI%_?H60[">#XT(/- M;=Z;-QS.:+I2^M&4B!:>*R'-S"NMK2>^;[(2*V:.58V23@JE*V9IJ9>^J36R MO 55PH^"8.A7C$MO/FWW;O1\JAHKN,0;#::I*J9?3E&HU23@Y39Q]:_"#X\J\F8.+9*'4HUM\ MRV=>X 2AP,PZ!D;#$YZA$(Z(9/Q9;!!YDC;&J6H-)0<5E-[+G]3V\ 8P_ M D1K0-3J[ARU*L^99?.I5BO0SIK8W*0-M463."Y=4NZLIE-..#N_T91?;5^ MR1PN_C2\IANW??A.[^'PGBT$FJ.I;\F3L_>S->MIQQI]P!K#M9*V-' A<\S? MXWU2N)49;62>1GL)KYD^ACCL0Q1$R1Z^>!MVW/+%_Q'VKY.%L9J>R^]=@7>\ MR6Y>5T(34[,,9Q[5B$']A-[\\Z=P&'S9HSK9JD[VL<_OJ"3S1B"H O9$L$OV M7N+=LM]YP%X=&DU"7A5##&$\*JO?*,@'USIN!<3\9)J0IC<;$9,R$ M>D[65(UH@\V1KC;CK&M&!&25TI;_[38.XWXZ3.'(389A"$=[775).("DGZ2# M=HS#$>QZ8?Z;UE"A7K8-T%#^&FF[+K'=W?;8DZZUO)IW#9I2L^32@,""H,'Q M:."![II>M["J;AO-0EEJ6^VTI.\$:F= YX52=K-P#K9?GOD_4$L#!!0 ( M (A\KUB8BPM&00, & ' 9 >&PO=V]R:W-H965T M_?L.*5OK (Z+ GT0Q&Y'!U4/J;:1 M/+5"FG786-O=QK$I&VR9N5$= M2EJIE6Z9I:'>Q:;3R"KOU(HX39)9W#(NP\W*SSWHS4KU5G")#QI,W[9,/]^A M4(=U. E/$Y_YKK%N(MZL.K;#1[1?NP=-HWA$J7B+TG E06.]#K>3V[OS%D?7"2%4M_V68>+$"JL62_L9W7X%8_Q3!U>J83Q+1P&V^DRA+(W5K5' M9U+0)X])M MRJ/5M,K)SVZV9:E[K.#]$VVS00-,5O#)-JCAOM<:I84/G!5<<,MI]Q)7('$9='HKN!*/T!408?E;2-@?>RPNI[_YA$C\K3D_*[]"K@1Z9O()M$ MD"9I?@4O&S.1>;SL_\G$G]O"6$V'ZJ]+N1BH\LM4[J+=FHZ5N [I)AG4>PPW M/[V:S)*?KP22CX'DU] WCW1QJUX@J!K^6U"7(KG*=3F2$RF>DRI/6@ZD@3C+ M9*GHBAOKY)(-U$I0I>!R!V^XI!G5&_(W;V^#K2&;@/:];/S&O\,2VX)0:1"< M2$O5.E8VW'DB+E!BS:V!UY!%\\G4_Y>S97#O;Q>Y5]@IXRS2Y0RF>1Y\E5SN M%2\]G/2[3!U#%HL$9O/)2&91MR 4&Y@T[I78.^7#%-6NJG4I=HLUETQ QY[] M3(T4>!KE23*T(Z+ '9D9M%:@LS0PC^9DY=L77O9$_LLLH>]%C<:"V6.Z2XV5 M"RE+2? \^-2AII0X:4@U#,[R'YTVA4)?P"R9CW@'IC63]OG%8A+E^=*U618, MIXB==)]M*&G-,UA$RVP1?%&6XF'_>B*^ W@-:1XMEIGKS*/%/(%+UR(^JWJT MC3M?V]UQZJ4="N X.SX?VZ%JOI@/;P^=J1V7AI)3DVMR,Y^&H(=Z/@RLZGP- M+92E,^.[#3V!J)T!K==*V=/ $8R/ZN8?4$L#!!0 ( (A\KUCYLD2Q>@, M ((' 9 >&PO=V]R:W-H965T*DM@'';;$%VMV@2;^KJP[B&:3 MAJWQ#NW7YE;3+CJ@E+Q&:;B2H'$U#>;)]4WNY+W 7QRWYF@-SI.E4@]N\[&< M!K$CA (+ZQ 8_3:X0"$<$-'XL<,,#B:=XO%ZC_[!^TZ^+)G!A1+?>&FK:3 . MH,05:X7]HK:_X\Z?D<,KE##^"]M.-B.+16NLJG?*M*^Y[/[L<1>'(X5Q?$(A MW2FDGG=GR+-\QRR;3;3:@G;2A.86WE6O3>2X=$FYLYIN.>G9V9^V0@WO'RG) M!D/X@\J@?\^6 LU@$EDRX,2B8@=VTX&E)\ R^*RDK0R\ER66_]:/B-B!7;IG M=Y.>!?S,]!"R)(0T3O,S>-G!V\SC9;_N[=_SI;&:BN/[2_YV,:-DRTGKK&$FF04$DYT3^-KT["+Y@63X2WTS=P$>;I%;QY-4Z3].U)M0_S MQ3TT[5+P(B0N?,,L<1*42YHX%LAK/TY<* K6<,O$LX5^/KZ"P?^:H(E)*B59 MH5C1X "VUMC![YWD:/K) /JC<'0Y/H+\I SE1$+)#<7,V2V4]RAY'$X]Z]=KQNXK8^LK UWKPW-]N,[U*/M" M<2=92&5A&O0C63R%'NQTO S0!UVM<&D534A;D;Z@E)$TTRZ,PY<:+CJ:BS7J MM9_^ALJPE;8;D8?3PP,S[^;JLWCW.I%#:RX-"%R1:CR\' 6@NXG?;:QJ_)1= M*DLSVR\K>B11.P&Z7REE]QMGX/#LSGX"4$L#!!0 ( (A\KU@,][1ZNP( M /L% 9 >&PO=V]R:W-H965T0,HFBO1#?^;[O MOCMS-]LK_6@* &3/E9!F[A2(]=3S3%I QZW!5H'5XRJ_D. M-H /]9TFR^M9LK(":4HEF89\[BR&TV5DX]N [R7LS(\D];J"HZYE<)'PENLK M%@Y=%OA!=($O[.L,6[[P?^K\N=@:U/2'^'6NTHXH.D]DAV1J:I["W*$I,*"? MP$G>OQO&_J<+,J->9G2)/=G0T&6- *9RMN[8,[8I.&6RKM,JSDF_2'Y>^GT! MEK;F\H45W#!]S&KZK&F7U;2]HSW 2F,:+E.@8,$1L@$JAL23*T%#7LK==+"P MR,'J%+GG6G.)A@77;AQ>NT$<#VZJ6J@7@$-(W>B41 "K!91/(&"Z7+/X2V%>4- M-AI>"PO=\?A.S?K,MNH%^#>_6(@W"KB3I G*"^E?7(X?I;M5T!JJZ'>^M0EH6[;&@[0S: M!M!]KA0>#9N@W_?)7U!+ P04 " "(?*]8DQ$CP9 " "?!0 &0 'AL M+W=O>\Z9,Y[,+%HA'U4!H,E3 MR2NU= NMZVO/4VD!)557HH8*;W(A2ZK1E#M/U1)H9D$E]T+?GWHE994;+^S9 M5L8+T6C.*MA*HIJRI/)Y#5RT2S=P#P=W;%=H<^#%BYKNX![TCWHKT?(&EHR5 M4"DF*B(A7[JKX'H]-O[6X2>#5IWLB+1&%^SI>L;0< AU8:!XK*'#7!N MB%#&GY[3'4(:X.G^P/[9YHZY)%3!1O 'ENEBZB2M%%:E#T8%92LZE;ZU+_#"6#NOP (>T!H=7>!K,H;JFF\D*(E MTG@CF]G85"T:Q;'*%.5>2[QEB-/Q Y625EJ1M]]IPD&]6W@::BTH4BGZH,LG_Q'LH9-(4'3>OP(N$ME5=H45M6S 1&AO:;@N:O/B 4O$:I>%* M@L;U))REU_.>B_/2MJM@?>RPNKG_)BV/##-7IC.L[. 'YF^@CR- M($NRWAF\_* \]WCYGRG_=[8R5M.E^7I*>PO=.PWM'M*U:5B)DY!>BD']A.'T MW9NT2&[.$.\=B/?.H4^7]#"KG4!0:U@H^83:F"EHE=I+%:.@Z78M1+"K\$%ES2C=H8.U5Q>!S-#,0$5 MK]SZZMUBB?4*M7,"5TI7SYRL= ASS:M-)P3>0II&^:!HC21/@P=\4H+DP@?% M)/2C;)30-RV&P1++G28V"_IP"W>LY(+;9TBSJ!B-W)#VA\&]$DP#]1DK?)%? MRPU>9'8#>9($C\HRT9%HV+-[ )"-HKSH0S:,BOX@N,65!=*Y6,)2"6X@[T?# M7@)Y'F7#%P#Y$X"[8N51L?QJ!)+:;D%*DCX4:33*!\$'-'2^.ZT=K49IW[LN MNIA+LGP87 :??A>?2O1_O+<'P:_6J9L9'S66&O7&MT]7_IVT;8\YS!XZ]*QM M3*_A;7NG&[#ATH# -:4F5X-^"+IMF:UC5>/;U$I9:GK>W-)?!K4+H/6U(DF= MXS8X_+>F_P%02P,$% @ B'RO6+<3Y>V!! R0L !D !X;"]W;W)K M&ULI59M<]HX$/[N7Z%Q.YUDAH!?P) $F"%IK]>9 MZR43DO;#S7T0]@*:V)(KR9#?0#TML\^NWJT['"M]+U9 ECV M4.32C/REM>59IV/2)13,%Y&H]\D-_NW C%DM+"YWQL.0+F(*]*Z\USCH- M2B8*D$8HR33,1_XD/+M(Z+P[\$7 VNR,&44R4^J>)I^RD1\0(<@AM83 \6<% MEY#G!(0TOFTP_<8E&>Z.M^B_N=@QEADW<*GRKR*SRY$_\%D&.Y7MN^7BH MU9II.HUH-'"A.FLD)R1=RM1JW!5H9\=3J]+[DPN,*V.7JL"[-MREZ^B6SW(P MQ\..13=TN)-N("]JR.@'D#'[K*1=&O9!9I ]M^\@O89CM.5X$1T$_,QUF\5A MBT5!U#V %S#TN,Y,R5/8>3CZS"@5^"/ MW[T)D^#\ .5N0[E["'T\Q<>853DP-6?3^OVX(47"KDK'?D("%_9Q'_>#Z/NY M3[8/E1P9YTB53R\)'3&L"WEVZ;"Z/5;A8 MVUSG7!HF#.,&<7(L#N;,JR,Q[*JRQG*9";GP_JR*&=H@B:_NB>&E35:@L6)\ MOS!9+#0LN 5O!^'=FT$41N?O(06'M"$3LS!L]<.DE703]I;%[>Z #=J]&,=1 MJ]]+&C(+S24Y<3CA^>;GQ;0Y#0^@4T'2.D)'83]AQRQH#^+F0,IEBD6)]H-^ M*SP=X(&H/4CV4'Z1/.0;]P>MJ!\YOKT ^48]XAOVO"]@B"3:(X42:QY.K&(K M7/Z_:"X@J@;[@;JM7IRTHI@RUVW' _SJ#W XVJ7_@N1/.-^2!9)(XOD];)P MU6E/0?_P0&-PP4\MU@5L)ZPADRN\/%X_2-HD*PU+:C96P#[)5!7 COY09O\? MX$%J^\5UBU*H[Q_?-[/TG#9R$_^ J0OLR *YDA&7CP1>25YE[L)2A3*4-:8T*A<9IV7S+!7J>2K29ZD0FU3DE IV)*1G MEZHR>- \C2"26NTV>8>\CZ,^9FC@6HI@&+$QZWJVR>.2GV9MK55 . M$+\B%SLQ(XU6W T=IV"O,CL[[54!>N&:2"SDJI*V[K2:U:9/G=3MV=/QNLG% MY"P$.LUACJ9!NX]E2M>-8SVQJG3-VDQ9;/W<<(F]-F@Z@/MSI>QV0@Z:[GW\ M+U!+ P04 " "(?*]8Z!MGDN$" "*!@ &0 'AL+W=O852"DC0;=H^5$)MMVJ:]L$D M!['JV)GME/+O=TX@91METK[D_'+/<\_9Y\MHK?2CR1$M/!="FK&76UL.?=^D M.1;,G*L2)>TLE2Z8I:E>^:;4R+(:5 @_"H*^7S NOH?U2SC7-_)8EXP5*PY4$C-[T?<@ MK8Q5Q19,"@HN&\N>M^>P!Q@$KP"B+2"J=3>!:I7OF663D59KT,Z;V-R@3K5& MDS@NW:7<64V[G'!V9LY%N*Y1!^ MNN6=-;S1*[PQW!!3;N"#S##['>^3QE9HM!,ZBXX2WC!]#G'8A2B(DB-\<9MX M7//%_Y7X]^G"6$TE\^-0Z@USB4']A-[D]"3L!U='=">M M[N08^^2.GF56"02UA*DK:6XWL-C '#57&=RB8"X/L ILCI1643*Y.3T91.'% ME8$'IC63!)EK]<3=TSJ4X%$)AQ/<:>F0EK+1HO^A9;W34NZTT!+=AH&E$M0M MJ/ZX)*2J#-V0.1MV[G.N+:)\!]^0Z::V.@]_T71A@2LNI8M-Q[25\P:2[B"Y M)!MW+P=A9YJFNF+"1=,@7?]HB-S]I.5F!3+F^C7@!G M9+IA0(.# I!*ZH_0_60GX2 BK;0F>O()NTDR:&P<'_252KZXQ]TD[+?V4(GY M>_VA0+VJNZ"!5%72-JVB76T;[;3I+R_N39>F9T@G:T#@DJ#!^47/ ]UTOF9B M55EWFX6RU+OJ84X_"]3.@?:72MG=Q 5H?S^37U!+ P04 " "(?*]8V66! M2E($ #>"@ &0 'AL+W=OBKQ4,S?5NIKT>BI.L>#J3%18TLU:R()KVLI- M3U42>6*-BKP7>-Z@5_"L=.=3>[:0\ZFH=9Z5N)"@ZJ+@\MN9>^)/+OGEO'_S,<*OVUF"4 MK(1X,)NOR:TS@AC+AFU *%BAAF7*)<'+'5SFJTVE/DTMCV(M;^,L&/G@#/H3O MHM2I@L]E@LE+^QY1[?@&.[Z7P5' [UR>0>@S"+P@.H(7=OI#BQ?^"?WPSS)S%78JP%CG5>E9N MH,%6J!4=2IV"INM8%!5YM45)7,T1N:YX^>OCAU'@#\^5L^KX)RW_DOCGAG]% M_)7ESU_QCQO^:H^_\6H=Z#23&K'\M$5\,!B92!2@24J@E(K3+J>LUXM*9KD3 MV),03K*2 $2MZ$HQP*<8*[TC0:_W*!6B+K4ZG3AW.X?PO+HGW\JYJ0N47 LY M<6YVHM92%,2_U%E9F[A1SY4V0 K^@I,QZX]&<&J6?I\-O3&N7Z$'(^GY$]]=8"FHV#"EIFXPUN76[_*$@4\HDL]GO11!\GT7A@(6#,8S9 MT(_8:!PYBS="_S+(1R(:1BP:>&Q,?= /F#_VF3<:P*%$[NW-'-30-G:R4N27 M&F S?G2GW?!VT#(?Y?*768?XZW:BD_,U#FJW# MHOPQ6P[S3:;"1=UH'0^=T2@8KL,H&4POZ\=NL^EENBWB*%&WF95OU^LP^WJC MXO3I:F /OCWP,5JNBNJ!X?1R$R[5G2K^V-QFY4_#'641K5621VEB9>KA:G!M MOY'!I&I0;_&O2#WE>]];U5.Y3]-/U0]O%U>#4;5'*E;SHD*$Y7^/:J;BN"*5 M^_&Y@0YV?58-][__1A?UDR^?S'V8JUD:_SM:%*NKP<7 6JB'?W5>GK>UI\,K/DV+])UT[C<@W64//\??FG^$'L-;.^%!D[3P#FU M@=LT<$]MX#4-O,,&_@L-_*:!?VH/0=,@.&P0O-!@W#08U\5Z_NO6I6%A$4XO ML_3)RJJM2UKU35W?NG59D2BIHGA79.5OH[)=,?V0+<,D^F]8Y^(7IHHPBO-? MK5?6'W?,^N6OOUX.B[*7:MOAO"'R9Z+S M&UWJ=)L-V[-",;GZ]R5Y;(^?%YHQN_C[,R-[Y MZTLV9FK^T\T8IW%W%6N?_Z=CEF^ M"6-(&$?"!!(F03 C0=XN01Y%G\["352$L54>&>>??K/R55CVT942$M,W)4@8 M0\+X,\RO8=6\XW'J^;[OCB;ER_5Q/P'(7B4(9B3 WR7 )Q-PN\WFJW+V86VR M:%Y^5=ES"JQ?HL1B:1R'6:X?[1K!;L@.^F8#"6-(&'^&!7O9L$<'J4#V)T$P M(Q7!+A4!F8J[^D!@17F^[9QUW)#-^]8<"6-(& ]:QP-[XD[&P4'=D7U*$,RH M^WA7]S%9]P]9M(R2,(Z_-K4GA@22U#<"2!@;MZKFN(X?^"//K!MO;^CYSF14 M'O$/"HSFDC MNY0@F%'YR:[R$[+RU\MEII9AH:QPG6Z38G^ [QS625S?&"!A;-(:B2\<9U3] M.WA](WL52)@$P8PDV".M*48G9F%C3O^.98+F]@T%E,:@- ZE"2A--K2+_7%K M4O][[>Q> 68T]@R634;C=U58<9KGY2!Q- PDJ7<8D#0&I?&&MG_$>37Q+RY: M1QS1M:7C^K;7VE2B=M$LM*,+[=#'@/E\N][&Y4%@4=GF:!X='Q)H9.^*(VD, M2N,-;7]V\,H-/+_?6-^KR-'L.X MS,8)QWVH#(32&)3&&YKA?"XZ)IH"VJU$T\:T(C>&8!:/RB-0VD"2I,HFAD4+0GMX.>__V1#52*4QJ T#J4)*$VB:&:2 MM':T:>]X\OM0-*=W6J#:$4KC=H?%+*>!GNNVIB50.XFBF4G0?M(^25"^_,X# MW;YW J!^$DKC=MM0!EUS#ZBB1-',\FM):=.6\O;M+;?>)H^J/!)D.3T%@0I* M*(U!:1Q*$U":1-',:Y&TR71&/W\*XD"M)I3&H#0.I0DH3:)H9I*T^'1H\:F= M^,NS#QK1.RA0XPFE\89FO//MCSM&'VBW$D4S,Z"=J$,[T7KT$5$2)O,H69*C M#TWJ'06H"H72.)0FH#2)HIEYT3K5.<,%F Y4LT)I#$KC4)J TB2*9B9)VUB' MMK%Z]%EF:9F?39;.E5H19MZB+DN#Q)J M7;])0\Y-H$H52F-0&H?2!)0F430S.%JI.N,SS$V@NA5*8U :A]($E"91-#-) M6LDZM)+]_KD)5-5":0Q*XPUM?V[B^IU3$ZBL1=',8&A9Z]"R]G?U5-U=J+Y: M/;0MS>P="JBVA=(XE":@-(FBF?\3:_O@MC'0/O1,"M;E0 M&F]H^S,5_S <4$6+HIGAV+M%GK[B]6".TGTZ34Y8Z YZ9P-[BSSV'GGL3?+8 MN^1_AI]UM9]UO3-,6*"N%DIC4!J'T@24)E$T,TG:Y[JTS_WNLVF:VSL]4,\+ MI7&W?:M]T'4R#>U5HFAF+K3H=6G1RZ)\D^9A?.JH!'6\4!J#TCB4)J TB:*9 MF=&.USV#XW6ACA=*8U :A]($E"91-#-)VO&ZISK>GG<$NVWS:=NCCJ/UC-Z# MWLF ^ELH34!I$D4SDZ$EKTM+WG?5).4A2]?6(LKG:5)$2;4N2*H/,$C5Q-X%WW>1HNH^%H/03*M+IV;IZQ<09-ZYZ6M5)W.=W\9M%_NM5<*F'2>)T.[E2B:668M=#U:Z'[/ MNA4TLG>]H0H72N,-S;@0(? Z+T6 =BQ1-#,5>^N8DM9N.HO#8?T#5+)3&H#0.I0DH3:)H M9I*TP/5H@7OZ6LI0=0NE,2B->^WU4P.WO9B!2+.G,%MH MDQ;N+MLF8P'UL% :@]*XUU[:P+8#V[J= M!:AY]3H63NV<87)HOP)*DRB:&09M53W:JIZR#B^-Z!T"J#=M:/LA&(\OO+$[ M.

U][4I[WIL7,6ZW_6*4MQT;WTC0F4QJ T#J4)*$VB:&:6 MM$;USZ!1?:A&A=(8E,:A- &E213-3)+6J#ZM46=I\JBR@IR>T(C>08%>+NNW MK:A],"9!.Q10FD31S.IKN^H?62#V^)@DKF?_//%>'[JSWCF!>E\,0Q/4U4)I#$KC4)J TB2*9B9I[Z.JZ$MG/ZKJXT"KRPN>AR8K MW19Y44:J?*@S--A/IL)^-%5[+0/;=CS7FP2'HQ54N4)I$D4S Z&5JW]$N=:C MU4\Z@8+Z72B-^6V_VSJ!@HI=*$VB:&;UM=CU:;$[2]?K\@AR5[T) M2(\Z4+L+I3$HC4-I DJ3*)KY*9M: 0=G6 AZ\,=.S:SW;'G'[P/+5$[9]96*]D =F4K M3>I=8JB9A=+X]]"LSL, ""11S\],B5:WP1%UVS7S./$4F$;WC@U4U$)I'$H3 M4)I$T

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end XML 93 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 94 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 350 418 1 true 135 0 false 4 false false R1.htm 995100 - Document - Cover Sheet http://xbrl.sec.gov/dei/role/document/Cover Cover Cover 1 false false R2.htm 995301 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 995302 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 995303 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 995304 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals) Sheet http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals) Statements 5 false false R6.htm 995305 - Statement - Unaudited Condensed Consolidated Statements of Stockholders??? Deficit Sheet http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3 Unaudited Condensed Consolidated Statements of Stockholders??? Deficit Statements 6 false false R7.htm 995306 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow Unaudited Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 995307 - Disclosure - Organization Sheet http://www.FreedomAcquisitionICorp.com/role/Organization Organization Notes 8 false false R9.htm 995308 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 995309 - Disclosure - Fair Value Measurements Sheet http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 995310 - Disclosure - Reverse Recapitalization Sheet http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalization Reverse Recapitalization Notes 11 false false R12.htm 995311 - Disclosure - Forward Purchase Agreements Sheet http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreements Forward Purchase Agreements Notes 12 false false R13.htm 995312 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 13 false false R14.htm 995313 - Disclosure - Divestiture Sheet http://www.FreedomAcquisitionICorp.com/role/Divestiture Divestiture Notes 14 false false R15.htm 995314 - Disclosure - Property and Equipment, Net Sheet http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNet Property and Equipment, Net Notes 15 false false R16.htm 995315 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 16 false false R17.htm 995316 - Disclosure - Other Expense, Net Sheet http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNet Other Expense, Net Notes 17 false false R18.htm 995317 - Disclosure - Common Stock Sheet http://www.FreedomAcquisitionICorp.com/role/CommonStock Common Stock Notes 18 false false R19.htm 995318 - Disclosure - Warrants Sheet http://www.FreedomAcquisitionICorp.com/role/Warrants Warrants Notes 19 false false R20.htm 995319 - Disclosure - Borrowings and SAFE Agreements Sheet http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreements Borrowings and SAFE Agreements Notes 20 false false R21.htm 995320 - Disclosure - Stock-Based Compensation Sheet http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensation Stock-Based Compensation Notes 21 false false R22.htm 995321 - Disclosure - Employee Stock Purchase Plan Sheet http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlan Employee Stock Purchase Plan Notes 22 false false R23.htm 995322 - Disclosure - Commitments and Contingencies Sheet http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 23 false false R24.htm 995323 - Disclosure - Basic and Diluted Net Loss Per Share Sheet http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShare Basic and Diluted Net Loss Per Share Notes 24 false false R25.htm 995324 - Disclosure - Related Party Transactions Sheet http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 25 false false R26.htm 995325 - Disclosure - Subsequent Events Sheet http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents Subsequent Events Notes 26 false false R27.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 27 false false R28.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 28 false false R29.htm 996000 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPolicies 29 false false R30.htm 996001 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPolicies 30 false false R31.htm 996002 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements 31 false false R32.htm 996003 - Disclosure - Reverse Recapitalization (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationTables Reverse Recapitalization (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalization 32 false false R33.htm 996004 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssets 33 false false R34.htm 996005 - Disclosure - Divestiture (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/DivestitureTables Divestiture (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/Divestiture 34 false false R35.htm 996006 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNet 35 false false R36.htm 996007 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilities 36 false false R37.htm 996008 - Disclosure - Other Expense, Net (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetTables Other Expense, Net (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNet 37 false false R38.htm 996009 - Disclosure - Common Stock (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/CommonStockTables Common Stock (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/CommonStock 38 false false R39.htm 996010 - Disclosure - Warrants (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/WarrantsTables Warrants (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/Warrants 39 false false R40.htm 996011 - Disclosure - Borrowings and SAFE Agreements (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsTables Borrowings and SAFE Agreements (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreements 40 false false R41.htm 996012 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensation 41 false false R42.htm 996013 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingencies 42 false false R43.htm 996014 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) Sheet http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables Basic and Diluted Net Loss Per Share (Tables) Tables http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShare 43 false false R44.htm 996015 - Disclosure - Organization (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails Organization (Details) Details http://www.FreedomAcquisitionICorp.com/role/Organization 44 false false R45.htm 996016 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables 45 false false R46.htm 996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash Details http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables 46 false false R47.htm 996018 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services Details http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables 47 false false R48.htm 996019 - Disclosure - Fair Value Measurements (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables 48 false false R49.htm 996020 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis Details http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables 49 false false R50.htm 996021 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method Details http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables 50 false false R51.htm 996022 - Disclosure - Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility Details http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables 51 false false R52.htm 996023 - Disclosure - Reverse Recapitalization (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails Reverse Recapitalization (Details) Details http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationTables 52 false false R53.htm 996024 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding Details http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationTables 53 false false R54.htm 996025 - Disclosure - Forward Purchase Agreements (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails Forward Purchase Agreements (Details) Details http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreements 54 false false R55.htm 996026 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets Details http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssetsTables 55 false false R56.htm 996027 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations Details http://www.FreedomAcquisitionICorp.com/role/DivestitureTables 56 false false R57.htm 996028 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetDetails Property and Equipment, Net (Details) Details http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetTables 57 false false R58.htm 996029 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net Details http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetTables 58 false false R59.htm 996030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities Details http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables 59 false false R60.htm 996031 - Disclosure - Other Expense, Net (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails Other Expense, Net (Details) Details http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetTables 60 false false R61.htm 996032 - Disclosure - Other Expense, Net (Details) - Schedule of Other Expense, Net Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable Other Expense, Net (Details) - Schedule of Other Expense, Net Details http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetTables 61 false false R62.htm 996033 - Disclosure - Common Stock (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails Common Stock (Details) Details http://www.FreedomAcquisitionICorp.com/role/CommonStockTables 62 false false R63.htm 996034 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable Common Stock (Details) - Schedule of Reserved Shares of Common Stock Details http://www.FreedomAcquisitionICorp.com/role/CommonStockTables 63 false false R64.htm 996035 - Disclosure - Warrants (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails Warrants (Details) Details http://www.FreedomAcquisitionICorp.com/role/WarrantsTables 64 false false R65.htm 996036 - Disclosure - Warrants (Details) - Schedule of Liability-Classified Warrants Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable Warrants (Details) - Schedule of Liability-Classified Warrants Details http://www.FreedomAcquisitionICorp.com/role/WarrantsTables 65 false false R66.htm 996037 - Disclosure - Borrowings and SAFE Agreements (Details) - Part-1 Sheet http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1 Borrowings and SAFE Agreements (Details) - Part-1 Details http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsTables 66 false false R67.htm 996038 - Disclosure - Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes Notes http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes Details http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsTables 67 false false R68.htm 996039 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables 68 false false R69.htm 996040 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity Details http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables 69 false false R70.htm 996041 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity Details http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables 70 false false R71.htm 996042 - Disclosure - Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) Details http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables 71 false false R72.htm 996043 - Disclosure - Employee Stock Purchase Plan (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlanDetails Employee Stock Purchase Plan (Details) Details http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlan 72 false false R73.htm 996044 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesTables 73 false false R74.htm 996045 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company???s Warranty Provision Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company???s Warranty Provision Details http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesTables 74 false false R75.htm 996046 - Disclosure - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareDetails Basic and Diluted Net Loss Per Share (Details) Details http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables 75 false false R76.htm 996047 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Details http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables 76 false false R77.htm 996048 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals) Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals) Details http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables 77 false false R78.htm 996049 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share Sheet http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share Details http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables 78 false false R79.htm 996050 - Disclosure - Related Party Transactions (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions 79 false false R80.htm 996051 - Disclosure - Subsequent Events (Details) Sheet http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents 80 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 15 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:AdditionalPaidInCapital, us-gaap:EarningsPerShareDiluted, us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare, us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - ea0205629-10q_complete.htm 8641, 8645, 8646, 8648, 8650, 8651, 8652, 8653, 8758, 8759, 8760, 8761, 8763, 8765, 8766 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare - ea0205629-10q_complete.htm 8649, 8764 cslr-20240331.xsd cslr-20240331_cal.xml cslr-20240331_def.xml cslr-20240331_lab.xml cslr-20240331_pre.xml ea0205629-10q_complete.htm http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0205629-10q_complete.htm": { "nsprefix": "cslr", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "dts": { "schema": { "local": [ "cslr-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd", "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd", "https://xbrl.sec.gov/sic/2024/sic-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "cslr-20240331_cal.xml" ] }, "definitionLink": { "local": [ "cslr-20240331_def.xml" ] }, "labelLink": { "local": [ "cslr-20240331_lab.xml" ] }, "presentationLink": { "local": [ "cslr-20240331_pre.xml" ] }, "inline": { "local": [ "ea0205629-10q_complete.htm" ] } }, "keyStandard": 341, "keyCustom": 77, "axisStandard": 32, "axisCustom": 0, "memberStandard": 37, "memberCustom": 87, "hidden": { "total": 136, "http://fasb.org/us-gaap/2024": 124, "http://xbrl.sec.gov/dei/2024": 4, "http://www.FreedomAcquisitionICorp.com/20240331": 8 }, "contextCount": 350, "entityCount": 1, "segmentCount": 135, "elementCount": 952, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 863, "http://xbrl.sec.gov/dei/2024": 33, "http://xbrl.sec.gov/ecd/2024": 4, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://xbrl.sec.gov/dei/role/document/Cover", "longName": "995100 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "longName": "995301 - Statement - Unaudited Condensed Consolidated Balance Sheets", "shortName": "Unaudited Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R3": { "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "995302 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:CommonStockSharesIssued", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R4": { "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "longName": "995303 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)", "shortName": "Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CostOfRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R5": { "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals", "longName": "995304 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": null, "uniqueAnchor": null }, "R6": { "role": "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "longName": "995305 - Statement - Unaudited Condensed Consolidated Statements of Stockholders\u2019 Deficit", "shortName": "Unaudited Condensed Consolidated Statements of Stockholders\u2019 Deficit", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c22", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c28", "name": "cslr:StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R7": { "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow", "longName": "995306 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows", "shortName": "Unaudited Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R8": { "role": "http://www.FreedomAcquisitionICorp.com/role/Organization", "longName": "995307 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPolicies", "longName": "995308 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements", "longName": "995309 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalization", "longName": "995310 - Disclosure - Reverse Recapitalization", "shortName": "Reverse Recapitalization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "cslr:ReverseRecapitalizationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:ReverseRecapitalizationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreements", "longName": "995311 - Disclosure - Forward Purchase Agreements", "shortName": "Forward Purchase Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "cslr:ForwardPurchaseAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:ForwardPurchaseAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssets", "longName": "995312 - Disclosure - Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.FreedomAcquisitionICorp.com/role/Divestiture", "longName": "995313 - Disclosure - Divestiture", "shortName": "Divestiture", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "cslr:DivestitureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:DivestitureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNet", "longName": "995314 - Disclosure - Property and Equipment, Net", "shortName": "Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilities", "longName": "995315 - Disclosure - Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNet", "longName": "995316 - Disclosure - Other Expense, Net", "shortName": "Other Expense, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "cslr:OtherExpenseNetDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:OtherExpenseNetDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommonStock", "longName": "995317 - Disclosure - Common Stock", "shortName": "Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "cslr:CommonStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:CommonStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.FreedomAcquisitionICorp.com/role/Warrants", "longName": "995318 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "cslr:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreements", "longName": "995319 - Disclosure - Borrowings and SAFE Agreements", "shortName": "Borrowings and SAFE Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensation", "longName": "995320 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlan", "longName": "995321 - Disclosure - Employee Stock Purchase Plan", "shortName": "Employee Stock Purchase Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingencies", "longName": "995322 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShare", "longName": "995323 - Disclosure - Basic and Diluted Net Loss Per Share", "shortName": "Basic and Diluted Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions", "longName": "995324 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents", "longName": "995325 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c0", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "ecd:NonRule10b51ArrTrmntdFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "ecd:NonRule10b51ArrTrmntdFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy", "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "996001 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables", "longName": "996002 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationTables", "longName": "996003 - Disclosure - Reverse Recapitalization (Tables)", "shortName": "Reverse Recapitalization (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssetsTables", "longName": "996004 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:OtherCurrentAssetsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:OtherCurrentAssetsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.FreedomAcquisitionICorp.com/role/DivestitureTables", "longName": "996005 - Disclosure - Divestiture (Tables)", "shortName": "Divestiture (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:DivestitureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:DivestitureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetTables", "longName": "996006 - Disclosure - Property and Equipment, Net (Tables)", "shortName": "Property and Equipment, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables", "longName": "996007 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetTables", "longName": "996008 - Disclosure - Other Expense, Net (Tables)", "shortName": "Other Expense, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommonStockTables", "longName": "996009 - Disclosure - Common Stock (Tables)", "shortName": "Common Stock (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c0", "name": "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.FreedomAcquisitionICorp.com/role/WarrantsTables", "longName": "996010 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c0", "name": "cslr:ScheduleOfLiabilityClassifiedWarrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:ScheduleOfLiabilityClassifiedWarrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "cslr:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsTables", "longName": "996011 - Disclosure - Borrowings and SAFE Agreements (Tables)", "shortName": "Borrowings and SAFE Agreements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables", "longName": "996012 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesTables", "longName": "996013 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables", "longName": "996014 - Disclosure - Basic and Diluted Net Loss Per Share (Tables)", "shortName": "Basic and Diluted Net Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "longName": "996015 - Disclosure - Organization (Details)", "shortName": "Organization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:PurchasePricePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R45": { "role": "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "996016 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:RestrictedCash", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R46": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable", "longName": "996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:RestrictedCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R47": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable", "longName": "996018 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c91", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c91", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails", "longName": "996019 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R49": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "longName": "996020 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis", "shortName": "Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable", "longName": "996021 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method", "shortName": "Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c150", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c150", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "longName": "996022 - Disclosure - Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility", "shortName": "Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CommonStockConvertibleConversionPriceDecrease", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CommonStockConvertibleConversionPriceDecrease", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "longName": "996023 - Disclosure - Reverse Recapitalization (Details)", "shortName": "Reverse Recapitalization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c167", "name": "us-gaap:RestructuringReserveSettledWithoutCash2", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c167", "name": "us-gaap:RestructuringReserveSettledWithoutCash2", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "longName": "996024 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding", "shortName": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:TemporaryEquityShareSubscriptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:TemporaryEquityShareSubscriptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:ReverseRecapitalizationTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "longName": "996025 - Disclosure - Forward Purchase Agreements (Details)", "shortName": "Forward Purchase Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:PurchasePercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "cslr:ForwardPurchaseAgreementsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R55": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable", "longName": "996026 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c4", "name": "cslr:PrepaidSalesCommissions", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:OtherCurrentAssetsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "cslr:PrepaidSalesCommissions", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:OtherCurrentAssetsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable", "longName": "996027 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations", "shortName": "Divestiture (Details) - Schedule of Operations and Comprehensive Income Related to Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c186", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:DivestitureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c186", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:DivestitureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetDetails", "longName": "996028 - Disclosure - Property and Equipment, Net (Details)", "shortName": "Property and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:UtilitiesOperatingExpenseDepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:UtilitiesOperatingExpenseDepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable", "longName": "996029 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net", "shortName": "Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable", "longName": "996030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails", "longName": "996031 - Disclosure - Other Expense, Net (Details)", "shortName": "Other Expense, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c195", "name": "us-gaap:InterestIncomeOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "link:footnote", "td", "tr", "table", "ix:continuation", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c195", "name": "us-gaap:InterestIncomeOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "link:footnote", "td", "tr", "table", "ix:continuation", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable", "longName": "996032 - Disclosure - Other Expense, Net (Details) - Schedule of Other Expense, Net", "shortName": "Other Expense, Net (Details) - Schedule of Other Expense, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c0", "name": "cslr:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:OtherExpenseNetDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "longName": "996033 - Disclosure - Common Stock (Details)", "shortName": "Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:SharePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R63": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable", "longName": "996034 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock", "shortName": "Common Stock (Details) - Schedule of Reserved Shares of Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c4", "name": "cslr:StockIssuedDuringEmployeeStockPurchasePlan", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:CommonStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R64": { "role": "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails", "longName": "996035 - Disclosure - Warrants (Details)", "shortName": "Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "longName": "996036 - Disclosure - Warrants (Details) - Schedule of Liability-Classified Warrants", "shortName": "Warrants (Details) - Schedule of Liability-Classified Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "longName": "996037 - Disclosure - Borrowings and SAFE Agreements (Details) - Part-1", "shortName": "Borrowings and SAFE Agreements (Details) - Part-1", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:TimeDepositsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:TimeDepositsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable", "longName": "996038 - Disclosure - Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes", "shortName": "Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:NotesAndLoansPayable", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:NotesAndLoansPayable", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails", "longName": "996039 - Disclosure - Stock-Based Compensation (Details)", "shortName": "Stock-Based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c299", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R69": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable", "longName": "996040 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity", "shortName": "Stock-Based Compensation (Details) - Schedule of Summary of Stock Option Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable", "longName": "996041 - Disclosure - Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity", "shortName": "Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c303", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c303", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable", "longName": "996042 - Disclosure - Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss)", "shortName": "Stock-Based Compensation (Details) - Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c311", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c311", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlanDetails", "longName": "996043 - Disclosure - Employee Stock Purchase Plan (Details)", "shortName": "Employee Stock Purchase Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c0", "name": "cslr:MarketFairValueOfferingProceedsPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cslr:MarketFairValueOfferingProceedsPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails", "longName": "996044 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c166", "name": "us-gaap:LeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c166", "name": "us-gaap:LeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable", "longName": "996045 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company\u2019s Warranty Provision", "shortName": "Commitments and Contingencies (Details) - Schedule of Activity by Period Relating to the Company\u2019s Warranty Provision", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c27", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } }, "R75": { "role": "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareDetails", "longName": "996046 - Disclosure - Basic and Diluted Net Loss Per Share (Details)", "shortName": "Basic and Diluted Net Loss Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": null, "uniqueAnchor": null }, "R76": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable", "longName": "996047 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "shortName": "Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals", "longName": "996048 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals)", "shortName": "Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Parentheticals)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "77", "firstAnchor": null, "uniqueAnchor": null }, "R78": { "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable", "longName": "996049 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "shortName": "Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "longName": "996050 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c332", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c332", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails", "longName": "996051 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c280", "name": "us-gaap:CommonStockConvertibleConversionPriceIncrease", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "first": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:SaleOfStockPricePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0205629-10q_complete.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses and Other Current Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [ "r400" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Accounts Payable and Other Accrued Liabilities, Current", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r69", "r707" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable [Member]", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r658" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r898" ] }, "cslr_AccretionOfLongtermDebtInCSSolis": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccretionOfLongtermDebtInCSSolis", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion of debt in CS Solis", "label": "Accretion Of Longterm Debt In CSSolis" } } }, "auth_ref": [] }, "cslr_AccruedCustomerDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccruedCustomerDeposits", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Customer deposits", "documentation": "Represents the amount of accrued customer deposits.", "label": "Accrued Customer Deposits" } } }, "auth_ref": [] }, "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Accrued Employee Benefits", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them." } } }, "auth_ref": [ "r130" ] }, "us-gaap_AccruedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxes", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued taxes", "label": "Accrued Income Taxes", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes." } } }, "auth_ref": [ "r71", "r76", "r129", "r513" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total accrued expenses and other current liabilities", "label": "Accrued Liabilities and Other Liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued legal settlements", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r71" ] }, "cslr_AccruedRebateAndCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccruedRebateAndCredits", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates and credits", "documentation": "Represents the amount of accrued rebates and credits.", "label": "Accrued Rebate And Credits" } } }, "auth_ref": [] }, "cslr_AccruedTermLoanAndRevolvingLoanAmendmentAndFinalPaymentFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccruedTermLoanAndRevolvingLoanAmendmentAndFinalPaymentFees", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued term loan and revolving loan amendment and final payment fees", "documentation": "Represents the amount of accrued term loan and revolving loan amendment and final payment fees.", "label": "Accrued Term Loan And Revolving Loan Amendment And Final Payment Fees" } } }, "auth_ref": [] }, "cslr_AccruedUninvoicedContractCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccruedUninvoicedContractCosts", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Uninvoiced contract costs", "documentation": "Represents the amount of un-invoiced contract costs.", "label": "Accrued Uninvoiced Contract Costs" } } }, "auth_ref": [] }, "cslr_AccruedWarrantyCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccruedWarrantyCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued warranty, current", "documentation": "Represents the amount of accrued warranty, current.", "label": "Accrued Warranty Current" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r20", "r21", "r88", "r197", "r519", "r550", "r554" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r11", "r21", "r425", "r428", "r482", "r545", "r546", "r872", "r873", "r874", "r883", "r884", "r885", "r887" ] }, "cslr_AccuredOperatingLeaseLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AccuredOperatingLeaseLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, current", "documentation": "Represents the amount of operating lease liabilities, current.", "label": "Accured Operating Lease Liabilities Current" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r783" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "verboseLabel": "Additional paid in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r82", "r707", "r1015" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r569", "r883", "r884", "r885", "r887", "r954", "r1018" ] }, "dei_AdditionalSecurities462b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AdditionalSecurities462b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "auth_ref": [ "r839" ] }, "dei_AdditionalSecurities462bFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AdditionalSecurities462bFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "auth_ref": [ "r839" ] }, "dei_AdditionalSecuritiesEffective413b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AdditionalSecuritiesEffective413b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "auth_ref": [ "r837" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AddressTypeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r796" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r796" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r796" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r796" ] }, "cslr_AdjustedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AdjustedMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Adjusted", "label": "Adjusted Member" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction to additional paid-in capital (in Dollars)", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r12", "r37", "r116" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Direct Offering Costs", "label": "Advertising Cost [Policy Text Block]", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r151" ] }, "cslr_AggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AggregateAmount", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount (in Dollars)", "documentation": "Amount of aggregate amount.", "label": "Aggregate Amount" } } }, "auth_ref": [] }, "cslr_AggregateAmountOfPurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AggregateAmountOfPurchasePrice", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate purchase price (in Dollars)", "documentation": "Aggregate amount of purchase price.", "label": "Aggregate Amount Of Purchase Price" } } }, "auth_ref": [] }, "cslr_AggregateGrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AggregateGrossProceeds", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate gross proceeds (in Dollars)", "label": "Aggregate Gross Proceeds" } } }, "auth_ref": [] }, "cslr_AggregateShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AggregateShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares", "verboseLabel": "Aggregate shares (in Shares)", "label": "Aggregate Shares" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r830" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r746", "r757", "r773", "r808" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r749", "r760", "r776", "r811" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r831" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r796" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r803" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r750", "r761", "r777", "r803", "r812", "r816", "r824" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r822" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock-based compensation expense from continuing operations", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r392", "r398" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmountOfDeferredCostsRelatedToLongTermContracts", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred long-term service contract (in Dollars)", "label": "Amount of Deferred Costs Related to Long-Term Contracts", "documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs." } } }, "auth_ref": [ "r198" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r753" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Potential common shares excluded from diluted net loss per share", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r254" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r29" ] }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "xbrltype": "dateOrAsapItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Approximate Date of Commencement of Proposed Sale to Public", "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r419" ] }, "us-gaap_AssetRecoveryDamagedPropertyCostsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetRecoveryDamagedPropertyCostsNoncurrent", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Siemens claimed damages", "label": "Asset Recovery Damaged Property Costs, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of the portion of the reserved funds established by a utility from customer payments to cover the repair costs of damages from major storms, which repairs are expected to be incurred beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r143" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r127", "r147", "r190", "r219", "r259", "r263", "r278", "r279", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r420", "r422", "r457", "r512", "r607", "r676", "r677", "r707", "r725", "r916", "r917", "r966" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r185", "r200", "r219", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r420", "r422", "r457", "r707", "r916", "r917", "r966" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "cslr_AttorneysFeesExpensesAndPrejudgementInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "AttorneysFeesExpensesAndPrejudgementInterest", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Attorneys\u2019 fees, expenses, and pre-judgement interest", "documentation": "The amount of attorneys\u2019 fees, expenses, and pre-judgement interest.", "label": "Attorneys Fees Expenses And Prejudgement Interest" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r753" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r738", "r741", "r753" ] }, "dei_AuditorLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLineItems", "lang": { "en-us": { "role": { "label": "Auditor [Line Items]" } } }, "auth_ref": [] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r738", "r741", "r753" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r738", "r741", "r753" ] }, "dei_AuditorOpinionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorOpinionTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Opinion [Text Block]" } } }, "auth_ref": [ "r835" ] }, "dei_AuditorTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor [Table]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r819" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r820" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r815" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r815" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r818" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r817" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r816" ] }, "cslr_BasicandDilutedNetLossPerShareTablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BasicandDilutedNetLossPerShareTablesLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Loss Per Share (Tables) [Line Items]" } } }, "auth_ref": [] }, "cslr_BasicandDilutedNetLossPerShareTablesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BasicandDilutedNetLossPerShareTablesTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]", "label": "Basicand Diluted Net Loss Per Share Tables Table" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r108" ] }, "cslr_BidPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BidPricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bid Price Per Share", "documentation": "Bid price per share.", "label": "Bid Price Per Share" } } }, "auth_ref": [] }, "cslr_BlackScholesModelMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BlackScholesModelMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Black-Scholes model [Member]", "label": "Black Scholes Model Member" } } }, "auth_ref": [] }, "cslr_BonusSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BonusSharesIssued", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Bonus shares issued", "documentation": "Bonus shares.", "label": "Bonus Shares Issued" } } }, "auth_ref": [] }, "cslr_BorrowingsandSAFEAgreementsDetailsPart1LineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BorrowingsandSAFEAgreementsDetailsPart1LineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Borrowings and SAFE Agreements [Line Items]" } } }, "auth_ref": [] }, "cslr_BorrowingsandSAFEAgreementsDetailsPart1Table": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BorrowingsandSAFEAgreementsDetailsPart1Table", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Borrowings and SAFE Agreements (Details) - Part-1 [Table]" } } }, "auth_ref": [] }, "cslr_BorrowingsandSAFEAgreementsDetailsScheduleofConvertibleNotesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BorrowingsandSAFEAgreementsDetailsScheduleofConvertibleNotesLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "label": "Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Line Items]" } } }, "auth_ref": [] }, "cslr_BorrowingsandSAFEAgreementsDetailsScheduleofConvertibleNotesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "BorrowingsandSAFEAgreementsDetailsScheduleofConvertibleNotesTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "label": "Borrowings and SAFE Agreements (Details) - Schedule of Convertible Notes [Table]" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "BusinessContactMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r741", "r753" ] }, "cslr_CSSoilsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CSSoilsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "CS Soils [Member]", "label": "CSSoils Member" } } }, "auth_ref": [] }, "cslr_CarlyleWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CarlyleWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carlyle warrants [Member[", "verboseLabel": "Carlyle warrants [Member]", "netLabel": "Carlyle Warrants [Member]", "label": "Carlyle Warrants Member" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payments", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r149", "r517", "r580", "r601", "r707", "r725", "r864" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r24", "r187", "r667" ] }, "us-gaap_CashAndCashEquivalentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r25" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r25", "r126" ] }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsAndShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents (in Dollars)", "label": "Cash, Cash Equivalents, and Short-Term Investments", "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable." } } }, "auth_ref": [ "r871" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r104", "r217" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r104", "r217" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r104" ] }, "cslr_CashPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CashPayment", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Payment (in Dollars)", "documentation": "Cash payment.", "label": "Cash Payment" } } }, "auth_ref": [] }, "us-gaap_CatastrophicEventDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CatastrophicEventDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Catastrophic Event [Domain]", "documentation": "Catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [ "r711" ] }, "cslr_ChangeInFairValueOfCarlyleWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ChangeInFairValueOfCarlyleWarrants", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of Carlyle warrants", "documentation": "Represents the amount of change in fair value of carlyle warrants.", "label": "Change In Fair Value Of Carlyle Warrants" } } }, "auth_ref": [] }, "cslr_ChangeInFairValueOfForwardPurchaseAgreementLiabilitie": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ChangeInFairValueOfForwardPurchaseAgreementLiabilitie", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of forward purchase agreement liabilities", "documentation": "Change in fair value of forward purchase agreement liabilities", "label": "Change In Fair Value Of Forward Purchase Agreement Liabilitie" } } }, "auth_ref": [] }, "cslr_ChangeInFairValueOfForwardPurchaseAgreementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ChangeInFairValueOfForwardPurchaseAgreementLiabilities", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of forward purchase agreement liabilities", "documentation": "The amount of change in fair value of forward purchase agreement liabilities.", "label": "Change In Fair Value Of Forward Purchase Agreement Liabilities" } } }, "auth_ref": [] }, "cslr_ChangeInReserveForExcessAndObsoleteInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ChangeInReserveForExcessAndObsoleteInventory", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Change in reserve for excess and obsolete inventory", "documentation": "The amount of change in reserve for excess and obsolete inventory.", "label": "Change In Reserve For Excess And Obsolete Inventory" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r794" ] }, "cslr_ChinaBridgeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ChinaBridgeMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China Bridge [Member]", "label": "China Bridge Member" } } }, "auth_ref": [] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r791" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r789" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "cslr_ClassACommonStockEqualsOrExceedsThresholdTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ClassACommonStockEqualsOrExceedsThresholdTwoMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class A Common Stock Equals or Exceeds Threshold Two [Member]", "label": "Class ACommon Stock Equals Or Exceeds Threshold Two Member" } } }, "auth_ref": [] }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "label": "Type of Borrower [Axis]", "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk." } } }, "auth_ref": [ "r680" ] }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "label": "Class of Financing Receivable, Type of Borrower [Domain]", "documentation": "Category of entity or individual who borrows funds." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r162", "r193", "r194", "r195", "r219", "r248", "r249", "r251", "r253", "r261", "r262", "r290", "r320", "r322", "r323", "r324", "r327", "r328", "r346", "r347", "r348", "r349", "r351", "r457", "r561", "r562", "r563", "r564", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r593", "r616", "r639", "r653", "r654", "r655", "r656", "r657", "r848", "r879", "r888" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price per share", "verboseLabel": "Warrant exercise price (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r352" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Liability-Classified Warrants [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant to purchase shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r352" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable": { "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock warrants", "verboseLabel": "Outstanding warrants", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "cslr_ClosingPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ClosingPricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Closing price per share (in Dollars per share)", "documentation": "Closing price per share.", "label": "Closing Price Per Share" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r795" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r795" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Business Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r419" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 16)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r77", "r133", "r516", "r592" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r113", "r306", "r307", "r659", "r902", "r907" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassAMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class A Ordinary Shares [Member]", "verboseLabel": "Common Class A [Member]", "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassBMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Class B Ordinary Shares [Member]", "verboseLabel": "Class B Ordinary Share [Member]", "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r1018" ] }, "cslr_CommonStockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockAbstract", "lang": { "en-us": { "role": { "label": "Common Stock [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total shares reserved", "terseLabel": "Capital stock, shares", "verboseLabel": "Issuance share (in Shares)", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r81" ] }, "us-gaap_CommonStockConvertibleConversionPriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockConvertibleConversionPriceDecrease", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock trading price (in Dollars per share)", "label": "Common Stock, Convertible, Conversion Price, Decrease", "documentation": "Per share decrease in conversion price of convertible common stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r352" ] }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockConvertibleConversionPriceIncrease", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible conversion price (in Dollars per share)", "verboseLabel": "Conversion share price", "label": "Common Stock, Convertible, Conversion Price, Increase", "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r352" ] }, "cslr_CommonStockDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Line Items]" } } }, "auth_ref": [] }, "cslr_CommonStockDetailsScheduleofReservedSharesofCommonStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockDetailsScheduleofReservedSharesofCommonStockLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Reserved Shares of Common Stock [Abstract]" } } }, "auth_ref": [] }, "cslr_CommonStockDetailsScheduleofReservedSharesofCommonStockTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockDetailsScheduleofReservedSharesofCommonStockTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable" ], "lang": { "en-us": { "role": { "label": "Common Stock (Details) - Schedule of Reserved Shares of Common Stock [Table]" } } }, "auth_ref": [] }, "cslr_CommonStockDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock (Details) [Table]" } } }, "auth_ref": [] }, "cslr_CommonStockForTheFirstTrancheMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockForTheFirstTrancheMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock for the First Tranche [Member]", "label": "Common Stock For The First Tranche Member" } } }, "auth_ref": [] }, "cslr_CommonStockForTheSecondTrancheMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockForTheSecondTrancheMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock for the Second Tranche [Member]", "label": "Common Stock For The Second Tranche Member" } } }, "auth_ref": [] }, "cslr_CommonStockIssuedAndOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockIssuedAndOutstandingPercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued and outstanding percentage", "documentation": "Common stock issued and outstanding percentage.", "label": "Common Stock Issued And Outstanding Percentage" } } }, "auth_ref": [] }, "cslr_CommonStockIssuedPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockIssuedPrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Issued Price", "documentation": "Common Stock Issued Price.", "label": "Common Stock Issued Price" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r716", "r717", "r718", "r720", "r721", "r722", "r723", "r883", "r884", "r887", "r954", "r1013", "r1018" ] }, "us-gaap_CommonStockOtherSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockOtherSharesOutstanding", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares, outstanding prior to Mergers", "label": "Common Stock, Other Shares, Outstanding", "documentation": "Number of shares of other common stock instruments held by shareholder, including, but not limited to, exchangeable shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Ordinary shares, par value (in Dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r81" ] }, "cslr_CommonStockParValue00001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockParValue00001PerShareMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value $0.0001 per share", "label": "Common Stock Par Value00001 Per Share Member" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stocks, shares authorized", "verboseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r81", "r593" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued", "verboseLabel": "Common stock, share issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r81" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r81", "r593", "r613", "r1018", "r1019" ] }, "cslr_CommonStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStock" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "documentation": "The entire disclosure for common stock.", "label": "Common Stock Text Block" } } }, "auth_ref": [] }, "cslr_CommonStockTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockTradingDays", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock trading days.", "documentation": "Common stock trading days.", "label": "Common Stock Trading Days" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value; Authorized 1,000,000,000 and 1,000,000,000 shares as of March 31, 2024 and December 31, 2023, respectively; issued and outstanding 49,096,537 and 49,065,361 shares as of March 31, 2024 and December 31, 2023, respectively", "verboseLabel": "Anti-dilution provisions", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r81", "r518", "r707" ] }, "cslr_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CommonStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock warrants [Member]", "label": "Common Stock Warrants Member" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r800" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r799" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r801" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r798" ] }, "cslr_CompleteSolariaCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CompleteSolariaCommonStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Complete Solaria Common Stock [Member]", "label": "Complete Solaria Common Stock Member" } } }, "auth_ref": [] }, "cslr_CompleteSolariaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CompleteSolariaMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Complete Solaria [Member]", "label": "Complete Solaria Member" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss (net of tax)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r22", "r203", "r205", "r210", "r508", "r528", "r529" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive (loss) income:", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r31", "r32", "r51", "r52", "r283", "r658" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r31", "r32", "r51", "r52", "r283", "r556", "r658" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r31", "r32", "r51", "r52", "r283", "r658", "r856" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration of Risks", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r55", "r154" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk percenatge", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r31", "r32", "r51", "r52", "r283" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r31", "r32", "r51", "r52", "r283", "r658" ] }, "srt_CondensedStatementOfComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CondensedStatementOfComprehensiveIncomeTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Comprehensive Income [Table]", "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r163", "r222", "r853" ] }, "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/DivestitureTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operations and Comprehensive Income Related to Discontinued Operations", "label": "Condensed Statement of Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r859", "r882" ] }, "srt_CondensedStatementOfIncomeCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CondensedStatementOfIncomeCaptionsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Income Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r163", "r222", "r853" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r163", "r175", "r222", "r420", "r421", "r422", "r423", "r493", "r660", "r860", "r861", "r862", "r915", "r918", "r919" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r163", "r175", "r222", "r420", "r421", "r422", "r423", "r493", "r660", "r860", "r861", "r862", "r915", "r918", "r919" ] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelFaxNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContactPersonnelFaxNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Fax Number", "documentation": "Fax Number of contact personnel." } } }, "auth_ref": [ "r741" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContactPersonnelName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContainedFileInformationFileDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Description", "documentation": "The description of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContainedFileInformationFileName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Name", "documentation": "The name of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContainedFileInformationFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Number", "documentation": "The SEC Document Number of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileType": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContainedFileInformationFileType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Type", "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Converted shares", "verboseLabel": "Convertible shares (in Shares)", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued", "label": "Conversion of Stock, Shares Issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Debt in CS Solis", "label": "Convertible Debt", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r18", "r132", "r977" ] }, "us-gaap_ConvertibleDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebtTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Convertible Notes", "label": "Convertible Debt [Table Text Block]", "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount." } } }, "auth_ref": [] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable": { "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable and convertible notes, net of current portion", "label": "Convertible Notes Payable, Noncurrent", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r18" ] }, "cslr_ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ConvertibleNoteMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Note [Member]", "label": "Convertible Note Member" } } }, "auth_ref": [] }, "cslr_ConvertibleNotesEmbeddedDerivativeLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ConvertibleNotesEmbeddedDerivativeLiabilityMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Notes Embedded Derivative Liability [Member]", "label": "Convertible Notes Embedded Derivative Liability Member" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayable", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total notes payable and convertible notes, net", "label": "Convertible Notes Payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r18", "r132", "r977" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable": { "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less current portion", "label": "Convertible Notes Payable, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable": { "parentTag": "cslr_SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Convertible Note Shares", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "documentation": "Number of shares issued for each share of convertible preferred stock that is converted." } } }, "auth_ref": [ "r19", "r40", "r80", "r115", "r350" ] }, "cslr_ConvertiblePromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ConvertiblePromissoryNotesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Promissory Notes [Member]", "label": "Convertible Promissory Notes Member" } } }, "auth_ref": [] }, "cslr_ConvertibleSecuredNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ConvertibleSecuredNoteMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Secured Note [Member]", "label": "Convertible Secured Note Member" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r94", "r219", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r457", "r676", "r916" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues [Member]", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditConcentrationRiskMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Concentration Risk [Member]", "label": "Credit Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement." } } }, "auth_ref": [ "r125" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "cslr_CurrentInsightPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CurrentInsightPromissoryNoteMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Current Insight Promissory Note [Member]", "label": "Current Insight Promissory Note Member" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r109", "r283" ] }, "cslr_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CustomerOneMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer One [Member]", "label": "Customer One Member" } } }, "auth_ref": [] }, "cslr_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CustomerThreeMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Three [Member]", "label": "Customer Three Member" } } }, "auth_ref": [] }, "cslr_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "CustomerTwoMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Two [Member]", "label": "Customer Two Member" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate", "label": "Debt Conversion, Converted Instrument, Rate", "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments." } } }, "auth_ref": [ "r26", "r28" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtCurrent", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current debt (in Dollars)", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r191" ] }, "cslr_DebtInCSSolisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DebtInCSSolisMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Debt in CS Solis [Member]", "label": "Debt In CSSolis Member" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r18", "r70", "r71", "r128", "r132", "r222", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r684", "r685", "r686", "r687", "r688", "r705", "r880", "r903", "r904", "r905", "r962", "r963" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price (in Dollars per share)", "label": "Debt Instrument, Convertible, Conversion Price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r114", "r331" ] }, "us-gaap_DebtInstrumentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFeeAmount", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Total amendment fees", "label": "Debt Instrument, Fee Amount", "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument." } } }, "auth_ref": [ "r74" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Simple interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r73", "r330" ] }, "us-gaap_DebtInstrumentIssuedPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentIssuedPrincipal", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Total Principal amount", "label": "Debt Instrument, Issued, Principal", "documentation": "Amount of principal of debt issued." } } }, "auth_ref": [ "r561" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity date", "label": "Debt Instrument, Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r192", "r684", "r958", "r959" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r18", "r222", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r684", "r685", "r686", "r687", "r688", "r705", "r880", "r903", "r904", "r905", "r962", "r963" ] }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionPricePercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price percentage", "label": "Debt Instrument, Redemption Price, Percentage", "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer." } } }, "auth_ref": [ "r142" ] }, "cslr_DeferredCommission": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DeferredCommission", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred commissions (in Dollars)", "documentation": "Amount of deferred commission.", "label": "Deferred Commission" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue (in Dollars)", "label": "Deferred Revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r867" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, current", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r866" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, noncurrent", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r867" ] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue (in Dollars)", "label": "Deferred Revenue, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "dei_DelayedOrContinuousOffering": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DelayedOrContinuousOffering", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "auth_ref": [ "r765", "r766", "r780" ] }, "us-gaap_DepositsPaidForSecuritiesBorrowedAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsPaidForSecuritiesBorrowedAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowing", "label": "Deposits Paid for Securities Borrowed, at Carrying Value", "documentation": "This is the amount of cash advanced as security in return for borrowing securities from another party." } } }, "auth_ref": [ "r54", "r865" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r9", "r36" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Forward purchase agreement liabilities", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r201" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cslr_DirectOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DirectOfferingCosts", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct offering costs (in Dollars)", "documentation": "Represents the amount of direct offering costs.", "label": "Direct Offering Costs" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r364", "r365", "r394", "r395", "r397", "r696" ] }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureTextBlockSupplementAbstract", "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Current Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from discontinued operations before income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal." } } }, "auth_ref": [ "r60", "r61", "r67" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r61", "r62", "r63", "r64", "r65", "r67", "r401", "r406", "r407" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from discontinued operations (in Dollars)", "label": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation", "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r62", "r64", "r67", "r949" ] }, "cslr_DisposalAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DisposalAgreementMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Agreement [Member]", "label": "Disposal Agreement Member" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r183" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Gross loss", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "label": "Disposal Group, Including Discontinued Operation, Other Income", "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r66", "r184" ] }, "cslr_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "documentation": "Amount of sales and marketing expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group Including Discontinued Operation Sales And Marketing" } } }, "auth_ref": [] }, "cslr_DivestitureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DivestitureAbstract", "lang": { "en-us": { "role": { "label": "Divestiture [Abstract]" } } }, "auth_ref": [] }, "cslr_DivestitureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "DivestitureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/Divestiture" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture", "label": "Divestiture Text Block" } } }, "auth_ref": [] }, "dei_DividendOrInterestReinvestmentPlanOnly": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DividendOrInterestReinvestmentPlanOnly", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "auth_ref": [ "r765", "r766", "r780" ] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend cash", "label": "Dividends, Cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r7", "r116" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Amount equal to the greater", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r116" ] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend paid", "label": "Dividends Payable, Amount Per Share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r26" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r741" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r738", "r741", "r753" ] }, "dei_DocumentCopyrightInformation": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentCopyrightInformation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Copyright Information", "documentation": "The copyright information for the document." } } }, "auth_ref": [] }, "dei_DocumentCreationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentCreationDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Creation Date", "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different." } } }, "auth_ref": [] }, "dei_DocumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Description", "documentation": "The description of the document." } } }, "auth_ref": [] }, "dei_DocumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document [Domain]", "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards." } } }, "auth_ref": [] }, "dei_DocumentEffectiveDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentEffectiveDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Effective Date", "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases." } } }, "auth_ref": [] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r738", "r741", "r753", "r804" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r738", "r741", "r753", "r804" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationDocumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationDocumentAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information, Document [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Text Block]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Name", "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the <FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r739" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r727" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r741" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r741" ] }, "dei_DocumentSubtitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentSubtitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Subtitle", "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'." } } }, "auth_ref": [] }, "dei_DocumentSynopsis": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentSynopsis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Synopsis", "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'" } } }, "auth_ref": [] }, "dei_DocumentTitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Title", "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r781" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentVersion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentVersion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Version", "documentation": "The version identifier of the document." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r730" ] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r793" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Loss Per Share [Abstract]", "terseLabel": "Net loss per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share attributable to common stockholders, basic (in Dollars per share)", "totalLabel": "Net loss per share - basic", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r211", "r232", "r233", "r235", "r236", "r237", "r239", "r246", "r248", "r251", "r252", "r253", "r258", "r415", "r418", "r434", "r435", "r509", "r530", "r671" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share attributable to common stockholders, diluted", "verboseLabel": "Net loss per share diluted", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r211", "r232", "r233", "r235", "r236", "r237", "r239", "r248", "r251", "r252", "r253", "r258", "r415", "r418", "r434", "r435", "r509", "r530", "r671" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r29", "r30", "r255" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and Diluted Net Loss Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r245", "r254", "r256", "r257" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r459" ] }, "dei_EffectiveAfter60Days486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveAfter60Days486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "auth_ref": [ "r843" ] }, "dei_EffectiveOnDate486a": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveOnDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "auth_ref": [ "r843" ] }, "dei_EffectiveOnDate486b": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveOnDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "auth_ref": [ "r844" ] }, "dei_EffectiveOnSetDate486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveOnSetDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "auth_ref": [ "r843" ] }, "dei_EffectiveOnSetDate486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveOnSetDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "auth_ref": [ "r844" ] }, "dei_EffectiveUponFiling462e": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveUponFiling462e", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "auth_ref": [ "r842" ] }, "dei_EffectiveUponFiling486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveUponFiling486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "auth_ref": [ "r844" ] }, "dei_EffectiveWhenDeclaredSection8c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EffectiveWhenDeclaredSection8c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "auth_ref": [ "r846" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation expense gross", "label": "Share-Based Payment Arrangement, Amount Capitalized", "documentation": "Amount of cost capitalized for award under share-based payment arrangement." } } }, "auth_ref": [ "r393" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r396" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r396" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserved for future issuance", "label": "Employee Stock Ownership Plan (ESOP), Number of Committed-to-be-Released Shares", "documentation": "The shares that, although not legally released, will be released by a future scheduled and committed debt service payment and will be allocated to employees for service rendered in the current accounting period. The ESOP documents typically define the period of service to which the shares relate. ESOP shares are released to compensate employees directly, to settle employer liabilities for other employee benefits, and to replace dividends on allocated shares that are used for debt service." } } }, "auth_ref": [ "r47" ] }, "us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOPAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOwnershipPlanESOPSharesInESOPAbstract", "lang": { "en-us": { "role": { "label": "Employee Stock Purchase Plan [Abstract]" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitiesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAccountingStandard": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Accounting Standard", "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element." } } }, "auth_ref": [] }, "dei_EntityAddressAddressDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Description", "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r729" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r733" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r729" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityContactPersonnelLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityContactPersonnelLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Contact Personnel [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r729" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r845" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r729" ] }, "dei_EntityHomeCountryISOCode": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityHomeCountryISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Home Country ISO Code", "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element." } } }, "auth_ref": [] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, Date of Incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r834" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Inv Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r833" ] }, "dei_EntityLegalForm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityLegalForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Legal Form", "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc." } } }, "auth_ref": [] }, "dei_EntityListingDepositoryReceiptRatio": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingDepositoryReceiptRatio", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Depository Receipt Ratio", "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'." } } }, "auth_ref": [] }, "dei_EntityListingDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Description", "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security." } } }, "auth_ref": [] }, "dei_EntityListingForeign": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingForeign", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Foreign", "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt." } } }, "auth_ref": [] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingParValuePerShare", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityListingPrimary": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingPrimary", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Primary", "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity." } } }, "auth_ref": [] }, "dei_EntityListingSecurityTradingCurrency": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingSecurityTradingCurrency", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Security Trading Currency", "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'" } } }, "auth_ref": [] }, "dei_EntityListingsExchangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsExchangeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings, Exchange [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityNumberOfEmployees": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityNumberOfEmployees", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Number of Employees", "documentation": "Number of persons employed by the Entity" } } }, "auth_ref": [] }, "dei_EntityPhoneFaxNumbersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPhoneFaxNumbersLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Phone Fax Numbers [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r753" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r729" ] }, "dei_EntityReportingCurrencyISOCode": { "xbrltype": "currencyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityReportingCurrencyISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Reporting Currency ISO Code", "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r729" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r729" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r729" ] }, "dei_EntityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Text Block]", "documentation": "Container to serve as parent of six Entity related Table concepts." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r836" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r787" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r829" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r829" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r829" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r180", "r206", "r207", "r208", "r223", "r224", "r225", "r229", "r237", "r240", "r242", "r260", "r291", "r296", "r300", "r353", "r404", "r405", "r410", "r411", "r412", "r416", "r417", "r418", "r424", "r425", "r426", "r427", "r428", "r430", "r433", "r460", "r461", "r462", "r463", "r464", "r466", "r471", "r473", "r482", "r527", "r545", "r546", "r547", "r569", "r639" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r287", "r288", "r289", "r409", "r850", "r851", "r852", "r950", "r951", "r952", "r953" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity financing percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r287" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r797" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r746", "r757", "r773", "r808" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r743", "r754", "r770", "r805" ] }, "us-gaap_ExcessStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ExcessStockSharesIssued", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Originally issued shares", "verboseLabel": "Common shares issued (in Shares)", "label": "Excess Stock, Shares Issued", "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders." } } }, "auth_ref": [] }, "us-gaap_ExcessStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ExcessStockSharesOutstanding", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares outstanding (in Shares)", "label": "Excess Stock, Shares Outstanding", "documentation": "Number of shares of excess stock held by shareholders." } } }, "auth_ref": [] }, "dei_ExchangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ExchangeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exchange [Domain]", "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r803" ] }, "cslr_ExercisableShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ExercisableShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable shares (in Shares)", "documentation": "Exercisable shares.", "label": "Exercisable Shares" } } }, "auth_ref": [] }, "dei_ExhibitsOnly462d": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ExhibitsOnly462d", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "auth_ref": [ "r841" ] }, "dei_ExhibitsOnly462dFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ExhibitsOnly462dFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "auth_ref": [ "r841" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "cslr_FACTInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FACTInvestorsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FACT Investors [Member]", "label": "FACTInvestors Member" } } }, "auth_ref": [] }, "cslr_FPAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FPAMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FPA [Member]", "label": "FPAMember" } } }, "auth_ref": [] }, "cslr_FPASMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FPASMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FPA'S [Member]", "label": "FPASMember" } } }, "auth_ref": [] }, "cslr_FairValueAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueAcquisition", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value acquisition", "documentation": "Fair value acquisition.", "label": "Fair Value Acquisition" } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of warrant liabilities", "verboseLabel": "Fair value of warrant (in Dollars)", "label": "Fair Value Adjustment of Warrants", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r0", "r9" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrants Based on a Black Scholes Option Pricing Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r438", "r439", "r440", "r701" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r438", "r439", "r440", "r701" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrants Based on a Black Scholes Option Pricing Method", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r438", "r439", "r701" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r441", "r442", "r443", "r444", "r445", "r446", "r451", "r699" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r441", "r442", "r443", "r444", "r445", "r446", "r451", "r699" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r337", "r355", "r356", "r357", "r358", "r359", "r360", "r436", "r437", "r438", "r439", "r440", "r449", "r450", "r452", "r497", "r498", "r499", "r685", "r686", "r692", "r693", "r694", "r698", "r701" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r445", "r447", "r448", "r449", "r452", "r453", "r454", "r455", "r456", "r507", "r698", "r702" ] }, "us-gaap_FairValueHedgeAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueHedgeAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of prepaid forward purchase agreements", "label": "Fair Value Hedge Assets", "documentation": "Fair value of all derivative assets designated as fair value hedging instruments." } } }, "auth_ref": [ "r123" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1 [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r337", "r355", "r360", "r437", "r450", "r497", "r692", "r693", "r694", "r698" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2 [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r337", "r355", "r360", "r437", "r438", "r450", "r498", "r685", "r686", "r692", "r693", "r694", "r698" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r337", "r355", "r356", "r357", "r358", "r359", "r360", "r437", "r438", "r439", "r440", "r450", "r499", "r685", "r686", "r692", "r693", "r694", "r698", "r701" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description warrant expires", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Planned Sale, Investments Not Identified, Description", "documentation": "Description of remaining actions required to complete the sale or liquidation of an investment in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest, but has not yet identified the specific investment to be sold or liquidated." } } }, "auth_ref": [ "r456", "r704" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r955", "r956" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueMeasurementsDetailsScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueMeasurementsDetailsScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Table]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueMeasurementsDetailsScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility [Line Items]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueMeasurementsDetailsScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of Expected Volatility is Determined Based on the Historical Equity Volatility [Table]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FairValueMeasurementsDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r337", "r355", "r356", "r357", "r358", "r359", "r360", "r436", "r437", "r438", "r439", "r440", "r449", "r450", "r452", "r497", "r498", "r499", "r685", "r686", "r692", "r693", "r694", "r698", "r701" ] }, "us-gaap_FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk free interest rate", "label": "Financial Guarantee Insurance Contract, Claim Liability, Weighted-Average Risk-Free Discount Rate", "documentation": "Weighted-average risk-free rate used to discount claim liability for financial guarantee insurance contract." } } }, "auth_ref": [ "r543" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Financial liabilities", "label": "Financial Liabilities Fair Value Disclosure", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [ "r955", "r956", "r960" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving loan", "label": "Financing Receivable, Excluding Accrued Interest, Revolving, Converted to Term Loan", "documentation": "Amortized cost excluding accrued interest, of revolving financing receivable converted to term loan." } } }, "auth_ref": [ "r298", "r299", "r681" ] }, "us-gaap_FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving loan amount", "label": "Financing Receivable, Revolving, Converted to Term Loan During Period", "documentation": "Amount of increase in term loan from conversion of revolving financing receivable." } } }, "auth_ref": [ "r299" ] }, "us-gaap_FinancingReceivableUnamortizedLoanFeeCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableUnamortizedLoanFeeCost", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued financing cost", "label": "Financing Receivable, Unamortized Loan Cost (Fee)", "documentation": "Amount of unamortized loan commitment, origination, and other costs (fees) on financing receivable recognized as adjustment to yield. Excludes financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r286", "r847", "r899" ] }, "cslr_FirstSAFEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "FirstSAFEMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First SAFE [Member]", "label": "First SAFEMember" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r750", "r761", "r777", "r812" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r750", "r761", "r777", "r812" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r750", "r761", "r777", "r812" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r750", "r761", "r777", "r812" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r750", "r761", "r777", "r812" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "FormerAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r740", "r764" ] }, "dei_FormerFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "FormerFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Fiscal Year End Date", "documentation": "Former end date of previous fiscal years" } } }, "auth_ref": [] }, "us-gaap_ForwardContractIndexedToIssuersEquityShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForwardContractIndexedToIssuersEquityShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forward purchase agreements, shares", "label": "Forward Contract Indexed to Issuer's Equity, Shares", "documentation": "Maximum number of shares that could be issued to settle forward contract indexed to equity." } } }, "auth_ref": [ "r124" ] }, "cslr_ForwardPurchaseAgreementLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementLiabilitiesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Forward purchase agreement liabilities [Member]", "label": "Forward Purchase Agreement Liabilities Member" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsAbstract", "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements [Abstract]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements [Line Items]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements (Details) [Table]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "FPA [Member]", "label": "Forward Purchase Agreements Member" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Forward Purchase Agreements", "documentation": "The policy disclosure of forward purchase agreements.", "label": "Forward Purchase Agreements Policy Text Block" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ForwardPurchaseAgreementsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreements" ], "lang": { "en-us": { "role": { "terseLabel": "Forward Purchase Agreements", "documentation": "The entire disclosure of forward purchase agreements.", "label": "Forward Purchase Agreements Text Block" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r792" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and equipment [Member]", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnContractTermination", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Breach of contract", "label": "Gain (Loss) on Contract Termination", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r106" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r9", "r38", "r39" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r96", "r619" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative [Member]", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r96" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r89", "r94", "r146", "r219", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r457", "r673", "r676", "r891", "r892", "r893", "r894", "r895", "r916" ] }, "cslr_ISOsUnderThe2023PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ISOsUnderThe2023PlanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ISOs under the 2023 Plan [Member]", "label": "ISOs Under The2023 Plan Member" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r738", "r741", "r753" ] }, "cslr_InclusiveAmountsOfIndemnity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "InclusiveAmountsOfIndemnity", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inclusive amounts of indemnity", "documentation": "The amount of Inclusive amounts of indemnity.", "label": "Inclusive Amounts Of Indemnity" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow", "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from continuing operations", "terseLabel": "Net loss from continuing operations, net of tax", "verboseLabel": "Net loss from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r48", "r91", "r106", "r232", "r233", "r235", "r236", "r237", "r250", "r253", "r418" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from continuing operations before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r90", "r136", "r146", "r510", "r524", "r673", "r676", "r891", "r892", "r893", "r894", "r895" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss from continuing operations per share attributable to common stockholders, basic (in Dollars per share)", "verboseLabel": "Continuing operations - basic", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r91", "r137", "r211", "r228", "r232", "r233", "r235", "r236", "r237", "r248", "r251", "r252", "r415", "r418", "r435", "r509", "r981" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss from continuing operations per share attributable to common stockholders, diluted", "verboseLabel": "Continuing operations diluted", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r91", "r211", "r228", "r232", "r233", "r235", "r236", "r237", "r248", "r251", "r252", "r253", "r418", "r435", "r509", "r981" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": 1.0, "order": 1.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from discontinued operations", "terseLabel": "Loss from discontinued operations, net of tax", "verboseLabel": "Net loss from discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r60", "r61", "r62", "r63", "r64", "r67", "r184", "r408", "r525" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow", "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from discontinued operations, net of taxes", "terseLabel": "Loss from discontinued operations, net of income taxes", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r60", "r61", "r62", "r63", "r64", "r65", "r67", "r121" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss from discontinued operations per share attributable to common stockholders, basic (in Dollars per share)", "verboseLabel": "Discontinued operations - basic", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r92", "r211", "r249", "r251", "r252", "r975", "r981" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss from discontinued operations per share attributable to common stockholders, diluted", "verboseLabel": "Discontinued operations diluted", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r122", "r249", "r251", "r252" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r301", "r302", "r304", "r442", "r446", "r451", "r541", "r544", "r624", "r663", "r700", "r983" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r302", "r304", "r442", "r446", "r451", "r541", "r544", "r624", "r663", "r700", "r983" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit (provision)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r148", "r160", "r241", "r242", "r259", "r268", "r279", "r401", "r402", "r406", "r532", "r697" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable, net", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r877" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Deferred Revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r664" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r857", "r877" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Other noncurrent assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r877" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r8" ] }, "cslr_IncreaseDecreaseInWarrantyProvisionNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "IncreaseDecreaseInWarrantyProvisionNoncurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty provision, noncurrent", "documentation": "The increase (decrease) during the reporting period warranty provision, noncurrent.", "label": "Increase Decrease In Warranty Provision Noncurrent" } } }, "auth_ref": [] }, "cslr_IncreasedRepaymentPremiumPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "IncreasedRepaymentPremiumPercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Increased repayment premium, percentage", "documentation": "Percentage of increased repayment premium, percentage.", "label": "Increased Repayment Premium Percentage" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r750", "r761", "r777", "r803", "r812", "r816", "r824" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r822" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r742", "r828" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r742", "r828" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r742", "r828" ] }, "us-gaap_InterestCostsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestCostsIncurred", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incurred amount", "label": "Interest Costs Incurred", "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings." } } }, "auth_ref": [ "r468", "r469" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense(1)", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r259", "r263", "r267", "r269", "r279", "r468", "r676", "r677" ] }, "us-gaap_InterestExpenseBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseBorrowings", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense recognized", "label": "Interest Expense, Borrowings", "documentation": "Aggregate amount of interest expense on all borrowings." } } }, "auth_ref": [ "r139", "r140" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r99", "r342", "r345", "r687", "r688" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense [Member]", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r17" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseOther", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense related party", "label": "Interest Expense, Other", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeOther", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income", "label": "Interest Income, Other", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid during the period for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r213", "r215", "r216" ] }, "cslr_InterestRate": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "InterestRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "documentation": "Percentage of interest rate.", "label": "Interest Rate" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r199", "r668", "r707" ] }, "dei_InvestmentCompanyActFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "InvestmentCompanyActFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "auth_ref": [ "r766", "r767", "r768", "r769" ] }, "dei_InvestmentCompanyActRegistration": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "InvestmentCompanyActRegistration", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "auth_ref": [ "r782" ] }, "dei_InvestmentCompanyRegistrationAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "InvestmentCompanyRegistrationAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "auth_ref": [ "r782" ] }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "InvestmentCompanyRegistrationAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "auth_ref": [ "r782" ] }, "cslr_InvestmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "InvestmentDescription", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Investment description", "documentation": "Investment description.", "label": "Investment Description" } } }, "auth_ref": [] }, "cslr_InvestmentDividendPayablePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "InvestmentDividendPayablePercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Investment dividend payable percentage", "documentation": "Investment dividend payable percentage.", "label": "Investment Dividend Payable Percentage" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r259", "r266", "r279", "r676", "r875" ] }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Balance owed amount", "label": "Investment Owned, Face Amount", "documentation": "Nominal or face amount on the investment owned." } } }, "auth_ref": [ "r49", "r50" ] }, "us-gaap_InvestmentSoldNotYetPurchasedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentSoldNotYetPurchasedBalancePrincipalAmount", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Principal balance", "label": "Security Sold Short, Principal Amount", "documentation": "For investments which are quantified by principal amount, principal balance held at close of period." } } }, "auth_ref": [ "r1020" ] }, "cslr_July2023CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "July2023CommonStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "July 2023 Common Stock Warrants [Member]", "label": "July2023 Common Stock Warrants Member" } } }, "auth_ref": [] }, "cslr_KlineHillMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "KlineHillMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Kline Hill [Member]", "label": "Kline Hill Member" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total lease expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r477", "r706" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold Improvements [Member]", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r112", "r479" ] }, "cslr_LegacyCompleteSolariaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "LegacyCompleteSolariaMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legacy Complete Solaria [Member]", "label": "Legacy Complete Solaria Member" } } }, "auth_ref": [] }, "cslr_LegacyInShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "LegacyInShares", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable": { "parentTag": "cslr_SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Legacy Complete Solaria shares", "documentation": "Legacyin shares.", "label": "Legacy In Shares" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LegalEntityIdentifier": { "xbrltype": "legalEntityIdentifierItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityIdentifier", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity Identifier", "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI." } } }, "auth_ref": [ "r726" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r18", "r70", "r71", "r72", "r75", "r76", "r77", "r78", "r219", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r421", "r422", "r423", "r457", "r591", "r672", "r725", "r916", "r966", "r967" ] }, "cslr_LiabilitiesAndStockholdersDeficitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "LiabilitiesAndStockholdersDeficitAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT", "label": "Liabilities And Stockholders Deficit Abstract" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r87", "r134", "r521", "r707", "r881", "r900", "r961" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r72", "r186", "r219", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r421", "r422", "r423", "r457", "r707", "r916", "r966", "r967" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total liability classified warrants", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r437", "r955" ] }, "us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForCatastropheClaimsByCatastrophicEventAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "label": "Catastrophic Event [Axis]", "documentation": "Information by type of catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [ "r711", "r1010" ] }, "cslr_LiquidityAndGoingConcernMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "LiquidityAndGoingConcernMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liquidity and Going Concern [Member]", "label": "Liquidity And Going Concern Member" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Long term debt fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r955", "r957", "r958", "r959" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r308", "r309", "r310", "r313", "r399", "r683", "r909", "r910" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r308", "r309", "r310", "r313", "r399", "r683", "r909", "r910" ] }, "us-gaap_LossContingencyDamagesAwardedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyDamagesAwardedValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Demanded approximately", "label": "Loss Contingency, Damages Awarded, Value", "documentation": "Amount of damages awarded to the plaintiff in the legal matter." } } }, "auth_ref": [ "r908", "r909", "r910" ] }, "us-gaap_LossContingencyDamagesSoughtValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyDamagesSoughtValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Damages amount", "label": "Loss Contingency, Damages Sought, Value", "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter." } } }, "auth_ref": [ "r908", "r909", "r910" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r283", "r691", "r709", "r713", "r922", "r982", "r984", "r985", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1011", "r1012" ] }, "cslr_ManufacturingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ManufacturingEquipmentMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Manufacturing equipment [Member]", "label": "Manufacturing Equipment Member" } } }, "auth_ref": [] }, "cslr_MarketFairValueOfferingProceedsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "MarketFairValueOfferingProceedsPercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market fair value offering proceeds percentage", "documentation": "Market fair value offering proceeds percentage.", "label": "Market Fair Value Offering Proceeds Percentage" } } }, "auth_ref": [] }, "cslr_MaxeonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "MaxeonMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maxeon [Member]", "label": "Maxeon Member" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r164", "r165", "r166", "r167", "r168", "r178", "r179", "r309", "r310", "r311", "r312", "r362", "r399", "r440", "r502", "r540", "r542", "r555", "r582", "r583", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r679", "r689", "r695", "r701", "r702", "r703", "r704", "r710", "r920", "r968", "r969", "r970", "r971", "r972", "r973" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r795" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r795" ] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield [Member]", "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r957", "r958", "r959" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term [Member]", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r957", "r958", "r959" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility [Member]", "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r701", "r957", "r958", "r959" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate [Member]", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r957", "r958", "r959" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r438", "r439", "r440", "r701" ] }, "cslr_MeasurementInputVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "MeasurementInputVolatilityMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility [Member]", "label": "Measurement Input Volatility Member" } } }, "auth_ref": [] }, "cslr_MergerTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "MergerTransactionMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Merger Transaction [Member]", "label": "Merger Transaction Member" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r164", "r165", "r166", "r167", "r168", "r178", "r179", "r309", "r310", "r311", "r312", "r362", "r399", "r440", "r502", "r540", "r542", "r555", "r582", "r583", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r679", "r689", "r695", "r701", "r702", "r703", "r710", "r920", "r968", "r969", "r970", "r971", "r972", "r973" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r815" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r823" ] }, "dei_NameChangeEventDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NameChangeEventDateAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event Date [Axis]", "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type." } } }, "auth_ref": [] }, "dei_NameChangeEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NameChangeEventLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Line Items]", "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table." } } }, "auth_ref": [] }, "dei_NameChangeEventTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NameChangeEventTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Table]", "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r283", "r691", "r709", "r713", "r922", "r982", "r984", "r985", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1011", "r1012" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r796" ] }, "us-gaap_NetAssetValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetAssetValuePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Per share", "label": "Net Asset Value Per Share", "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure." } } }, "auth_ref": [ "r572", "r579", "r581", "r595", "r613", "r653", "r725" ] }, "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash used in operating activities from discontinued operations", "label": "Net Cash Provided by (Used in) Discontinued Operations", "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations." } } }, "auth_ref": [ "r104" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities from continuing operations", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r214" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities from continuing operations", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities from continuing operations", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r214" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities from continuing operations", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r104", "r105", "r106" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities from continuing operations", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities from continuing operations", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r104", "r105", "r106" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow", "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "verboseLabel": "Net loss", "netLabel": "Net losses (in Dollars)", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r95", "r106", "r138", "r184", "r202", "r204", "r208", "r219", "r228", "r232", "r233", "r235", "r236", "r237", "r241", "r242", "r250", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r415", "r418", "r435", "r457", "r526", "r615", "r637", "r638", "r724", "r916" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Pronouncements Not Yet Adopted", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r161", "r182", "r226", "r227", "r230", "r231", "r243", "r244", "r284", "r292", "r293", "r413", "r414", "r416", "r418", "r429", "r432", "r480", "r483", "r484", "r504", "r505", "r506", "r549", "r550", "r551", "r552", "r554" ] }, "dei_NewEffectiveDateForPreviousFiling": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NewEffectiveDateForPreviousFiling", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "auth_ref": [ "r766", "r767", "r768", "r769" ] }, "cslr_NewMoneyPIPEInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "NewMoneyPIPEInvestorsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Money PIPE Investors [Member]", "label": "New Money PIPEInvestors Member" } } }, "auth_ref": [] }, "cslr_NewMoneyPIPESubscriptionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "NewMoneyPIPESubscriptionAgreementMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Money PIPE Subscription Agreement [Member]", "label": "New Money PIPESubscription Agreement Member" } } }, "auth_ref": [] }, "dei_NoSubstantiveChanges462c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoSubstantiveChanges462c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "auth_ref": [ "r840" ] }, "dei_NoSubstantiveChanges462cFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoSubstantiveChanges462cFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "auth_ref": [ "r840" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "cslr_NonCashLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "NonCashLeaseExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash lease expense", "documentation": "Represents the amount of non-cash lease expense.", "label": "Non Cash Lease Expense" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r795" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r750", "r761", "r777", "r803", "r812" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r786" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r785" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r803" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r823" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r823" ] }, "us-gaap_NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash net liabilities assumed", "label": "Noncash or Part Noncash Acquisition, Other Liabilities Assumed", "documentation": "Amount of liabilities, classified as other, assumed in acquiring a business or in consideration for an asset received in a noncash or part noncash acquisition." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other expense", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r98" ] }, "us-gaap_NotesAndLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesAndLoansPayable", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total Notes payable", "label": "Notes and Loans Payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r18", "r132", "r977" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, net", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r70", "r71" ] }, "cslr_November2022CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "November2022CommonStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "November 2022 Common Stock Warrants [Member]", "label": "November2022 Common Stock Warrants Member" } } }, "auth_ref": [] }, "cslr_OneSupplierMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OneSupplierMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Supplier [Member]", "label": "One Supplier Member" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from continuing operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r146", "r673", "r891", "r892", "r893", "r894", "r895" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, net of current portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r475" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases payments", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r476", "r478" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r474" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/Organization" ], "lang": { "en-us": { "role": { "terseLabel": "Organization", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r56", "r120", "r557", "r558" ] }, "cslr_OrganizationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OrganizationDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Organization (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r71" ] }, "dei_OtherAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Address [Member]", "documentation": "Other address for entity" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Other noncurrent assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r189" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r527" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r4", "r458", "r465" ] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses and Other Current Assets", "label": "Other Current Assets [Text Block]", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "cslr_OtherExpenseNetDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OtherExpenseNetDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Other Expense, Net (Details) [Line Items]" } } }, "auth_ref": [] }, "cslr_OtherExpenseNetDetailsScheduleofOtherExpenseNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OtherExpenseNetDetailsScheduleofOtherExpenseNetLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Income (Expense), Net [Abstract]" } } }, "auth_ref": [] }, "cslr_OtherExpenseNetDetailsScheduleofOtherExpenseNetTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OtherExpenseNetDetailsScheduleofOtherExpenseNetTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "label": "Other Expense, Net (Details) - Schedule of Other Expense, Net [Table]" } } }, "auth_ref": [] }, "cslr_OtherExpenseNetDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OtherExpenseNetDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Other Expense, Net (Details) [Table]" } } }, "auth_ref": [] }, "cslr_OtherExpenseNetDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OtherExpenseNetDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNet" ], "lang": { "en-us": { "role": { "terseLabel": "Other Expense, Net", "documentation": "The entire disclosure of other expense, net.", "label": "Other Expense Net Disclosure Text Block" } } }, "auth_ref": [] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other expense", "verboseLabel": "Other expenses", "label": "Other Expenses", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r96", "r97" ] }, "us-gaap_OtherExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Expense, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherGeneralExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherGeneralExpense", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid forward purchase liability", "label": "Other General Expense", "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses." } } }, "auth_ref": [ "r97", "r676" ] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income expense", "verboseLabel": "Other income (expense)", "label": "Other Income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r531", "r617", "r650", "r651", "r652" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase liabilities", "label": "Other Liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r131", "r514", "r586", "r587", "r725", "r978", "r1014" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty provision, noncurrent", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r76" ] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt with CS Solis", "label": "Other Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r18", "r590" ] }, "us-gaap_OtherNoncashIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashIncomeTaxExpense", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income and expense (in Dollars)", "label": "Other Noncash Income Tax Expense", "documentation": "The portion of the noncash component of income tax expense for the period other than the portion from the net change in the entity's deferred tax assets and liabilities." } } }, "auth_ref": [ "r106" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense), net", "terseLabel": "Other income, net", "verboseLabel": "Other income (expense) (in Dollars)", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r100" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on discontinued Solaria business and other, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r795" ] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r870", "r901" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Other Receivables", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r196", "r602", "r677", "r980" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r741" ] }, "us-gaap_OtherSellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherSellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "label": "Other Selling and Marketing Expense", "documentation": "Amount of selling and marketing expense classified as other." } } }, "auth_ref": [ "r96" ] }, "us-gaap_OtherShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term debt with CS Solis", "label": "Other Short-Term Borrowings", "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r68", "r590" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r748", "r759", "r775", "r810" ] }, "cslr_OutstandingNetDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "OutstandingNetDebtAmount", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding net debt", "documentation": "The amount of outstanding net debt.", "label": "Outstanding Net Debt Amount" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r751", "r762", "r778", "r813" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r751", "r762", "r778", "r813" ] }, "cslr_PIPEFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PIPEFinancingMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PIPE Financing [Member]", "label": "PIPEFinancing Member" } } }, "auth_ref": [] }, "cslr_PIPEInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PIPEInvestorsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PIPE Investors [Member]", "label": "PIPEInvestors Member" } } }, "auth_ref": [] }, "us-gaap_PaidInKindInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaidInKindInterest", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash interest expense", "label": "Paid-in-Kind Interest", "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9" ] }, "dei_ParentEntityLegalName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ParentEntityLegalName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Parent Entity Legal Name", "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r784" ] }, "us-gaap_PaymentsForCapitalImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForCapitalImprovements", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Pay return capital", "label": "Payments for Capital Improvements", "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use." } } }, "auth_ref": [ "r102" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r102" ] }, "us-gaap_PaymentsToAcquireSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireSoftware", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalization of internal-use software costs", "label": "Payments to Acquire Software", "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization." } } }, "auth_ref": [ "r102" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r794" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r794" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r786" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r803" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r796" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r785" ] }, "dei_PhoneFaxNumberDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PhoneFaxNumberDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Phone Fax Number Description", "documentation": "Description of Phone or Fax Number" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r787" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r832" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r786" ] }, "cslr_PolarSettlementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PolarSettlementAgreementMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Polar Settlement Agreement [Member]", "label": "Polar Settlement Agreement Member" } } }, "auth_ref": [] }, "dei_PostEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PostEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "auth_ref": [ "r727" ] }, "dei_PostEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PostEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective." } } }, "auth_ref": [ "r727" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r734" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r736" ] }, "dei_PreEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "auth_ref": [ "r727" ] }, "dei_PreEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective." } } }, "auth_ref": [ "r727" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "verboseLabel": "Preferred Stock [Member]", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r716", "r717", "r720", "r721", "r722", "r723", "r1013", "r1018" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r80", "r593" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock issued", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r80", "r346" ] }, "cslr_PreferredStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PreferredStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock warrants [Member]", "label": "Preferred Stock Warrants Member" } } }, "auth_ref": [] }, "us-gaap_PreferredUnitsContributedCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredUnitsContributedCapital", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Contributed", "label": "Preferred Units, Contributed Capital", "documentation": "The amount of capital contributed by the preferred partners." } } }, "auth_ref": [ "r117" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r871" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expenses and Other Current Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidRent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory deposits", "label": "Prepaid Rent", "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r669", "r682", "r901" ] }, "cslr_PrepaidSalesCommissions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PrepaidSalesCommissions", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred commissions", "documentation": "Prepaid sales commissions.", "label": "Prepaid Sales Commissions" } } }, "auth_ref": [] }, "cslr_PriceOnFloor": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PriceOnFloor", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price on floor (in Dollars per share)", "documentation": "Price on floor.", "label": "Price On Floor" } } }, "auth_ref": [] }, "cslr_PrimeRatePlus": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PrimeRatePlus", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Prime rate plus", "documentation": "Percentage of prime rate plus.", "label": "Prime Rate Plus" } } }, "auth_ref": [] }, "cslr_PrivateInvestmentInPublicEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PrivateInvestmentInPublicEquityMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "PIPE [Member]", "label": "Private Investment In Public Equity Member" } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrivatePlacementMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement Warrants [Member]", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "cslr_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement warrants [Member]", "verboseLabel": "Private placements warrants [Member]", "netLabel": "Private Placement Warrants [Member]", "documentation": "Private placement warrants [Member].", "label": "Private Placement Warrants Member" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of convertible notes, net of issuance cost", "label": "Proceeds from Convertible Debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ProceedsFromInterestReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromInterestReceived", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received proceeds", "label": "Proceeds from Interest Received", "documentation": "Interest received on loans and other debt instruments during the current period." } } }, "auth_ref": [ "r876" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of FACT public, private placement and working capital warrants", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r5" ] }, "cslr_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of redeemable convertible preferred stock warrant liability", "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.", "label": "Proceeds From Issuance Of Redeemable Convertible Preferred Stock1" } } }, "auth_ref": [] }, "cslr_ProceedsFromIssuanceOfSAFEAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ProceedsFromIssuanceOfSAFEAgreements", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of SAFE agreements", "documentation": "Proceeds from issuance of SAFE agreements.", "label": "Proceeds From Issuance Of SAFEAgreements" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of property and equipment", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r101" ] }, "us-gaap_ProceedsFromSecuredNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSecuredNotesPayable", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of notes payable, net", "label": "Proceeds from Secured Notes Payable", "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of common stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r5", "r16" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenue Recognized By Product and Services [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r281", "r503", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r666", "r690", "r708", "r710", "r712", "r714", "r715", "r863", "r911", "r912", "r922", "r982", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1011", "r1012" ] }, "us-gaap_ProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warranty provision, beginning of period", "periodEndLabel": "Warranty provision, end of period", "label": "Standard and Extended Product Warranty Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r130", "r314", "r316", "r319" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty provision, current", "label": "Product Warranty Accrual, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r71", "r913", "r914" ] }, "us-gaap_ProductWarrantyAccrualNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrualNoncurrent", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty provision, noncurrent", "label": "Product Warranty Accrual, Noncurrent", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r76", "r913", "r914" ] }, "us-gaap_ProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlements", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty." } } }, "auth_ref": [ "r317" ] }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrualWarrantiesIssued", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accruals for new warranties issued", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued." } } }, "auth_ref": [ "r318" ] }, "us-gaap_ProductWarrantyLiabilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyLiabilityLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Activity by Period Relating to the Company\u2019s Warranty Provision [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductWarrantyLiabilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyLiabilityTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable" ], "lang": { "en-us": { "role": { "label": "Product Warranty Liability [Table]", "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties." } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r281", "r503", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r666", "r690", "r708", "r710", "r712", "r714", "r715", "r863", "r911", "r912", "r922", "r982", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1011", "r1012" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional fees", "label": "Professional Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r676", "r724", "r1016", "r1017" ] }, "cslr_PromissoryNoteCommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PromissoryNoteCommonStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note Common Stock Warrants [Member]", "label": "Promissory Note Common Stock Warrants Member" } } }, "auth_ref": [] }, "cslr_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PromissoryNoteMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note [Member]", "label": "Promissory Note Member" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r10", "r479" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNet" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r111", "r155", "r158", "r159" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable": { "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total property and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r112", "r188", "r523" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable", "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Significant Accounting Policies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r479" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r479", "r511", "r523", "r707" ] }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNetAbstract", "lang": { "en-us": { "role": { "label": "Property and Equipment, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentOtherAccumulatedDepreciation", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable": { "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation and amortization", "label": "Property, Plant and Equipment, Other, Accumulated Depreciation", "documentation": "Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentOtherNet", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total property and equipment, net", "label": "Property, Plant and Equipment, Other, Net", "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property and Equipment, Net", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r112", "r479" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Useful Lives", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "cslr_PropertyandEquipmentNetDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PropertyandEquipmentNetDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net [Abstract]", "label": "Propertyand Equipment Net Details Line Items" } } }, "auth_ref": [] }, "cslr_PropertyandEquipmentNetDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PropertyandEquipmentNetDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property and Equipment, Net (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r212", "r297" ] }, "cslr_PublicPrivatePlacementAndWorkingCapitalWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PublicPrivatePlacementAndWorkingCapitalWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public, Private Placement, and Working Capital Warrants [Member]", "label": "Public Private Placement And Working Capital Warrants Member" } } }, "auth_ref": [] }, "cslr_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PublicWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public warrants [Member]", "verboseLabel": "Public warrents [Member]", "netLabel": "Public Warrants [Member]", "label": "Public Warrants Member" } } }, "auth_ref": [] }, "cslr_PurchasePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PurchasePercentage", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase percentage", "documentation": "Purchase percentage.", "label": "Purchase Percentage" } } }, "auth_ref": [] }, "cslr_PurchasePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PurchasePricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price per share (in Dollars per share)", "documentation": "Number of shares are Purchase Price Per Share.", "label": "Purchase Price Per Share" } } }, "auth_ref": [] }, "cslr_PurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PurchaseShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase shares", "documentation": "Purchase shares.", "label": "Purchase Shares" } } }, "auth_ref": [] }, "cslr_PurchaserInvesting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "PurchaserInvesting", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchaser investing", "verboseLabel": "Purchaser investing (in Dollars)", "documentation": "Purchaser investing.", "label": "Purchaser Investing" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r784" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r784" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r164", "r165", "r166", "r167", "r168", "r178", "r179", "r309", "r310", "r311", "r312", "r354", "r362", "r388", "r389", "r390", "r399", "r440", "r500", "r501", "r502", "r540", "r542", "r555", "r582", "r583", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r679", "r689", "r695", "r701", "r702", "r703", "r704", "r710", "r718", "r906", "r920", "r958", "r969", "r970", "r971", "r972", "r973" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r164", "r165", "r166", "r167", "r168", "r178", "r179", "r309", "r310", "r311", "r312", "r354", "r362", "r388", "r389", "r390", "r399", "r440", "r500", "r501", "r502", "r540", "r542", "r555", "r582", "r583", "r645", "r646", "r647", "r648", "r649", "r661", "r662", "r679", "r689", "r695", "r701", "r702", "r703", "r704", "r710", "r718", "r906", "r920", "r958", "r969", "r970", "r971", "r972", "r973" ] }, "cslr_ReceivedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReceivedAmount", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received amount (in Dollars)", "documentation": "Received amount.", "label": "Received Amount" } } }, "auth_ref": [] }, "cslr_RecognizedALiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RecognizedALiability", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognized a liability", "documentation": "Recognized a liability.", "label": "Recognized ALiability" } } }, "auth_ref": [] }, "cslr_RecognizedInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RecognizedInterestExpense", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Recognized interest expense", "documentation": "The amount of recognized interest expense.", "label": "Recognized Interest Expense" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r743", "r754", "r770", "r805" ] }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible", "label": "Redeemable Convertible Preferred Stock [Member]", "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer." } } }, "auth_ref": [] }, "cslr_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneCommonStockMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable warrants, each whole warrant exercisable for one common stock", "label": "Redeemable Warrants Each Whole Warrant Exercisable For One Common Stock Member" } } }, "auth_ref": [] }, "dei_RegistrationStatementAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "RegistrationStatementAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Registration Statement Amendment Number", "documentation": "Amendment number to registration statement under the Investment Company Act of 1940." } } }, "auth_ref": [ "r727" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r285", "r361", "r488", "r489", "r515", "r522", "r585", "r586", "r587", "r588", "r589", "r612", "r614", "r644" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Member]", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r220", "r221", "r488", "r489", "r490", "r491", "r515", "r522", "r585", "r586", "r587", "r588", "r589", "r612", "r614", "r644" ] }, "us-gaap_RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding remains", "label": "Related Party Tax Expense Effect of Change in Allocation Methodology", "documentation": "Amount of increase (decrease) in tax expense resulting from change in methodology used to allocate tax expense to members of a group for which a consolidated tax return is filed." } } }, "auth_ref": [ "r403" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related party issued", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r53", "r488" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r488", "r489", "r965" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r285", "r620", "r621", "r624" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest percentage", "label": "Related Party Transaction, Rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r285", "r361", "r488", "r489", "r515", "r522", "r585", "r586", "r587", "r588", "r589", "r612", "r614", "r644", "r965" ] }, "cslr_RelatedPartyTransactionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RelatedPartyTransactionsDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r485", "r486", "r487", "r489", "r492", "r566", "r567", "r568", "r622", "r623", "r624", "r642", "r643" ] }, "cslr_RemainingOutstandingShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RemainingOutstandingShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining shares outstanding", "documentation": "Number of remaining outstanding shares.", "label": "Remaining Outstanding Shares" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongtermLoansFromVendors": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongtermLoansFromVendors", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Vendor purchase net amount", "label": "Repayments of Long-Term Loans from Vendors", "documentation": "Cash outflows under financing arrangements with vendors (seller-financed debt), which had a maturity date at inception of more than one year (or more than one operating cycle, if longer); such debt may have arisen from purchases of property, plant and equipment or other productive assets." } } }, "auth_ref": [ "r107" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal repayment of notes payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r103" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreed related party", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r103" ] }, "cslr_ReplacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReplacementWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Replacement warrants [Member]", "label": "Replacement Warrants Member" } } }, "auth_ref": [] }, "cslr_ReplacementsWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReplacementsWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Replacements Warrants [Member]", "label": "Replacements Warrants Member" } } }, "auth_ref": [] }, "cslr_ResetFloorPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ResetFloorPrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reset floor price (in Dollars per share)", "documentation": "Reset floor price.", "label": "Reset Floor Price" } } }, "auth_ref": [] }, "cslr_ResetPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ResetPricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reset price per share (in Dollars per share)", "documentation": "Reset price per share.", "label": "Reset Price Per Share" } } }, "auth_ref": [] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r177", "r181", "r223", "r224", "r225", "r228", "r229", "r232", "r233", "r234", "r235", "r238", "r239", "r240", "r241", "r242", "r243", "r258", "r294", "r295", "r411", "r412", "r415", "r416", "r417", "r418", "r431", "r433", "r434", "r435", "r470", "r472", "r481", "r482", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r559", "r896" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r744", "r755", "r771", "r806" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r745", "r756", "r772", "r807" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r752", "r763", "r779", "r814" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r177", "r181", "r223", "r224", "r225", "r228", "r229", "r232", "r233", "r234", "r235", "r238", "r239", "r240", "r241", "r242", "r243", "r258", "r294", "r295", "r411", "r412", "r415", "r416", "r417", "r418", "r431", "r433", "r434", "r435", "r470", "r472", "r481", "r482", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r559", "r896" ] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCash", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails", "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash balance (in Dollars)", "verboseLabel": "Restricted cash accounts", "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r864", "r878", "r974", "r979" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r126", "r187", "r217", "r517" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r150", "r865", "r878" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs) [Member]", "verboseLabel": "RSU [Member]", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveSettledWithoutCash2", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash proceeds", "label": "Restructuring Reserve, Settled without Cash", "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash." } } }, "auth_ref": [ "r303", "r305" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit (in Dollars)", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r84", "r116", "r520", "r549", "r554", "r565", "r594", "r707" ] }, "us-gaap_RetainedEarningsUnappropriatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsUnappropriatedMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings, Unappropriated [Member]", "documentation": "Accumulated undistributed earnings (deficit) available for dividend distribution. Includes, but is not limited to, retained earnings not appropriated for specific business purpose." } } }, "auth_ref": [ "r83" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r618", "r665", "r670" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "verboseLabel": "Total revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r144", "r145", "r209", "r219", "r259", "r264", "r265", "r277", "r279", "r281", "r282", "r283", "r290", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r457", "r510", "r676", "r916" ] }, "cslr_ReverseRecapitalizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationAbstract", "lang": { "en-us": { "role": { "label": "Reverse Recapitalization [Abstract]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) [Line Items]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Table]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) [Table]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ReverseRecapitalizationTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalization" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse Recapitalization", "documentation": "The entire disclosure for reverse recapitalization.", "label": "Reverse Recapitalization Text Block" } } }, "auth_ref": [] }, "cslr_RevolverLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RevolverLoanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revolver Loan [Member]", "label": "Revolver Loan Member" } } }, "auth_ref": [] }, "cslr_RevolvingLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RevolvingLoanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Loan [Member]", "label": "Revolving Loan Member" } } }, "auth_ref": [] }, "cslr_RodgersMasseyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "RodgersMasseyMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Rodgers Massey [Member]", "label": "Rodgers Massey Member" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r823" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r823" ] }, "cslr_SAFEAgreementsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SAFEAgreementsCurrent", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "SAFE Agreements", "documentation": "The amount of safe agreements.", "label": "SAFEAgreements Current" } } }, "auth_ref": [] }, "cslr_SAFEAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SAFEAgreementsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "SAFE Agreements [Member]", "label": "SAFEAgreements Member" } } }, "auth_ref": [] }, "cslr_SAFEPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SAFEPriceMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "SAFE Price [Member]", "label": "SAFEPrice Member" } } }, "auth_ref": [] }, "cslr_SCITermLoanAndRevolverLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SCITermLoanAndRevolverLoanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "SCI Term Loan and Revolver Loan [Member]", "label": "SCITerm Loan And Revolver Loan Member" } } }, "auth_ref": [] }, "cslr_SVBCommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SVBCommonStockWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SVB Common Stock Warrants [Member]", "label": "SVBCommon Stock Warrants Member" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of aggregate shares", "verboseLabel": "Number of shares (in Shares)", "netLabel": "Issuance of common stock (in Shares)", "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Least per price", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "cslr_SalesAndMarketingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SalesAndMarketingMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing [Member]", "label": "Sales And Marketing Member" } } }, "auth_ref": [] }, "us-gaap_SalesCommissionsAndFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesCommissionsAndFees", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Sales commissions", "label": "Sales Commissions and Fees", "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)." } } }, "auth_ref": [ "r96" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark [Member]", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r283", "r855" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioForecastMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast [Member]", "label": "Forecast [Member]", "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact." } } }, "auth_ref": [ "r363", "r858", "r886" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r177", "r243", "r363", "r849", "r886" ] }, "cslr_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Accrued Expenses and Other Current Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "cslr_ScheduleOfActivityByPeriodRelatingToTheCompanySWarrantyProvisionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfActivityByPeriodRelatingToTheCompanySWarrantyProvisionAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Activity By Period Relating To The Company SWarranty Provision Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r29" ] }, "cslr_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Assets That Are Measured At Fair Value On ARecurring Basis Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Reconciles Cash Cash Equivalents and Restricted Cash [Abstract]", "documentation": "Disclosure of information about cash and cash equivalent by type. Excludes restricted cash and cash equivalent." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciles Cash, Cash Equivalents, and Restricted Cash", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "cslr_ScheduleOfCommonStockOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfCommonStockOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Common Stock Outstanding [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Common Stock Outstanding", "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "cslr_ScheduleOfConvertibleNotesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfConvertibleNotesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Convertible Notes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BasicandDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r889" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r45" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss)", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r45" ] }, "us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/EmployeeStockPurchasePlan" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "label": "Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]", "documentation": "Tabular disclosure of the details pertaining to each employee stock ownership plan." } } }, "auth_ref": [ "r46" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r287", "r288", "r289", "r409", "r850", "r851", "r852", "r950", "r951", "r952", "r953" ] }, "cslr_ScheduleOfExpectedVolatilityIsDeterminedBasedOnTheHistoricalEquityVolatilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfExpectedVolatilityIsDeterminedBasedOnTheHistoricalEquityVolatilityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Expected Volatility Is Determined Based On The Historical Equity Volatility Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets that are Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r955", "r956" ] }, "cslr_ScheduleOfLiabilityClassifiedWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfLiabilityClassifiedWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Liability Classified Warrants Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfLiabilityClassifiedWarrantsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfLiabilityClassifiedWarrantsTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Liability-Classified Warrants", "documentation": "Tabular disclosure of liability-classified warrants.", "label": "Schedule Of Liability Classified Warrants Table Text Block" } } }, "auth_ref": [] }, "cslr_ScheduleOfOperationsAndComprehensiveIncomeRelatedToDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfOperationsAndComprehensiveIncomeRelatedToDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PrepaidExpensesandOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "cslr_ScheduleOfOtherExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfOtherExpenseNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Other Expense Net Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OtherExpenseNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Expense, Net", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "cslr_ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Prepaid Expenses and Other Current Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenue Recognized By Product and Services", "label": "Schedule of Product Information [Table Text Block]", "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Activity by Period Relating to the Company\u2019s Warranty Provision", "label": "Schedule of Product Warranty Liability [Table Text Block]", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r315" ] }, "cslr_ScheduleOfPropertyAndEquipmentNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfPropertyAndEquipmentNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Property And Equipment Net Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10", "r479" ] }, "cslr_ScheduleOfReconcilesCashCashEquivalentsAndRestrictedCashAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfReconcilesCashCashEquivalentsAndRestrictedCashAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles Cash Cash Equivalents And Restricted Cash Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfReservedSharesOfCommonStockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfReservedSharesOfCommonStockAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reserved Shares Of Common Stock Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfReservedSharesOfCommonStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfReservedSharesOfCommonStockTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reserved Shares of Common Stock", "documentation": "Tabular disclosure of reserved shares of common stock.", "label": "Schedule Of Reserved Shares Of Common Stock Table Text Block" } } }, "auth_ref": [] }, "cslr_ScheduleOfRevenueRecognizedByProductAndServicesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfRevenueRecognizedByProductAndServicesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Revenue Recognized By Product And Services Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summary of RSU Activity", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r118" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summary of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r14", "r15", "r118" ] }, "cslr_ScheduleOfStockBasedCompensationExpenseAndStatementsOfOperationsAndComprehensiveIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfStockBasedCompensationExpenseAndStatementsOfOperationsAndComprehensiveIncomeLossAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Loss [Abstract]" } } }, "auth_ref": [] }, "cslr_ScheduleOfSummaryOfRsuActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfSummaryOfRsuActivityAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Summary of RSU Activity [Abstract]" } } }, "auth_ref": [] }, "cslr_ScheduleOfSummaryOfStockOptionActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfSummaryOfStockOptionActivityAbstract", "lang": { "en-us": { "role": { "label": "Summary of Summary of Stock Option Activity [Abstract]" } } }, "auth_ref": [] }, "cslr_ScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethodAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Based On ABlack Scholes Option Pricing Method Abstract" } } }, "auth_ref": [] }, "cslr_SecondSAFEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SecondSAFEMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Second SAFE {Member]", "label": "Second SAFEMember" } } }, "auth_ref": [] }, "cslr_SecondTrancheSeriesD7PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SecondTrancheSeriesD7PreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Second Tranche Series D-7 preferred stock [Member]", "label": "Second Tranche Series D7 Preferred Stock Member" } } }, "auth_ref": [] }, "cslr_SecuredCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SecuredCreditFacilityMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Credit Facility [Member]", "label": "Secured Credit Facility Member" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r728" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r732" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r731" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r737" ] }, "us-gaap_SegmentDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDiscontinuedOperationsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOperationsandComprehensiveIncomeRelatedtoDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations [Member]", "label": "Discontinued Operations [Member]", "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale." } } }, "auth_ref": [ "r6", "r57", "r58", "r59" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r280", "r282", "r674", "r675", "r678" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series B Preferred Stock [Member]", "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r868", "r869", "r921" ] }, "cslr_SeriesBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesBWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series B Warrants [Member]", "label": "Series BWarrants Member" } } }, "auth_ref": [] }, "cslr_SeriesC1WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesC1WarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series C-1 Warrants [Member]", "label": "Series C1 Warrants Member" } } }, "auth_ref": [] }, "us-gaap_SeriesCPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesCPreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series C Preferred Stock [Member]", "label": "Series C Preferred Stock [Member]", "documentation": "Series C preferred stock." } } }, "auth_ref": [ "r868", "r869", "r921" ] }, "cslr_SeriesCWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesCWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series C Warrants [Member]", "label": "Series CWarrants Member" } } }, "auth_ref": [] }, "cslr_SeriesD7PreferredStockConvertedIntoWarrantsToPurchaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesD7PreferredStockConvertedIntoWarrantsToPurchaseMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series D-7 Preferred Stock Converted into Warrants to Purchase [Member]", "label": "Series D7 Preferred Stock Converted Into Warrants To Purchase Member" } } }, "auth_ref": [] }, "cslr_SeriesD7PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesD7PreferredStockMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series D-7 Preferred Stock [Member]", "label": "Series D7 Preferred Stock Member" } } }, "auth_ref": [] }, "cslr_SeriesD7WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SeriesD7WarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series D-7 Warrants [Member]", "label": "Series D7 Warrants Member" } } }, "auth_ref": [] }, "cslr_ServiceBasedOptioMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "ServiceBasedOptioMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "service-based options [Member]", "label": "Service Based Optio Member" } } }, "auth_ref": [] }, "cslr_SettlementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SettlementAgreementMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement Agreement [Member]", "label": "Settlement Agreement Member" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs, Cancelled or forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r382" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value, Cancelled or forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r382" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of RSUs, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r380" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair valuem, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r380" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of RSUs, Unvested, Beginning balance", "periodEndLabel": "Number of RSUs, Unvested , Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r377", "r378" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average grant date fair value, Unvested, Beginning balance", "periodEndLabel": "Weighted average grant date fair value, Unvested, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r377", "r378" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs, Vested and released", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r381" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value, Vested and released", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r381" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield (in Dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments", "documentation": "The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends." } } }, "auth_ref": [ "r389" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value measurement input", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r389" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility", "verboseLabel": "Expected volatility, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r388" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "verboseLabel": "Risk free interest rate, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r390" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of shares, Options canceled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares, Options granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of shares, outstanding,", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r369", "r370" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price per share, outstanding,", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r369", "r370" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value , Vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r386" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares, Vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r386" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price per Share, Vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r386" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per share, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails", "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per share, Options exercised", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per share, Options canceled", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per share, Options granted", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of share exercisable", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Axis]", "documentation": "Information by supplier." } } }, "auth_ref": [] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Domain]", "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price per share (in Dollars per share)", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r387" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term (Years), outstanding,", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r119" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term (Years), Vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r386" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term (Years), Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r385" ] }, "cslr_SharesFromTheMergersAndPIPEFinancing": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SharesFromTheMergersAndPIPEFinancing", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable": { "parentTag": "cslr_SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total shares from the Mergers and PIPE Financing", "documentation": "The number of total shares from the mergers and PIPE financing.", "label": "Shares From The Mergers And PIPEFinancing" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssued", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ForwardPurchaseAgreementsDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued", "verboseLabel": "Issuance of shares (in Shares)", "netLabel": "Share issued (in Shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r12" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock price (in Dollars per share)", "verboseLabel": "Price per share (in Dollars per share)", "label": "Shares Issued, Price Per Share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "cslr_SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SharesOfCompleteSolariaCommonStockImmediatelyAfterMergers", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "totalLabel": "Shares of Complete Solaria Common stock immediately after Mergers", "documentation": "Shares of complete solaria common stock immediately after mergers.", "label": "Shares Of Complete Solaria Common Stock Immediately After Mergers" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in Shares)", "periodEndLabel": "Balance (in Shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermBorrowings", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Short term debt", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r69", "r128", "r707", "r976" ] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r70", "r903", "r904", "r905" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r69", "r903", "r904", "r905" ] }, "us-gaap_ShorttermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShorttermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of short term debt", "label": "Short-Term Debt, Fair Value", "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date." } } }, "auth_ref": [ "r955" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r108", "r218" ] }, "cslr_SimulationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SimulationPeriod", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Simulation period", "label": "Simulation Period" } } }, "auth_ref": [] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPropertyandEquipmentNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Developed software [Member]", "label": "Software Development [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "cslr_SoftwareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SoftwareServicesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Software enhanced services [Member]", "label": "Software Services Member" } } }, "auth_ref": [] }, "cslr_SolarEnergySystemInstallationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SolarEnergySystemInstallationsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofRevenueRecognizedByProductandServicesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Solar energy system installations [Member]", "label": "Solar Energy System Installations Member" } } }, "auth_ref": [] }, "cslr_SolarParkKoreaCoLTDMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SolarParkKoreaCoLTDMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SolarPark Korea Co., LTD [Member]", "label": "Solar Park Korea Co LTDMember" } } }, "auth_ref": [] }, "cslr_SolariaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SolariaMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Solaria [Member]", "label": "Solaria Member" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r735" ] }, "cslr_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SponsorMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor [Member]", "documentation": "Sponsor [Member].", "label": "Sponsor Member" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ReverseRecapitalizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r162", "r193", "r194", "r195", "r219", "r248", "r249", "r251", "r253", "r261", "r262", "r290", "r320", "r322", "r323", "r324", "r327", "r328", "r346", "r347", "r348", "r349", "r351", "r457", "r561", "r562", "r563", "r564", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r593", "r616", "r639", "r653", "r654", "r655", "r656", "r657", "r848", "r879", "r888" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/CommonStockDetails", "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r81", "r85", "r86", "r180", "r206", "r207", "r208", "r223", "r224", "r225", "r229", "r237", "r240", "r242", "r260", "r291", "r296", "r300", "r353", "r404", "r405", "r410", "r411", "r412", "r416", "r417", "r418", "r424", "r425", "r426", "r427", "r428", "r430", "r433", "r460", "r461", "r462", "r463", "r464", "r466", "r471", "r473", "r482", "r527", "r545", "r546", "r547", "r569", "r639" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r223", "r224", "r225", "r260", "r473", "r503", "r560", "r581", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r596", "r597", "r598", "r599", "r600", "r603", "r604", "r605", "r606", "r608", "r609", "r610", "r611", "r612", "r614", "r618", "r619", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r639", "r719" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementScenarioAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofActivitybyPeriodRelatingtotheCompanysWarrantyProvisionTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofExpectedVolatilityisDeterminedBasedontheHistoricalEquityVolatilityTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofOtherExpenseNetTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReconcilesCashCashEquivalentsandRestrictedCashTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r177", "r243", "r363", "r849", "r854", "r886" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r223", "r224", "r225", "r260", "r285", "r473", "r503", "r560", "r581", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r596", "r597", "r598", "r599", "r600", "r603", "r604", "r605", "r606", "r608", "r609", "r610", "r611", "r612", "r614", "r618", "r619", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r639", "r719" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r747", "r758", "r774", "r809" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "cslr_StockBasedCompensationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockBasedCompensationDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Line Items]" } } }, "auth_ref": [] }, "cslr_StockBasedCompensationDetailsScheduleofSummaryofRSUActivityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockBasedCompensationDetailsScheduleofSummaryofRSUActivityLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity [Line Items]" } } }, "auth_ref": [] }, "cslr_StockBasedCompensationDetailsScheduleofSummaryofRSUActivityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockBasedCompensationDetailsScheduleofSummaryofRSUActivityTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofRSUActivityTable" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) - Schedule of Summary of RSU Activity [Table]" } } }, "auth_ref": [] }, "cslr_StockBasedCompensationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockBasedCompensationDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofStockBasedCompensationExpenseandStatementsofOperationsandComprehensiveIncomeLossTable" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement [Member]", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r890" ] }, "cslr_StockIssuedDuringEmployeeStockPurchasePlan": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockIssuedDuringEmployeeStockPurchasePlan", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable": { "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan", "label": "Stock Issued During Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharebasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharebasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Stock-Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible shares (in Shares)", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r12", "r40", "r81", "r85", "r116", "r339" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued", "verboseLabel": "Issuance shares", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r80", "r81", "r116", "r561", "r639", "r654" ] }, "cslr_StockIssuedDuringPeriodSharesRetroactiveApplicationOfRecapitalization": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockIssuedDuringPeriodSharesRetroactiveApplicationOfRecapitalization", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Retroactive application of recapitalization (in Shares)", "documentation": "Number of shares are retroactive application of recapitalization.", "label": "Stock Issued During Period Shares Retroactive Application Of Recapitalization" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofSummaryofStockOptionActivityTable", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of common stock options (in Shares)", "negatedLabel": "Number of shares, Options exercised", "verboseLabel": "Shares exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r12", "r80", "r81", "r116", "r374" ] }, "cslr_StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockIssuedDuringPeriodValueRetroactiveApplicationOfRecapitalization", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Retroactive application of recapitalization", "documentation": "Amount of retroactive application of recapitalization.", "label": "Stock Issued During Period Value Retroactive Application Of Recapitalization" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r44", "r80", "r81", "r116" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of common stock options", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r12", "r81", "r85", "r86", "r116" ] }, "cslr_StockOptionsAndRSUsIssuedAndOutstandingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockOptionsAndRSUsIssuedAndOutstandingMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofPotentialCommonSharesExcludedfromDilutedNetLossPerShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options and RSUs Issued and Outstanding [Member]", "label": "Stock Options And RSUs Issued And Outstanding Member" } } }, "auth_ref": [] }, "cslr_StockOptionsAndRestrictedStockUnitsAuthorizedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockOptionsAndRestrictedStockUnitsAuthorizedForFutureIssuance", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable": { "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options and RSUs, authorized for future issuance", "label": "Stock Options And Restricted Stock Units Authorized For Future Issuance" } } }, "auth_ref": [] }, "cslr_StockOptionsAndRestrictedStockUnitsIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockOptionsAndRestrictedStockUnitsIssuedAndOutstanding", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable": { "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofReservedSharesofCommonStockTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options and RSUs, issued and outstanding", "documentation": "Stock options and RSUs, issued and outstanding.", "label": "Stock Options And Restricted Stock Units Issued And Outstanding" } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase shares (in Shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r12", "r80", "r81", "r116", "r564", "r639", "r656" ] }, "cslr_StockholdersDeficitEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "StockholdersDeficitEquityAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 (deficit) equity:", "label": "Stockholders Deficit Equity Abstract" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 (deficit) equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r81", "r85", "r86", "r110", "r595", "r613", "r640", "r641", "r707", "r725", "r881", "r900", "r961", "r1018" ] }, "us-gaap_SubadvisoryFeesForMutualFunds": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubadvisoryFeesForMutualFunds", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advisory fee", "label": "Subadvisory Fees for Mutual Funds", "documentation": "Subadvisory fees that the funds adviser pays for out of the management fee, which it receives from the fund." } } }, "auth_ref": [ "r135" ] }, "us-gaap_SubordinatedBorrowingInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubordinatedBorrowingInterestRate", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Borrow, percentage", "label": "Subordinated Borrowing, Interest Rate", "documentation": "Stated interest rate of the subordinated debt." } } }, "auth_ref": [] }, "us-gaap_SubordinatedBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubordinatedBorrowingsAbstract", "lang": { "en-us": { "role": { "label": "Borrowings and SAFE Agreements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubordinatedBorrowingsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubordinatedBorrowingsDisclosureTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreements" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings and SAFE Agreements", "label": "Subordinated Borrowings Disclosure [Text Block]", "documentation": "The entire disclosure for borrowings under subordinated debt agreements that qualify as available in computing net capital under SEC's uniform net capital rule, including restrictive covenants, collateral, interest rates and due dates, amounts due by date and amount owed in total." } } }, "auth_ref": [ "r141" ] }, "cslr_SubscriptionAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SubscriptionAgreementsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription Agreements [Member]", "label": "Subscription Agreements Member" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r467", "r495" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r467", "r495" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r467", "r495" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "cslr_SubsequentEventsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SubsequentEventsDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "auth_ref": [] }, "cslr_SubsequentEventsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SubsequentEventsDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r494", "r496" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "cslr_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r802" ] }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TemporaryEquityAccretionToRedemptionValue", "crdr": "credit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption amount", "label": "Temporary Equity, Accretion to Redemption Value", "documentation": "Value of accretion of temporary equity to its redemption value during the period." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityShareSubscriptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TemporaryEquityShareSubscriptions", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofCommonStockOutstandingTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Redemption of FACT Class A Ordinary Shares", "label": "Temporary Equity, Share Subscriptions", "documentation": "The number of securities classified as temporary equity that have been allocated to investors to buy. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r79" ] }, "us-gaap_TimeDepositsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TimeDepositsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value", "label": "Time Deposits, at Carrying Value", "documentation": "Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [ "r864" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]", "documentation": "Information by title and position of individual or group within organization." } } }, "auth_ref": [ "r897", "r964" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Domain]", "documentation": "Title and position of individual or group within organization." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r794" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r801" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r822" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r824" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r825" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r826" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r826" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r824" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r824" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r827" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r825" ] }, "cslr_TwoThousandNineteenAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "TwoThousandNineteenAConvertibleNotesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Two Thousand Nineteen A Convertible Notes [Member]", "label": "Two Thousand Nineteen AConvertible Notes Member" } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "TwoThousandTwentyAConvertibleNotesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Convertible Notes [Member]", "verboseLabel": "2020-A Convertible Notes [Member]", "label": "Two Thousand Twenty AConvertible Notes Member" } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyThreeEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Two Thousand Twenty Three Equity Incentive Plan [Member]", "label": "Two Thousand Twenty Three Equity Incentive Plan Member" } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyTwoConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "TwoThousandTwentyTwoConvertibleNotesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Convertible Notes [Member]", "label": "Two Thousand Twenty Two Convertible Notes Member" } } }, "auth_ref": [] }, "cslr_TwoZeroOneEightBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "TwoZeroOneEightBridgeNotesMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Bridge Notes [Member]", "label": "Two Zero One Eight Bridge Notes Member" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r419" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r821" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r33", "r34", "r35", "r152", "r153", "r156", "r157" ] }, "us-gaap_UtilitiesOperatingExpenseDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UtilitiesOperatingExpenseDepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization expense", "label": "Utilities Operating Expense, Depreciation and Amortization", "documentation": "Amount of operating expense for depreciation and amortization of regulated operation." } } }, "auth_ref": [ "r93" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r790" ] }, "cslr_WarrantConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantConsiderationMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Consideration [Member]", "label": "Warrant Consideration Member" } } }, "auth_ref": [] }, "us-gaap_WarrantExercisePriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantExercisePriceIncrease", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share", "label": "Warrant, Exercise Price, Increase", "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r352" ] }, "cslr_WarrantExpiredTerm": { "xbrltype": "dateItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantExpiredTerm", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant expired term", "documentation": "Warrant expired term.", "label": "Warrant Expired Term" } } }, "auth_ref": [] }, "cslr_WarrantLiabilitiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantLiabilitiesPolicyTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Liabilities", "documentation": "The disclosure of accounting policies for warrant liabilities.", "label": "Warrant Liabilities Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofWarrantsBasedonaBlackScholesOptionPricingMethodTable", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants [Member]", "verboseLabel": "Warrants", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r716", "r717", "r720", "r721", "r722", "r723" ] }, "cslr_WarrantToPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantToPurchaseShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/BorrowingsandSAFEAgreementsDetailsPart1" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant to purchase shares (in Shares)", "documentation": "Warrant to purchase shares.", "label": "Warrant To Purchase Shares" } } }, "auth_ref": [] }, "cslr_WarrantVestingAgreementExercisableShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantVestingAgreementExercisableShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant vesting agreement exercisable shares.", "documentation": "Warrant vesting agreement exercisable shares.", "label": "Warrant Vesting Agreement Exercisable Shares" } } }, "auth_ref": [] }, "cslr_WarrantVestingShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantVestingShares", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant vesting shares", "documentation": "Warrant vesting shares.", "label": "Warrant Vesting Shares" } } }, "auth_ref": [] }, "cslr_WarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "calculation": { "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet", "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant liability", "verboseLabel": "Warrant liability (in Dollars)", "label": "Warrants and Rights Outstanding", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [ "r957", "r958", "r959" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant term", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r957", "r958", "r959" ] }, "cslr_WarrantsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantsDetailsLineItems", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [Line Items]" } } }, "auth_ref": [] }, "cslr_WarrantsDetailsScheduleofLiabilityClassifiedWarrantsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantsDetailsScheduleofLiabilityClassifiedWarrantsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable" ], "lang": { "en-us": { "role": { "label": "Warrants (Details) - Schedule of Liability-Classified Warrants [Table]" } } }, "auth_ref": [] }, "cslr_WarrantsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantsDetailsTable", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants (Details) [Table]" } } }, "auth_ref": [] }, "cslr_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WarrantsTextBlock", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/Warrants" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "documentation": "The entire disclosure on information about warrants.", "label": "Warrants Text Block" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in Shares)", "verboseLabel": "Diluted weighted average shares outstanding (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r247", "r253" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofBasicandDilutedNetLossPerShareAttributabletoCommonStockholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares used to compute net loss per share attributable to common stockholders\u2019, basic (in Shares)", "verboseLabel": "Weighted average common shares outstanding, basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r246", "r253" ] }, "cslr_WorkingCapitalWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WorkingCapitalWarrants", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital warrants", "documentation": "Working capital warrants.", "label": "Working Capital Warrants" } } }, "auth_ref": [] }, "cslr_WorkingCapitalWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.FreedomAcquisitionICorp.com/20240331", "localname": "WorkingCapitalWarrantsMember", "presentation": [ "http://www.FreedomAcquisitionICorp.com/role/ScheduleofAssetsthatareMeasuredatFairValueonaRecurringBasisTable", "http://www.FreedomAcquisitionICorp.com/role/ScheduleofLiabilityClassifiedWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital warrants [Member]", "verboseLabel": "Working capital warrents [Member]", "label": "Working Capital Warrants Member" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r838" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r788" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "10", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480679/815-10-10-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "20", "Section": "10", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480769/815-20-10-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1C" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(c)", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479836/810-10-S99-5" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478878/942-470-45-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "980", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477711/980-340-25-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Footnote": "4", "Publisher": "SEC" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "M", "Paragraph": "Question 2", "Publisher": "SEC" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(d)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-6A" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-5" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-21" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-79" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "Global LEI Foundation" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form F-3" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-3" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-4" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form S-3" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Investment Company Act", "Number": "270" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-X", "Number": "210", "Section": "2", "Subsection": "2" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "413", "Subsection": "b" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "b" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "c" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "d" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "e" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "a" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "b" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Section": "8", "Subsection": "c" }, "r847": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-3" }, "r848": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r849": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r850": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11" }, "r854": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "11", "Subsection": "03", "Publisher": "SEC" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-16" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481598/310-20-45-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" } } } ZIP 100 0001213900-24-043520-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-043520-xbrl.zip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�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end XML 102 ea0205629-10q_complete_htm.xml IDEA: XBRL DOCUMENT 0001838987 2024-01-01 2024-03-31 0001838987 cslr:CommonStockParValue00001PerShareMember 2024-01-01 2024-03-31 0001838987 cslr:RedeemableWarrantsEachWholeWarrantExercisableForOneCommonStockMember 2024-01-01 2024-03-31 0001838987 2024-05-13 0001838987 2024-03-31 0001838987 2023-12-31 0001838987 2023-01-01 2023-04-02 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001838987 us-gaap:CommonStockMember 2023-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001838987 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2024-01-01 2024-03-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001838987 us-gaap:CommonStockMember 2024-03-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2024-03-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-01-01 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-01-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-01-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-01-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-01-01 0001838987 2023-01-01 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0001838987 cslr:AdjustedMember 2023-01-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-04-02 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-04-02 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-04-02 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-02 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-04-02 0001838987 us-gaap:CommonStockMember 2023-04-02 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-04-02 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0001838987 2023-04-02 0001838987 cslr:SolariaMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001838987 cslr:SolariaMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEInvestorsMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEFinancingMember 2024-01-01 2024-03-31 0001838987 cslr:SubscriptionAgreementsMember 2024-01-01 2024-03-31 0001838987 cslr:PIPEFinancingMember 2024-03-31 0001838987 cslr:NewMoneyPIPEInvestorsMember 2024-01-01 2024-03-31 0001838987 cslr:NewMoneyPIPESubscriptionAgreementMember 2024-01-01 2024-03-31 0001838987 cslr:SolariaMember us-gaap:CommonStockMember 2024-03-31 0001838987 2023-03-31 0001838987 us-gaap:CommonClassAMember 2023-03-31 0001838987 cslr:FACTInvestorsMember us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 2023-03-31 2023-03-31 0001838987 cslr:SolariaMember us-gaap:CommonClassAMember 2023-03-31 2023-03-31 0001838987 cslr:SolariaMember us-gaap:CommonClassBMember 2023-03-31 2023-03-31 0001838987 cslr:DisposalAgreementMember 2023-10-31 2023-10-31 0001838987 cslr:MaxeonMember us-gaap:CommonStockMember 2023-10-31 0001838987 cslr:DisposalAgreementMember 2023-01-01 2023-12-31 0001838987 cslr:LiquidityAndGoingConcernMember 2024-01-01 2024-03-31 0001838987 cslr:LiquidityAndGoingConcernMember 2023-04-02 2023-04-02 0001838987 cslr:LiquidityAndGoingConcernMember 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001838987 cslr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-12-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 cslr:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 cslr:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-08 2023-04-02 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:OneSupplierMember 2023-01-08 2023-04-02 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:OneSupplierMember 2023-01-01 2023-12-31 0001838987 2023-04-01 2024-03-31 0001838987 2022-04-01 2023-04-02 0001838987 cslr:SolarEnergySystemInstallationsMember 2024-01-01 2024-03-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-04-02 2023-04-02 0001838987 cslr:SoftwareServicesMember 2024-01-01 2024-03-31 0001838987 cslr:SoftwareServicesMember 2023-04-02 2023-04-02 0001838987 2023-04-02 2023-04-02 0001838987 us-gaap:FairValueInputsLevel1Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:CarlyleWarrantsMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PublicWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ReplacementWarrantsMember 2024-03-31 0001838987 cslr:ReplacementWarrantsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 cslr:ForwardPurchaseAgreementLiabilitiesMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:SAFEAgreementsMember 2024-03-31 0001838987 cslr:SAFEAgreementsMember 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:CarlyleWarrantsMember 2023-12-31 0001838987 cslr:CarlyleWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PublicWarrantsMember 2023-12-31 0001838987 cslr:PublicWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ReplacementWarrantsMember 2023-12-31 0001838987 cslr:ReplacementWarrantsMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementLiabilitiesMember 2023-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember cslr:MeasurementInputVolatilityMember 2024-01-01 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember cslr:MeasurementInputVolatilityMember 2023-01-01 2023-12-31 0001838987 2023-01-01 2023-12-31 0001838987 2023-01-01 2023-07-31 0001838987 cslr:LegacyCompleteSolariaMember us-gaap:CommonClassAMember 2024-03-31 0001838987 srt:MaximumMember 2024-03-31 0001838987 srt:MinimumMember 2024-03-31 0001838987 us-gaap:CommonClassAMember 2023-12-31 0001838987 us-gaap:CommonClassBMember 2023-12-31 0001838987 cslr:SponsorMember 2023-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-01-01 2023-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-01-01 2023-12-31 0001838987 cslr:FPASMember 2024-01-01 2024-03-31 0001838987 cslr:FPASMember 2024-03-31 0001838987 cslr:CompleteSolariaCommonStockMember 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2023-12-31 0001838987 cslr:FPASMember 2023-12-18 2023-12-18 0001838987 2023-12-18 2023-12-18 0001838987 2023-12-18 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-04-02 0001838987 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001838987 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001838987 cslr:ManufacturingEquipmentMember 2024-03-31 0001838987 cslr:ManufacturingEquipmentMember 2023-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001838987 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001838987 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001838987 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-04-02 0001838987 us-gaap:PreferredStockMember 2023-12-31 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001838987 cslr:CarlyleWarrantsMember 2022-02-28 0001838987 cslr:BlackScholesModelMember 2024-01-01 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-31 0001838987 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001838987 cslr:CompleteSolariaMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember cslr:BlackScholesModelMember 2024-01-01 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember 2022-11-30 0001838987 cslr:SeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:SeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:SeriesD7WarrantsMember 2024-03-31 0001838987 cslr:SecondTrancheSeriesD7PreferredStockMember 2024-03-31 0001838987 cslr:MergerTransactionMember 2024-03-31 0001838987 cslr:SeriesD7WarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2023-07-18 2023-07-18 0001838987 cslr:CommonStockForTheFirstTrancheMember 2023-07-18 0001838987 cslr:CommonStockForTheSecondTrancheMember 2023-07-18 0001838987 cslr:SeriesD7PreferredStockConvertedIntoWarrantsToPurchaseMember 2023-10-31 0001838987 cslr:ReplacementWarrantsMember 2023-10-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:WarrantMember cslr:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001838987 us-gaap:SeriesBPreferredStockMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember us-gaap:CommonClassAMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesBWarrantsMember 2022-12-01 2022-12-31 0001838987 cslr:SeriesCWarrantsMember 2016-07-30 0001838987 us-gaap:SeriesCPreferredStockMember 2016-07-30 0001838987 cslr:SeriesCWarrantsMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 2020-01-31 0001838987 cslr:SeriesCWarrantsMember 2020-01-31 2020-01-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-05-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-08-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-08-31 2021-08-31 0001838987 cslr:SVBCommonStockWarrantsMember 2021-05-31 2021-05-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 2021-10-31 0001838987 cslr:November2022CommonStockWarrantsMember 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-31 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-01 2023-05-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:ClassACommonStockEqualsOrExceedsThresholdTwoMember us-gaap:PrivatePlacementMember 2023-07-31 0001838987 cslr:WarrantConsiderationMember 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2024-03-31 0001838987 cslr:CarlyleWarrantsMember 2023-12-31 0001838987 cslr:ReplacementsWarrantsMember 2024-03-31 0001838987 cslr:ReplacementsWarrantsMember 2023-12-31 0001838987 cslr:PublicWarrantsMember 2024-03-31 0001838987 cslr:PublicWarrantsMember 2023-12-31 0001838987 cslr:PrivatePlacementWarrantsMember 2024-03-31 0001838987 cslr:PrivatePlacementWarrantsMember 2023-12-31 0001838987 cslr:WorkingCapitalWarrantsMember 2024-03-31 0001838987 cslr:WorkingCapitalWarrantsMember 2023-12-31 0001838987 cslr:ConvertibleSecuredNoteMember cslr:TwoZeroOneEightBridgeNotesMember 2018-12-31 0001838987 cslr:ConvertibleNotesEmbeddedDerivativeLiabilityMember 2022-01-01 2022-12-31 0001838987 cslr:ConvertibleSecuredNoteMember 2018-12-31 0001838987 srt:MinimumMember 2018-12-31 2022-12-31 0001838987 srt:MaximumMember 2018-12-31 2022-12-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-01-01 2023-12-31 0001838987 cslr:RevolvingLoanMember 2023-01-01 2023-12-31 0001838987 cslr:RevolvingLoanMember 2024-01-01 2024-03-31 0001838987 cslr:RevolvingLoanMember 2024-03-31 0001838987 cslr:RevolvingLoanMember 2023-04-02 2023-04-02 0001838987 cslr:RodgersMasseyMember 2023-10-31 2023-10-31 0001838987 2022-01-01 2022-12-31 0001838987 2023-09-30 2023-09-30 0001838987 cslr:DebtInCSSolisMember 2024-01-01 2024-03-31 0001838987 2023-10-01 2023-10-01 0001838987 cslr:CSSoilsMember 2024-03-31 0001838987 cslr:CSSoilsMember 2023-04-02 0001838987 us-gaap:InterestExpenseMember 2023-04-02 2023-04-02 0001838987 cslr:PromissoryNoteMember cslr:CurrentInsightPromissoryNoteMember 2024-01-31 2024-01-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2024-01-31 2024-01-31 0001838987 2024-01-31 2024-01-31 0001838987 us-gaap:InterestExpenseMember 2024-01-31 2024-01-31 0001838987 cslr:CSSoilsMember 2024-01-31 2024-01-31 0001838987 cslr:SAFEPriceMember 2024-01-31 0001838987 2024-02-15 2024-02-15 0001838987 cslr:ConvertibleNoteMember cslr:TwoThousandNineteenAConvertibleNotesMember 2024-02-15 2024-02-15 0001838987 cslr:CSSoilsMember 2024-02-15 2024-02-15 0001838987 cslr:SecondSAFEMember 2024-02-15 0001838987 cslr:SecondSAFEMember 2024-02-15 2024-02-15 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2024-03-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-12-31 0001838987 cslr:RevolverLoanMember 2024-03-31 0001838987 cslr:RevolverLoanMember 2023-12-31 0001838987 cslr:SecuredCreditFacilityMember 2024-03-31 0001838987 cslr:SecuredCreditFacilityMember 2023-12-31 0001838987 cslr:PolarSettlementAgreementMember 2024-03-31 0001838987 cslr:PolarSettlementAgreementMember 2023-12-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-07-31 0001838987 cslr:ISOsUnderThe2023PlanMember 2023-07-31 2023-07-31 0001838987 cslr:ServiceBasedOptioMember 2024-03-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001838987 cslr:ServiceBasedOptioMember 2024-01-01 2024-03-31 0001838987 2023-12-31 2023-12-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-04-02 0001838987 us-gaap:StockCompensationPlanMember 2024-01-01 2024-03-31 0001838987 us-gaap:StockCompensationPlanMember 2023-01-01 2023-04-02 0001838987 cslr:SolarParkKoreaCoLTDMember 2023-01-31 2023-01-31 0001838987 2023-02-28 2023-02-28 0001838987 2023-03-16 2023-03-16 0001838987 2021-07-22 0001838987 2024-02-01 2024-02-22 0001838987 2023-08-24 2023-08-24 0001838987 cslr:ChinaBridgeMember 2023-08-24 2023-08-24 0001838987 cslr:CommonStockWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:CommonStockWarrantsMember 2023-01-01 2023-12-31 0001838987 cslr:PreferredStockWarrantsMember 2024-01-01 2024-03-31 0001838987 cslr:PreferredStockWarrantsMember 2023-01-01 2023-12-31 0001838987 cslr:StockOptionsAndRSUsIssuedAndOutstandingMember 2024-01-01 2024-03-31 0001838987 cslr:StockOptionsAndRSUsIssuedAndOutstandingMember 2023-01-01 2023-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember cslr:ConvertiblePromissoryNotesMember 2022-10-01 2023-06-30 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-10-01 2023-06-30 0001838987 2022-10-01 2023-06-30 0001838987 srt:MaximumMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001838987 srt:MinimumMember us-gaap:RelatedPartyMember 2023-04-02 2023-04-02 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 2020-01-01 2020-12-31 0001838987 us-gaap:RelatedPartyMember cslr:ConvertiblePromissoryNotesMember 2023-07-31 0001838987 cslr:FPAMember 2023-01-01 2023-12-31 0001838987 us-gaap:RelatedPartyMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001838987 2022-03-01 2022-03-31 0001838987 2022-03-31 0001838987 cslr:SettlementAgreementMember 2023-01-01 2023-12-31 0001838987 us-gaap:SubsequentEventMember 2024-04-19 2024-04-19 0001838987 cslr:FirstSAFEMember us-gaap:SubsequentEventMember 2024-04-19 0001838987 cslr:FirstSAFEMember 2024-01-01 2024-03-31 0001838987 cslr:SecondSAFEMember 2024-01-01 2024-03-31 0001838987 us-gaap:SubsequentEventMember 2024-04-16 2024-04-16 0001838987 2024-04-19 2024-04-19 0001838987 srt:ScenarioForecastMember 2024-05-01 0001838987 srt:ScenarioForecastMember 2024-05-01 2024-05-01 0001838987 2024-05-01 2024-05-01 0001838987 srt:ScenarioForecastMember cslr:KlineHillMember 2024-04-19 0001838987 cslr:KlineHillMember 2024-04-19 shares iso4217:USD iso4217:USD shares pure 10-Q true 2024-03-31 2024 false 001-40117 COMPLETE SOLARIA, INC. DE 93-2279786 45700 Northport Loop East Fremont CA 94538 (510) 270-2507 Common stock, par value $0.0001 per share CSLR NASDAQ Redeemable warrants, each whole warrant exercisable for one common stock CSLRW NASDAQ Yes Yes Non-accelerated Filer true true false false 49096537 1786000 2593000 20939000 26281000 2773000 3058000 5776000 5817000 31274000 37749000 3829000 3823000 4495000 4317000 1054000 1235000 198000 198000 40850000 47322000 10521000 13122000 24893000 27870000 29365000 28657000 2010000 2423000 35840000 33280000 5000000 9409000 3831000 117038000 109183000 3416000 3416000 3877000 9817000 1055000 1055000 543000 664000 125929000 124135000 0.0001 0.0001 1000000000 1000000000 49096537 49096537 49065361 49065361 7000 7000 279332000 98000 143000 -364516000 -354928000 -85079000 -76813000 40850000 47322000 10040000 16677000 7757000 13827000 2283000 2850000 3116000 5677000 1618000 683000 5093000 8913000 9827000 15273000 -7544000 -12423000 3568000 3611000 6000 8000 1519000 317000 -2043000 -3286000 -9587000 -15709000 1000 -9588000 -15709000 -7805000 -7805000 -9588000 -23514000 -45000 1000 -9633000 -23513000 -0.2 -0.62 -0.31 -0.2 -0.93 49077330 25200347 49065361 7000 277965000 -354928000 143000 -76813000 31176 26000 26000 1341000 1341000 -9588000 -9588000 -45000 -45000 49096537 7000 279332000 -364516000 98000 -85079000 34311133 155630000 6959618 34997000 -85373000 27000 -50349000 -34311133 -155630000 12972811 3000 155627000 155630000 19932429 3000 190624000 -85373000 27000 -105281000 137452 55000 55000 1022000 1022000 1000 1000 -23514000 -23514000 20069881 3000 191701000 -108887000 28000 82845000 -9588000 -23514000 -7805000 -9588000 -15709000 1341000 270000 1008000 1248000 181000 248000 357000 189000 62000 2117000 -344000 791000 5578000 -7246000 -209000 2560000 752000 -5280000 3197000 -629000 570000 -41000 1857000 848000 -2599000 2132000 -1613000 -581000 -180000 -86000 100000 -413000 -906000 -4946000 -16116000 -162000 -4946000 -16278000 30000 536000 457000 1000 -536000 -486000 14102000 300000 9603000 11000000 26000 55000 5000000 4726000 15554000 -45000 1000 -801000 -1209000 6416000 8316000 5615000 7107000 1608000 <table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td><td>Organization</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>(a) Description of Business</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”).</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. were transferred to Complete Solar Holdings at their carrying value, and there were no changes to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT effected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the closing of the Mergers:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Each share of the Company’s capital stock, inclusive of shares converted from the 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2022, Complete Solar Holdings acquired Solaria and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. Refer to Note 1(b) – Divestiture and Note 7 – Divestiture.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>(b) Divestiture</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. As of December 31, 2023, the Company sold all its Maxeon shares and recorded a loss of $4.2 million in its unaudited condensed consolidated statements of operations and comprehensive loss within loss from continuing operations.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This divestiture represented a strategic shift in Complete Solaria’s business and qualified as held for sale and as a discontinued operation. Based on the held for sale classification of the assets, the Company reduced the carrying value of the disposal group to its fair value, less its cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive loss for all periods presented. The cash flows related to discontinued operations were segregated from continuing operations within the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 7 – Divestiture for additional information.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>(c) Liquidity and Going Concern</i></b></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $9.6 million and $23.5 million, during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, and had an accumulated deficit of $364.5 million and current debt of $65.2 million as of March 31, 2024. The Company had cash and cash equivalents of $1.8 million as of March 31, 2024. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management plans to obtain additional funding and restructure its current debt. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.</p> 25494332 6300000 1161512 420000 1570000 10 15700000 3500000 60000 120000 5 600000 60000 193976 150000 23256504 34500000 11243496 7784739 82200000 1 1 11000000 1100000 4200000 9600000 23500000 364500000 65.2 1800000 <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in">(2)</td><td>Summary of Significant Accounting Policies</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(a)</i></b></td><td><b><i>Basis of Presentation</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the Unites States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(b)</i></b></td><td><b><i>Use of Estimates</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The allocation of the transaction price to identified performance obligations;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Fair value of warrant liabilities;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for inventory obsolescence;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for product warranty;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for the allowance for credit losses;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The fair value of the forward purchase agreements; and</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The measurement of stock-based compensation.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(c)</i></b></td><td><b><i>Segment Information</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated Company. All the Company’s long-lived assets are maintained in the United States of America.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(d)</i></b></td><td><b><i>Concentration of Risks </i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of March 31, 2024, two customers had an outstanding balance that represented 36% and 19% of the total accounts receivable balance. As of December 31, 2023, two customers had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of customers</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">For the thirteen-weeks ended March 31, 2024, one customer represented 76% of gross revenues. For the thirteen-weeks ended and April 2, 2023, three customers represented 29%, 23% and 12% of gross revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of suppliers</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the thirteen-weeks ended March 31, 2024, and December 31, 2023, one supplier represented 34% and 40% of the Company’s inventory purchases, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(e)</i></b></td><td><b><i>Cash and Cash Equivalents</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(f)</i></b></td><td><b><i>Restricted Cash</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. The restricted cash balance was $3.8 million at each of March 31, 2024 and December 31, 2023. Restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in its unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,786</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,593</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,829</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,823</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total cash, cash equivalents and restricted cash</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,615</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,416</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(g)</i></b></td><td><b><i>Revenue Recognition </i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><b><i>Disaggregation of revenue</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Thirteen-weeks Ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">March 31,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">April 2,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Solar energy system installations</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">9,922</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">15,843</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Software enhanced services</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">118</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">834</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total revenue</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,040</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">16,677</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Remaining performance obligations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of March 31, 2024, the Company has deferred $1.1 million associated with a long-term service contract. As of December 31, 2023, the Company has deferred $1.2 million associated with a long-term service contract, which will be recognized evenly through 2028.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Incremental costs of obtaining customer contracts</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. As of March 31, 2024 and December 31, 2023, deferred commissions were $5.1 million and $4.2 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Deferred revenue</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within 12-months, the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirteen-week periods ended March 31, 2024 and April 2, 2023 that was included in deferred revenue at the beginning of each period was $1.3 million and $1.9 million, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(h)</i></b></td><td><b><i>Fair Value Measurements</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities, SAFE Agreements and FPA liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><b><i>(i)</i></b></td><td style="text-align: justify"><b><i>Direct Offering Costs</i></b></td></tr></table> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional paid-in capital and netted against the Mergers proceeds received upon close. As of March 31, 2024 and December 31, 2023, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(j)</i></b></td><td><b>Warrant Liabilities</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company accounts for its warrant liabilities in accordance with the guidance in ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 12 – Warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(k)</i></b></td><td><b><i>Forward Purchase Agreements</i></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company accounts for its FPAs in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(l)</i></b></td><td><b>Net Loss Per Share</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company computes net loss per share following ASC 260, Earnings Per Share. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><b><i>(m)</i></b></td><td style="text-align: justify"><b><i>Accounting Pronouncements Not Yet Adopted</i></b></td></tr></table> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the FASB issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. The Company is currently evaluating ASU 2023-07,but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. The Company is currently evaluating ASU 2023-09 but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(a)</i></b></td><td><b><i>Basis of Presentation</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the Unites States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all normal and recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(b)</i></b></td><td><b><i>Use of Estimates</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The allocation of the transaction price to identified performance obligations;</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Fair value of warrant liabilities;</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for inventory obsolescence;</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for product warranty;</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The reserve methodology for the allowance for credit losses;</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The fair value of the forward purchase agreements; and</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The measurement of stock-based compensation.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and management is not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(c)</i></b></td><td><b><i>Segment Information</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated Company. All the Company’s long-lived assets are maintained in the United States of America.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(d)</i></b></td><td><b><i>Concentration of Risks </i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits from time to time. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for credit losses. As of March 31, 2024, two customers had an outstanding balance that represented 36% and 19% of the total accounts receivable balance. As of December 31, 2023, two customers had an outstanding balance that represented 38% and 16% of the total accounts receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of customers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">For the thirteen-weeks ended March 31, 2024, one customer represented 76% of gross revenues. For the thirteen-weeks ended and April 2, 2023, three customers represented 29%, 23% and 12% of gross revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of suppliers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the thirteen-weeks ended March 31, 2024, and December 31, 2023, one supplier represented 34% and 40% of the Company’s inventory purchases, respectively.</p> 0.36 0.19 0.38 0.16 0.76 0.29 0.23 0.12 0.34 0.40 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(e)</i></b></td><td><b><i>Cash and Cash Equivalents</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(f)</i></b></td><td><b><i>Restricted Cash</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. The restricted cash balance was $3.8 million at each of March 31, 2024 and December 31, 2023. Restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in its unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,786</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,593</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,829</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,823</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total cash, cash equivalents and restricted cash</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,615</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,416</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 3800000 3800000 The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,786</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,593</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,829</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,823</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total cash, cash equivalents and restricted cash</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,615</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,416</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 1786000 2593000 3829000 3823000 5615000 6416000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(g)</i></b></td><td><b><i>Revenue Recognition </i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><b><i>Disaggregation of revenue</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Thirteen-weeks Ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">March 31,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">April 2,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Solar energy system installations</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">9,922</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">15,843</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Software enhanced services</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">118</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">834</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total revenue</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,040</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">16,677</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was in the United States.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Remaining performance obligations</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of March 31, 2024, the Company has deferred $1.1 million associated with a long-term service contract. As of December 31, 2023, the Company has deferred $1.2 million associated with a long-term service contract, which will be recognized evenly through 2028.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Incremental costs of obtaining customer contracts</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. As of March 31, 2024 and December 31, 2023, deferred commissions were $5.1 million and $4.2 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Deferred revenue</i></b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within 12-months, the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirteen-week periods ended March 31, 2024 and April 2, 2023 that was included in deferred revenue at the beginning of each period was $1.3 million and $1.9 million, respectively.</p> Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Thirteen-weeks Ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">March 31,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">April 2,</td><td style="text-align: center; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 10pt"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Solar energy system installations</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">9,922</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">15,843</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Software enhanced services</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">118</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">834</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total revenue</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,040</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">16,677</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table> 9922000 15843000 118000 834000 10040000 16677000 1100000 1200000 5100000 4200000 1300000 1900000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(h)</i></b></td><td><b><i>Fair Value Measurements</i></b></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities, SAFE Agreements and FPA liabilities.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><b><i>(i)</i></b></td><td style="text-align: justify"><b><i>Direct Offering Costs</i></b></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional paid-in capital and netted against the Mergers proceeds received upon close. As of March 31, 2024 and December 31, 2023, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.</p> 5700000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(j)</i></b></td><td><b>Warrant Liabilities</b></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company accounts for its warrant liabilities in accordance with the guidance in ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 12 – Warrants.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(k)</i></b></td><td><b><i>Forward Purchase Agreements</i></b></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company accounts for its FPAs in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, Fair Value Measurement, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><b><i>(l)</i></b></td><td><b>Net Loss Per Share</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company computes net loss per share following ASC 260, Earnings Per Share. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><b><i>(m)</i></b></td><td style="text-align: justify"><b><i>Accounting Pronouncements Not Yet Adopted</i></b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the FASB issued ASU No. 2023-07 “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. The Company is currently evaluating ASU 2023-07,but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements. </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. The Company is currently evaluating ASU 2023-09 but expects the impact of the disclosures to be immaterial to the Company’s unaudited condensed consolidated financial statements.</p> <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in">(3)</td><td>Fair Value Measurements</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlyle warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private placement warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working capital warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Replacement warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward purchase agreement liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE Agreements</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">354</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,291</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Financial Liabilities</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left">Carlyle warrants</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">—</div></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">—</div></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,515</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,515</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Public warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Private placement warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Replacement warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">–</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">–</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forward purchase agreement liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,831</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,831</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">136</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,656</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,959</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Carlyle Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC and its affiliates (“Carlyle”), the Company issued Carlyle a warrant to purchase shares of Complete Solaria Common Stock at a price per share of $0.01. Refer to Note 12 – Warrants for further details. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.0 years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.0 years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">77.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">77.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Public, Private Placement and Working Capital Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly-traded instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Forward Purchase Agreement Liabilities</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 1pt 0pt 0">The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock trading price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.66</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Simulation period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30 years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.55 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.90</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95.0</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Replacement Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.8 years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.3 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 76%; text-align: left">Expected volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">78.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">78.5</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.49</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify">The Series D-7 redeemable convertible preferred stock warrants were initially accounted for as liabilities and measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 12 – Warrants, the redeemable convertible preferred stock warrants were reclassified to additional paid-in capital upon the closing of the Mergers. In October 2023, in connection with the Assignment and Acceptance Agreement as further described in Note 12 – Warrants, these warrants were replaced (“Replacement Warrants”), and the Replacement Warrants are classified as liabilities. Refer to Note 13 – Borrowings and SAFE Agreements.</p> The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlyle warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private placement warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working capital warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Replacement warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward purchase agreement liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE Agreements</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">354</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,291</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Financial Liabilities</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left">Carlyle warrants</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">—</div></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">—</div></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,515</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,515</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Public warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Private placement warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">122</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Replacement warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">–</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">–</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forward purchase agreement liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,831</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,831</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">167</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">136</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,656</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">14,959</td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 3086000 3086000 437000 437000 318000 318000 36000 36000 5000 5000 9409000 9409000 5000000 5000000 437000 354000 17500000 18291000 9515000 9515000 167000 167000 122000 122000 14000 14000 1310000 1310000 3831000 3831000 167000 136000 14656000 14959000 0.01 The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.0 years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.0 years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">77.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">77.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.8 years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.3 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 76%; text-align: left">Expected volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">78.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">78.5</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.49</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> </table> P7Y P7Y P7Y P7Y 0.77 0.77 0.77 0.77 0.0392 0.0392 0.0392 0.0392 0 0 0 0 The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock trading price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.66</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Simulation period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30 years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.55 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.90</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95.0</td><td style="text-align: left">%</td></tr> </table> 0.59 1.66 P1Y3M18D P1Y6M18D 0.049 0.0448 1.12 0.95 P0Y9M18D P0Y9M18D P0Y3M18D P0Y3M18D 0.785 0.785 0.785 0.785 0.0549 0.0549 0.054 0.054 0 0 0 0 The Series D-7 redeemable convertible preferred stock warrants were initially accounted for as liabilities and measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 12 – Warrants, the redeemable convertible preferred stock warrants were reclassified to additional paid-in capital upon the closing of the Mergers. In October 2023, in connection with the Assignment and Acceptance Agreement as further described in Note 12 – Warrants, these warrants were replaced (“Replacement Warrants”), and the Replacement Warrants are classified as liabilities. Refer to Note 13 – Borrowings and SAFE Agreements. <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in">(4)</td><td>Reverse Recapitalization</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria was determined to be the accounting acquirer based on an evaluation of the following facts and circumstances:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post- merged company;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Legacy Complete Solaria’s management team is considered the management team of the post-merged company;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Legacy Complete Solaria’s prior operations are comprised of the ongoing operations of the post-merged company;</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">Complete Solaria is the larger entity based on historical revenues and business operations; and</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">the post-merged company has assumed Complete Solaria’s operating name.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The unaudited condensed consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million less non-cash net liabilities assumed from FACT of $10.1 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recapitalization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">FACT Class A Ordinary Shares, outstanding prior to Mergers</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">34,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">FACT Class B Ordinary Shares, outstanding prior to Mergers</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,625,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to sponsor</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">193,976</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to PIPE investors</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to FPA investors</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issued from PIPE financing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,690,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issued from FPA agreements, net of recycled shares</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,558,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: redemption of FACT Class A Ordinary Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(31,041,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total shares from the Mergers and PIPE Financing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,796,221</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Legacy Complete Solaria shares</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,034,257</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">2022 Convertible Note Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,460,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Shares of Complete Solaria Common stock immediately after Mergers</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,290,553</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. The Company did not make any cash payments to settle transaction costs in the thirteen-weeks ended March 31, 2024. As of December 31, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.</p> 19700000 10100000 45290553 45290553 The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recapitalization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">FACT Class A Ordinary Shares, outstanding prior to Mergers</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">34,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">FACT Class B Ordinary Shares, outstanding prior to Mergers</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,625,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to sponsor</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">193,976</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to PIPE investors</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Bonus shares issued to FPA investors</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issued from PIPE financing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,690,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issued from FPA agreements, net of recycled shares</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,558,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: redemption of FACT Class A Ordinary Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(31,041,243</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total shares from the Mergers and PIPE Financing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,796,221</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Legacy Complete Solaria shares</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,034,257</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">2022 Convertible Note Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,460,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Shares of Complete Solaria Common stock immediately after Mergers</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,290,553</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 34500000 8625000 193976 120000 150000 1690000 5558488 31041243 19796221 20034257 5460075 45290553 15800000 15800000 5200000 10600000 5400000 <table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in">(5)</td><td>Forward Purchase Agreements</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The key terms of the forward contracts are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">●</td><td style="text-align: justify">The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the Seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to the Counterparty at the Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading day-period (the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815, <i>Derivatives and Hedging</i>, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in accordance with ASC 480, <i>Distinguishing Liabilities from Equity</i>, the Company has determined that the forward contracts are financial instruments other than shares that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the forward purchase liabilities at fair value and has subsequently remeasured them at fair value with changes in fair value recognized in earnings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock in association with the FPAs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss. Subsequently, the change of fair value of the forward purchase liabilities amounted to an expense of $5.6 million for the thirteen-weeks ended March 31, 2024. As of March 31, 2024, and December 31, 2023, the forward purchase liabilities amounted to $9.4 million and $3.8 million, respectively. Of the balances as of March 31, 2024 and December 31, 2023, $7.9 million and $3.2 million, respectively, are due to related parties Refer to Note 19 – Related Party Transactions for further details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 18, 2023, the Company and the FPA Sellers entered into separate amendments to the FPAs (the “Amendments”). The Amendments lower the reset floor price of each FPA from $5.00 to $3.00 and allow the Company to raise up to $10.0 million of equity from existing stockholders without triggering certain anti-dilution provisions contained in the FPAs; provided, the insiders pay a price per share for their initial investment equal to the closing price per share as quoted on the Nasdaq on the day of purchase; provided, further, that any subsequent investments are made at a price per share equal to the greater of (a) the closing price per share as quoted by Nasdaq on the day of the purchase or (b) the amount paid in connection with the initial investment.</p> 0.0001 6720000 0.099 10.56 5 2 6300000 35500000 6720000 100000 5600000 9400000 3800000 7900000 3200000 5 3 10000000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(6)</b></td><td style="text-align: justify"><b>Prepaid Expenses and Other Current Assets</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expenses and other current assets consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Deferred commissions</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">5,098</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">4,185</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">678</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,016</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,776</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,817</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Prepaid expenses and other current assets consist of the following (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Deferred commissions</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">5,098</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">4,185</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">678</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,016</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,776</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,817</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5098000 4185000 616000 678000 1016000 5776000 5817000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(7)</b></td><td style="text-align: justify"><b>Divestiture </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Discontinued operations</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement Disposal Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive loss related to discontinued operations are presented in the table, as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-Weeks</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ended April 2,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">18,721</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Cost of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,479</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross loss</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(758</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sales and marketing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,866</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,185</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,051</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,809</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from discontinued operations before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,809</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax benefit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Net loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,805</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> The components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive loss related to discontinued operations are presented in the table, as follows (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-Weeks</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ended April 2,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">18,721</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Cost of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,479</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross loss</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(758</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sales and marketing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,866</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,185</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,051</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,809</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">—</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from discontinued operations before income taxes</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,809</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax benefit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Net loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,805</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 18721000 19479000 -758000 2866000 4185000 7051000 -7809000 -7809000 -4000 -7805000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(8)</b></td><td><b>Property and Equipment, Net</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment, net consists of the following (in thousands, except year data):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Estimated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">   </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Useful Lives<br/> (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 65%; text-align: left">Developed software</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">5</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">7,529</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">6,993</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Manufacturing equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Leasehold improvements</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">5</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">708</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">708</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,464</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: center">         </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,969</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,611</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total property and equipment, net</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: center"> </td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,495</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation and amortization expense from continuing operations totaled $0.4 million and $0.2 million for the thirteen-week periods ended March 31, 2024 and April 2, 2023.</p> Property and equipment, net consists of the following (in thousands, except year data):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Estimated</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">   </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Useful Lives<br/> (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 65%; text-align: left">Developed software</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">5</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">7,529</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">6,993</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Manufacturing equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Furniture and equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Leasehold improvements</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">5</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">708</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">708</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,464</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: center">         </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,969</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,611</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total property and equipment, net</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: center"> </td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,495</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,317</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P5Y 7529000 6993000 P3Y 131000 131000 P3Y 90000 96000 P5Y 708000 708000 8464000 7928000 3969000 3611000 4495000 4317000 400000 200000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(9)</b></td><td><b>Accrued Expenses and Other Current Liabilities</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses and other current liabilities consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Accrued compensation and benefits</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3,715</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3,969</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">296</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">544</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Uninvoiced contract costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">671</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued term loan and revolving loan amendment and final payment fees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal settlements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued taxes</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">930</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">931</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued rebates and credits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">677</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease liabilities, current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">607</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued warranty, current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,449</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,433</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,743</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,938</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total accrued expenses and other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">24,893</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">27,870</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Accrued expenses and other current liabilities consist of the following (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Accrued compensation and benefits</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3,715</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3,969</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer deposits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">296</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">544</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Uninvoiced contract costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">671</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued term loan and revolving loan amendment and final payment fees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal settlements</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued taxes</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">930</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">931</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued rebates and credits</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">677</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease liabilities, current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">548</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">607</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued warranty, current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,449</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,433</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,743</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,938</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total accrued expenses and other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">24,893</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">27,870</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3715000 3969000 296000 544000 80000 671000 2400000 2400000 7700000 7700000 930000 931000 32000 677000 548000 607000 1449000 1433000 7743000 8938000 24893000 27870000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(10)</b></td><td><b>Other Expense, Net </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other expense, net consists of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Thirteen-Weeks<br/> Ended</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">April 2,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Change in fair value of redeemable convertible preferred stock warrant liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">209</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in fair value of Carlyle warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of FACT public, private placement and working capital warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(489</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in fair value of forward purchase agreement liabilities(1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,578</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Loss on discontinued Solaria business and other, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(148</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total other income (expense), net</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,519</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">317</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 16.6pt">(1)</td><td style="text-align: justify">Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.</td></tr></table> Other expense, net consists of the following (in thousands):<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Thirteen-Weeks<br/> Ended</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">March 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">April 2,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Change in fair value of redeemable convertible preferred stock warrant liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,305</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">209</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in fair value of Carlyle warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of FACT public, private placement and working capital warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(489</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in fair value of forward purchase agreement liabilities(1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,578</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Loss on discontinued Solaria business and other, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(148</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total other income (expense), net</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,519</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">317</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 16.6pt">(1)</td><td style="text-align: justify">Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.</td></tr></table> -1305000 -209000 6429000 489000 5578000 -148000 108000 1519000 317000 4700000 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(11)</b></td><td><b>Common Stock</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of March 31, 2024. <span style="-sec-ix-hidden: hidden-fact-98">No</span> preferred stock has been issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Common Stock Purchase Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On December 18, 2023, the Company entered into separate common stock purchase agreements (the “Purchase Agreements”) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a “Purchaser”, and together, the “Purchasers”). Pursuant to the terms of the Purchase Agreements, each Purchaser purchased 1,838,235 shares of common stock of the Company, par value $0.0001, (the “Shares”), at a price per share of $1.36, representing an aggregate purchase price of $4,999,999.20. The Purchasers paid for the Shares in cash. Thurman J. Rodgers is a trustee of each Purchaser and is the Executive Chairman of the board of directors of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has reserved shares of common stock for issuance related to the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of <br/> March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">Common stock warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">27,637,266</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Employee stock purchase plan</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,628,996</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options and RSUs, issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,436,369</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Stock options and RSUs, authorized for future issuance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,850,462</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total shares reserved</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,553,093</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000000000 10000000 1838235 0.0001 1.36 4999999.2 The Company has reserved shares of common stock for issuance related to the following:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of <br/> March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">Common stock warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">27,637,266</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Employee stock purchase plan</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,628,996</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options and RSUs, issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,436,369</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Stock options and RSUs, authorized for future issuance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,850,462</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total shares reserved</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,553,093</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 27637266 2628996 11436369 3850462 45553093 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(12)</b></td><td><b>Warrants</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Liability-classified warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlyle warrants</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,515</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Replacement warrants</p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public warrants</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private placements warrants</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working capital warrants</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double">$</td> <td style="border-bottom: Black 4pt double; text-align: right">3,882</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double">$</td> <td style="border-bottom: Black 4pt double; text-align: right">11,127</td> <td style="padding-bottom: 4pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Carlyle Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2022, as part of a debt financing from Carlyle (Refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with long-term debt issued to Carlyle (“CS Solis Debt”). The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, expired on December 31, 2022 prior to becoming exercisable. In December 2023, Carlyle was issued an additional warrant to purchase an additional 2,190,604 shares of the Company’s common stock related to an anti-dilution provision within the CS Solis Debt that provides for such additional warrants under such circumstances as provided within the CS Solis Debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and <span style="-sec-ix-hidden: hidden-fact-99">no</span> dividend yield. The fair value of the warrant was initially recorded within additional paid-in capital as it met the conditions for equity classification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The modification of the warrant resulted in the reclassification of previously equity-classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718, <i>Compensation – Stock Compensation</i>. The Company recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the pre-modification fair value of the warrants as a reduction to additional paid-in capital of $10.9 million and an expense of $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be $20.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and <span style="-sec-ix-hidden: hidden-fact-100">no</span> dividend yield. As of March 31, 2024, the fair value of the warrant was $3.1 million, and the Company recorded an income of $6.4 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series D-7 Warrants (Converted to common stock warrants “Replacement Warrants”)</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2022, the Company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series D-7 warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), (Refer to Note 13 – Borrowings and SAFE Agreements). In connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series D-7 warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series D-7 preferred stock converted into warrants to purchase 656,630 shares of common stock, the Replacement Warrants. As a result of the warrant amendment, the Company reclassified the Replacement Warrants from equity to liability. The Replacement Warrants were remeasured to their fair value on the amendment effective date, and the Company has recorded subsequent changes in fair value in other income (expense), net on its unaudited condensed consolidated statements of operations and comprehensive loss. The Replacement Warrants remain outstanding as of March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Public, Private Placement, and Working Capital Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, the Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the Company’s unaudited condensed consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.7 million. The fair value of these warrants was $0.8 million as of March 31, 2024, and the Company recorded the change in fair value of $0.5 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of March 31, 2024, the Working Capital warrants had a fair value of $0.03 million, and the Company recorded the change in fair value of $0.02 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Classified Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series B Warrants (Converted to Common Stock Warrants) </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other non-current liabilities upon issuance. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. Prior to its reclassification from equity to a liability during 2023, the changes in fair value were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series C Warrants (Converted to Common Stock Warrants)</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability and changes in the fair value of the warrant were recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended April 2, 2023. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, upon the warrant becoming exercisable into shares of Complete Solaria Common Stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series C-1 Warrants (Converted to Common Stock Warrants)</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series C-1 preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and <span style="-sec-ix-hidden: hidden-fact-101">no</span> dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>SVB Common Stock Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of March 31, 2024. At issuance, the relative fair value of the warrants was determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and <span style="-sec-ix-hidden: hidden-fact-102"><span style="-sec-ix-hidden: hidden-fact-103">no</span></span> dividend yield. The fair value of the warrant was recorded within additional paid-in-capital on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Promissory Note Common Stock Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of March 31, 2024. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and <span style="-sec-ix-hidden: hidden-fact-104">no</span> dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>November 2022 Common Stock Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying (i) the shares of common stock to be purchased to 31,680, (ii) the exercise price to $0.01, and (iii) the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and <span style="-sec-ix-hidden: hidden-fact-105">no</span> dividend yield. The fair value of the warrant was recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>July 2023 Common Stock Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of the Company’s common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded within additional paid-in capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Warrant Consideration</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional paid-in capital, net of the issuance costs of the Mergers. As of March 31, 2024, all warrants issued as warrant consideration remain outstanding.</p> <i>Liability-classified warrants</i><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlyle warrants</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,086</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,515</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Replacement warrants</p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public warrants</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private placements warrants</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working capital warrants</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double">$</td> <td style="border-bottom: Black 4pt double; text-align: right">3,882</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double">$</td> <td style="border-bottom: Black 4pt double; text-align: right">11,127</td> <td style="padding-bottom: 4pt"> </td></tr> </table> 3086000 9515000 5000 1310000 437000 167000 318000 122000 36000 13000 3882000 11127000 2886952 1995879 2190604 3400000 P7Y 0.73 0.019 1995879 1995879 2030-07-18 1995879 0.02795 350000 150000 250000 0.01 350000 P10D 150000 20400000 10900000 9500000 20400000 P7Y 0.77 0.039 3100000 6400000 656630 518752 2.5 2.04 137878 5 4.09 7.8 2400000 2.5 5 1376414 656630 6266667 11.5 8625000 11.5 6700000 800000 500000 716668 300000 20000.00 5054 4.3 100000 100000 148477 482969 1 2300000 173067 0.01 100000 P10Y 0.625 0.015 2473 2525 0.38 0.62 100000 100000 P12Y P12Y 0.73 0.73 0.017 0.013 24148 0.01 100000 P10Y 0.73 0.015 78962 8 31680 0.01 100000 P1Y6M 0.785 0.047 31680 38981 0.01 200000 0.01 6266572 11.5 P10Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(13)</b></td><td><b>Borrowings and SAFE Agreements</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s borrowings consisted of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">2018 Bridge Notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,376</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,031</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Revolver Loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,290</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,168</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Credit Facility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,699</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,158</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Polar Settlement Agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,365</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,657</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Debt in CS Solis</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,840</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,280</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable and convertible notes, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,205</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,937</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,205</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(61,937</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Notes payable and convertible notes, net of current portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Notes Payable</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>2018 Bridge Notes</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice the face value of the 2018 Notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria. The 2018 Notes are secured by substantially all of the assets of Complete Solaria.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023, and the 2018 Notes remain outstanding as of March 31, 2024. In connection with the amendment, the 2018 Notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company concluded that the amendment represented a troubled debt restructuring as the Company was experiencing financial difficulty, and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of March 31, 2024 and December 31, 2023, the carrying value of the 2018 Notes was $11.4 million and $11.0 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.3 million and $0.3 million, respectively. As of March 31, 2024, the carrying value of the 2018 Notes approximates their fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Revolver Loan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SCI Loan Agreement is comprised of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Loan has a term of thirty-six months, with the principal due at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement requires the Company to meet certain financial covenants relating to the maintenance of specified restricted cash balance, achieve specified revenue targets and maintain specified contribution margins (“Financial Covenants”) over the term of the Revolving Loan. The Revolving Loan is collateralized by substantially all assets and property of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements with SCI to forbear SCI from exercising any rights and remedies available to it as a result of the Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendments changes were made to the Financial Covenants, and Solaria recorded a total of $1.9 million in amendment fees which amount was recorded in Other Liabilities, and this liability was included in the assumed liabilities for purchase price accounting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Solaria had historically issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria (“SCI Series E-1 warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series E-1 warrants were assumed by the parent company, Complete Solaria.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting. The Revolving Loan principal balance at March 31, 2024 and December 31, 2023 amounted to $5.3 million and $5.1 million, respectively. Interest expense recognized for the thirteen-week periods ended March 31, 2024 and April 2, 2023 was $0.1 million and $0.1 million, respectively. The Company was in compliance with all the Financial Covenants as of March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2023, the Company entered into an Assignment Agreement whereby Structural Capital Investments III, LP assigned the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, (collectively “Kline Hill”) and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this arrangement as a related party transaction, as discussed in Note 18 – Related Party Transactions. The SCI Revolving Loan continued to remain outstanding as of March 31, 2024 and is currently being renegotiated. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 1 - Subsequent Events for further details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Secured Credit Facility</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC (“Secured Credit Facility”). The Secured Credit Facility agreement allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as collateral. The amounts drawn under the Secured Credit Facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the Secured Credit Facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the Secured Credit Facility agreement was due to mature in April 2023. The Company is in the process of amending the Secured Credit Facility agreement to extend its maturity date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2024, the balance outstanding was $12.7 million, including accrued financing cost of $5.0 million, and as of December 31, 2023, the balance outstanding was $12.2 million, including accrued financing cost of $4.5 million. The Company recognized interest expense of $0.5 million and $1.7 million related to the Secured Credit Facility during the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively. As of March 31, 2024, the total estimated fair value of the Secured Credit Facility approximated its carrying value. On May 1, 2024, the Company entered into an agreement with Kline Hill that will cancel this obligation upon satisfaction of certain events. Refer to Note 19 - Subsequent Events for further details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Polar Settlement Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. The settlement agreement required the Company to pay Polar $0.5 million in ten equal monthly installments and did not accrue interest. As of December 31, 2023, the balance owed to Polar was $0.3 million all of which was paid in the period ended March 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Debt in CS Solis</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the Reorganization described in Note 1(a) Organization - Description of Business and Note 12 - Warrants, the Company received cash and recorded debt for an investment by Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment by Carlyle, the Company issued Carlyle a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, the purchase of 4,132,513 shares of the Company’s common stock is immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 11 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is now March 31, 2024 subsequent to the modification. The acceleration of the redemption date of the investment, resulted in the total redemption amount to be 1.3 times the principal at December 31, 2023. The redemption amount will increase to 1.4 times the original investment at March 31, 2024. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the Company’s unaudited condensed consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the modification of the debt due with CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million in the thirteen-week period ended October 1, 2023. As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt with CS Solis. As of March 31, 2024, the debt has a redemption obligation of $35.8 million under the Carlyle Debt Modification Agreement. The debt in CS Solis is currently under negotiation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has recorded a liability of $35.8 million and $33.3 million included in short-term debt with CS Solis on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recorded accretion of the liability as interest expense of $2.5 million and $0.8 million, respectively, and made no payments of interest expense. For the thirteen-week periods ended March 31, 2024 and April 2, 2023 the Company recorded amortization of issuance costs as interest expense of zero and $0.3 million, respectively. As of March 31, 2024, the total estimated fair value of the Company’s debt with CS Solis was $35.8 million, which was estimated based on Level 3 inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>SAFE Agreements </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>First SAFE</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On January 31, 2024, the Company entered into a simple agreement for future equity (the “First SAFE”) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the “Purchaser”), a related party, in connection with the Purchaser investing $1.5 million in the Company. The First SAFE does not accrued interest. The First SAFE was initially convertible into shares of the Company’s common stock, par value $0.0001 per share, upon the initial closing of a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company would have issued and sold shares of its common stock at a fixed valuation (an “Equity Financing”), at a per share conversion price which was equal to the lower of (i)(a) $53.54 million divided by (b) the Company’s capitalization immediately prior to such Equity Financing (such conversion price, the “SAFE Price”), and (ii) 80% of the price per share of its common stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the First SAFE, the Purchaser would have been automatically entitled to receive a portion of the proceeds of such liquidity event equal to the greater of (i) $1.5 million and (ii) the amount payable on the number of shares of common stock equal to (a) $1.5 million divided by (b)(1) $53.54 million divided by (2) the Company’s capitalization immediately prior to such liquidity event (the “Liquidity Price”), subject to certain adjustments as set forth in the First SAFE. The First SAFE was convertible into a maximum of 1,431,297 shares of the Company’s common stock, assuming a per share conversion price of $1.05, which is the product of (i) $1.31, the closing price per share of the Company’s common stock on January 31, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the First SAFE which resulted in the First SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Second SAFE </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On February 15, 2024, the Company entered into a simple agreement for future equity (the “Second SAFE” and together with the First SAFE, the “SAFEs”) with the Purchaser, a related party, in connection with the Purchaser investing $3.5 million in the Company. The First SAFE does not accrued interest. The Second SAFE was initially convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing at a per share conversion price which was equal to the lower of (i) the SAFE Price, and (ii) 80% of the price per share of Common Stock sold in the Equity Financing. If the Company consummated a change of control prior to the termination of the Second SAFE, the Purchaser would have been automatically entitled to receive an amount equal to the greater of (i) $3.5 million and (ii) the amount payable on the number of shares of Common Stock equal to $3.5 million divided by the Liquidity Price, subject to certain adjustments as set forth in the Second SAFE. The Second SAFE was convertible into a maximum of 3,707,627 shares of the Company’s common stock, assuming a per share conversion price of $0.94, which is the product of (i) $1.18, the closing per share price of its common stock on February 15, 2024, multiplied by (ii) 80%. On April 21, 2024, the Company entered into an amendment of the Second SAFE which resulted in the conversion of the Second SAFE into shares of the Company’s common stock. Refer to Note 19 – Subsequent Events for further details.</p> The Company’s borrowings consisted of the following (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">2018 Bridge Notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,376</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,031</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Revolver Loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,290</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,168</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Credit Facility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,699</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,158</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Polar Settlement Agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,365</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,657</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Debt in CS Solis</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,840</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,280</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable and convertible notes, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,205</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,937</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,205</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(61,937</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Notes payable and convertible notes, net of current portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 11376000 11031000 5290000 5168000 12699000 12158000 300000 29365000 28657000 35840000 33280000 65205000 61937000 65205000 61937000 0.08 0 0.08 1.10 1.20 11400000 11000000 300000 300000 5000000 2023-10-31 0.0775 0.045 1900000 5000000 5300000 5100000 100000 100000 5000000 0.70 10000000 20000000 12700000 5000000 12200000 4500000 500000 1700000 500000 300000 25600000 0.105 0.25 5978960 0.01 4132513 The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is now March 31, 2024 subsequent to the modification. The acceleration of the redemption date of the investment, resulted in the total redemption amount to be 1.3 times the principal at December 31, 2023. The redemption amount will increase to 1.4 times the original investment at March 31, 2024. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the Company’s unaudited condensed consolidated statements of operations and comprehensive loss. 10300000 28400000 35800000 35800000 33300000 2500000 800000 0 300000 35800000 1500000 0.80 1500000 1500000 53540000 1431297 1.05 1.31 3500000 0.80 3500000 3500000 3707627 0.94 1.18 0.80 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(14)</b></td><td><b>Stock-Based Compensation </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria common stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria common stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s common stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s board of directors prior to the date of the increase. The maximum number of shares of Complete Solaria common stock that may be issued on the exercise of incentive stock options (“ISOs”) under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Outstanding</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average<br/> Exercise Price per Share</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average<br/> Contractual Term (Years)</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Aggregate<br/> Intrinsic Value<br/> (in thousands)</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%">Outstanding—December 31, 2023</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">11,716,646</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3.48</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">8.53</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2,756</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options granted</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">––</div></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">––</div></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options exercised</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(31,176</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.83</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Options canceled</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(307,198</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2.86</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,378,272</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3.50</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">215</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Vested and expected to vest—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,378,272</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3.50</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">215</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Vested and exercisable—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,536,233</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4.38</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4.78</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">139</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of RSUs</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted <br/> Average <br/> Grant Date <br/> Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%">Unvested at December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">58,097</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2.07</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vested and released</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled or forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Unvested at March 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">58,097</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right">2.07</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Stock-based compensation expense</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-<br/> Weeks<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-<br/> Weeks<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 2,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%">Cost of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">27</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">11</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sales and marketing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">94</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,098</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">165</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Total stock-based compensation expense from continuing operations</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,341</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">270</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">As of March 31, 2024, there was a total of $18.8 million and <span style="-sec-ix-hidden: hidden-fact-117">zero</span> unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.16 years for service-based options.</p> 8763322 26289966 A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Outstanding</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/> Shares</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average<br/> Exercise Price per Share</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average<br/> Contractual Term (Years)</td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Aggregate<br/> Intrinsic Value<br/> (in thousands)</b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%">Outstanding—December 31, 2023</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">11,716,646</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">3.48</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">8.53</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2,756</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options granted</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">––</div></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">––</div></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options exercised</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(31,176</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.83</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Options canceled</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(307,198</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2.86</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,378,272</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3.50</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">215</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Vested and expected to vest—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,378,272</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3.50</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">215</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Vested and exercisable—March 31, 2024</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,536,233</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4.38</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4.78</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">139</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 11716646 3.48 P8Y6M10D 2756000 31176 0.83 307198 2.86 11378272 3.5 P8Y3M 215000 11378272 3.5 P8Y3M 215000 4536233 4.38 P4Y9M10D 139000 A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of RSUs</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted <br/> Average <br/> Grant Date <br/> Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%">Unvested at December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">58,097</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2.07</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vested and released</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled or forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">––</div></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Unvested at March 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">58,097</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: right">2.07</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 58097 2.07 58097 2.07 The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-<br/> Weeks<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Thirteen-<br/> Weeks<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,<br/> 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 2,<br/> 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%">Cost of revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">27</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">11</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sales and marketing</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">216</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">94</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,098</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">165</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Total stock-based compensation expense from continuing operations</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,341</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">270</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 27000 11000 216000 94000 1098000 165000 1341000 270000 18800000 P2Y1M28D <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(15) </b></td><td><b>Employee Stock Purchase Plan </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase shares of the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of March 31, 2024, 2,628,996 shares were reserved for future issuance under the ESPP Plan.</p> 0.85 2628996 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(16)</b></td><td><b>Commitments and Contingencies</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Warranty Provision</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company typically provides a 10-year warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a 30-year warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Activity by period relating to the Company’s warranty provision was as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen-<br/> Weeks<br/> Ended <br/> March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended <br/> December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warranty provision, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,981</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Accruals for new warranties issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,968</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Settlements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,100</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Warranty provision, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,864</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,849</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warranty provision, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Warranty provision, noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,416</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,416</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Indemnification Agreements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Legal Matters</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that may have a material adverse effect on its business, financial position, results of operations, or cash flows. The Company has recorded <span style="-sec-ix-hidden: hidden-fact-118">zero</span> and $7.9 million as a loss contingency in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively, primarily associated with the pending settlement of the following legal matters.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>SolarPark Litigation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the U.S. District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, the Company filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Siemens Litigation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On July 22, 2021, Siemens filed a lawsuit in which Siemens alleged that the Company breached express and implied warranties under a purchase order that Siemens placed with the Company for a solar module system. Siemens claimed damages of approximately $6.9 million, inclusive of amounts of the Company’s indemnity obligations to Siemens, plus legal fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 22, 2024, the Court issued an order against the Company which awarded Siemens approximately $6.9 million, inclusive of the Company’s indemnity obligations to Siemens, plus legal fees, the amount of which will be determined at a later hearing. On March 15, 2024, Siemens filed a motion seeking to recover $2.67 million for attorneys’ fees, expenses, and pre-judgment interest. The Court will conduct a hearing on Siemens’ motion in late May 2024. Pending entry of a final judgment by the Court, the Company intends to appeal such judgment. The Company has recorded $6.9 million as a legal loss related to this litigation, excluding the $2.67 million for attorneys’ fees, expenses, and pre-judgment interest, in accrued expenses and other current liabilities on its unaudited condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>China Bridge Litigation </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Letters of Credit</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of March 31, 2024. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.8 million as of March 31, 2024 and December 31, 2023, respectively.</p> Activity by period relating to the Company’s warranty provision was as follows (in thousands):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen-<br/> Weeks<br/> Ended <br/> March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended <br/> December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warranty provision, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,981</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Accruals for new warranties issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,968</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Settlements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,100</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Warranty provision, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,864</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,849</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warranty provision, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Warranty provision, noncurrent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,416</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,416</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 4849000 3981000 265000 2968000 250000 2100000 4864000 4849000 1448000 1433000 3416000 3416000 7900000 80000000 26400000 220000000 6900000 6900000 2670000 6900000 2670000 6000000 6000000 6000000 3500000 3800000 3800000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><b>(17)</b></td><td style="text-align: justify"><b>Basic and Diluted Net Loss Per Share </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company uses the two-class method to calculate net loss per share. <span style="-sec-ix-hidden: hidden-fact-130"><span style="-sec-ix-hidden: hidden-fact-131">No</span></span> dividends were declared or paid for the thirteen-week periods ended March 31, 2024 and April 2, 2023. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. The Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The unaudited basic and diluted shares and net loss per share for the thirteen-week period ended April 2, 2023 has been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen-week periods ended March 31, 2024 and April 2, 2023 (in thousands, except share and per share amounts):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen-<br/> Weeks<br/> Ended<br/> March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen- Weeks<br/> Ended<br/> April 2,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Numerator:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Net loss from continuing operations</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,588</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,709</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">––</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,805</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,588</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(23,514</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><div style="-sec-ix-hidden: hidden-fact-121; -sec-ix-hidden: hidden-fact-120">Weighted average common shares outstanding, basic and diluted</div></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,077,330</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,200,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Net loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-123; -sec-ix-hidden: hidden-fact-122">Continuing operations – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.62</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-126; -sec-ix-hidden: hidden-fact-125">Discontinued operations – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">––</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-128; -sec-ix-hidden: hidden-fact-127">Net loss per share – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The computation of basic and diluted net loss per share attributable to common stockholders is the same for the thirteen-week periods ended March 31, 2024 and April 2, 2023 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">April 2, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">23,024,556</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">89,313</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Preferred stock warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,386,879</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Stock options and RSUs issued and outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,436,369</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,714,894</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Potential common shares excluded from diluted net loss per share</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">34,460,924</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,191,086</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen-week periods ended March 31, 2024 and April 2, 2023 (in thousands, except share and per share amounts):<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen-<br/> Weeks<br/> Ended<br/> March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Thirteen- Weeks<br/> Ended<br/> April 2,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Numerator:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Net loss from continuing operations</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,588</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,709</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">––</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,805</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,588</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(23,514</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><div style="-sec-ix-hidden: hidden-fact-121; -sec-ix-hidden: hidden-fact-120">Weighted average common shares outstanding, basic and diluted</div></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,077,330</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,200,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Net loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-123; -sec-ix-hidden: hidden-fact-122">Continuing operations – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.62</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-126; -sec-ix-hidden: hidden-fact-125">Discontinued operations – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">––</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-128; -sec-ix-hidden: hidden-fact-127">Net loss per share – basic and diluted</div></td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.93</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -9588000 -15709000 -7805000 -9588000 -23514000 49077330 25200347 -0.2 -0.62 -0.31 -0.2 -0.93 The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">April 2, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">23,024,556</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">89,313</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Preferred stock warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,386,879</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Stock options and RSUs issued and outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,436,369</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,714,894</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Potential common shares excluded from diluted net loss per share</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">34,460,924</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">12,191,086</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 23024556 89313 2386879 11436369 9714894 34460924 12191086 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><b>(18)</b></td><td><b>Related Party Transactions </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen-week periods ended March 31, 2024 and April 2, 2023, the Company has recognized zero and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp. In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million. In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. Refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization for further discussion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for the fiscal year ended December 31, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of March 31, 2024, the Company has recognized a liability associated with the FPAs of $7.9 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $4.7 million in its unaudited condensed consolidated statements of operations and comprehensive loss for the thirteen-weeks ended March 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. The Company paid $0.2 million in 2023 and the remaining balance of $0.3 million was paid in the thirteen-week period ended March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The SAFEs, as described in Note 13 – Borrowing Arrangements, entered into in January 2024 and February 2024 were with the Rodgers Massey Freedom and Free Markets Charitable Trust, a related party. The Company received proceeds from the SAFEs totaling $5.0 million in exchange for debt that was subsequently converted into shares of the Company’s common stock as discussed in Note 19 – Subsequent Events.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">There were no other material related party transactions during the thirteen-week periods ended March 31, 2024 and April 2, 2023.</p> 33300000 12100000 6700000 0.05 0 400000 3500000 12100000 120000 30700000 5670000 300000 7900000 4700000 500000 200000 300000 5000000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><b>(19)</b></td><td style="text-align: justify"><b>Subsequent Events</b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Amendment to SAFEs Agreements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">As described in Note 13 – Borrowing Arrangements, the Company’s SAFEs were convertible into shares of the Company’s common stock upon the initial closing of an Equity Financing. On April 21, 2024, the Company entered into an amendment for each of its First SAFE and Second SAFE to convert the invested amounts into shares of the Company’s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The conversion share price was $0.36, calculated as the product of (i) $0.45, the closing price of the Common Stock on April 19, 2024, multiplied by (ii) 80%. The First SAFE and Second SAFE converted into 4,166,667 and 9,722,222 shares of the Company’s common stock, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Bid Price Requirement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On April 16, 2024, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Notice does not impact the listing of the Company’s common stock on The Nasdaq Global Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days before October 14, 2024. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period by effecting a reverse stock split if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company intends to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the minimum bid price requirement.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendments to Forward Purchase Agreements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 7 and 8, 2024, respectively, the Company entered into separate amendments to the Forward Purchase Agreements (the collectively the “Second Amendments”) with Sandia (the “Sandia Second Amendment”) and Polar (the “Polar Second Amendment”). The Second Amendments lower the reset price of each Forward Purchase Agreement from $3.00 to $1.00 per share and amend the VWAP Trigger Event provision to read as “After December 31, 2024, an event that occurs if the VWAP Price, for any 20 trading days during a 30 consecutive trading day-period, is below $1.00 per Share.”. The Sandia Second Amendment is not effective until the Company executes similar amendments with both Polar and Meteora.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Minimum Market Value of Listed Securities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 16, 2024, the Company received a letter (the “Letter”) from the staff at Nasdaq notifying the Company that, for the 30 consecutive trading days prior to the date of the Letter, the Company’s common stock had traded at a value below the minimum $50,000,000 “Market Value of Listed Securities” (“MVLS”) requirement set forth in Nasdaq Listing Rule 5450(b)(2)(A), which is required for continued listing of the Company’s common stock on The Nasdaq Global Market. The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until October 14, 2024, to regain compliance. The Letter notes that to regain compliance, the Company’s common stock must trade at or above a level such that the Company’s MVLS closes at or above $50,000,000 for a minimum of ten consecutive business days during the compliance period, which ends October 14, 2024. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Capital Market (provided that the Company then satisfies the requirements for continued listing on that market).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">If the Company does not regain compliance by October 14, 2024, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company intends to actively monitor the Company’s MVLS between now and October 14, 2024, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Entry into a Definitive Agreement to Cancel Debt in Exchange for Equity and Other Consideration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On May 1, 2024, the Company entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) with Kline Hill providing for (a) the cancellation of all indebtedness owed to Kline Hill by the Company, termination of all debt instruments by and between the Company and Kline Hill, and the satisfaction of all obligations owed to Kline Hill by the Company under the terminated debt instruments, (b) the issuance of 9,800,000 shares of the Company’s common stock to Kline Hill, (c) the issuance of warrants (the “Kline Hill Warrants” and the shares issuable therefrom, the “Warrant Shares”) to Kline Hill to purchase up to 3,700,000 shares of the Company’s common stock, with an exercise price per share of $0.62 (the closing price per share of the Company’s common stock as reported on the Nasdaq Capital Market of the date of the Agreement), and (d) a one-time $3,750,000 cash payment to Kline Hill upon the earlier of (i) the Company achieving $100,000,000 of trailing twelve month revenue, or (ii) the Company achieving $10,000,000 of trailing twelve month EBITDA. The Kline Hill Warrants will be sold to Kline Hill at a price of $0.125 per Warrant Share. The closing of the foregoing transactions will occur when the following conditions are met: Carlyle executes an agreement to cancel all debt owed to Carlyle by the Company, and all debt owed to Carlyle and its affiliates by the Company is no longer outstanding.</p> 0.36 0.45 0.80 4166667 9722222 1 1 1 50000000 50000000 9800000 3700000 0.62 3750000 100000000 10000000 0.125 false false false false 277965000 -0.20 -0.62 -0.31 -0.20 -0.93 25200347 49077330 25200347 49077330 -0.20 -0.62 -0.31 -0.20 -0.93 false --12-31 Q1 0001838987 Includes $4.7 million and zero of other expense for the thirteen-weeks ended March 31, 2024 and April 2, 2023, respectively, for forward purchase agreements entered into with related parties.

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